Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Melanoma in situ,A1BG,Alpha-1B-glycoprotein,21249,41,1.96 [0.34-11.23],0.450957007827886
Chapter II Neoplasms,Melanoma in situ,AAMDC,Mth938 domain-containing protein,20637,41,1.43 [0.83-2.45],0.196470066077579
Chapter II Neoplasms,Melanoma in situ,AARSD1,Alanyl-tRNA editing protein Aarsd1,24350,50,0.91 [0.57-1.43],0.6667066912274823
Chapter II Neoplasms,Melanoma in situ,ABCA2,ATP-binding cassette sub-family A member 2,20559,37,0.94 [0.39-2.28],0.8888083351524787
Chapter II Neoplasms,Melanoma in situ,ABHD14B,Protein ABHD14B,24226,49,1.11 [0.72-1.72],0.6227128391137493
Chapter II Neoplasms,Melanoma in situ,ABL1,Tyrosine-protein kinase ABL1,24350,50,1.15 [0.81-1.64],0.4385871937755792
Chapter II Neoplasms,Melanoma in situ,ABO,Histo-blood group ABO system transferase,21229,41,0.96 [0.78-1.18],0.7208529430310855
Chapter II Neoplasms,Melanoma in situ,ABRAXAS2,BRISC complex subunit Abraxas 2,20559,37,1.13 [0.71-1.80],0.5920819939572356
Chapter II Neoplasms,Melanoma in situ,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23885,50,1.18 [0.88-1.57],0.2637909792781319
Chapter II Neoplasms,Melanoma in situ,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",20824,40,1.17 [0.83-1.66],0.3665218626920744
Chapter II Neoplasms,Melanoma in situ,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",21225,41,1.31 [0.98-1.76],0.0698567951062205
Chapter II Neoplasms,Melanoma in situ,ACAN,Aggrecan core protein,24254,50,0.64 [0.26-1.56],0.3233335658525849
Chapter II Neoplasms,Melanoma in situ,ACE,Angiotensin-converting enzyme,21229,41,2.06 [0.65-6.48],0.2187001365979685
Chapter II Neoplasms,Melanoma in situ,ACE2,Angiotensin-converting enzyme 2,24041,51,1.06 [0.64-1.76],0.8125406007161469
Chapter II Neoplasms,Melanoma in situ,ACHE,Acetylcholinesterase,20746,40,0.69 [0.27-1.79],0.4465887170353567
Chapter II Neoplasms,Melanoma in situ,ACOT13,Acyl-coenzyme A thioesterase 13,21131,40,1.27 [0.97-1.66],0.0764743639715501
Chapter II Neoplasms,Melanoma in situ,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,24482,53,1.39 [0.91-2.12],0.1331128393603361
Chapter II Neoplasms,Melanoma in situ,ACP1,Low molecular weight phosphotyrosine protein phosphatase,20617,41,1.16 [0.62-2.19],0.6381416245469372
Chapter II Neoplasms,Melanoma in situ,ACP5,Tartrate-resistant acid phosphatase type 5,24554,53,0.67 [0.32-1.40],0.2895030360091605
Chapter II Neoplasms,Melanoma in situ,ACP6,Lysophosphatidic acid phosphatase type 6,24657,52,1.20 [0.81-1.80],0.3638244579373962
Chapter II Neoplasms,Melanoma in situ,ACRBP,Acrosin-binding protein,21108,40,1.77 [0.90-3.50],0.0983387148627324
Chapter II Neoplasms,Melanoma in situ,ACRV1,Acrosomal protein SP-10,20617,41,0.82 [0.52-1.31],0.4072215158453646
Chapter II Neoplasms,Melanoma in situ,ACSL1,Long-chain-fatty-acid--CoA ligase 1,20559,37,1.10 [0.48-2.51],0.8154007453724581
Chapter II Neoplasms,Melanoma in situ,ACTA2,"Actin, aortic smooth muscle",24041,51,0.83 [0.44-1.56],0.5562544099715041
Chapter II Neoplasms,Melanoma in situ,ACTN2,Alpha-actinin-2,20559,37,0.94 [0.54-1.65],0.8311751075184289
Chapter II Neoplasms,Melanoma in situ,ACTN4,Alpha-actinin-4,24024,50,0.40 [0.14-1.13],0.0832154468507202
Chapter II Neoplasms,Melanoma in situ,ACVRL1,Serine/threonine-protein kinase receptor R3,24272,49,0.91 [0.29-2.83],0.8707925930633658
Chapter II Neoplasms,Melanoma in situ,ACY1,Aminoacylase-1,24482,53,1.30 [0.90-1.90],0.1661210901293277
Chapter II Neoplasms,Melanoma in situ,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,20559,37,1.33 [0.77-2.28],0.308597892777521
Chapter II Neoplasms,Melanoma in situ,ACYP1,Acylphosphatase-1,20667,40,1.26 [0.80-1.98],0.3108743861303891
Chapter II Neoplasms,Melanoma in situ,ADA,Adenosine deaminase,24769,52,0.74 [0.36-1.53],0.4125115091651964
Chapter II Neoplasms,Melanoma in situ,ADA2,Adenosine deaminase 2,24293,53,0.68 [0.37-1.24],0.2083066063719744
Chapter II Neoplasms,Melanoma in situ,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,20617,41,1.11 [0.49-2.54],0.8045526256449282
Chapter II Neoplasms,Melanoma in situ,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,24041,51,1.60 [0.72-3.59],0.2518460860183196
Chapter II Neoplasms,Melanoma in situ,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,24313,49,0.98 [0.46-2.06],0.9538811637680276
Chapter II Neoplasms,Melanoma in situ,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,24769,52,0.88 [0.45-1.73],0.7062491714587436
Chapter II Neoplasms,Melanoma in situ,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,24669,53,0.90 [0.37-2.16],0.8069398920903159
Chapter II Neoplasms,Melanoma in situ,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,21131,40,0.62 [0.22-1.74],0.3654040985810509
Chapter II Neoplasms,Melanoma in situ,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,20617,41,1.18 [0.49-2.81],0.715547054001384
Chapter II Neoplasms,Melanoma in situ,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,24765,53,0.88 [0.31-2.52],0.8091693252321468
Chapter II Neoplasms,Melanoma in situ,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,24350,50,1.43 [0.77-2.67],0.2571991942105167
Chapter II Neoplasms,Melanoma in situ,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,24041,51,1.23 [0.65-2.33],0.5203009279864309
Chapter II Neoplasms,Melanoma in situ,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,20617,41,0.95 [0.42-2.17],0.9091588645137582
Chapter II Neoplasms,Melanoma in situ,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,24519,53,1.34 [0.79-2.28],0.2777498628907818
Chapter II Neoplasms,Melanoma in situ,ADAMTSL2,ADAMTS-like protein 2,21216,41,0.80 [0.31-2.08],0.6420617040995751
Chapter II Neoplasms,Melanoma in situ,ADAMTSL4,ADAMTS-like protein 4,20637,41,2.10 [0.72-6.17],0.1759335199439783
Chapter II Neoplasms,Melanoma in situ,ADAMTSL5,ADAMTS-like protein 5,21225,41,0.74 [0.35-1.59],0.4399064951349992
Chapter II Neoplasms,Melanoma in situ,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,23885,50,1.03 [0.51-2.12],0.9265307957734884
Chapter II Neoplasms,Melanoma in situ,ADD1,Alpha-adducin,20746,40,1.02 [0.66-1.58],0.9198913927917912
Chapter II Neoplasms,Melanoma in situ,ADGRB3,Adhesion G protein-coupled receptor B3,24272,49,0.40 [0.18-0.88],0.0235190682030283
Chapter II Neoplasms,Melanoma in situ,ADGRD1,Adhesion G-protein coupled receptor D1,20746,40,1.25 [0.57-2.74],0.5801356118758053
Chapter II Neoplasms,Melanoma in situ,ADGRE1,Adhesion G protein-coupled receptor E1,21131,40,1.03 [0.58-1.81],0.922249959277029
Chapter II Neoplasms,Melanoma in situ,ADGRE2,Adhesion G protein-coupled receptor E2,24564,52,1.49 [0.62-3.56],0.3717501226646822
Chapter II Neoplasms,Melanoma in situ,ADGRE5,Adhesion G protein-coupled receptor E5,24627,51,1.53 [0.68-3.44],0.308574968566588
Chapter II Neoplasms,Melanoma in situ,ADGRF5,Adhesion G protein-coupled receptor F5,21225,41,1.22 [0.43-3.44],0.7032933418049289
Chapter II Neoplasms,Melanoma in situ,ADGRG1,Adhesion G-protein coupled receptor G1,24350,50,0.91 [0.55-1.52],0.723998804806307
Chapter II Neoplasms,Melanoma in situ,ADGRG2,Adhesion G-protein coupled receptor G2,24482,53,0.93 [0.37-2.33],0.8813595263080065
Chapter II Neoplasms,Melanoma in situ,ADGRV1,Adhesion G-protein coupled receptor V1,20569,40,1.02 [0.67-1.55],0.9200281576695596
Chapter II Neoplasms,Melanoma in situ,ADH1B,All-trans-retinol dehydrogenase,20746,40,0.97 [0.66-1.45],0.8933991582027406
Chapter II Neoplasms,Melanoma in situ,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,24041,51,1.06 [0.79-1.42],0.6944639751676766
Chapter II Neoplasms,Melanoma in situ,ADIPOQ,Adiponectin,21249,41,1.42 [0.90-2.23],0.1347732546491059
Chapter II Neoplasms,Melanoma in situ,ADM,Pro-adrenomedullin,24689,52,0.83 [0.32-2.15],0.7028231960653002
Chapter II Neoplasms,Melanoma in situ,ADRA2A,Alpha-2A adrenergic receptor,20559,37,0.97 [0.63-1.50],0.8973085263239655
Chapter II Neoplasms,Melanoma in situ,AFAP1,Actin filament-associated protein 1,20746,40,1.14 [0.81-1.60],0.4507504619541831
Chapter II Neoplasms,Melanoma in situ,AFM,Afamin,21249,41,3.40 [0.74-15.55],0.1142228287450788
Chapter II Neoplasms,Melanoma in situ,AFP,Alpha-fetoprotein,24236,49,0.93 [0.64-1.36],0.7134165599688174
Chapter II Neoplasms,Melanoma in situ,AGBL2,Cytosolic carboxypeptidase 2,20569,40,1.05 [0.75-1.47],0.7659611280779975
Chapter II Neoplasms,Melanoma in situ,AGER,Advanced glycosylation end product-specific receptor,24398,50,0.72 [0.38-1.38],0.324200024927729
Chapter II Neoplasms,Melanoma in situ,AGR2,Anterior gradient protein 2 homolog,23697,51,1.13 [0.88-1.45],0.3360873481877001
Chapter II Neoplasms,Melanoma in situ,AGR3,Anterior gradient protein 3,23854,50,1.48 [1.05-2.09],0.0247210214864853
Chapter II Neoplasms,Melanoma in situ,AGRN,Agrin,24564,52,1.61 [0.77-3.34],0.204338192842953
Chapter II Neoplasms,Melanoma in situ,AGRP,Agouti-related protein,24769,52,1.27 [0.79-2.04],0.3189768469523297
Chapter II Neoplasms,Melanoma in situ,AGT,Angiotensinogen,21229,41,0.73 [0.17-3.21],0.6771275432893602
Chapter II Neoplasms,Melanoma in situ,AGXT,Serine--pyruvate aminotransferase,24482,53,0.98 [0.72-1.34],0.8993853435033128
Chapter II Neoplasms,Melanoma in situ,AHCY,Adenosylhomocysteinase,24482,53,0.94 [0.66-1.35],0.7460574702397369
Chapter II Neoplasms,Melanoma in situ,AHNAK,Neuroblast differentiation-associated protein AHNAK,20637,41,0.68 [0.25-1.84],0.4521876170053073
Chapter II Neoplasms,Melanoma in situ,AHNAK2,Protein AHNAK2,20637,41,0.81 [0.27-2.38],0.6967799697993713
Chapter II Neoplasms,Melanoma in situ,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,21108,40,1.31 [0.94-1.83],0.1107841308015541
Chapter II Neoplasms,Melanoma in situ,AHSG,Alpha-2-HS-glycoprotein,21229,41,2.65 [0.93-7.54],0.0677300115917326
Chapter II Neoplasms,Melanoma in situ,AHSP,Alpha-hemoglobin-stabilizing protein,24424,53,0.71 [0.53-0.96],0.0232475294991528
Chapter II Neoplasms,Melanoma in situ,AIDA,"Axin interactor, dorsalization-associated protein",20638,38,0.95 [0.65-1.38],0.7705381856167284
Chapter II Neoplasms,Melanoma in situ,AIF1,Allograft inflammatory factor 1,23885,50,1.43 [0.91-2.24],0.1247475455649913
Chapter II Neoplasms,Melanoma in situ,AIF1L,Allograft inflammatory factor 1-like,20637,41,0.81 [0.44-1.50],0.504842473836211
Chapter II Neoplasms,Melanoma in situ,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",24306,50,1.16 [0.92-1.46],0.2252194118521542
Chapter II Neoplasms,Melanoma in situ,AK1,Adenylate kinase isoenzyme 1,24482,53,0.85 [0.58-1.25],0.4116875423405148
Chapter II Neoplasms,Melanoma in situ,AK2,"Adenylate kinase 2, mitochondrial",21166,40,1.29 [0.98-1.70],0.0735640823655298
Chapter II Neoplasms,Melanoma in situ,AKAP12,A-kinase anchor protein 12,20746,40,2.39 [1.15-4.97],0.0196984862538582
Chapter II Neoplasms,Melanoma in situ,AKR1B1,Aldo-keto reductase family 1 member B1,23885,50,1.23 [0.90-1.68],0.1854536666975243
Chapter II Neoplasms,Melanoma in situ,AKR1B10,Aldo-keto reductase family 1 member B10,20638,38,0.98 [0.59-1.63],0.927539203031564
Chapter II Neoplasms,Melanoma in situ,AKR1C4,Aldo-keto reductase family 1 member C4,24041,51,1.15 [0.76-1.74],0.5160910363480757
Chapter II Neoplasms,Melanoma in situ,AKR7L,Aflatoxin B1 aldehyde reductase member 4,20617,41,0.86 [0.55-1.36],0.5200977043350706
Chapter II Neoplasms,Melanoma in situ,AKT1S1,Proline-rich AKT1 substrate 1,23895,51,1.04 [0.72-1.50],0.8449908174384341
Chapter II Neoplasms,Melanoma in situ,AKT2,RAC-beta serine/threonine-protein kinase,21191,40,1.28 [1.00-1.63],0.046180162805518
Chapter II Neoplasms,Melanoma in situ,AKT3,RAC-gamma serine/threonine-protein kinase,23758,50,1.16 [0.75-1.78],0.5124697982850406
Chapter II Neoplasms,Melanoma in situ,ALCAM,CD166 antigen,24765,53,0.75 [0.21-2.67],0.6570933569344206
Chapter II Neoplasms,Melanoma in situ,ALDH1A1,Retinal dehydrogenase 1,24462,53,0.68 [0.42-1.12],0.1279334747122496
Chapter II Neoplasms,Melanoma in situ,ALDH2,"Aldehyde dehydrogenase, mitochondrial",21108,40,0.94 [0.51-1.72],0.8355227683802684
Chapter II Neoplasms,Melanoma in situ,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",24431,52,0.89 [0.59-1.35],0.5818486194519756
Chapter II Neoplasms,Melanoma in situ,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",21191,40,1.11 [0.60-2.05],0.7497703541468782
Chapter II Neoplasms,Melanoma in situ,ALMS1,Alstrom syndrome protein 1,20824,40,0.78 [0.37-1.66],0.5192478339427493
Chapter II Neoplasms,Melanoma in situ,ALPI,Intestinal-type alkaline phosphatase,20617,41,1.23 [0.97-1.56],0.0886854740357475
Chapter II Neoplasms,Melanoma in situ,ALPP,"Alkaline phosphatase, placental type",24350,50,1.24 [0.97-1.59],0.0821097628823475
Chapter II Neoplasms,Melanoma in situ,AMBN,Ameloblastin,24024,50,0.69 [0.24-1.94],0.4774946736254335
Chapter II Neoplasms,Melanoma in situ,AMBP,Protein AMBP,24658,52,1.41 [0.38-5.15],0.6062186958941185
Chapter II Neoplasms,Melanoma in situ,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,21216,41,1.37 [0.42-4.49],0.6022712035784068
Chapter II Neoplasms,Melanoma in situ,AMFR,E3 ubiquitin-protein ligase AMFR,23895,51,1.06 [0.73-1.52],0.7670962010368948
Chapter II Neoplasms,Melanoma in situ,AMIGO1,Amphoterin-induced protein 1,20638,38,0.86 [0.44-1.69],0.6575742269346379
Chapter II Neoplasms,Melanoma in situ,AMIGO2,Amphoterin-induced protein 2,24350,50,1.94 [0.67-5.67],0.2234872388300705
Chapter II Neoplasms,Melanoma in situ,AMN,Protein amnionless,24024,50,1.09 [0.65-1.84],0.745863546711415
Chapter II Neoplasms,Melanoma in situ,AMOT,Angiomotin,20746,40,1.82 [0.95-3.49],0.0695111919508082
Chapter II Neoplasms,Melanoma in situ,AMOTL2,Angiomotin-like protein 2,21041,40,1.30 [0.79-2.14],0.3066152180320904
Chapter II Neoplasms,Melanoma in situ,AMPD3,AMP deaminase 3,21166,40,0.75 [0.50-1.14],0.178460403798674
Chapter II Neoplasms,Melanoma in situ,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,19894,38,1.41 [0.86-2.32],0.1749475648265843
Chapter II Neoplasms,Melanoma in situ,AMY2A,Pancreatic alpha-amylase,23559,50,1.18 [0.69-2.03],0.5449076706518701
Chapter II Neoplasms,Melanoma in situ,AMY2B,Alpha-amylase 2B,22819,48,1.13 [0.65-1.94],0.6678424588091063
Chapter II Neoplasms,Melanoma in situ,ANG,Angiogenin,24368,53,0.85 [0.41-1.76],0.6609323170126967
Chapter II Neoplasms,Melanoma in situ,ANGPT1,Angiopoietin-1,24387,50,0.97 [0.73-1.31],0.8615449512871063
Chapter II Neoplasms,Melanoma in situ,ANGPT2,Angiopoietin-2,24689,52,1.19 [0.63-2.23],0.5887322428093434
Chapter II Neoplasms,Melanoma in situ,ANGPTL1,Angiopoietin-related protein 1,24122,52,1.42 [0.62-3.25],0.4018321227257664
Chapter II Neoplasms,Melanoma in situ,ANGPTL2,Angiopoietin-related protein 2,24483,52,0.75 [0.40-1.39],0.3611144482281689
Chapter II Neoplasms,Melanoma in situ,ANGPTL3,Angiopoietin-related protein 3,24457,53,0.78 [0.39-1.55],0.4741984157190211
Chapter II Neoplasms,Melanoma in situ,ANGPTL4,Angiopoietin-related protein 4,24529,52,1.19 [0.69-2.05],0.5229316045607098
Chapter II Neoplasms,Melanoma in situ,ANGPTL7,Angiopoietin-related protein 7,24689,52,1.28 [0.68-2.42],0.4423883077782691
Chapter II Neoplasms,Melanoma in situ,ANK2,Ankyrin-2,20559,37,1.25 [0.87-1.80],0.2300735324332246
Chapter II Neoplasms,Melanoma in situ,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,20617,41,1.48 [1.03-2.12],0.0338675566604263
Chapter II Neoplasms,Melanoma in situ,ANKRA2,Ankyrin repeat family A protein 2,20471,40,1.60 [1.09-2.37],0.0173388305699749
Chapter II Neoplasms,Melanoma in situ,ANKRD54,Ankyrin repeat domain-containing protein 54,23885,50,1.20 [0.82-1.75],0.3394522559327614
Chapter II Neoplasms,Melanoma in situ,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,20637,41,0.84 [0.37-1.92],0.6829249738722558
Chapter II Neoplasms,Melanoma in situ,ANPEP,Aminopeptidase N,24483,53,0.82 [0.34-2.00],0.6690544031077682
Chapter II Neoplasms,Melanoma in situ,ANXA1,Annexin A1,20617,40,0.50 [0.23-1.08],0.0756767798313206
Chapter II Neoplasms,Melanoma in situ,ANXA10,Annexin A10,23895,51,1.13 [0.84-1.54],0.4173818900197448
Chapter II Neoplasms,Melanoma in situ,ANXA11,Annexin A11,24417,52,1.20 [0.82-1.75],0.3456579814302967
Chapter II Neoplasms,Melanoma in situ,ANXA2,Annexin A2,20341,41,1.20 [0.82-1.77],0.3521767328221734
Chapter II Neoplasms,Melanoma in situ,ANXA3,Annexin A3,24669,53,1.11 [0.79-1.55],0.5415582083532215
Chapter II Neoplasms,Melanoma in situ,ANXA4,Annexin A4,24358,53,1.16 [0.83-1.60],0.3818125998702526
Chapter II Neoplasms,Melanoma in situ,ANXA5,Annexin A5,23822,51,1.21 [0.55-2.64],0.6392029038381515
Chapter II Neoplasms,Melanoma in situ,AOC1,Amiloride-sensitive amine oxidase [copper-containing],24024,50,0.96 [0.60-1.53],0.8496732217264905
Chapter II Neoplasms,Melanoma in situ,AOC3,Membrane primary amine oxidase,24528,53,1.05 [0.47-2.39],0.8981593936900033
Chapter II Neoplasms,Melanoma in situ,AP1G2,AP-1 complex subunit gamma-like 2,21108,40,1.43 [1.01-2.02],0.042321248695501
Chapter II Neoplasms,Melanoma in situ,AP2B1,AP-2 complex subunit beta,20638,38,1.38 [0.79-2.40],0.2561109064285522
Chapter II Neoplasms,Melanoma in situ,AP3B1,AP-3 complex subunit beta-1,21131,40,1.46 [1.01-2.12],0.0437765574871545
Chapter II Neoplasms,Melanoma in situ,AP3S2,AP-3 complex subunit sigma-2,21166,40,1.61 [0.91-2.85],0.0998547055800226
Chapter II Neoplasms,Melanoma in situ,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,24350,50,0.66 [0.36-1.22],0.1866776334334635
Chapter II Neoplasms,Melanoma in situ,APCS,Serum amyloid P-component,21072,41,0.60 [0.26-1.39],0.2341249619250979
Chapter II Neoplasms,Melanoma in situ,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,24624,52,1.08 [0.73-1.60],0.7085494217176352
Chapter II Neoplasms,Melanoma in situ,APLP1,Amyloid-like protein 1,24482,53,0.97 [0.60-1.56],0.899805323525458
Chapter II Neoplasms,Melanoma in situ,APOA1,Apolipoprotein A-I,21249,41,0.93 [0.30-2.83],0.8949898467767239
Chapter II Neoplasms,Melanoma in situ,APOA2,Apolipoprotein A-II,21229,41,0.89 [0.48-1.66],0.7069729400161175
Chapter II Neoplasms,Melanoma in situ,APOA4,Apolipoprotein A-IV,21249,41,0.77 [0.31-1.90],0.5671715171988083
Chapter II Neoplasms,Melanoma in situ,APOB,Apolipoprotein B-100,21229,41,2.29 [0.60-8.76],0.227812331940434
Chapter II Neoplasms,Melanoma in situ,APOBR,Apolipoprotein B receptor,20637,41,1.04 [0.52-2.07],0.9181315618142404
Chapter II Neoplasms,Melanoma in situ,APOC1,Apolipoprotein C-I,21207,41,0.76 [0.33-1.80],0.5369733497201442
Chapter II Neoplasms,Melanoma in situ,APOD,Apolipoprotein D,20251,40,1.19 [0.66-2.14],0.5731370492158199
Chapter II Neoplasms,Melanoma in situ,APOE,Apolipoprotein E,21249,41,1.02 [0.69-1.53],0.9093744071706644
Chapter II Neoplasms,Melanoma in situ,APOF,Apolipoprotein F,21229,41,0.81 [0.21-3.06],0.7521263393999021
Chapter II Neoplasms,Melanoma in situ,APOH,Beta-2-glycoprotein 1,24462,53,0.87 [0.44-1.74],0.7014750402860711
Chapter II Neoplasms,Melanoma in situ,APOL1,Apolipoprotein L1,21229,41,1.27 [0.84-1.93],0.2627991622257349
Chapter II Neoplasms,Melanoma in situ,APOM,Apolipoprotein M,24499,53,1.29 [0.52-3.19],0.5839156498020628
Chapter II Neoplasms,Melanoma in situ,APP,Amyloid-beta precursor protein,24420,53,0.99 [0.68-1.42],0.9383498860313144
Chapter II Neoplasms,Melanoma in situ,APPL2,DCC-interacting protein 13-beta,20746,40,1.28 [0.97-1.69],0.0841713068979809
Chapter II Neoplasms,Melanoma in situ,APRT,Adenine phosphoribosyltransferase,24286,49,1.30 [0.76-2.23],0.3364030966571728
Chapter II Neoplasms,Melanoma in situ,ARAF,Serine/threonine-protein kinase A-Raf,20824,40,1.37 [0.95-1.96],0.0887048352483598
Chapter II Neoplasms,Melanoma in situ,AREG,Amphiregulin,24350,50,1.25 [0.74-2.11],0.3936675617777455
Chapter II Neoplasms,Melanoma in situ,ARF6,ADP-ribosylation factor 6,21131,40,1.33 [0.99-1.78],0.0582705165275544
Chapter II Neoplasms,Melanoma in situ,ARFIP1,Arfaptin-1,21191,40,1.41 [0.93-2.14],0.1078825445105664
Chapter II Neoplasms,Melanoma in situ,ARG1,Arginase-1,24353,51,0.77 [0.48-1.23],0.270517713890965
Chapter II Neoplasms,Melanoma in situ,ARG2,"Arginase-2, mitochondrial",21108,40,0.95 [0.47-1.91],0.882594222936303
Chapter II Neoplasms,Melanoma in situ,ARHGAP1,Rho GTPase-activating protein 1,23885,50,1.31 [0.77-2.23],0.324803960808391
Chapter II Neoplasms,Melanoma in situ,ARHGAP25,Rho GTPase-activating protein 25,23885,50,1.12 [0.75-1.66],0.5787786307057692
Chapter II Neoplasms,Melanoma in situ,ARHGAP30,Rho GTPase-activating protein 30,20824,40,0.89 [0.39-2.01],0.7741690470593365
Chapter II Neoplasms,Melanoma in situ,ARHGAP45,Rho GTPase-activating protein 45,20746,40,1.34 [0.93-1.93],0.1152484234832265
Chapter II Neoplasms,Melanoma in situ,ARHGAP5,Rho GTPase-activating protein 5,20471,40,1.10 [0.75-1.62],0.6081510264375518
Chapter II Neoplasms,Melanoma in situ,ARHGEF1,Rho guanine nucleotide exchange factor 1,21166,40,1.17 [0.84-1.63],0.3514610405853049
Chapter II Neoplasms,Melanoma in situ,ARHGEF10,Rho guanine nucleotide exchange factor 10,21191,40,1.23 [0.90-1.68],0.1969983487286554
Chapter II Neoplasms,Melanoma in situ,ARHGEF12,Rho guanine nucleotide exchange factor 12,24460,52,1.11 [0.88-1.41],0.3704733162429966
Chapter II Neoplasms,Melanoma in situ,ARHGEF5,Rho guanine nucleotide exchange factor 5,20569,40,0.81 [0.51-1.28],0.365907442953208
Chapter II Neoplasms,Melanoma in situ,ARID3A,AT-rich interactive domain-containing protein 3A,20569,40,0.66 [0.29-1.50],0.3207819439291408
Chapter II Neoplasms,Melanoma in situ,ARID4B,AT-rich interactive domain-containing protein 4B,23895,51,0.79 [0.40-1.55],0.4975128783434642
Chapter II Neoplasms,Melanoma in situ,ARL13B,ADP-ribosylation factor-like protein 13B,20559,37,1.29 [0.87-1.92],0.2003830470287545
Chapter II Neoplasms,Melanoma in situ,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,20559,37,1.79 [0.89-3.61],0.1036927657413832
Chapter II Neoplasms,Melanoma in situ,ARMCX2,Armadillo repeat-containing X-linked protein 2,20569,40,0.59 [0.30-1.20],0.1459763996441635
Chapter II Neoplasms,Melanoma in situ,ARNT,Aryl hydrocarbon receptor nuclear translocator,24024,50,0.76 [0.37-1.56],0.4584958209670412
Chapter II Neoplasms,Melanoma in situ,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,20559,37,1.08 [0.61-1.90],0.7945761247337093
Chapter II Neoplasms,Melanoma in situ,ARSA,Arylsulfatase A,24462,53,1.05 [0.60-1.83],0.8568901855003852
Chapter II Neoplasms,Melanoma in situ,ARSB,Arylsulfatase B,24350,50,1.11 [0.71-1.73],0.6482129505999656
Chapter II Neoplasms,Melanoma in situ,ART3,Ecto-ADP-ribosyltransferase 3,24528,53,0.62 [0.29-1.30],0.2038366694297835
Chapter II Neoplasms,Melanoma in situ,ART5,Ecto-ADP-ribosyltransferase 5,20569,40,1.10 [0.72-1.69],0.6522172200957566
Chapter II Neoplasms,Melanoma in situ,ARTN,Artemin,24024,50,1.09 [0.67-1.79],0.7187143494965866
Chapter II Neoplasms,Melanoma in situ,ASAH1,Acid ceramidase,21039,41,1.61 [1.05-2.47],0.0294938146127888
Chapter II Neoplasms,Melanoma in situ,ASAH2,Neutral ceramidase,24313,49,1.58 [0.92-2.70],0.0992606360146325
Chapter II Neoplasms,Melanoma in situ,ASGR1,Asialoglycoprotein receptor 1,24313,49,1.58 [0.68-3.67],0.2919675268189275
Chapter II Neoplasms,Melanoma in situ,ASGR2,Asialoglycoprotein receptor 2,21229,41,1.06 [0.32-3.48],0.9187680837289688
Chapter II Neoplasms,Melanoma in situ,ASPN,Asporin,21225,41,0.87 [0.29-2.63],0.8011656577037364
Chapter II Neoplasms,Melanoma in situ,ASPSCR1,Tether containing UBX domain for GLUT4,21191,40,1.77 [1.16-2.71],0.0081572596652387
Chapter II Neoplasms,Melanoma in situ,ASRGL1,Isoaspartyl peptidase/L-asparaginase,20637,41,1.20 [0.90-1.61],0.218626421319344
Chapter II Neoplasms,Melanoma in situ,ASS1,Argininosuccinate synthase,20559,37,1.01 [0.68-1.50],0.950027079728058
Chapter II Neoplasms,Melanoma in situ,ATF2,Cyclic AMP-dependent transcription factor ATF-2,23895,51,0.85 [0.56-1.31],0.4726520568506447
Chapter II Neoplasms,Melanoma in situ,ATF4,Cyclic AMP-dependent transcription factor ATF-4,20471,40,1.48 [0.68-3.20],0.3206071175210191
Chapter II Neoplasms,Melanoma in situ,ATG16L1,Autophagy-related protein 16-1,21131,40,1.34 [0.95-1.89],0.0989737117085496
Chapter II Neoplasms,Melanoma in situ,ATG4A,Cysteine protease ATG4A,23885,50,0.88 [0.57-1.35],0.5596950641374479
Chapter II Neoplasms,Melanoma in situ,ATOX1,Copper transport protein ATOX1,24519,53,1.21 [0.86-1.69],0.2663192071832494
Chapter II Neoplasms,Melanoma in situ,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,20559,37,1.12 [0.66-1.93],0.6725943781443415
Chapter II Neoplasms,Melanoma in situ,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,20559,37,0.55 [0.18-1.67],0.2909888507018843
Chapter II Neoplasms,Melanoma in situ,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,20559,37,1.15 [0.57-2.33],0.6882089236038795
Chapter II Neoplasms,Melanoma in situ,ATP1B4,Protein ATP1B4,20471,40,0.83 [0.38-1.82],0.6477411264014821
Chapter II Neoplasms,Melanoma in situ,ATP2B4,Plasma membrane calcium-transporting ATPase 4,20559,37,0.98 [0.60-1.59],0.9312967645379048
Chapter II Neoplasms,Melanoma in situ,ATP5F1D,"ATP synthase subunit delta, mitochondrial",20559,37,1.15 [0.69-1.93],0.5912455588073795
Chapter II Neoplasms,Melanoma in situ,ATP5IF1,"ATPase inhibitor, mitochondrial",24564,52,1.19 [0.95-1.49],0.1303249338334356
Chapter II Neoplasms,Melanoma in situ,ATP5PO,"ATP synthase subunit O, mitochondrial",23895,51,0.74 [0.39-1.40],0.3597684200793214
Chapter II Neoplasms,Melanoma in situ,ATP6AP2,Renin receptor,23885,50,1.11 [0.63-1.95],0.7282742254377712
Chapter II Neoplasms,Melanoma in situ,ATP6V1D,V-type proton ATPase subunit D,24350,50,1.16 [0.48-2.78],0.7439126436365655
Chapter II Neoplasms,Melanoma in situ,ATP6V1F,V-type proton ATPase subunit F,23848,51,0.95 [0.65-1.39],0.7943691619878956
Chapter II Neoplasms,Melanoma in situ,ATP6V1G1,V-type proton ATPase subunit G 1,20637,41,1.58 [1.08-2.31],0.0180602974556328
Chapter II Neoplasms,Melanoma in situ,ATP6V1G2,V-type proton ATPase subunit G 2,20559,37,1.18 [0.90-1.54],0.2418816378932919
Chapter II Neoplasms,Melanoma in situ,ATRAID,All-trans retinoic acid-induced differentiation factor,21131,40,0.69 [0.21-2.29],0.5440429625426841
Chapter II Neoplasms,Melanoma in situ,ATRN,"Attractin, Isoform 2",21249,41,1.03 [0.17-6.12],0.9774545660071412
Chapter II Neoplasms,Melanoma in situ,ATXN10,Ataxin-10,23895,51,1.37 [0.97-1.94],0.0739071147805229
Chapter II Neoplasms,Melanoma in situ,ATXN2,Ataxin-2,20569,40,1.02 [0.78-1.33],0.883103662181385
Chapter II Neoplasms,Melanoma in situ,ATXN2L,Ataxin-2-like protein,21191,40,1.54 [0.96-2.48],0.0731443671171389
Chapter II Neoplasms,Melanoma in situ,ATXN3,Ataxin-3,21166,40,1.14 [0.71-1.83],0.5844198651595309
Chapter II Neoplasms,Melanoma in situ,AXIN1,Axin-1,24460,52,1.21 [0.93-1.56],0.1489823959919742
Chapter II Neoplasms,Melanoma in situ,AXL,Tyrosine-protein kinase receptor UFO,24528,53,1.06 [0.43-2.58],0.9037778557309836
Chapter II Neoplasms,Melanoma in situ,AZI2,5-azacytidine-induced protein 2,21191,40,1.42 [0.86-2.33],0.1704755469802901
Chapter II Neoplasms,Melanoma in situ,AZU1,Azurocidin,23722,49,0.71 [0.48-1.05],0.0821682505300439
Chapter II Neoplasms,Melanoma in situ,B2M,Beta-2-microglobulin,21249,41,1.42 [0.89-2.25],0.1421625197076484
Chapter II Neoplasms,Melanoma in situ,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,20559,37,0.89 [0.18-4.30],0.8833915217688306
Chapter II Neoplasms,Melanoma in situ,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",20637,41,0.72 [0.32-1.62],0.4243848072675021
Chapter II Neoplasms,Melanoma in situ,B4GALT1,"Beta-1,4-galactosyltransferase 1",24564,52,0.76 [0.30-1.92],0.5578805920372572
Chapter II Neoplasms,Melanoma in situ,B4GAT1,"Beta-1,4-glucuronyltransferase 1",24462,53,0.62 [0.23-1.68],0.3463579499393986
Chapter II Neoplasms,Melanoma in situ,BABAM1,BRISC and BRCA1-A complex member 1,20617,41,1.35 [0.54-3.34],0.5184039979906285
Chapter II Neoplasms,Melanoma in situ,BACH1,Transcription regulator protein BACH1,24460,52,1.19 [0.87-1.64],0.2820282103039576
Chapter II Neoplasms,Melanoma in situ,BAG3,BAG family molecular chaperone regulator 3,24272,49,1.04 [0.55-1.98],0.8994409725622018
Chapter II Neoplasms,Melanoma in situ,BAG4,BAG family molecular chaperone regulator 4,20617,41,1.33 [0.78-2.26],0.2993473287522522
Chapter II Neoplasms,Melanoma in situ,BAG6,Large proline-rich protein BAG6,24041,51,1.16 [0.59-2.30],0.6660359513516564
Chapter II Neoplasms,Melanoma in situ,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23885,50,1.31 [0.91-1.89],0.1490731081809425
Chapter II Neoplasms,Melanoma in situ,BAMBI,BMP and activin membrane-bound inhibitor homolog,23885,50,0.77 [0.31-1.88],0.5621994834831529
Chapter II Neoplasms,Melanoma in situ,BANK1,B-cell scaffold protein with ankyrin repeats,24460,52,1.12 [0.89-1.41],0.3431981273041731
Chapter II Neoplasms,Melanoma in situ,BAP18,Chromatin complexes subunit BAP18,21166,40,0.76 [0.46-1.26],0.2856382951590466
Chapter II Neoplasms,Melanoma in situ,BATF,Basic leucine zipper transcriptional factor ATF-like,20638,38,0.97 [0.67-1.41],0.892434007631076
Chapter II Neoplasms,Melanoma in situ,BAX,Apoptosis regulator BAX,23858,51,1.21 [0.92-1.58],0.1688673883714563
Chapter II Neoplasms,Melanoma in situ,BCAM,Basal cell adhesion molecule,24462,53,0.47 [0.16-1.36],0.1626077564008823
Chapter II Neoplasms,Melanoma in situ,BCAN,Brevican core protein,24313,49,0.83 [0.39-1.78],0.6319459512906944
Chapter II Neoplasms,Melanoma in situ,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",21225,41,1.95 [0.93-4.09],0.0759577962261602
Chapter II Neoplasms,Melanoma in situ,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",20569,40,1.14 [0.69-1.88],0.6170729273813684
Chapter II Neoplasms,Melanoma in situ,BCHE,Cholinesterase,20831,41,1.21 [0.40-3.64],0.7332825659237598
Chapter II Neoplasms,Melanoma in situ,BCL2,Apoptosis regulator Bcl-2,21131,40,0.92 [0.50-1.70],0.7937342447220729
Chapter II Neoplasms,Melanoma in situ,BCL2L1,Bcl-2-like protein 1,21166,40,1.51 [1.11-2.06],0.0082756424965872
Chapter II Neoplasms,Melanoma in situ,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",24460,52,0.92 [0.54-1.58],0.7748522448895485
Chapter II Neoplasms,Melanoma in situ,BCL2L15,Bcl-2-like protein 15,20617,41,0.56 [0.30-1.07],0.0801171013576984
Chapter II Neoplasms,Melanoma in situ,BCL7A,B-cell CLL/lymphoma 7 protein family member A,20471,40,1.03 [0.65-1.62],0.910340461658913
Chapter II Neoplasms,Melanoma in situ,BCL7B,B-cell CLL/lymphoma 7 protein family member B,21108,40,0.51 [0.22-1.20],0.1248911834425188
Chapter II Neoplasms,Melanoma in situ,BCR,Breakpoint cluster region protein,24460,52,1.13 [0.87-1.48],0.3549101779669475
Chapter II Neoplasms,Melanoma in situ,BDNF,Brain-derived neurotrophic factor,21216,41,1.33 [0.91-1.94],0.1402537017471838
Chapter II Neoplasms,Melanoma in situ,BECN1,Beclin-1,20637,41,1.46 [0.93-2.28],0.099066661440491
Chapter II Neoplasms,Melanoma in situ,BEX3,Protein BEX3,20471,40,0.91 [0.46-1.81],0.7981480687963666
Chapter II Neoplasms,Melanoma in situ,BGLAP,Osteocalcin,21216,41,1.19 [0.83-1.72],0.3420168225216123
Chapter II Neoplasms,Melanoma in situ,BGN,Biglycan,23852,50,1.06 [0.86-1.31],0.5663419101154464
Chapter II Neoplasms,Melanoma in situ,BHLHE40,Class E basic helix-loop-helix protein 40,20569,40,0.77 [0.47-1.26],0.3015475690830778
Chapter II Neoplasms,Melanoma in situ,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,20559,37,1.71 [0.53-5.58],0.3724859818718156
Chapter II Neoplasms,Melanoma in situ,BID,BH3-interacting domain death agonist,24460,52,1.15 [0.81-1.62],0.4394378986801168
Chapter II Neoplasms,Melanoma in situ,BIN2,Bridging integrator 2,24462,53,1.14 [0.87-1.49],0.3332216942738816
Chapter II Neoplasms,Melanoma in situ,BIRC2,Baculoviral IAP repeat-containing protein 2,23885,50,1.06 [0.72-1.57],0.7526530031651358
Chapter II Neoplasms,Melanoma in situ,BLMH,Bleomycin hydrolase,24765,53,0.72 [0.34-1.54],0.4011324974492057
Chapter II Neoplasms,Melanoma in situ,BLNK,B-cell linker protein,20617,41,1.77 [1.00-3.13],0.0503853124990109
Chapter II Neoplasms,Melanoma in situ,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,20569,40,1.07 [0.73-1.56],0.7287397223069397
Chapter II Neoplasms,Melanoma in situ,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,21166,40,2.13 [1.16-3.90],0.0146875450800766
Chapter II Neoplasms,Melanoma in situ,BLVRB,Flavin reductase,24462,53,0.69 [0.46-1.02],0.0656216080805155
Chapter II Neoplasms,Melanoma in situ,BMP10,Bone morphogenetic protein 10,20746,40,1.76 [0.59-5.31],0.3126373876317906
Chapter II Neoplasms,Melanoma in situ,BMP4,Bone morphogenetic protein 4,24272,49,1.12 [0.64-1.99],0.6862798672690787
Chapter II Neoplasms,Melanoma in situ,BMP6,Bone morphogenetic protein 6,23994,51,0.91 [0.50-1.66],0.7545308633671881
Chapter II Neoplasms,Melanoma in situ,BMPER,BMP-binding endothelial regulator protein,20746,40,1.62 [0.44-6.02],0.4682559624590148
Chapter II Neoplasms,Melanoma in situ,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,21225,41,2.04 [1.17-3.55],0.0117666632967749
Chapter II Neoplasms,Melanoma in situ,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20617,41,1.45 [0.81-2.62],0.2147712972717203
Chapter II Neoplasms,Melanoma in situ,BOC,Brother of CDO,24041,51,0.92 [0.32-2.67],0.8787560306090849
Chapter II Neoplasms,Melanoma in situ,BOLA1,BolA-like protein 1,20569,40,1.28 [0.80-2.05],0.3047842603773509
Chapter II Neoplasms,Melanoma in situ,BOLA2_BOLA2B,BolA-like protein 2,20637,41,0.93 [0.54-1.58],0.7766565030724505
Chapter II Neoplasms,Melanoma in situ,BPIFA2,BPI fold-containing family A member 2,19903,38,1.38 [1.05-1.82],0.021389734251868
Chapter II Neoplasms,Melanoma in situ,BPIFB1,BPI fold-containing family B member 1,24422,51,0.85 [0.58-1.25],0.4110384934428195
Chapter II Neoplasms,Melanoma in situ,BPIFB2,BPI fold-containing family B member 2,21192,41,0.91 [0.56-1.49],0.7134930127737493
Chapter II Neoplasms,Melanoma in situ,BRAP,BRCA1-associated protein,20933,40,1.27 [0.95-1.68],0.1035711549669692
Chapter II Neoplasms,Melanoma in situ,BRD1,Bromodomain-containing protein 1,20824,40,1.22 [0.50-3.00],0.6596180480944365
Chapter II Neoplasms,Melanoma in situ,BRD2,Bromodomain-containing protein 2,20569,40,0.91 [0.36-2.28],0.8441589481442375
Chapter II Neoplasms,Melanoma in situ,BRD3,Bromodomain-containing protein 3,20559,37,1.34 [0.90-1.99],0.1483508740719689
Chapter II Neoplasms,Melanoma in situ,BRDT,Bromodomain testis-specific protein,20559,37,2.74 [1.51-4.98],0.000903375930541
Chapter II Neoplasms,Melanoma in situ,BRK1,Protein BRICK1,23895,51,1.29 [0.74-2.24],0.3697012373429797
Chapter II Neoplasms,Melanoma in situ,BRME1,Break repair meiotic recombinase recruitment factor 1,20569,40,1.22 [0.69-2.15],0.5030621543525601
Chapter II Neoplasms,Melanoma in situ,BRSK2,Serine/threonine-protein kinase BRSK2,21191,40,1.92 [1.07-3.46],0.0289471179949665
Chapter II Neoplasms,Melanoma in situ,BSG,Basigin,24721,52,0.86 [0.24-3.08],0.8167867954336181
Chapter II Neoplasms,Melanoma in situ,BSND,Barttin,20471,40,0.99 [0.40-2.44],0.97604517116689
Chapter II Neoplasms,Melanoma in situ,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,24707,53,0.88 [0.56-1.38],0.569888792368126
Chapter II Neoplasms,Melanoma in situ,BST2,Bone marrow stromal antigen 2,24707,53,0.74 [0.44-1.26],0.2674311304399851
Chapter II Neoplasms,Melanoma in situ,BTC,Probetacellulin,23885,50,1.09 [0.78-1.51],0.6097571319612873
Chapter II Neoplasms,Melanoma in situ,BTD,Biotinidase,21249,41,1.81 [0.43-7.71],0.4201768879441103
Chapter II Neoplasms,Melanoma in situ,BTLA,B- and T-lymphocyte attenuator,20471,40,1.09 [0.82-1.46],0.5597809572441784
Chapter II Neoplasms,Melanoma in situ,BTN1A1,Butyrophilin subfamily 1 member A1,21070,40,0.52 [0.20-1.37],0.1843779488217983
Chapter II Neoplasms,Melanoma in situ,BTN2A1,Butyrophilin subfamily 2 member A1,24564,52,0.89 [0.32-2.45],0.8154749598371008
Chapter II Neoplasms,Melanoma in situ,BTN3A2,Butyrophilin subfamily 3 member A2,24460,52,0.87 [0.45-1.70],0.691493591107581
Chapter II Neoplasms,Melanoma in situ,BTNL10,Butyrophilin-like protein 10,20471,40,0.85 [0.36-2.00],0.7052080548166989
Chapter II Neoplasms,Melanoma in situ,C19orf12,Protein C19orf12,23895,51,0.75 [0.47-1.18],0.2145332514213665
Chapter II Neoplasms,Melanoma in situ,C1GALT1C1,C1GALT1-specific chaperone 1,20559,37,0.96 [0.36-2.59],0.9422514149299444
Chapter II Neoplasms,Melanoma in situ,C1QA,Complement C1q subcomponent subunit A,24639,52,0.66 [0.23-1.94],0.450688111249574
Chapter II Neoplasms,Melanoma in situ,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",21191,40,0.90 [0.54-1.50],0.6999132469241025
Chapter II Neoplasms,Melanoma in situ,C1QL2,Complement C1q-like protein 2,20617,41,1.60 [0.91-2.83],0.1012913454631462
Chapter II Neoplasms,Melanoma in situ,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,24528,53,1.03 [0.59-1.82],0.9109030641951096
Chapter II Neoplasms,Melanoma in situ,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,20746,40,0.78 [0.35-1.69],0.5233445484327102
Chapter II Neoplasms,Melanoma in situ,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,21191,40,1.18 [0.50-2.82],0.7033580614821532
Chapter II Neoplasms,Melanoma in situ,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,20707,40,1.08 [0.57-2.04],0.8176387838501442
Chapter II Neoplasms,Melanoma in situ,C1R,Complement C1r subcomponent,21249,41,0.57 [0.09-3.57],0.5498433544829848
Chapter II Neoplasms,Melanoma in situ,C1RL,Complement C1r subcomponent-like protein,21213,41,2.63 [0.54-12.82],0.2312123381898832
Chapter II Neoplasms,Melanoma in situ,C1S,Complement C1s subcomponent,21249,41,0.78 [0.19-3.30],0.7405248678021393
Chapter II Neoplasms,Melanoma in situ,C2,Complement C2,24499,53,1.23 [0.40-3.72],0.7176249750322259
Chapter II Neoplasms,Melanoma in situ,C2CD2L,Phospholipid transfer protein C2CD2L,23848,51,1.48 [1.01-2.18],0.0436616896870049
Chapter II Neoplasms,Melanoma in situ,C2orf69,UPF0565 protein C2orf69,20638,38,1.10 [0.68-1.78],0.7003703260155849
Chapter II Neoplasms,Melanoma in situ,C3,Complement C3,20192,40,1.10 [0.57-2.09],0.78193647704963
Chapter II Neoplasms,Melanoma in situ,C4BPB,C4b-binding protein beta chain,24519,53,0.89 [0.48-1.65],0.7027232926388252
Chapter II Neoplasms,Melanoma in situ,C5,Complement C5,21249,41,0.61 [0.08-4.59],0.6315881282823131
Chapter II Neoplasms,Melanoma in situ,C7,Complement component C7,20763,41,0.74 [0.30-1.86],0.5249450971267673
Chapter II Neoplasms,Melanoma in situ,C7orf50,Uncharacterized protein C7orf50,21166,40,1.07 [0.34-3.41],0.9062266583574806
Chapter II Neoplasms,Melanoma in situ,C8B,Complement component C8 beta chain,21249,41,1.73 [0.65-4.61],0.2745019139500162
Chapter II Neoplasms,Melanoma in situ,C9,Complement component C9,21229,41,1.03 [0.58-1.81],0.9298415388145186
Chapter II Neoplasms,Melanoma in situ,C9orf40,Uncharacterized protein C9orf40,21131,40,0.71 [0.48-1.04],0.0819627330808652
Chapter II Neoplasms,Melanoma in situ,CA1,Carbonic anhydrase 1,23898,52,0.74 [0.49-1.12],0.1602593526083826
Chapter II Neoplasms,Melanoma in situ,CA11,Carbonic anhydrase-related protein 11,23885,50,0.89 [0.38-2.09],0.7801529685572383
Chapter II Neoplasms,Melanoma in situ,CA12,Carbonic anhydrase 12,24350,50,0.93 [0.41-2.08],0.8577221946752982
Chapter II Neoplasms,Melanoma in situ,CA13,Carbonic anhydrase 13,24189,53,1.17 [0.92-1.48],0.2065635865143434
Chapter II Neoplasms,Melanoma in situ,CA14,Carbonic anhydrase 14,24689,52,0.90 [0.44-1.84],0.7746885921764768
Chapter II Neoplasms,Melanoma in situ,CA2,Carbonic anhydrase 2,24391,53,0.74 [0.51-1.06],0.0970195220685554
Chapter II Neoplasms,Melanoma in situ,CA3,Carbonic anhydrase 3,24723,53,0.55 [0.36-0.86],0.0090507173834363
Chapter II Neoplasms,Melanoma in situ,CA4,Carbonic anhydrase 4,24765,53,0.93 [0.33-2.64],0.8906637680483417
Chapter II Neoplasms,Melanoma in situ,CA5A,"Carbonic anhydrase 5A, mitochondrial",24041,51,0.88 [0.66-1.17],0.3683762616224733
Chapter II Neoplasms,Melanoma in situ,CA6,Carbonic anhydrase 6,24385,53,0.96 [0.65-1.41],0.823852876990076
Chapter II Neoplasms,Melanoma in situ,CA7,Carbonic anhydrase 7,20824,40,1.08 [0.47-2.50],0.8591005303631924
Chapter II Neoplasms,Melanoma in situ,CA8,Carbonic anhydrase-related protein,20617,41,1.15 [0.43-3.07],0.7854438457585597
Chapter II Neoplasms,Melanoma in situ,CA9,Carbonic anhydrase 9,24689,52,1.19 [0.67-2.09],0.5552856109659756
Chapter II Neoplasms,Melanoma in situ,CABP2,Calcium-binding protein 2,20638,38,1.13 [0.74-1.72],0.5839213555325944
Chapter II Neoplasms,Melanoma in situ,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,20569,40,0.93 [0.36-2.42],0.883290463068531
Chapter II Neoplasms,Melanoma in situ,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,20559,37,1.26 [0.88-1.81],0.209418739363686
Chapter II Neoplasms,Melanoma in situ,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,20569,40,1.00 [0.61-1.64],0.9930636569595296
Chapter II Neoplasms,Melanoma in situ,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,21191,40,1.29 [0.91-1.84],0.1533410627408389
Chapter II Neoplasms,Melanoma in situ,CACYBP,Calcyclin-binding protein,20700,40,1.33 [0.98-1.79],0.067119829349202
Chapter II Neoplasms,Melanoma in situ,CADPS,Calcium-dependent secretion activator 1,20638,38,0.89 [0.42-1.92],0.7755626832486471
Chapter II Neoplasms,Melanoma in situ,CALB1,Calbindin,24350,50,0.97 [0.53-1.77],0.927984874473584
Chapter II Neoplasms,Melanoma in situ,CALB2,Calretinin,23895,51,2.01 [1.04-3.87],0.0365958936487286
Chapter II Neoplasms,Melanoma in situ,CALCA,Calcitonin,24266,49,0.85 [0.54-1.32],0.4684847060099454
Chapter II Neoplasms,Melanoma in situ,CALCB,Calcitonin gene-related peptide 2,21166,40,0.47 [0.18-1.20],0.1137822462918702
Chapter II Neoplasms,Melanoma in situ,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,24619,52,1.09 [0.86-1.37],0.4803993973185363
Chapter II Neoplasms,Melanoma in situ,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,20637,41,1.40 [0.97-2.02],0.076136093537948
Chapter II Neoplasms,Melanoma in situ,CALY,Neuron-specific vesicular protein calcyon,20559,37,1.06 [0.47-2.41],0.8821237850511697
Chapter II Neoplasms,Melanoma in situ,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,23885,50,1.14 [0.67-1.96],0.624294802942698
Chapter II Neoplasms,Melanoma in situ,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,20638,38,0.91 [0.49-1.69],0.7682595183289869
Chapter II Neoplasms,Melanoma in situ,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,21191,40,1.34 [1.03-1.76],0.0310930272879571
Chapter II Neoplasms,Melanoma in situ,CANT1,Soluble calcium-activated nucleotidase 1,24413,52,1.26 [0.36-4.34],0.7171318683251644
Chapter II Neoplasms,Melanoma in situ,CAPG,Macrophage-capping protein,24318,52,0.94 [0.62-1.42],0.7764545099707272
Chapter II Neoplasms,Melanoma in situ,CAPN3,Calpain-3,21108,40,0.77 [0.31-1.90],0.5689425002238653
Chapter II Neoplasms,Melanoma in situ,CAPS,Calcyphosin,21166,40,1.09 [0.83-1.44],0.5220566999189982
Chapter II Neoplasms,Melanoma in situ,CARHSP1,Calcium-regulated heat-stable protein 1,23895,51,0.83 [0.50-1.36],0.4544239628807266
Chapter II Neoplasms,Melanoma in situ,CASC3,Protein CASC3,20638,38,1.69 [0.91-3.14],0.0994473646128787
Chapter II Neoplasms,Melanoma in situ,CASP1,Caspase-1,23895,51,1.13 [0.81-1.59],0.4695414665532064
Chapter II Neoplasms,Melanoma in situ,CASP10,Caspase-10,23895,51,0.90 [0.64-1.27],0.5587752527557097
Chapter II Neoplasms,Melanoma in situ,CASP2,Caspase-2,24460,52,1.11 [0.78-1.58],0.5502229275943473
Chapter II Neoplasms,Melanoma in situ,CASP3,Caspase-3,24765,53,1.14 [0.87-1.50],0.3388230539597002
Chapter II Neoplasms,Melanoma in situ,CASP4,Caspase-4,20824,40,1.01 [0.85-1.21],0.8687400350660276
Chapter II Neoplasms,Melanoma in situ,CASP7,Caspase-7,21166,40,1.42 [1.00-2.01],0.0496546094046016
Chapter II Neoplasms,Melanoma in situ,CASP8,Caspase-8,24626,52,1.06 [0.73-1.54],0.7698843297490544
Chapter II Neoplasms,Melanoma in situ,CASP9,Caspase-9,20617,41,1.32 [0.88-1.97],0.1837294368101892
Chapter II Neoplasms,Melanoma in situ,CASQ2,Calsequestrin-2,20559,37,0.65 [0.28-1.52],0.3229482554973985
Chapter II Neoplasms,Melanoma in situ,CAT,Catalase,20904,41,0.51 [0.27-0.95],0.034644396370239
Chapter II Neoplasms,Melanoma in situ,CBLIF,Cobalamin binding intrinsic factor,24454,53,1.00 [0.70-1.43],0.992109351500176
Chapter II Neoplasms,Melanoma in situ,CBLN1,Cerebellin-1,20569,40,0.75 [0.48-1.16],0.1928709870051468
Chapter II Neoplasms,Melanoma in situ,CBLN4,Cerebellin-4,24689,52,0.52 [0.24-1.11],0.0919577681438683
Chapter II Neoplasms,Melanoma in situ,CBS,Cystathionine beta-synthase,20637,41,1.07 [0.61-1.87],0.8167813348933162
Chapter II Neoplasms,Melanoma in situ,CBX2,Chromobox protein homolog 2,20559,37,1.40 [0.81-2.42],0.2306172582601902
Chapter II Neoplasms,Melanoma in situ,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,24313,49,1.11 [0.80-1.55],0.5357325228005764
Chapter II Neoplasms,Melanoma in situ,CCAR2,Cell cycle and apoptosis regulator protein 2,21166,40,0.61 [0.27-1.37],0.2323360190338218
Chapter II Neoplasms,Melanoma in situ,CCDC134,Coiled-coil domain-containing protein 134,21108,40,1.36 [0.79-2.34],0.2596277752437234
Chapter II Neoplasms,Melanoma in situ,CCDC28A,Coiled-coil domain-containing protein 28A,20638,38,1.61 [0.58-4.50],0.3637607829437513
Chapter II Neoplasms,Melanoma in situ,CCDC50,Coiled-coil domain-containing protein 50,21191,40,0.99 [0.67-1.46],0.958227408608984
Chapter II Neoplasms,Melanoma in situ,CCDC80,Coiled-coil domain-containing protein 80,24482,53,0.79 [0.37-1.70],0.5492706781507194
Chapter II Neoplasms,Melanoma in situ,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,20637,41,0.86 [0.52-1.43],0.5658595056132815
Chapter II Neoplasms,Melanoma in situ,CCL11,Eotaxin,24769,52,0.82 [0.43-1.54],0.5296366043943752
Chapter II Neoplasms,Melanoma in situ,CCL13,C-C motif chemokine 13,24729,52,0.89 [0.62-1.27],0.524266456152367
Chapter II Neoplasms,Melanoma in situ,CCL14,C-C motif chemokine 14,24368,53,1.03 [0.55-1.91],0.9292873412366728
Chapter II Neoplasms,Melanoma in situ,CCL15,C-C motif chemokine 15,24765,53,0.81 [0.44-1.49],0.5071560690226637
Chapter II Neoplasms,Melanoma in situ,CCL16,C-C motif chemokine 16,24765,53,1.24 [0.74-2.07],0.408013354437292
Chapter II Neoplasms,Melanoma in situ,CCL17,C-C motif chemokine 17,24400,52,1.12 [0.86-1.46],0.4114292995128693
Chapter II Neoplasms,Melanoma in situ,CCL18,C-C motif chemokine 18,24104,52,1.06 [0.76-1.46],0.7383095262260542
Chapter II Neoplasms,Melanoma in situ,CCL19,C-C motif chemokine 19,24707,53,1.01 [0.83-1.24],0.8958511449917649
Chapter II Neoplasms,Melanoma in situ,CCL2,C-C motif chemokine 2,24272,49,0.82 [0.50-1.34],0.4259104660413617
Chapter II Neoplasms,Melanoma in situ,CCL20,C-C motif chemokine 20,24769,52,0.88 [0.64-1.21],0.4318649616976743
Chapter II Neoplasms,Melanoma in situ,CCL21,C-C motif chemokine 21,24564,52,0.47 [0.23-0.94],0.0317388508537998
Chapter II Neoplasms,Melanoma in situ,CCL22,C-C motif chemokine 22,24175,51,0.99 [0.61-1.61],0.9592326436008493
Chapter II Neoplasms,Melanoma in situ,CCL23,C-C motif chemokine 23,24564,52,1.29 [0.71-2.34],0.4102398525474244
Chapter II Neoplasms,Melanoma in situ,CCL24,C-C motif chemokine 24,24529,52,1.08 [0.81-1.44],0.6092741365101448
Chapter II Neoplasms,Melanoma in situ,CCL25,C-C motif chemokine 25,24769,52,1.62 [1.01-2.61],0.0460628834146258
Chapter II Neoplasms,Melanoma in situ,CCL26,C-C motif chemokine 26,24460,52,1.03 [0.79-1.36],0.8051135508842183
Chapter II Neoplasms,Melanoma in situ,CCL27,C-C motif chemokine 27,24482,53,0.96 [0.65-1.41],0.8239704204150953
Chapter II Neoplasms,Melanoma in situ,CCL28,C-C motif chemokine 28,24387,52,1.10 [0.73-1.67],0.6400322156481769
Chapter II Neoplasms,Melanoma in situ,CCL3,C-C motif chemokine 3,24460,52,1.23 [0.85-1.78],0.278521056699562
Chapter II Neoplasms,Melanoma in situ,CCL4,C-C motif chemokine 4,24476,52,0.99 [0.67-1.46],0.965866930993918
Chapter II Neoplasms,Melanoma in situ,CCL5,C-C motif chemokine 5,24528,53,1.04 [0.82-1.32],0.7351016362972661
Chapter II Neoplasms,Melanoma in situ,CCL7,C-C motif chemokine 7,24460,52,1.16 [0.80-1.68],0.4432915076855129
Chapter II Neoplasms,Melanoma in situ,CCL8,C-C motif chemokine 8,24658,52,1.11 [0.74-1.67],0.5990650672295104
Chapter II Neoplasms,Melanoma in situ,CCN1,CCN family member 1,24316,50,1.05 [0.76-1.46],0.7733567714003333
Chapter II Neoplasms,Melanoma in situ,CCN2,CCN family member 2,24462,52,0.98 [0.65-1.49],0.9410386569187364
Chapter II Neoplasms,Melanoma in situ,CCN3,CCN family member 3,24724,53,1.26 [0.60-2.66],0.5468450216500147
Chapter II Neoplasms,Melanoma in situ,CCN4,CCN family member 4,24689,52,1.52 [0.86-2.67],0.1485942165443568
Chapter II Neoplasms,Melanoma in situ,CCN5,CCN family member 5,24462,53,0.82 [0.44-1.53],0.5308689087215815
Chapter II Neoplasms,Melanoma in situ,CCND2,G1/S-specific cyclin-D2,20824,40,1.56 [0.68-3.60],0.2977228901165053
Chapter II Neoplasms,Melanoma in situ,CCNE1,G1/S-specific cyclin-E1,20617,41,0.99 [0.73-1.34],0.9270301809079468
Chapter II Neoplasms,Melanoma in situ,CCS,Copper chaperone for superoxide dismutase,24313,49,0.96 [0.56-1.62],0.8650044065935598
Chapter II Neoplasms,Melanoma in situ,CCT5,T-complex protein 1 subunit epsilon,23885,50,0.91 [0.50-1.64],0.753415883986371
Chapter II Neoplasms,Melanoma in situ,CD101,Immunoglobulin superfamily member 2,21131,40,0.59 [0.32-1.09],0.0905080997411241
Chapter II Neoplasms,Melanoma in situ,CD109,CD109 antigen,24462,53,0.91 [0.44-1.88],0.7935678042221392
Chapter II Neoplasms,Melanoma in situ,CD14,Monocyte differentiation antigen CD14,23919,52,1.50 [0.83-2.68],0.1758636392481372
Chapter II Neoplasms,Melanoma in situ,CD160,CD160 antigen,24769,52,1.25 [0.73-2.15],0.4197889899558708
Chapter II Neoplasms,Melanoma in situ,CD163,Scavenger receptor cysteine-rich type 1 protein M130,24528,53,1.11 [0.63-1.96],0.7082797730388337
Chapter II Neoplasms,Melanoma in situ,CD164,Sialomucin core protein 24,24462,53,0.87 [0.32-2.33],0.7814982844449345
Chapter II Neoplasms,Melanoma in situ,CD164L2,CD164 sialomucin-like 2 protein,20638,38,1.37 [0.66-2.86],0.4016360922250183
Chapter II Neoplasms,Melanoma in situ,CD177,CD177 antigen,24427,53,0.84 [0.72-0.99],0.0417720796934335
Chapter II Neoplasms,Melanoma in situ,CD1C,T-cell surface glycoprotein CD1c,24519,53,1.08 [0.38-3.12],0.8814823423303133
Chapter II Neoplasms,Melanoma in situ,CD2,T-cell surface antigen CD2,20559,37,1.13 [0.55-2.34],0.7439952561674892
Chapter II Neoplasms,Melanoma in situ,CD200,OX-2 membrane glycoprotein,24460,52,0.75 [0.28-2.00],0.5633867464602048
Chapter II Neoplasms,Melanoma in situ,CD200R1,Cell surface glycoprotein CD200 receptor 1,24379,52,0.61 [0.29-1.29],0.1939729408760671
Chapter II Neoplasms,Melanoma in situ,CD207,C-type lectin domain family 4 member K,23936,49,0.91 [0.46-1.80],0.7910386617952949
Chapter II Neoplasms,Melanoma in situ,CD209,CD209 antigen,24509,53,0.66 [0.34-1.25],0.2027259424928036
Chapter II Neoplasms,Melanoma in situ,CD22,B-cell receptor CD22,24769,52,0.58 [0.31-1.10],0.0942067505841763
Chapter II Neoplasms,Melanoma in situ,CD226,CD226 antigen,20617,41,2.03 [1.03-4.02],0.0412169465720989
Chapter II Neoplasms,Melanoma in situ,CD244,Natural killer cell receptor 2B4,24769,52,1.31 [0.53-3.22],0.5579655324344999
Chapter II Neoplasms,Melanoma in situ,CD248,Endosialin,21216,41,1.08 [0.51-2.31],0.8401013634722502
Chapter II Neoplasms,Melanoma in situ,CD27,CD27 antigen,24519,53,0.88 [0.46-1.68],0.690494359540669
Chapter II Neoplasms,Melanoma in situ,CD274,Programmed cell death 1 ligand 1,24313,49,1.18 [0.57-2.45],0.6577937194676846
Chapter II Neoplasms,Melanoma in situ,CD276,CD276 antigen,24444,52,0.72 [0.37-1.40],0.333507817158313
Chapter II Neoplasms,Melanoma in situ,CD28,T-cell-specific surface glycoprotein CD28,23885,50,0.56 [0.26-1.18],0.1259475979468117
Chapter II Neoplasms,Melanoma in situ,CD2AP,CD2-associated protein,24482,53,1.24 [0.86-1.79],0.2574612486861889
Chapter II Neoplasms,Melanoma in situ,CD300A,CMRF35-like molecule 8,20746,40,1.19 [0.42-3.34],0.7432695671176038
Chapter II Neoplasms,Melanoma in situ,CD300C,CMRF35-like molecule 6,24707,53,0.95 [0.45-2.00],0.8904817893332811
Chapter II Neoplasms,Melanoma in situ,CD300E,CMRF35-like molecule 2,24614,52,1.10 [0.58-2.08],0.7741614371289899
Chapter II Neoplasms,Melanoma in situ,CD300LF,CMRF35-like molecule 1,24689,52,1.18 [0.75-1.86],0.4726375386156068
Chapter II Neoplasms,Melanoma in situ,CD300LG,CMRF35-like molecule 9,24462,53,0.85 [0.43-1.64],0.6202752291512351
Chapter II Neoplasms,Melanoma in situ,CD302,CD302 antigen,24350,50,1.34 [0.56-3.20],0.5146226238922402
Chapter II Neoplasms,Melanoma in situ,CD33,Myeloid cell surface antigen CD33,24519,53,0.84 [0.63-1.12],0.2478456902018155
Chapter II Neoplasms,Melanoma in situ,CD34,Hematopoietic progenitor cell antigen CD34,24612,53,1.08 [0.40-2.94],0.8775390803269362
Chapter II Neoplasms,Melanoma in situ,CD36,Platelet glycoprotein 4,20617,41,1.73 [0.93-3.23],0.0862420333736367
Chapter II Neoplasms,Melanoma in situ,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,24350,50,1.12 [0.48-2.60],0.7996264710579247
Chapter II Neoplasms,Melanoma in situ,CD3D,T-cell surface glycoprotein CD3 delta chain,20569,40,0.73 [0.27-2.00],0.540057592245796
Chapter II Neoplasms,Melanoma in situ,CD3E,T-cell surface glycoprotein CD3 epsilon chain,20824,40,0.79 [0.29-2.13],0.6457411118123032
Chapter II Neoplasms,Melanoma in situ,CD3G,T-cell surface glycoprotein CD3 gamma chain,20617,41,0.94 [0.66-1.35],0.7523955416647353
Chapter II Neoplasms,Melanoma in situ,CD4,T-cell surface glycoprotein CD4,24416,52,0.81 [0.32-2.01],0.644074041997689
Chapter II Neoplasms,Melanoma in situ,CD40,Tumor necrosis factor receptor superfamily member 5,24441,52,1.18 [0.73-1.90],0.4928033937903119
Chapter II Neoplasms,Melanoma in situ,CD40LG,CD40 ligand,24769,52,1.09 [0.80-1.49],0.589660483256109
Chapter II Neoplasms,Melanoma in situ,CD46,Membrane cofactor protein,24283,53,1.31 [0.57-3.02],0.523884496769984
Chapter II Neoplasms,Melanoma in situ,CD48,CD48 antigen,24529,52,0.76 [0.32-1.77],0.5204205500776494
Chapter II Neoplasms,Melanoma in situ,CD5,T-cell surface glycoprotein CD5,24658,52,1.17 [0.55-2.49],0.6754390219987214
Chapter II Neoplasms,Melanoma in situ,CD55,Complement decay-accelerating factor,23593,51,0.73 [0.26-2.06],0.5577067940820177
Chapter II Neoplasms,Melanoma in situ,CD58,Lymphocyte function-associated antigen 3,24393,51,1.24 [0.30-5.18],0.7681546681738881
Chapter II Neoplasms,Melanoma in situ,CD59,CD59 glycoprotein,23551,49,0.84 [0.23-3.08],0.7923261984500051
Chapter II Neoplasms,Melanoma in situ,CD5L,CD5 antigen-like,21139,41,1.46 [0.79-2.70],0.2325112357989277
Chapter II Neoplasms,Melanoma in situ,CD6,T-cell differentiation antigen CD6,24721,52,1.03 [0.65-1.62],0.9147584686789912
Chapter II Neoplasms,Melanoma in situ,CD63,CD63 antigen,24272,49,1.00 [0.62-1.64],0.9864277771332486
Chapter II Neoplasms,Melanoma in situ,CD69,Early activation antigen CD69,24349,53,1.13 [0.86-1.49],0.3878294583517035
Chapter II Neoplasms,Melanoma in situ,CD7,T-cell antigen CD7,20583,41,1.15 [0.58-2.30],0.6841016394748426
Chapter II Neoplasms,Melanoma in situ,CD70,CD70 antigen,24460,52,1.30 [0.73-2.32],0.3734016047766654
Chapter II Neoplasms,Melanoma in situ,CD72,B-cell differentiation antigen CD72,20746,40,0.88 [0.41-1.89],0.7425537279137919
Chapter II Neoplasms,Melanoma in situ,CD74,HLA class II histocompatibility antigen gamma chain,24707,53,0.80 [0.38-1.69],0.5650682129532862
Chapter II Neoplasms,Melanoma in situ,CD79B,B-cell antigen receptor complex-associated protein beta chain,24769,52,0.66 [0.35-1.23],0.1927269998697969
Chapter II Neoplasms,Melanoma in situ,CD80,T-lymphocyte activation antigen CD80,21225,41,0.69 [0.27-1.77],0.4358647476643271
Chapter II Neoplasms,Melanoma in situ,CD82,CD82 antigen,20824,40,1.37 [0.81-2.34],0.2417698500123626
Chapter II Neoplasms,Melanoma in situ,CD83,CD83 antigen,24460,52,0.97 [0.45-2.12],0.9418013442661786
Chapter II Neoplasms,Melanoma in situ,CD84,SLAM family member 5,24460,52,1.26 [0.57-2.78],0.5726988457119861
Chapter II Neoplasms,Melanoma in situ,CD86,T-lymphocyte activation antigen CD86,21131,40,0.77 [0.29-2.07],0.6050893410419454
Chapter II Neoplasms,Melanoma in situ,CD8A,T-cell surface glycoprotein CD8 alpha chain,24707,53,0.87 [0.52-1.44],0.5815548733189009
Chapter II Neoplasms,Melanoma in situ,CD93,Complement component C1q receptor,23499,52,0.99 [0.43-2.24],0.9716567519826328
Chapter II Neoplasms,Melanoma in situ,CD99,CD99 antigen,24462,53,1.49 [0.42-5.27],0.5387769284622577
Chapter II Neoplasms,Melanoma in situ,CD99L2,CD99 antigen-like protein 2,24462,53,1.29 [0.46-3.59],0.6241736496314036
Chapter II Neoplasms,Melanoma in situ,CDA,Cytidine deaminase,21191,41,0.67 [0.35-1.29],0.2326391838262681
Chapter II Neoplasms,Melanoma in situ,CDAN1,Codanin-1,21166,40,1.60 [0.61-4.25],0.3419906126535771
Chapter II Neoplasms,Melanoma in situ,CDC123,Cell division cycle protein 123 homolog,20471,40,1.21 [0.83-1.76],0.3167328054217193
Chapter II Neoplasms,Melanoma in situ,CDC25A,M-phase inducer phosphatase 1,20471,40,1.35 [0.77-2.36],0.2890229851469132
Chapter II Neoplasms,Melanoma in situ,CDC26,Anaphase-promoting complex subunit CDC26,21095,40,1.58 [1.06-2.34],0.0235185116064497
Chapter II Neoplasms,Melanoma in situ,CDC27,Cell division cycle protein 27 homolog,23885,50,1.32 [0.90-1.92],0.1508912756407067
Chapter II Neoplasms,Melanoma in situ,CDC37,Hsp90 co-chaperone Cdc37,24519,53,1.16 [0.87-1.54],0.3161854021410856
Chapter II Neoplasms,Melanoma in situ,CDC42BPB,Serine/threonine-protein kinase MRCK beta,21131,40,1.29 [0.97-1.71],0.0778444267060441
Chapter II Neoplasms,Melanoma in situ,CDCP1,CUB domain-containing protein 1,24313,49,1.40 [0.86-2.26],0.1728228672750422
Chapter II Neoplasms,Melanoma in situ,CDH1,Cadherin-1,23611,52,1.31 [0.78-2.19],0.3037327681440757
Chapter II Neoplasms,Melanoma in situ,CDH15,Cadherin-15,24660,53,1.09 [0.71-1.69],0.6962574078821655
Chapter II Neoplasms,Melanoma in situ,CDH17,Cadherin-17,24482,53,1.11 [0.77-1.58],0.5769764338011554
Chapter II Neoplasms,Melanoma in situ,CDH2,Cadherin-2,24482,53,1.31 [0.65-2.66],0.4484408141631588
Chapter II Neoplasms,Melanoma in situ,CDH22,Cadherin-22,20824,40,0.45 [0.13-1.52],0.198900720078369
Chapter II Neoplasms,Melanoma in situ,CDH23,Cadherin-23,21166,40,0.99 [0.33-3.02],0.989182191831856
Chapter II Neoplasms,Melanoma in situ,CDH3,Cadherin-3,24707,53,0.95 [0.47-1.95],0.8986162083551759
Chapter II Neoplasms,Melanoma in situ,CDH4,Cadherin-4,20569,40,0.65 [0.31-1.38],0.2622543591060126
Chapter II Neoplasms,Melanoma in situ,CDH5,Cadherin-5,24765,53,1.34 [0.61-2.94],0.4610943169780008
Chapter II Neoplasms,Melanoma in situ,CDH6,Cadherin-6,24482,53,0.81 [0.42-1.54],0.520943441691365
Chapter II Neoplasms,Melanoma in situ,CDHR1,Cadherin-related family member 1,23895,51,0.87 [0.47-1.62],0.6611606333507106
Chapter II Neoplasms,Melanoma in situ,CDHR2,Cadherin-related family member 2,24350,50,0.83 [0.59-1.16],0.2779657176643137
Chapter II Neoplasms,Melanoma in situ,CDHR5,Cadherin-related family member 5,24482,53,0.70 [0.39-1.27],0.243253763454981
Chapter II Neoplasms,Melanoma in situ,CDK1,Cyclin-dependent kinase 1,20471,40,1.09 [0.48-2.50],0.8339529606957878
Chapter II Neoplasms,Melanoma in situ,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,21191,40,1.12 [0.71-1.78],0.6143337862418354
Chapter II Neoplasms,Melanoma in situ,CDKL5,Cyclin-dependent kinase-like 5,20569,40,1.21 [0.75-1.95],0.4295383220350821
Chapter II Neoplasms,Melanoma in situ,CDKN1A,Cyclin-dependent kinase inhibitor 1,24350,50,1.14 [0.90-1.44],0.2877713934861175
Chapter II Neoplasms,Melanoma in situ,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,24350,50,1.12 [0.86-1.47],0.406943831299821
Chapter II Neoplasms,Melanoma in situ,CDNF,Cerebral dopamine neurotrophic factor,24350,50,1.38 [0.69-2.78],0.3584603705063531
Chapter II Neoplasms,Melanoma in situ,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,24488,52,0.54 [0.22-1.34],0.1841369369514616
Chapter II Neoplasms,Melanoma in situ,CDSN,Corneodesmosin,24688,52,1.19 [0.67-2.13],0.5500578304897433
Chapter II Neoplasms,Melanoma in situ,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,24481,53,0.51 [0.18-1.49],0.2199407877181748
Chapter II Neoplasms,Melanoma in situ,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,21131,40,1.03 [0.71-1.49],0.8755833682452261
Chapter II Neoplasms,Melanoma in situ,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,20824,40,1.23 [0.88-1.73],0.2220745191198657
Chapter II Neoplasms,Melanoma in situ,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,21131,40,0.73 [0.33-1.59],0.4241058497220583
Chapter II Neoplasms,Melanoma in situ,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20824,40,1.01 [0.51-2.01],0.972382254431165
Chapter II Neoplasms,Melanoma in situ,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,24460,52,0.82 [0.60-1.12],0.2202184363934302
Chapter II Neoplasms,Melanoma in situ,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,23885,50,0.67 [0.38-1.20],0.176436902946882
Chapter II Neoplasms,Melanoma in situ,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,23536,50,1.19 [0.79-1.79],0.4169247729086307
Chapter II Neoplasms,Melanoma in situ,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,21216,41,0.93 [0.41-2.09],0.8518208025765844
Chapter II Neoplasms,Melanoma in situ,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,24041,51,0.78 [0.46-1.33],0.3588319261349638
Chapter II Neoplasms,Melanoma in situ,CEBPA,CCAAT/enhancer-binding protein alpha,20617,41,1.17 [0.62-2.19],0.6247268579599929
Chapter II Neoplasms,Melanoma in situ,CEBPB,CCAAT/enhancer-binding protein beta,24041,51,0.41 [0.20-0.85],0.0171181084549894
Chapter II Neoplasms,Melanoma in situ,CELA2A,Chymotrypsin-like elastase family member 2A,21216,41,0.89 [0.54-1.48],0.6509133730117931
Chapter II Neoplasms,Melanoma in situ,CELA3A,Chymotrypsin-like elastase family member 3A,24720,53,0.87 [0.56-1.34],0.5197089792940432
Chapter II Neoplasms,Melanoma in situ,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,20746,40,0.49 [0.16-1.46],0.199520455573678
Chapter II Neoplasms,Melanoma in situ,CEMIP2,Cell surface hyaluronidase,20617,41,1.42 [0.76-2.65],0.2660186704516436
Chapter II Neoplasms,Melanoma in situ,CEND1,Cell cycle exit and neuronal differentiation protein 1,20569,40,0.70 [0.36-1.38],0.3066416226076462
Chapter II Neoplasms,Melanoma in situ,CENPF,Centromere protein F,20824,40,0.67 [0.37-1.23],0.1978334405417326
Chapter II Neoplasms,Melanoma in situ,CENPJ,Centromere protein J,20824,40,1.28 [0.92-1.78],0.143972446155905
Chapter II Neoplasms,Melanoma in situ,CEP112,Centrosomal protein of 112 kDa,20559,37,0.92 [0.44-1.93],0.8295963789520434
Chapter II Neoplasms,Melanoma in situ,CEP152,Centrosomal protein of 152 kDa,20471,40,0.96 [0.47-1.96],0.9190911169098124
Chapter II Neoplasms,Melanoma in situ,CEP164,Centrosomal protein of 164 kDa,24024,50,1.12 [0.80-1.59],0.5028979065472177
Chapter II Neoplasms,Melanoma in situ,CEP170,Centrosomal protein of 170 kDa,20637,41,1.30 [0.91-1.86],0.1464131547869091
Chapter II Neoplasms,Melanoma in situ,CEP20,Centrosomal protein 20,23885,50,1.07 [0.77-1.50],0.6791231950591475
Chapter II Neoplasms,Melanoma in situ,CEP290,Centrosomal protein of 290 kDa,20824,40,0.71 [0.36-1.42],0.3343627960649864
Chapter II Neoplasms,Melanoma in situ,CEP350,Centrosome-associated protein 350,20471,40,0.78 [0.33-1.87],0.5817078461025982
Chapter II Neoplasms,Melanoma in situ,CEP43,Centrosomal protein 43,23847,49,1.15 [0.80-1.65],0.4420509366138789
Chapter II Neoplasms,Melanoma in situ,CEP85,Centrosomal protein of 85 kDa,23885,50,1.27 [0.88-1.84],0.2072670289682149
Chapter II Neoplasms,Melanoma in situ,CERT,Ceramide transfer protein,23895,51,1.24 [0.83-1.84],0.2936528374157338
Chapter II Neoplasms,Melanoma in situ,CES1,Liver carboxylesterase 1,24504,51,1.27 [0.96-1.69],0.0976109938185187
Chapter II Neoplasms,Melanoma in situ,CES2,Cocaine esterase,24350,50,1.09 [0.69-1.72],0.706136319123198
Chapter II Neoplasms,Melanoma in situ,CES3,Carboxylesterase 3,24350,50,1.15 [0.81-1.63],0.4451544451351947
Chapter II Neoplasms,Melanoma in situ,CETN2,Centrin-2,23895,51,1.18 [0.83-1.68],0.3502275142942987
Chapter II Neoplasms,Melanoma in situ,CETN3,Centrin-3,21131,40,1.54 [1.08-2.20],0.0173099205096769
Chapter II Neoplasms,Melanoma in situ,CFB,Complement factor B,20859,41,0.73 [0.30-1.82],0.5042448974130018
Chapter II Neoplasms,Melanoma in situ,CFC1,Cryptic protein,23885,50,1.09 [0.66-1.80],0.7356002599830815
Chapter II Neoplasms,Melanoma in situ,CFD,Complement factor D,21249,41,1.05 [0.22-4.99],0.948573984957112
Chapter II Neoplasms,Melanoma in situ,CFH,Complement factor H,20031,40,1.07 [0.29-3.90],0.919531588816554
Chapter II Neoplasms,Melanoma in situ,CFHR2,Complement factor H-related protein 2,21097,41,1.52 [0.83-2.76],0.172053034451732
Chapter II Neoplasms,Melanoma in situ,CFHR4,Complement factor H-related protein 4,21210,41,1.08 [0.71-1.65],0.712513372688714
Chapter II Neoplasms,Melanoma in situ,CFHR5,Complement factor H-related protein 5,20961,40,1.79 [0.83-3.88],0.1407610104815441
Chapter II Neoplasms,Melanoma in situ,CFI,Complement factor I,21249,41,0.61 [0.14-2.70],0.518398907598771
Chapter II Neoplasms,Melanoma in situ,CFP,Properdin,21249,41,0.84 [0.22-3.24],0.7946805570526614
Chapter II Neoplasms,Melanoma in situ,CGA,Glycoprotein hormones alpha chain,24462,53,1.09 [0.82-1.44],0.5655697656384846
Chapter II Neoplasms,Melanoma in situ,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,21229,41,1.35 [0.98-1.86],0.0698177455812304
Chapter II Neoplasms,Melanoma in situ,CGN,Cingulin,20638,38,0.65 [0.25-1.64],0.355738837223216
Chapter II Neoplasms,Melanoma in situ,CGREF1,Cell growth regulator with EF hand domain protein 1,24482,53,1.03 [0.57-1.85],0.9216070754796998
Chapter II Neoplasms,Melanoma in situ,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,23885,50,0.91 [0.59-1.39],0.6581656709108956
Chapter II Neoplasms,Melanoma in situ,CHAD,Chondroadherin,20746,40,0.67 [0.37-1.21],0.1854171857320989
Chapter II Neoplasms,Melanoma in situ,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21166,40,0.99 [0.45-2.16],0.971528125396336
Chapter II Neoplasms,Melanoma in situ,CHCHD6,MICOS complex subunit MIC25,21108,40,0.90 [0.30-2.72],0.8511352093527578
Chapter II Neoplasms,Melanoma in situ,CHEK2,Serine/threonine-protein kinase Chk2,24041,51,0.99 [0.48-2.04],0.9752622538314611
Chapter II Neoplasms,Melanoma in situ,CHGA,Chromogranin-A,21216,41,1.08 [0.75-1.54],0.6820051339838237
Chapter II Neoplasms,Melanoma in situ,CHGB,Secretogranin-1,24619,53,0.59 [0.31-1.10],0.0969820419852188
Chapter II Neoplasms,Melanoma in situ,CHI3L1,Chitinase-3-like protein 1,23875,52,1.11 [0.80-1.53],0.5453622169394876
Chapter II Neoplasms,Melanoma in situ,CHIT1,Chitotriosidase-1,24557,51,1.11 [0.90-1.37],0.3374919019073264
Chapter II Neoplasms,Melanoma in situ,CHL1,Neural cell adhesion molecule L1-like protein,24485,53,0.35 [0.16-0.80],0.0127491365959699
Chapter II Neoplasms,Melanoma in situ,CHM,Rab proteins geranylgeranyltransferase component A 1,20638,38,1.24 [0.76-2.02],0.3901866847393677
Chapter II Neoplasms,Melanoma in situ,CHMP1A,Charged multivesicular body protein 1a,24313,49,1.15 [0.83-1.59],0.3936192514503867
Chapter II Neoplasms,Melanoma in situ,CHMP6,Charged multivesicular body protein 6,21225,41,1.72 [1.03-2.88],0.0384567076718562
Chapter II Neoplasms,Melanoma in situ,CHP1,Calcineurin B homologous protein 1,20569,40,0.79 [0.49-1.28],0.3387959827188055
Chapter II Neoplasms,Melanoma in situ,CHRDL1,Chordin-like protein 1,24529,52,0.62 [0.28-1.38],0.2443145667795597
Chapter II Neoplasms,Melanoma in situ,CHRDL2,Chordin-like protein 2,24482,53,0.90 [0.58-1.39],0.6349921166913626
Chapter II Neoplasms,Melanoma in situ,CHRM1,Muscarinic acetylcholine receptor M1,20638,38,0.83 [0.33-2.07],0.692344036426461
Chapter II Neoplasms,Melanoma in situ,CIAPIN1,Anamorsin,24519,53,1.13 [0.78-1.65],0.5253919660148363
Chapter II Neoplasms,Melanoma in situ,CILP,Cartilage intermediate layer protein 1,21216,41,1.23 [0.70-2.16],0.4756617671038584
Chapter II Neoplasms,Melanoma in situ,CINP,Cyclin-dependent kinase 2-interacting protein,20824,40,0.86 [0.41-1.81],0.6881776060985778
Chapter II Neoplasms,Melanoma in situ,CIRBP,Cold-inducible RNA-binding protein,21131,40,1.49 [1.08-2.06],0.0153658855735444
Chapter II Neoplasms,Melanoma in situ,CIT,Citron Rho-interacting kinase,20638,38,1.02 [0.53-1.99],0.9482460703922748
Chapter II Neoplasms,Melanoma in situ,CKAP4,Cytoskeleton-associated protein 4,24633,52,0.38 [0.13-1.13],0.0810066463781407
Chapter II Neoplasms,Melanoma in situ,CKB,Creatine kinase B-type,21216,41,0.57 [0.35-0.95],0.0320045382317646
Chapter II Neoplasms,Melanoma in situ,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",24346,51,1.11 [0.75-1.62],0.6067420972046504
Chapter II Neoplasms,Melanoma in situ,CLASP1,CLIP-associating protein 1,20471,40,0.97 [0.64-1.47],0.8971670356560261
Chapter II Neoplasms,Melanoma in situ,CLC,Galectin-10,24447,53,0.68 [0.45-1.03],0.066086153994178
Chapter II Neoplasms,Melanoma in situ,CLEC10A,C-type lectin domain family 10 member A,24313,49,1.02 [0.50-2.08],0.9477018093157632
Chapter II Neoplasms,Melanoma in situ,CLEC11A,C-type lectin domain family 11 member A,24415,53,0.93 [0.55-1.55],0.7737550761721269
Chapter II Neoplasms,Melanoma in situ,CLEC12A,C-type lectin domain family 12 member A,20617,41,2.96 [1.25-7.01],0.0135580587691898
Chapter II Neoplasms,Melanoma in situ,CLEC14A,C-type lectin domain family 14 member A,24462,53,0.71 [0.31-1.62],0.417789496924292
Chapter II Neoplasms,Melanoma in situ,CLEC1A,C-type lectin domain family 1 member A,24041,51,1.32 [0.61-2.87],0.4812788202363253
Chapter II Neoplasms,Melanoma in situ,CLEC1B,C-type lectin domain family 1 member B,24707,53,1.02 [0.80-1.32],0.8527286969216837
Chapter II Neoplasms,Melanoma in situ,CLEC2L,C-type lectin domain family 2 member L,20638,38,0.96 [0.53-1.75],0.894270043599691
Chapter II Neoplasms,Melanoma in situ,CLEC3B,Tetranectin,20765,41,1.14 [0.32-4.03],0.8422281310009002
Chapter II Neoplasms,Melanoma in situ,CLEC4A,C-type lectin domain family 4 member A,24460,52,1.00 [0.49-2.02],0.9956529025886324
Chapter II Neoplasms,Melanoma in situ,CLEC4C,C-type lectin domain family 4 member C,24460,52,1.17 [0.69-1.98],0.5591555817403826
Chapter II Neoplasms,Melanoma in situ,CLEC4D,C-type lectin domain family 4 member D,24460,52,0.83 [0.54-1.26],0.3710708072389715
Chapter II Neoplasms,Melanoma in situ,CLEC4G,C-type lectin domain family 4 member G,24460,52,1.24 [0.59-2.59],0.5729500504987637
Chapter II Neoplasms,Melanoma in situ,CLEC4M,C-type lectin domain family 4 member M,21181,41,0.69 [0.37-1.30],0.2549417698966554
Chapter II Neoplasms,Melanoma in situ,CLEC5A,C-type lectin domain family 5 member A,24392,53,0.74 [0.31-1.78],0.4984112011849492
Chapter II Neoplasms,Melanoma in situ,CLEC6A,C-type lectin domain family 6 member A,23885,50,0.68 [0.38-1.22],0.1954432823408039
Chapter II Neoplasms,Melanoma in situ,CLEC7A,C-type lectin domain family 7 member A,24769,52,0.79 [0.58-1.07],0.1298438213771716
Chapter II Neoplasms,Melanoma in situ,CLGN,Calmegin,20638,38,1.28 [0.67-2.46],0.4600537060783134
Chapter II Neoplasms,Melanoma in situ,CLIC5,Chloride intracellular channel protein 5,20638,38,0.36 [0.10-1.25],0.1078135106912294
Chapter II Neoplasms,Melanoma in situ,CLINT1,Clathrin interactor 1,20471,40,1.40 [0.91-2.14],0.1222481883758575
Chapter II Neoplasms,Melanoma in situ,CLIP2,CAP-Gly domain-containing linker protein 2,24460,52,1.12 [0.90-1.39],0.3167509915661295
Chapter II Neoplasms,Melanoma in situ,CLMP,CXADR-like membrane protein,24689,52,0.57 [0.17-1.93],0.3644331625981856
Chapter II Neoplasms,Melanoma in situ,CLNS1A,Methylosome subunit pICln,20638,38,0.74 [0.28-1.97],0.54462961236737
Chapter II Neoplasms,Melanoma in situ,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",24266,49,1.17 [0.90-1.52],0.231620895126925
Chapter II Neoplasms,Melanoma in situ,CLPS,Colipase,24424,53,0.83 [0.58-1.18],0.2947807800825676
Chapter II Neoplasms,Melanoma in situ,CLSPN,Claspin,23848,51,1.01 [0.50-2.05],0.97765808193244
Chapter II Neoplasms,Melanoma in situ,CLSTN1,Calsyntenin-1,23895,51,0.88 [0.53-1.47],0.6239997359890372
Chapter II Neoplasms,Melanoma in situ,CLSTN2,Calsyntenin-2,24769,52,0.63 [0.32-1.24],0.1852089438559222
Chapter II Neoplasms,Melanoma in situ,CLSTN3,Calsyntenin-3,21166,40,1.53 [0.62-3.77],0.3543526719306729
Chapter II Neoplasms,Melanoma in situ,CLTA,Clathrin light chain A,24041,51,1.03 [0.61-1.75],0.90798464344484
Chapter II Neoplasms,Melanoma in situ,CLU,Clusterin,21249,41,1.17 [0.54-2.54],0.6851183219071199
Chapter II Neoplasms,Melanoma in situ,CLUL1,Clusterin-like protein 1,24443,52,1.09 [0.63-1.86],0.7651209207741458
Chapter II Neoplasms,Melanoma in situ,CMC1,COX assembly mitochondrial protein homolog,21225,41,1.41 [1.03-1.94],0.0321947176621003
Chapter II Neoplasms,Melanoma in situ,CMIP,C-Maf-inducing protein,21108,40,1.45 [1.02-2.05],0.0379710214173531
Chapter II Neoplasms,Melanoma in situ,CNDP1,Beta-Ala-His dipeptidase,24528,53,2.06 [1.14-3.74],0.0169568493126049
Chapter II Neoplasms,Melanoma in situ,CNGB3,Cyclic nucleotide-gated cation channel beta-3,20569,40,0.44 [0.19-1.02],0.054788002783913
Chapter II Neoplasms,Melanoma in situ,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",20599,41,1.26 [0.87-1.82],0.226164360569452
Chapter II Neoplasms,Melanoma in situ,CNPY2,Protein canopy homolog 2,24041,51,0.93 [0.60-1.45],0.7471382501819661
Chapter II Neoplasms,Melanoma in situ,CNPY4,Protein canopy homolog 4,24350,50,1.23 [0.89-1.71],0.2158944644909569
Chapter II Neoplasms,Melanoma in situ,CNST,Consortin,24482,53,1.12 [0.90-1.40],0.3196481754931954
Chapter II Neoplasms,Melanoma in situ,CNTF,Ciliary neurotrophic factor,20569,40,0.93 [0.38-2.28],0.8811253283548224
Chapter II Neoplasms,Melanoma in situ,CNTN1,Contactin-1,24765,53,0.54 [0.22-1.34],0.1861251167625503
Chapter II Neoplasms,Melanoma in situ,CNTN2,Contactin-2,24689,52,0.93 [0.54-1.61],0.7963464138063343
Chapter II Neoplasms,Melanoma in situ,CNTN3,Contactin-3,24462,53,0.80 [0.37-1.70],0.5534533242426318
Chapter II Neoplasms,Melanoma in situ,CNTN4,Contactin-4,24462,53,0.61 [0.22-1.72],0.3545726475548777
Chapter II Neoplasms,Melanoma in situ,CNTN5,Contactin-5,24541,53,1.14 [0.58-2.22],0.7114708199523656
Chapter II Neoplasms,Melanoma in situ,CNTNAP2,Contactin-associated protein-like 2,24460,52,1.15 [0.63-2.09],0.6509611287764352
Chapter II Neoplasms,Melanoma in situ,CNTNAP4,Contactin-associated protein-like 4,20638,38,1.09 [0.84-1.41],0.5140580404141324
Chapter II Neoplasms,Melanoma in situ,COCH,Cochlin,21225,41,1.47 [0.79-2.74],0.219795184668858
Chapter II Neoplasms,Melanoma in situ,COL15A1,Collagen alpha-1(XV) chain,21216,41,0.82 [0.25-2.68],0.7447837099967569
Chapter II Neoplasms,Melanoma in situ,COL18A1,Collagen alpha-1(XVIII) chain,24543,51,1.34 [0.45-4.03],0.6014608679839966
Chapter II Neoplasms,Melanoma in situ,COL1A1,Collagen alpha-1(I) chain,24765,53,0.85 [0.32-2.26],0.7418245581723177
Chapter II Neoplasms,Melanoma in situ,COL24A1,Collagen alpha-1(XXIV) chain,21131,40,0.79 [0.48-1.32],0.3711711731795801
Chapter II Neoplasms,Melanoma in situ,COL28A1,Collagen alpha-1(XXVIII) chain,20638,38,0.84 [0.55-1.29],0.423627838847821
Chapter II Neoplasms,Melanoma in situ,COL2A1,Collagen alpha-1(II) chain,20637,41,0.96 [0.66-1.39],0.8158625949501062
Chapter II Neoplasms,Melanoma in situ,COL3A1,Collagen alpha-1(III) chain,21216,41,3.31 [1.30-8.45],0.0122436078548384
Chapter II Neoplasms,Melanoma in situ,COL4A1,Collagen alpha-1(IV) chain,24482,53,1.63 [0.90-2.96],0.1055205078453557
Chapter II Neoplasms,Melanoma in situ,COL4A4,Collagen alpha-4(IV) chain,20789,40,0.75 [0.46-1.21],0.2368333837145357
Chapter II Neoplasms,Melanoma in situ,COL5A1,Collagen alpha-1(V) chain,20746,40,1.18 [0.55-2.52],0.6678765433601742
Chapter II Neoplasms,Melanoma in situ,COL6A3,Collagen alpha-3(VI) chain,24765,53,1.02 [0.47-2.23],0.9518652686108404
Chapter II Neoplasms,Melanoma in situ,COL9A1,Collagen alpha-1(IX) chain,24460,52,0.77 [0.43-1.38],0.3751673555155115
Chapter II Neoplasms,Melanoma in situ,COL9A2,Collagen alpha-2(IX) chain,20824,40,1.13 [0.62-2.07],0.6813735580500295
Chapter II Neoplasms,Melanoma in situ,COLEC12,Collectin-12,24444,52,0.70 [0.25-1.93],0.4867043336443334
Chapter II Neoplasms,Melanoma in situ,COMMD1,COMM domain-containing protein 1,20637,41,1.49 [0.95-2.34],0.082466106167428
Chapter II Neoplasms,Melanoma in situ,COMMD9,COMM domain-containing protein 9,21108,40,1.92 [1.22-3.03],0.0047972291305768
Chapter II Neoplasms,Melanoma in situ,COMP,Cartilage oligomeric matrix protein,24188,52,1.08 [0.52-2.26],0.834612768550922
Chapter II Neoplasms,Melanoma in situ,COMT,Catechol O-methyltransferase,23767,51,1.04 [0.78-1.40],0.7721232058416613
Chapter II Neoplasms,Melanoma in situ,COPB2,Coatomer subunit beta',20559,37,1.01 [0.48-2.12],0.9691246765652736
Chapter II Neoplasms,Melanoma in situ,COPE,Coatomer subunit epsilon,23895,51,1.14 [0.72-1.80],0.5791649340848595
Chapter II Neoplasms,Melanoma in situ,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",20637,41,0.83 [0.41-1.71],0.6208931784177925
Chapter II Neoplasms,Melanoma in situ,CORO1A,Coronin-1A,23961,49,1.06 [0.81-1.40],0.6658011651992063
Chapter II Neoplasms,Melanoma in situ,CORO6,Coronin-6,20569,40,0.71 [0.28-1.76],0.4588645091281752
Chapter II Neoplasms,Melanoma in situ,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",24350,50,1.10 [0.77-1.55],0.6066953651129263
Chapter II Neoplasms,Melanoma in situ,COX6B1,Cytochrome c oxidase subunit 6B1,21225,41,2.89 [1.40-5.96],0.0039686546680285
Chapter II Neoplasms,Melanoma in situ,CPA1,Carboxypeptidase A1,24765,53,1.11 [0.74-1.67],0.602411965939261
Chapter II Neoplasms,Melanoma in situ,CPA2,Carboxypeptidase A2,24618,53,1.03 [0.71-1.50],0.8763971466049045
Chapter II Neoplasms,Melanoma in situ,CPA4,Carboxypeptidase A4,20333,40,0.90 [0.44-1.81],0.757770147245735
Chapter II Neoplasms,Melanoma in situ,CPB1,Carboxypeptidase B,24765,53,1.07 [0.71-1.63],0.7360659598805466
Chapter II Neoplasms,Melanoma in situ,CPB2,Carboxypeptidase B2,21207,41,1.15 [0.31-4.17],0.8369270981214306
Chapter II Neoplasms,Melanoma in situ,CPE,Carboxypeptidase E,24511,52,0.60 [0.35-1.02],0.059121392612198
Chapter II Neoplasms,Melanoma in situ,CPLX2,Complexin-2,20471,40,0.56 [0.19-1.67],0.299100148005316
Chapter II Neoplasms,Melanoma in situ,CPM,Carboxypeptidase M,24603,53,1.15 [0.57-2.32],0.7008179286188272
Chapter II Neoplasms,Melanoma in situ,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",20617,41,1.99 [0.86-4.65],0.1093710057680061
Chapter II Neoplasms,Melanoma in situ,CPPED1,Serine/threonine-protein phosphatase CPPED1,24707,53,0.95 [0.67-1.37],0.794294563731335
Chapter II Neoplasms,Melanoma in situ,CPQ,Carboxypeptidase Q,21180,41,1.54 [0.64-3.71],0.3324133194017878
Chapter II Neoplasms,Melanoma in situ,CPTP,Ceramide-1-phosphate transfer protein,20559,37,1.09 [0.53-2.25],0.8075864997651702
Chapter II Neoplasms,Melanoma in situ,CPVL,Probable serine carboxypeptidase CPVL,24646,51,0.61 [0.36-1.05],0.0726367430837417
Chapter II Neoplasms,Melanoma in situ,CPXM1,Probable carboxypeptidase X1,24519,53,1.02 [0.72-1.46],0.8958877141680384
Chapter II Neoplasms,Melanoma in situ,CPXM2,Inactive carboxypeptidase-like protein X2,21225,41,1.58 [0.49-5.08],0.4458548942174445
Chapter II Neoplasms,Melanoma in situ,CR1,Complement receptor type 1,21144,41,0.91 [0.39-2.13],0.8262960405872053
Chapter II Neoplasms,Melanoma in situ,CR2,Complement receptor type 2,24528,53,0.74 [0.44-1.26],0.266260484273381
Chapter II Neoplasms,Melanoma in situ,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,23885,50,1.07 [0.81-1.42],0.618849716759438
Chapter II Neoplasms,Melanoma in situ,CRADD,Death domain-containing protein CRADD,24266,49,1.13 [0.81-1.57],0.481463343689487
Chapter II Neoplasms,Melanoma in situ,CREB3,Cyclic AMP-responsive element-binding protein 3,20471,40,1.41 [0.96-2.06],0.0776727069972087
Chapter II Neoplasms,Melanoma in situ,CREBZF,CREB/ATF bZIP transcription factor,20471,40,2.59 [1.57-4.26],0.0001867542629213
Chapter II Neoplasms,Melanoma in situ,CREG1,Protein CREG1,24117,51,1.21 [0.63-2.32],0.5582432568899816
Chapter II Neoplasms,Melanoma in situ,CRELD1,Protein disulfide isomerase CRELD1,20746,40,1.06 [0.47-2.38],0.8870926900940774
Chapter II Neoplasms,Melanoma in situ,CRELD2,Protein disulfide isomerase CRELD2,24529,52,1.24 [0.78-1.96],0.3598801034115619
Chapter II Neoplasms,Melanoma in situ,CRH,Corticoliberin,23844,50,0.87 [0.64-1.16],0.3384713311998218
Chapter II Neoplasms,Melanoma in situ,CRHBP,Corticotropin-releasing factor-binding protein,24444,52,0.74 [0.31-1.79],0.5087064073634786
Chapter II Neoplasms,Melanoma in situ,CRHR1,Corticotropin-releasing factor receptor 1,24041,51,0.88 [0.57-1.35],0.5506319257986201
Chapter II Neoplasms,Melanoma in situ,CRIM1,Cysteine-rich motor neuron 1 protein,24564,52,0.96 [0.28-3.35],0.951223495275362
Chapter II Neoplasms,Melanoma in situ,CRIP2,Cysteine-rich protein 2,24313,49,0.72 [0.34-1.50],0.3761898302405538
Chapter II Neoplasms,Melanoma in situ,CRISP2,Cysteine-rich secretory protein 2,24689,52,0.81 [0.54-1.23],0.3276925834486531
Chapter II Neoplasms,Melanoma in situ,CRISP3,Cysteine-rich secretory protein 3,21023,41,1.05 [0.34-3.22],0.9325494579049391
Chapter II Neoplasms,Melanoma in situ,CRKL,Crk-like protein,24478,51,1.15 [0.91-1.45],0.2535635465238812
Chapter II Neoplasms,Melanoma in situ,CRLF1,Cytokine receptor-like factor 1,24564,52,1.74 [0.67-4.54],0.2560612725328332
Chapter II Neoplasms,Melanoma in situ,CRNN,Cornulin,23731,49,0.81 [0.55-1.19],0.2812081615219635
Chapter II Neoplasms,Melanoma in situ,CRTAC1,Cartilage acidic protein 1,24765,53,0.44 [0.21-0.93],0.0318866079224564
Chapter II Neoplasms,Melanoma in situ,CRTAM,Cytotoxic and regulatory T-cell molecule,24313,49,0.84 [0.50-1.41],0.503951964756701
Chapter II Neoplasms,Melanoma in situ,CRTAP,Cartilage-associated protein,20638,38,0.81 [0.40-1.62],0.5507437487129316
Chapter II Neoplasms,Melanoma in situ,CRX,Cone-rod homeobox protein,24041,51,0.99 [0.78-1.25],0.9026338640601088
Chapter II Neoplasms,Melanoma in situ,CRYBB1,Beta-crystallin B1,21225,41,1.81 [1.19-2.77],0.0057469305160559
Chapter II Neoplasms,Melanoma in situ,CRYBB2,Beta-crystallin B2,21166,40,0.96 [0.53-1.71],0.8789583399706766
Chapter II Neoplasms,Melanoma in situ,CRYGD,Gamma-crystallin D,21166,40,1.10 [0.81-1.51],0.5398399427675977
Chapter II Neoplasms,Melanoma in situ,CRYM,Ketimine reductase mu-crystallin,20569,40,1.12 [0.78-1.61],0.5350650925927312
Chapter II Neoplasms,Melanoma in situ,CRYZL1,Quinone oxidoreductase-like protein 1,20637,41,1.26 [0.91-1.75],0.1667815468427372
Chapter II Neoplasms,Melanoma in situ,CSDE1,Cold shock domain-containing protein E1,20559,37,1.02 [0.80-1.31],0.852568375672286
Chapter II Neoplasms,Melanoma in situ,CSF1,Macrophage colony-stimulating factor 1,24564,52,1.01 [0.39-2.63],0.9770556201827252
Chapter II Neoplasms,Melanoma in situ,CSF1R,Macrophage colony-stimulating factor 1 receptor,21229,41,1.09 [0.51-2.32],0.8225162799016993
Chapter II Neoplasms,Melanoma in situ,CSF2,Granulocyte-macrophage colony-stimulating factor,20559,37,0.38 [0.14-1.00],0.0492435093592303
Chapter II Neoplasms,Melanoma in situ,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,24313,49,1.03 [0.69-1.55],0.8732380114755123
Chapter II Neoplasms,Melanoma in situ,CSF2RB,Cytokine receptor common subunit beta,20617,41,0.46 [0.24-0.90],0.0224310620160156
Chapter II Neoplasms,Melanoma in situ,CSF3,Granulocyte colony-stimulating factor,24024,50,0.84 [0.49-1.43],0.5154680141077254
Chapter II Neoplasms,Melanoma in situ,CSF3R,Granulocyte colony-stimulating factor receptor,20617,41,1.57 [0.66-3.72],0.3030771185203387
Chapter II Neoplasms,Melanoma in situ,CSH1,Chorionic somatomammotropin hormone 1,21229,41,0.89 [0.32-2.46],0.8288032571133623
Chapter II Neoplasms,Melanoma in situ,CSNK1D,Casein kinase I isoform delta,20617,41,1.02 [0.65-1.61],0.9233294449051686
Chapter II Neoplasms,Melanoma in situ,CSNK2A1,Casein kinase II subunit alpha,21191,40,1.60 [0.85-3.02],0.1446556732172002
Chapter II Neoplasms,Melanoma in situ,CSPG4,Chondroitin sulfate proteoglycan 4,21216,41,1.32 [0.53-3.27],0.5513123853660791
Chapter II Neoplasms,Melanoma in situ,CSPG5,Chondroitin sulfate proteoglycan 5,20569,40,1.02 [0.56-1.88],0.9417420644283988
Chapter II Neoplasms,Melanoma in situ,CSRP3,Cysteine and glycine-rich protein 3,20559,37,0.72 [0.48-1.09],0.118892049313625
Chapter II Neoplasms,Melanoma in situ,CST1,Cystatin-SN,18383,35,1.34 [0.99-1.82],0.060297411681219
Chapter II Neoplasms,Melanoma in situ,CST3,Cystatin-C,24487,53,0.72 [0.28-1.86],0.5002106117138254
Chapter II Neoplasms,Melanoma in situ,CST5,Cystatin-D,24027,49,1.05 [0.66-1.68],0.838124548796652
Chapter II Neoplasms,Melanoma in situ,CST6,Cystatin-M,23853,52,0.76 [0.45-1.30],0.3188231086960209
Chapter II Neoplasms,Melanoma in situ,CST7,Cystatin-F,24476,52,0.93 [0.69-1.23],0.595289292670615
Chapter II Neoplasms,Melanoma in situ,CSTB,Cystatin-B,24124,50,0.81 [0.44-1.48],0.4951113154000669
Chapter II Neoplasms,Melanoma in situ,CTAG1A_CTAG1B,Cancer/testis antigen 1,20778,40,0.80 [0.44-1.47],0.477211947457954
Chapter II Neoplasms,Melanoma in situ,CTBS,Di-N-acetylchitobiase,20935,40,2.55 [0.81-8.04],0.1104806272685182
Chapter II Neoplasms,Melanoma in situ,CTF1,Cardiotrophin-1,24041,51,1.10 [0.83-1.46],0.5063181563627768
Chapter II Neoplasms,Melanoma in situ,CTHRC1,Collagen triple helix repeat-containing protein 1,21216,41,1.27 [0.42-3.83],0.6746219731547267
Chapter II Neoplasms,Melanoma in situ,CTLA4,Cytotoxic T-lymphocyte protein 4,21216,41,1.15 [0.47-2.82],0.7643238124045441
Chapter II Neoplasms,Melanoma in situ,CTNNA1,Catenin alpha-1,20569,40,1.34 [0.68-2.63],0.4006041478039228
Chapter II Neoplasms,Melanoma in situ,CTRB1,Chymotrypsinogen B,24462,53,0.94 [0.59-1.48],0.7850963300182993
Chapter II Neoplasms,Melanoma in situ,CTRC,Chymotrypsin-C,24445,52,0.98 [0.66-1.47],0.933432981392796
Chapter II Neoplasms,Melanoma in situ,CTRL,Chymotrypsin-like protease CTRL-1,21166,40,0.97 [0.62-1.54],0.9073170972390692
Chapter II Neoplasms,Melanoma in situ,CTSB,Cathepsin B,24454,51,1.02 [0.63-1.65],0.9285881789583108
Chapter II Neoplasms,Melanoma in situ,CTSC,Dipeptidyl peptidase 1,24393,51,1.16 [0.67-2.02],0.5969838381325532
Chapter II Neoplasms,Melanoma in situ,CTSD,Cathepsin D,22805,50,1.22 [0.66-2.23],0.5290581892225081
Chapter II Neoplasms,Melanoma in situ,CTSE,Cathepsin E,20746,40,0.97 [0.55-1.73],0.92759073548153
Chapter II Neoplasms,Melanoma in situ,CTSF,Cathepsin F,24519,53,1.15 [0.63-2.10],0.6390155182723181
Chapter II Neoplasms,Melanoma in situ,CTSH,Pro-cathepsin H,23974,51,1.01 [0.71-1.42],0.9653089170023844
Chapter II Neoplasms,Melanoma in situ,CTSL,Cathepsin L1,24482,53,1.13 [0.40-3.16],0.8210132598374245
Chapter II Neoplasms,Melanoma in situ,CTSO,Cathepsin O,24769,52,0.73 [0.32-1.66],0.450151656498753
Chapter II Neoplasms,Melanoma in situ,CTSS,Cathepsin S,19332,44,2.59 [0.80-8.39],0.1120902954005945
Chapter II Neoplasms,Melanoma in situ,CTSV,Cathepsin L2,24614,51,1.04 [0.57-1.89],0.8977490320605508
Chapter II Neoplasms,Melanoma in situ,CTSZ,Cathepsin Z,24435,52,1.51 [0.69-3.32],0.3029744482103902
Chapter II Neoplasms,Melanoma in situ,CUZD1,CUB and zona pellucida-like domain-containing protein 1,20638,38,0.33 [0.11-1.03],0.0555392954020388
Chapter II Neoplasms,Melanoma in situ,CWC15,Spliceosome-associated protein CWC15 homolog,21014,40,0.82 [0.47-1.43],0.4827047093416184
Chapter II Neoplasms,Melanoma in situ,CX3CL1,Fractalkine,24313,49,1.18 [0.55-2.53],0.665527627212825
Chapter II Neoplasms,Melanoma in situ,CXADR,Coxsackievirus and adenovirus receptor,24460,52,1.00 [0.62-1.63],0.9897995710110206
Chapter II Neoplasms,Melanoma in situ,CXCL1,Growth-regulated alpha protein,24394,52,1.03 [0.79-1.33],0.841130330308046
Chapter II Neoplasms,Melanoma in situ,CXCL10,C-X-C motif chemokine 10,24564,52,1.03 [0.72-1.49],0.8533366268380469
Chapter II Neoplasms,Melanoma in situ,CXCL11,C-X-C motif chemokine 11,24707,53,1.27 [0.96-1.68],0.0930851530017376
Chapter II Neoplasms,Melanoma in situ,CXCL12,Stromal cell-derived factor 1,24024,50,0.84 [0.44-1.58],0.5847878513990603
Chapter II Neoplasms,Melanoma in situ,CXCL13,C-X-C motif chemokine 13,24707,53,1.10 [0.75-1.61],0.6217026912616955
Chapter II Neoplasms,Melanoma in situ,CXCL14,C-X-C motif chemokine 14,24024,50,1.06 [0.72-1.56],0.7546677862155056
Chapter II Neoplasms,Melanoma in situ,CXCL16,C-X-C motif chemokine 16,24715,53,1.16 [0.40-3.34],0.7822578305098725
Chapter II Neoplasms,Melanoma in situ,CXCL17,C-X-C motif chemokine 17,24769,52,0.84 [0.45-1.57],0.5904665191850291
Chapter II Neoplasms,Melanoma in situ,CXCL3,C-X-C motif chemokine 3,24441,52,1.13 [0.87-1.47],0.3466932328413395
Chapter II Neoplasms,Melanoma in situ,CXCL5,C-X-C motif chemokine 5,24397,53,1.08 [0.88-1.34],0.4601461166367306
Chapter II Neoplasms,Melanoma in situ,CXCL6,C-X-C motif chemokine 6,24769,52,1.03 [0.76-1.42],0.8335288828008843
Chapter II Neoplasms,Melanoma in situ,CXCL8,Interleukin-8,24278,52,0.96 [0.66-1.39],0.8295395324358754
Chapter II Neoplasms,Melanoma in situ,CXCL9,C-X-C motif chemokine 9,24564,52,1.30 [0.94-1.80],0.1097812933674674
Chapter II Neoplasms,Melanoma in situ,CYB5A,Cytochrome b5,20471,40,1.01 [0.67-1.53],0.945375362067438
Chapter II Neoplasms,Melanoma in situ,CYB5R2,NADH-cytochrome b5 reductase 2,20876,39,1.46 [0.89-2.37],0.1305515259710186
Chapter II Neoplasms,Melanoma in situ,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",20559,37,1.23 [0.93-1.62],0.1412285187547051
Chapter II Neoplasms,Melanoma in situ,CYTH3,Cytohesin-3,20471,40,1.02 [0.69-1.52],0.9259481394160132
Chapter II Neoplasms,Melanoma in situ,CYTL1,Cytokine-like protein 1,21216,41,0.48 [0.13-1.70],0.253975298527259
Chapter II Neoplasms,Melanoma in situ,DAAM1,Disheveled-associated activator of morphogenesis 1,20746,40,1.26 [0.88-1.81],0.207813400605826
Chapter II Neoplasms,Melanoma in situ,DAB2,Disabled homolog 2,24689,52,1.23 [0.98-1.54],0.0720598166523112
Chapter II Neoplasms,Melanoma in situ,DAG1,Dystroglycan,24564,52,1.42 [0.87-2.33],0.1607504247177847
Chapter II Neoplasms,Melanoma in situ,DAND5,DAN domain family member 5,20617,41,0.71 [0.42-1.19],0.194232795732585
Chapter II Neoplasms,Melanoma in situ,DAPK2,Death-associated protein kinase 2,20617,41,0.97 [0.56-1.66],0.900055965813089
Chapter II Neoplasms,Melanoma in situ,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,24460,52,1.05 [0.86-1.30],0.6261176184688955
Chapter II Neoplasms,Melanoma in situ,DARS1,"Aspartate--tRNA ligase, cytoplasmic",24266,49,1.12 [0.79-1.58],0.5210424687658115
Chapter II Neoplasms,Melanoma in situ,DBH,Dopamine beta-hydroxylase,21195,41,0.91 [0.71-1.16],0.4283116873852993
Chapter II Neoplasms,Melanoma in situ,DBI,Acyl-CoA-binding protein,24346,53,1.12 [0.83-1.51],0.4621629151635504
Chapter II Neoplasms,Melanoma in situ,DBN1,Drebrin,20617,41,2.08 [1.42-3.05],0.0001593514982743
Chapter II Neoplasms,Melanoma in situ,DBNL,Drebrin-like protein,24564,52,1.16 [0.89-1.51],0.2774542485562089
Chapter II Neoplasms,Melanoma in situ,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",24519,53,0.77 [0.38-1.54],0.4568320831431213
Chapter II Neoplasms,Melanoma in situ,DCC,Netrin receptor DCC,20638,38,0.98 [0.24-3.92],0.9754962778848127
Chapter II Neoplasms,Melanoma in situ,DCDC2C,Doublecortin domain-containing protein 2C,20471,40,0.94 [0.57-1.55],0.8003284748057993
Chapter II Neoplasms,Melanoma in situ,DCLRE1C,Protein artemis,20471,40,2.02 [1.04-3.92],0.037219871401994
Chapter II Neoplasms,Melanoma in situ,DCN,Decorin,24041,51,1.25 [0.40-3.95],0.7021066804197988
Chapter II Neoplasms,Melanoma in situ,DCTD,Deoxycytidylate deaminase,20746,40,1.38 [0.99-1.91],0.0566804107665676
Chapter II Neoplasms,Melanoma in situ,DCTN1,Dynactin subunit 1,24689,52,1.16 [0.80-1.68],0.435956347641896
Chapter II Neoplasms,Melanoma in situ,DCTN2,Dynactin subunit 2,24350,50,1.11 [0.85-1.43],0.4491152010713953
Chapter II Neoplasms,Melanoma in situ,DCTN6,Dynactin subunit 6,23895,51,0.92 [0.63-1.34],0.6623920278831279
Chapter II Neoplasms,Melanoma in situ,DCTPP1,dCTP pyrophosphatase 1,24482,53,1.66 [0.77-3.55],0.1937862025556818
Chapter II Neoplasms,Melanoma in situ,DCUN1D1,DCN1-like protein 1,20569,40,0.82 [0.51-1.30],0.3914483569431631
Chapter II Neoplasms,Melanoma in situ,DCUN1D2,DCN1-like protein 2,20471,40,1.20 [0.88-1.63],0.2516640561813616
Chapter II Neoplasms,Melanoma in situ,DCXR,L-xylulose reductase,24519,53,0.80 [0.50-1.26],0.3314405215179958
Chapter II Neoplasms,Melanoma in situ,DDA1,DET1- and DDB1-associated protein 1,20559,37,1.23 [0.61-2.47],0.5569420298350578
Chapter II Neoplasms,Melanoma in situ,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",24350,50,1.00 [0.57-1.75],0.9953166811680744
Chapter II Neoplasms,Melanoma in situ,DDC,Aromatic-L-amino-acid decarboxylase,24454,53,1.43 [0.88-2.34],0.15114919582279
Chapter II Neoplasms,Melanoma in situ,DDHD2,Phospholipase DDHD2,21191,40,1.47 [0.94-2.29],0.0921242231365929
Chapter II Neoplasms,Melanoma in situ,DDI2,Protein DDI1 homolog 2,20746,40,0.80 [0.54-1.20],0.2842334845702091
Chapter II Neoplasms,Melanoma in situ,DDR1,Epithelial discoidin domain-containing receptor 1,24707,53,0.98 [0.33-2.89],0.9696582915122226
Chapter II Neoplasms,Melanoma in situ,DDT,D-dopachrome decarboxylase,21216,41,0.62 [0.29-1.36],0.2321542641805521
Chapter II Neoplasms,Melanoma in situ,DDX1,ATP-dependent RNA helicase DDX1,21131,40,0.87 [0.46-1.63],0.6591250897195995
Chapter II Neoplasms,Melanoma in situ,DDX25,ATP-dependent RNA helicase DDX25,20638,38,0.95 [0.41-2.21],0.91190476081974
Chapter II Neoplasms,Melanoma in situ,DDX39A,ATP-dependent RNA helicase DDX39A,20617,41,1.56 [0.49-5.03],0.4540418166187001
Chapter II Neoplasms,Melanoma in situ,DDX4,Probable ATP-dependent RNA helicase DDX4,20617,41,0.85 [0.46-1.55],0.5857684176633242
Chapter II Neoplasms,Melanoma in situ,DDX53,Probable ATP-dependent RNA helicase DDX53,20638,38,1.44 [0.73-2.85],0.2978421562903232
Chapter II Neoplasms,Melanoma in situ,DDX58,Antiviral innate immune response receptor RIG-I,23885,50,0.99 [0.64-1.52],0.95159899402697
Chapter II Neoplasms,Melanoma in situ,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",24460,52,1.13 [0.88-1.46],0.335011726513362
Chapter II Neoplasms,Melanoma in situ,DEFA1_DEFA1B,Neutrophil defensin 1,23947,51,0.64 [0.37-1.12],0.1162712287321067
Chapter II Neoplasms,Melanoma in situ,DEFB103A_DEFB103B,Beta-defensin 103,20472,41,1.61 [1.03-2.50],0.0351953757584086
Chapter II Neoplasms,Melanoma in situ,DEFB104A_DEFB104B,Beta-defensin 104,20569,40,0.91 [0.52-1.59],0.7342161352676851
Chapter II Neoplasms,Melanoma in situ,DEFB116,Beta-defensin 116,20569,40,1.03 [0.71-1.50],0.8584422562675139
Chapter II Neoplasms,Melanoma in situ,DEFB118,Beta-defensin 118,20569,40,0.91 [0.51-1.62],0.7430224371701607
Chapter II Neoplasms,Melanoma in situ,DEFB4A_DEFB4B,Beta-defensin 4A,24090,47,0.95 [0.79-1.13],0.5413071036097199
Chapter II Neoplasms,Melanoma in situ,DENND2B,DENN domain-containing protein 2B,20559,37,1.00 [0.54-1.85],0.996815786662659
Chapter II Neoplasms,Melanoma in situ,DENR,Density-regulated protein,20617,41,1.44 [0.98-2.13],0.064686494467955
Chapter II Neoplasms,Melanoma in situ,DFFA,DNA fragmentation factor subunit alpha,24769,52,1.14 [0.80-1.62],0.4603459134597851
Chapter II Neoplasms,Melanoma in situ,DGCR6,Protein DGCR6,20569,40,0.96 [0.47-1.94],0.9020915256291308
Chapter II Neoplasms,Melanoma in situ,DGKA,Diacylglycerol kinase alpha,20617,41,1.38 [0.82-2.31],0.2247579342040056
Chapter II Neoplasms,Melanoma in situ,DGKZ,Diacylglycerol kinase zeta,24024,50,0.96 [0.47-1.94],0.9002511296907035
Chapter II Neoplasms,Melanoma in situ,DHODH,Dihydroorotate dehydrogenase,20559,37,1.66 [1.11-2.47],0.0138990730422618
Chapter II Neoplasms,Melanoma in situ,DHPS,Deoxyhypusine synthase,21108,40,1.05 [0.51-2.15],0.8986180870405618
Chapter II Neoplasms,Melanoma in situ,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,21166,40,1.28 [0.75-2.16],0.3662120280336386
Chapter II Neoplasms,Melanoma in situ,DIABLO,"Diablo homolog, mitochondrial",24392,53,1.14 [0.91-1.42],0.2448691174489625
Chapter II Neoplasms,Melanoma in situ,DIPK1C,Divergent protein kinase domain 1C,20638,38,0.95 [0.45-2.02],0.8990693329541405
Chapter II Neoplasms,Melanoma in situ,DIPK2B,Divergent protein kinase domain 2B,20746,40,0.66 [0.22-1.98],0.4561381682068164
Chapter II Neoplasms,Melanoma in situ,DKK1,Dickkopf-related protein 1,24707,53,1.01 [0.67-1.51],0.9645141224917848
Chapter II Neoplasms,Melanoma in situ,DKK3,Dickkopf-related protein 3,24765,53,0.81 [0.35-1.90],0.6304954052678859
Chapter II Neoplasms,Melanoma in situ,DKK4,Dickkopf-related protein 4,24270,49,1.20 [0.71-2.05],0.4916483725027029
Chapter II Neoplasms,Melanoma in situ,DKKL1,Dickkopf-like protein 1,24350,50,1.02 [0.76-1.37],0.8921231184562936
Chapter II Neoplasms,Melanoma in situ,DLG4,Disks large homolog 4,21166,40,1.41 [0.97-2.04],0.0725828813317092
Chapter II Neoplasms,Melanoma in situ,DLGAP5,Disks large-associated protein 5,21191,40,0.98 [0.54-1.75],0.9346100403822742
Chapter II Neoplasms,Melanoma in situ,DLK1,Protein delta homolog 1,24765,53,0.66 [0.43-1.01],0.0579432484033519
Chapter II Neoplasms,Melanoma in situ,DLL1,Delta-like protein 1,24519,53,0.64 [0.27-1.50],0.3035749907834527
Chapter II Neoplasms,Melanoma in situ,DLL4,Delta-like protein 4,20637,41,0.85 [0.52-1.40],0.5306457869741542
Chapter II Neoplasms,Melanoma in situ,DMD,Dystrophin,20637,41,1.31 [0.79-2.16],0.2960299448406536
Chapter II Neoplasms,Melanoma in situ,DMP1,Dentin matrix acidic phosphoprotein 1,20637,41,0.71 [0.47-1.07],0.0995403726183333
Chapter II Neoplasms,Melanoma in situ,DNAJA1,DnaJ homolog subfamily A member 1,20471,40,1.08 [0.59-1.97],0.7993634998966466
Chapter II Neoplasms,Melanoma in situ,DNAJA2,DnaJ homolog subfamily A member 2,24681,52,1.18 [0.88-1.59],0.2652254995567818
Chapter II Neoplasms,Melanoma in situ,DNAJA4,DnaJ homolog subfamily A member 4,21166,40,0.83 [0.54-1.28],0.4021487278116158
Chapter II Neoplasms,Melanoma in situ,DNAJB1,DnaJ homolog subfamily B member 1,24350,50,1.10 [0.83-1.46],0.5118799616340128
Chapter II Neoplasms,Melanoma in situ,DNAJB14,DnaJ homolog subfamily B member 14,21131,40,1.65 [1.14-2.39],0.0081334659380284
Chapter II Neoplasms,Melanoma in situ,DNAJB2,DnaJ homolog subfamily B member 2,20746,40,0.82 [0.46-1.46],0.4981631034326823
Chapter II Neoplasms,Melanoma in situ,DNAJB6,DnaJ homolog subfamily B member 6,20548,40,1.39 [0.97-1.97],0.0705811876959669
Chapter II Neoplasms,Melanoma in situ,DNAJB8,DnaJ homolog subfamily B member 8,24041,51,1.26 [0.90-1.77],0.1747578702987589
Chapter II Neoplasms,Melanoma in situ,DNAJC21,DnaJ homolog subfamily C member 21,21166,40,1.63 [0.85-3.15],0.1426626702474424
Chapter II Neoplasms,Melanoma in situ,DNAJC6,Putative tyrosine-protein phosphatase auxilin,20637,41,1.42 [1.02-2.00],0.0399399949038645
Chapter II Neoplasms,Melanoma in situ,DNAJC9,DnaJ homolog subfamily C member 9,21131,40,1.11 [0.76-1.64],0.5839258810720788
Chapter II Neoplasms,Melanoma in situ,DNER,Delta and Notch-like epidermal growth factor-related receptor,24408,52,0.81 [0.31-2.15],0.6742147258587258
Chapter II Neoplasms,Melanoma in situ,DNLZ,DNL-type zinc finger protein,20569,40,0.84 [0.56-1.26],0.3908466678478355
Chapter II Neoplasms,Melanoma in situ,DNM1,Dynamin-1,21131,40,1.28 [0.97-1.69],0.0776878601002316
Chapter II Neoplasms,Melanoma in situ,DNM3,Dynamin-3,21191,40,1.41 [0.88-2.25],0.1504398419868624
Chapter II Neoplasms,Melanoma in situ,DNMBP,Dynamin-binding protein,24313,49,1.23 [0.84-1.79],0.2853887440545137
Chapter II Neoplasms,Melanoma in situ,DNPEP,Aspartyl aminopeptidase,21166,40,0.81 [0.51-1.29],0.3770885304290833
Chapter II Neoplasms,Melanoma in situ,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,24513,51,0.93 [0.58-1.49],0.7528816668369293
Chapter II Neoplasms,Melanoma in situ,DOC2B,Double C2-like domain-containing protein beta,20638,38,1.11 [0.52-2.39],0.7806909362020811
Chapter II Neoplasms,Melanoma in situ,DOCK9,Dedicator of cytokinesis protein 9,20569,40,0.85 [0.62-1.17],0.3233732715656418
Chapter II Neoplasms,Melanoma in situ,DOK1,Docking protein 1,21166,40,1.28 [1.01-1.63],0.0391860755879187
Chapter II Neoplasms,Melanoma in situ,DOK2,Docking protein 2,24482,53,1.13 [0.93-1.37],0.2323044025057848
Chapter II Neoplasms,Melanoma in situ,DPEP1,Dipeptidase 1,24266,49,0.76 [0.46-1.25],0.2787553353414661
Chapter II Neoplasms,Melanoma in situ,DPEP2,Dipeptidase 2,24350,50,0.56 [0.23-1.35],0.1971045640842582
Chapter II Neoplasms,Melanoma in situ,DPP10,Inactive dipeptidyl peptidase 10,24460,52,0.77 [0.36-1.65],0.4958116701677226
Chapter II Neoplasms,Melanoma in situ,DPP4,Dipeptidyl peptidase 4,23958,51,0.71 [0.31-1.63],0.4209347051997961
Chapter II Neoplasms,Melanoma in situ,DPP6,Dipeptidyl aminopeptidase-like protein 6,24350,50,0.97 [0.45-2.09],0.9330919093819968
Chapter II Neoplasms,Melanoma in situ,DPP7,Dipeptidyl peptidase 2,24278,53,1.39 [0.93-2.06],0.1092253207383003
Chapter II Neoplasms,Melanoma in situ,DPT,Dermatopontin,24765,53,0.62 [0.26-1.45],0.2664457376268314
Chapter II Neoplasms,Melanoma in situ,DPY30,Protein dpy-30 homolog,24624,52,1.15 [0.78-1.69],0.4729831693821799
Chapter II Neoplasms,Melanoma in situ,DRAXIN,Draxin,24313,49,0.96 [0.53-1.76],0.8964873447723828
Chapter II Neoplasms,Melanoma in situ,DRG2,Developmentally-regulated GTP-binding protein 2,24350,50,1.21 [0.78-1.85],0.3944139964704958
Chapter II Neoplasms,Melanoma in situ,DSC2,Desmocollin-2,24164,52,0.91 [0.42-1.98],0.8202503213473553
Chapter II Neoplasms,Melanoma in situ,DSCAM,Down syndrome cell adhesion molecule,21191,40,0.70 [0.29-1.66],0.4160222548193563
Chapter II Neoplasms,Melanoma in situ,DSG2,Desmoglein-2,24462,53,0.84 [0.34-2.11],0.7173086842495301
Chapter II Neoplasms,Melanoma in situ,DSG3,Desmoglein-3,24618,52,0.59 [0.28-1.23],0.1575999590675066
Chapter II Neoplasms,Melanoma in situ,DSG4,Desmoglein-4,24260,50,0.80 [0.48-1.33],0.3908874777492636
Chapter II Neoplasms,Melanoma in situ,DTD1,D-aminoacyl-tRNA deacylase 1,20746,40,1.50 [1.07-2.11],0.018835885957837
Chapter II Neoplasms,Melanoma in situ,DTNB,Dystrobrevin beta,21072,40,1.17 [0.61-2.25],0.6279512789459131
Chapter II Neoplasms,Melanoma in situ,DTX2,Probable E3 ubiquitin-protein ligase DTX2,20638,38,0.81 [0.47-1.41],0.4564336086665991
Chapter II Neoplasms,Melanoma in situ,DTX3,Probable E3 ubiquitin-protein ligase DTX3,24350,50,0.63 [0.21-1.91],0.4152006591812273
Chapter II Neoplasms,Melanoma in situ,DTYMK,Thymidylate kinase,21225,41,1.31 [0.86-1.99],0.2148677283721349
Chapter II Neoplasms,Melanoma in situ,DUOX2,Dual oxidase 2,24041,51,0.92 [0.63-1.34],0.6546838336886773
Chapter II Neoplasms,Melanoma in situ,DUSP13,Dual specificity protein phosphatase 13 isoform A,21108,40,1.13 [0.56-2.27],0.7396527438892373
Chapter II Neoplasms,Melanoma in situ,DUSP29,Dual specificity phosphatase 29,20638,38,0.74 [0.41-1.32],0.306337358731954
Chapter II Neoplasms,Melanoma in situ,DUSP3,Dual specificity protein phosphatase 3,23895,51,1.27 [1.02-1.58],0.0290831146462963
Chapter II Neoplasms,Melanoma in situ,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",21131,40,1.24 [0.93-1.65],0.1479030633208002
Chapter II Neoplasms,Melanoma in situ,DXO,Decapping and exoribonuclease protein,21166,40,1.97 [1.10-3.52],0.0229538793593129
Chapter II Neoplasms,Melanoma in situ,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,21108,40,1.39 [0.91-2.13],0.1303421738555978
Chapter II Neoplasms,Melanoma in situ,DYNLT1,Dynein light chain Tctex-type 1,20638,38,1.17 [0.83-1.66],0.3630525151441119
Chapter II Neoplasms,Melanoma in situ,DYNLT3,Dynein light chain Tctex-type 3,21108,40,2.02 [1.20-3.41],0.0085287404382273
Chapter II Neoplasms,Melanoma in situ,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,24313,49,1.16 [0.89-1.52],0.2666345548590548
Chapter II Neoplasms,Melanoma in situ,EBI3_IL27,Interleukin-27,24657,52,0.69 [0.30-1.60],0.3919922901978107
Chapter II Neoplasms,Melanoma in situ,ECE1,Endothelin-converting enzyme 1,23895,51,2.04 [1.20-3.49],0.0089396952155597
Chapter II Neoplasms,Melanoma in situ,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",21225,41,0.80 [0.52-1.22],0.2938681175317718
Chapter II Neoplasms,Melanoma in situ,ECHS1,"Enoyl-CoA hydratase, mitochondrial",20637,41,1.16 [0.86-1.56],0.3390484545847101
Chapter II Neoplasms,Melanoma in situ,ECI2,Enoyl-CoA delta isomerase 2,20559,37,1.34 [0.87-2.06],0.1818113179896573
Chapter II Neoplasms,Melanoma in situ,ECM1,Extracellular matrix protein 1,20650,41,0.87 [0.39-1.93],0.7322387379930706
Chapter II Neoplasms,Melanoma in situ,ECSCR,Endothelial cell-specific chemotaxis regulator,20569,40,0.52 [0.22-1.23],0.1379236791740651
Chapter II Neoplasms,Melanoma in situ,EDA2R,Tumor necrosis factor receptor superfamily member 27,24689,52,0.75 [0.38-1.49],0.4102738758093818
Chapter II Neoplasms,Melanoma in situ,EDAR,Tumor necrosis factor receptor superfamily member EDAR,24460,52,1.02 [0.78-1.33],0.8915343859878454
Chapter II Neoplasms,Melanoma in situ,EDDM3B,Epididymal secretory protein E3-beta,21108,40,0.75 [0.40-1.41],0.3710065602555039
Chapter II Neoplasms,Melanoma in situ,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,20559,37,1.30 [0.66-2.58],0.4449941361457908
Chapter II Neoplasms,Melanoma in situ,EDF1,Endothelial differentiation-related factor 1,21191,40,1.32 [0.96-1.81],0.090802585679518
Chapter II Neoplasms,Melanoma in situ,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,24041,51,0.67 [0.32-1.39],0.2772415034697659
Chapter II Neoplasms,Melanoma in situ,EDN1,Endothelin-1,20637,41,2.31 [0.84-6.35],0.1051522909250889
Chapter II Neoplasms,Melanoma in situ,EDNRB,Endothelin receptor type B,20617,41,0.99 [0.51-1.91],0.9729778601907292
Chapter II Neoplasms,Melanoma in situ,EEF1D,Elongation factor 1-delta,21225,41,1.37 [1.02-1.84],0.0373846749460373
Chapter II Neoplasms,Melanoma in situ,EFCAB14,EF-hand calcium-binding domain-containing protein 14,21131,40,1.18 [0.39-3.57],0.7709068101912794
Chapter II Neoplasms,Melanoma in situ,EFCAB2,Dynein regulatory complex protein 8,20824,40,1.62 [0.79-3.29],0.1853294551768865
Chapter II Neoplasms,Melanoma in situ,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,24479,53,0.88 [0.39-1.99],0.7658045117800163
Chapter II Neoplasms,Melanoma in situ,EFHD1,EF-hand domain-containing protein D1,21191,40,0.82 [0.33-2.06],0.6767946245661463
Chapter II Neoplasms,Melanoma in situ,EFNA1,Ephrin-A1,24418,53,0.84 [0.32-2.21],0.7268116959288193
Chapter II Neoplasms,Melanoma in situ,EFNA4,Ephrin-A4,24272,49,1.37 [0.54-3.47],0.5131538813879877
Chapter II Neoplasms,Melanoma in situ,EFNB2,Ephrin-B2,20638,38,0.62 [0.34-1.11],0.1084733596012719
Chapter II Neoplasms,Melanoma in situ,EGF,Pro-epidermal growth factor,24403,51,1.10 [0.87-1.40],0.4325560728650283
Chapter II Neoplasms,Melanoma in situ,EGFL7,Epidermal growth factor-like protein 7,23885,50,0.94 [0.49-1.78],0.8430559294028052
Chapter II Neoplasms,Melanoma in situ,EGFLAM,Pikachurin,21131,40,1.47 [0.62-3.46],0.3830866979362828
Chapter II Neoplasms,Melanoma in situ,EGFR,Epidermal growth factor receptor,24765,53,1.75 [0.39-7.95],0.4679706266275878
Chapter II Neoplasms,Melanoma in situ,EGLN1,Egl nine homolog 1,24460,52,0.78 [0.47-1.32],0.3554759959764808
Chapter II Neoplasms,Melanoma in situ,EHBP1,EH domain-binding protein 1,21225,41,1.47 [1.01-2.15],0.0455921596065197
Chapter II Neoplasms,Melanoma in situ,EHD3,EH domain-containing protein 3,20637,41,1.19 [0.91-1.54],0.1993973037475585
Chapter II Neoplasms,Melanoma in situ,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",21166,40,1.10 [0.67-1.81],0.7064435985074224
Chapter II Neoplasms,Melanoma in situ,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",21069,40,1.26 [0.97-1.63],0.0799516650398842
Chapter II Neoplasms,Melanoma in situ,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,20559,37,1.03 [0.63-1.69],0.897945804881503
Chapter II Neoplasms,Melanoma in situ,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,20637,41,1.04 [0.53-2.06],0.904344530065094
Chapter II Neoplasms,Melanoma in situ,EIF4B,Eukaryotic translation initiation factor 4B,24313,49,1.30 [0.84-2.03],0.2363070899334295
Chapter II Neoplasms,Melanoma in situ,EIF4E,Eukaryotic translation initiation factor 4E,20617,41,1.47 [1.07-2.03],0.0187764778610953
Chapter II Neoplasms,Melanoma in situ,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,24482,53,0.95 [0.66-1.39],0.8097956107621167
Chapter II Neoplasms,Melanoma in situ,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,24769,52,1.17 [0.91-1.49],0.2124345119871045
Chapter II Neoplasms,Melanoma in situ,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,21191,40,1.28 [0.84-1.95],0.2490091449258911
Chapter II Neoplasms,Melanoma in situ,EIF5,Eukaryotic translation initiation factor 5,20559,37,1.15 [0.60-2.21],0.6783664677822325
Chapter II Neoplasms,Melanoma in situ,EIF5A,Eukaryotic translation initiation factor 5A-1,24024,50,0.66 [0.27-1.60],0.3561813301351897
Chapter II Neoplasms,Melanoma in situ,ELAC1,Zinc phosphodiesterase ELAC protein 1,21191,40,1.35 [0.95-1.93],0.0990156945494849
Chapter II Neoplasms,Melanoma in situ,ELAVL4,ELAV-like protein 4,20569,40,0.84 [0.57-1.25],0.3857497728720868
Chapter II Neoplasms,Melanoma in situ,ELN,Elastin,21225,41,1.79 [0.75-4.30],0.1921489345363077
Chapter II Neoplasms,Melanoma in situ,ELOA,Elongin-A,24350,50,0.84 [0.51-1.40],0.5071744594017091
Chapter II Neoplasms,Melanoma in situ,ELOB,Elongin-B,20559,37,1.02 [0.46-2.23],0.9666436020047848
Chapter II Neoplasms,Melanoma in situ,ENAH,Protein enabled homolog,24024,50,1.38 [0.86-2.22],0.1832138699836619
Chapter II Neoplasms,Melanoma in situ,ENDOU,Poly(U)-specific endoribonuclease,19613,38,1.22 [0.68-2.18],0.5064700096955469
Chapter II Neoplasms,Melanoma in situ,ENG,Endoglin,24765,53,0.87 [0.21-3.65],0.8533598810647788
Chapter II Neoplasms,Melanoma in situ,ENO1,Alpha-enolase,24452,53,1.14 [0.84-1.55],0.4133064100149699
Chapter II Neoplasms,Melanoma in situ,ENO2,Gamma-enolase,24707,53,1.16 [0.81-1.66],0.4296091854598114
Chapter II Neoplasms,Melanoma in situ,ENO3,Beta-enolase,20637,41,1.27 [0.82-1.97],0.2927652775182233
Chapter II Neoplasms,Melanoma in situ,ENOPH1,Enolase-phosphatase E1,21108,40,0.85 [0.48-1.51],0.5837881228086956
Chapter II Neoplasms,Melanoma in situ,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,20559,37,2.08 [0.96-4.50],0.062442694758142
Chapter II Neoplasms,Melanoma in situ,ENPEP,Glutamyl aminopeptidase,20559,37,1.10 [0.56-2.15],0.7798375588590879
Chapter II Neoplasms,Melanoma in situ,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,24765,53,0.65 [0.26-1.63],0.3536809541011089
Chapter II Neoplasms,Melanoma in situ,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,24564,52,0.64 [0.44-0.93],0.018681863331883
Chapter II Neoplasms,Melanoma in situ,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,20637,41,0.51 [0.23-1.12],0.0951062587850137
Chapter II Neoplasms,Melanoma in situ,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,23750,50,1.13 [0.84-1.50],0.4166598710014094
Chapter II Neoplasms,Melanoma in situ,ENSA,Alpha-endosulfine,21108,40,1.97 [1.36-2.87],0.0003647920772596
Chapter II Neoplasms,Melanoma in situ,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,23885,50,1.24 [0.70-2.20],0.4633157918145087
Chapter II Neoplasms,Melanoma in situ,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,24041,51,1.35 [0.41-4.42],0.6230604826173588
Chapter II Neoplasms,Melanoma in situ,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,24041,51,1.26 [0.49-3.29],0.6304520830006307
Chapter II Neoplasms,Melanoma in situ,ENTR1,Endosome-associated-trafficking regulator 1,20637,41,1.26 [0.81-1.96],0.2977142956825641
Chapter II Neoplasms,Melanoma in situ,EP300,Histone acetyltransferase p300,20617,41,1.32 [0.54-3.24],0.545330543149796
Chapter II Neoplasms,Melanoma in situ,EPB41L5,Band 4.1-like protein 5,20638,38,0.93 [0.56-1.55],0.7769055671093117
Chapter II Neoplasms,Melanoma in situ,EPCAM,Epithelial cell adhesion molecule,24448,52,1.09 [0.85-1.40],0.516580270314408
Chapter II Neoplasms,Melanoma in situ,EPGN,Epigen,21108,40,1.09 [0.63-1.91],0.7484719991645397
Chapter II Neoplasms,Melanoma in situ,EPHA1,Ephrin type-A receptor 1,24513,51,0.90 [0.43-1.89],0.7813146094454758
Chapter II Neoplasms,Melanoma in situ,EPHA10,Ephrin type-A receptor 10,23895,51,1.16 [0.84-1.61],0.3576361415190991
Chapter II Neoplasms,Melanoma in situ,EPHA2,Ephrin type-A receptor 2,23592,46,0.81 [0.31-2.10],0.6689330747669638
Chapter II Neoplasms,Melanoma in situ,EPHA4,Ephrin type-A receptor 4,20746,40,1.28 [0.44-3.75],0.6538109413332189
Chapter II Neoplasms,Melanoma in situ,EPHB4,Ephrin type-B receptor 4,24765,53,0.83 [0.29-2.39],0.7279826660014529
Chapter II Neoplasms,Melanoma in situ,EPHB6,Ephrin type-B receptor 6,24266,49,0.63 [0.27-1.48],0.2896276139119759
Chapter II Neoplasms,Melanoma in situ,EPHX2,Bifunctional epoxide hydrolase 2,24041,51,0.89 [0.58-1.38],0.6092609915772562
Chapter II Neoplasms,Melanoma in situ,EPN1,Epsin-1,20824,40,1.07 [0.54-2.11],0.8407847003440936
Chapter II Neoplasms,Melanoma in situ,EPO,Erythropoietin,24460,52,0.91 [0.65-1.28],0.5819353628333567
Chapter II Neoplasms,Melanoma in situ,EPPK1,Epiplakin,20637,41,1.12 [0.74-1.68],0.5923521229201623
Chapter II Neoplasms,Melanoma in situ,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,24656,52,1.43 [0.65-3.16],0.373046887428387
Chapter II Neoplasms,Melanoma in situ,ERBB2,Receptor tyrosine-protein kinase erbB-2,24519,53,0.51 [0.20-1.28],0.1496232575367753
Chapter II Neoplasms,Melanoma in situ,ERBB3,Receptor tyrosine-protein kinase erbB-3,24349,51,1.89 [0.55-6.52],0.315415552091013
Chapter II Neoplasms,Melanoma in situ,ERBB4,Receptor tyrosine-protein kinase erbB-4,24519,53,0.63 [0.23-1.74],0.367749594373041
Chapter II Neoplasms,Melanoma in situ,ERBIN,Erbin,24350,50,1.11 [0.87-1.41],0.4115327021500543
Chapter II Neoplasms,Melanoma in situ,ERC2,ERC protein 2,20638,38,0.99 [0.66-1.49],0.9655143083308564
Chapter II Neoplasms,Melanoma in situ,ERCC1,DNA excision repair protein ERCC-1,20471,40,1.34 [0.67-2.64],0.4065663087058389
Chapter II Neoplasms,Melanoma in situ,EREG,Proepiregulin,24266,49,0.90 [0.65-1.24],0.5115542631837231
Chapter II Neoplasms,Melanoma in situ,ERI1,3'-5' exoribonuclease 1,20824,40,1.14 [0.49-2.64],0.7629367776273996
Chapter II Neoplasms,Melanoma in situ,ERMAP,Erythroid membrane-associated protein,20617,41,1.47 [0.77-2.81],0.2389764442241946
Chapter II Neoplasms,Melanoma in situ,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,21108,40,0.99 [0.45-2.18],0.9832087481147624
Chapter II Neoplasms,Melanoma in situ,ERP29,Endoplasmic reticulum resident protein 29,20746,40,1.33 [1.02-1.72],0.0334313554898834
Chapter II Neoplasms,Melanoma in situ,ERP44,Endoplasmic reticulum resident protein 44,24316,50,2.40 [0.94-6.14],0.0680148382086447
Chapter II Neoplasms,Melanoma in situ,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,20559,37,1.28 [0.76-2.17],0.35304185933348
Chapter II Neoplasms,Melanoma in situ,ESAM,Endothelial cell-selective adhesion molecule,24765,53,1.09 [0.50-2.38],0.8267431951033107
Chapter II Neoplasms,Melanoma in situ,ESM1,Endothelial cell-specific molecule 1,24444,52,0.77 [0.37-1.62],0.4940546533500742
Chapter II Neoplasms,Melanoma in situ,ESPL1,Separin,20471,40,1.25 [0.83-1.87],0.2796387008651227
Chapter II Neoplasms,Melanoma in situ,ESR1,Estrogen receptor,20617,41,1.16 [0.77-1.75],0.4814498687681652
Chapter II Neoplasms,Melanoma in situ,ESYT2,Extended synaptotagmin-2,21166,40,1.43 [1.01-2.01],0.0420308680278305
Chapter II Neoplasms,Melanoma in situ,EVI2B,Protein EVI2B,20471,40,1.17 [0.62-2.23],0.6237852999811022
Chapter II Neoplasms,Melanoma in situ,EVI5,Ecotropic viral integration site 5 protein homolog,20617,41,1.26 [0.91-1.74],0.1627765711221896
Chapter II Neoplasms,Melanoma in situ,EVPL,Envoplakin,20824,40,0.58 [0.20-1.72],0.3286438692048126
Chapter II Neoplasms,Melanoma in situ,EXOSC10,Exosome component 10,20559,37,1.20 [0.80-1.81],0.3740145850534085
Chapter II Neoplasms,Melanoma in situ,EXTL1,Exostosin-like 1,20559,37,0.68 [0.31-1.51],0.3438792366774599
Chapter II Neoplasms,Melanoma in situ,EZR,Ezrin,24707,53,1.18 [0.44-3.18],0.737244731754811
Chapter II Neoplasms,Melanoma in situ,F10,Coagulation factor X,21229,41,2.15 [1.36-3.41],0.001061047674694
Chapter II Neoplasms,Melanoma in situ,F11,Coagulation factor XI,20941,41,1.37 [0.75-2.51],0.3014969089488021
Chapter II Neoplasms,Melanoma in situ,F11R,Junctional adhesion molecule A,24462,53,1.15 [0.75-1.75],0.5220969675638448
Chapter II Neoplasms,Melanoma in situ,F12,Coagulation factor XII,21249,41,1.24 [0.59-2.62],0.5722968918984475
Chapter II Neoplasms,Melanoma in situ,F13B,Coagulation factor XIII B chain,21139,41,1.40 [0.45-4.41],0.5605159587561817
Chapter II Neoplasms,Melanoma in situ,F2,Prothrombin,21249,41,7.41 [1.65-33.22],0.0088749310594245
Chapter II Neoplasms,Melanoma in situ,F2R,Proteinase-activated receptor 1,24529,52,1.24 [0.82-1.88],0.3125372160076409
Chapter II Neoplasms,Melanoma in situ,F3,Tissue factor,24533,52,1.07 [0.43-2.66],0.8836546293191706
Chapter II Neoplasms,Melanoma in situ,F7,Coagulation factor VII,24488,53,1.58 [0.70-3.59],0.2742129756156771
Chapter II Neoplasms,Melanoma in situ,F9,Coagulation factor IX,24499,53,2.28 [0.59-8.74],0.2299799135840431
Chapter II Neoplasms,Melanoma in situ,FABP1,"Fatty acid-binding protein, liver",24444,52,1.02 [0.78-1.33],0.908046987884226
Chapter II Neoplasms,Melanoma in situ,FABP2,"Fatty acid-binding protein, intestinal",24482,53,1.02 [0.74-1.40],0.9033415752604868
Chapter II Neoplasms,Melanoma in situ,FABP3,"Fatty acid-binding protein, heart",21225,41,0.64 [0.33-1.26],0.2011154023091815
Chapter II Neoplasms,Melanoma in situ,FABP4,"Fatty acid-binding protein, adipocyte",24765,53,1.46 [0.90-2.37],0.124778711860918
Chapter II Neoplasms,Melanoma in situ,FABP5,Fatty acid-binding protein 5,24640,53,1.18 [0.84-1.66],0.3351432102961787
Chapter II Neoplasms,Melanoma in situ,FABP6,Gastrotropin,24008,51,1.20 [0.78-1.86],0.4130227376575409
Chapter II Neoplasms,Melanoma in situ,FABP9,Fatty acid-binding protein 9,24460,52,0.83 [0.53-1.31],0.4263126190223454
Chapter II Neoplasms,Melanoma in situ,FADD,FAS-associated death domain protein,24482,53,1.22 [0.89-1.66],0.2128484773988099
Chapter II Neoplasms,Melanoma in situ,FAM13A,Protein FAM13A,21131,40,1.40 [0.93-2.12],0.1099312633418889
Chapter II Neoplasms,Melanoma in situ,FAM171A2,Protein FAM171A2,21191,40,1.02 [0.85-1.23],0.8434780238858637
Chapter II Neoplasms,Melanoma in situ,FAM171B,Protein FAM171B,21108,40,1.00 [0.34-2.92],0.9944632990802936
Chapter II Neoplasms,Melanoma in situ,FAM172A,Cotranscriptional regulator FAM172A,20637,41,1.83 [1.16-2.88],0.0095277256554679
Chapter II Neoplasms,Melanoma in situ,FAM20A,Pseudokinase FAM20A,21225,41,0.76 [0.46-1.26],0.280830317426765
Chapter II Neoplasms,Melanoma in situ,FAM3B,Protein FAM3B,24350,50,1.11 [0.53-2.31],0.7837869120415002
Chapter II Neoplasms,Melanoma in situ,FAM3C,Protein FAM3C,24454,53,1.75 [0.76-4.01],0.1889457272955141
Chapter II Neoplasms,Melanoma in situ,FAM3D,Protein FAM3D,21131,40,0.80 [0.55-1.16],0.2362756077898689
Chapter II Neoplasms,Melanoma in situ,FAP,Prolyl endopeptidase FAP,24765,53,0.67 [0.27-1.64],0.3826648512652892
Chapter II Neoplasms,Melanoma in situ,FARSA,Phenylalanine--tRNA ligase alpha subunit,20638,38,1.40 [0.98-2.00],0.0672134474125905
Chapter II Neoplasms,Melanoma in situ,FAS,Tumor necrosis factor receptor superfamily member 6,24675,53,0.71 [0.30-1.69],0.4415522315882347
Chapter II Neoplasms,Melanoma in situ,FASLG,Tumor necrosis factor ligand superfamily member 6,24769,52,0.88 [0.45-1.69],0.6926776338872416
Chapter II Neoplasms,Melanoma in situ,FBLN2,Fibulin-2,21216,41,1.01 [0.36-2.81],0.9828340280350524
Chapter II Neoplasms,Melanoma in situ,FBN2,Fibrillin-2,20638,38,1.13 [0.67-1.89],0.6439241106341649
Chapter II Neoplasms,Melanoma in situ,FBP1,"Fructose-1,6-bisphosphatase 1",24482,53,0.89 [0.64-1.25],0.5112596301218499
Chapter II Neoplasms,Melanoma in situ,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,21225,41,1.15 [0.76-1.73],0.5189088129548987
Chapter II Neoplasms,Melanoma in situ,FCAR,Immunoglobulin alpha Fc receptor,24460,52,0.87 [0.51-1.46],0.593334376139796
Chapter II Neoplasms,Melanoma in situ,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,21191,40,0.56 [0.16-1.88],0.344423313872194
Chapter II Neoplasms,Melanoma in situ,FCER2,Low affinity immunoglobulin epsilon Fc receptor,24462,53,0.66 [0.39-1.13],0.1289335449576145
Chapter II Neoplasms,Melanoma in situ,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,24334,53,0.90 [0.63-1.30],0.5914106973304211
Chapter II Neoplasms,Melanoma in situ,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,23885,50,0.96 [0.61-1.50],0.8500154227136029
Chapter II Neoplasms,Melanoma in situ,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,24448,53,1.31 [0.79-2.18],0.2984308034320773
Chapter II Neoplasms,Melanoma in situ,FCN1,Ficolin-1,21195,41,1.31 [0.72-2.37],0.3784579543403434
Chapter II Neoplasms,Melanoma in situ,FCN2,Ficolin-2,24330,53,1.91 [0.97-3.74],0.0596378742450249
Chapter II Neoplasms,Melanoma in situ,FCRL1,Fc receptor-like protein 1,24482,53,0.51 [0.29-0.90],0.0211458233482724
Chapter II Neoplasms,Melanoma in situ,FCRL2,Fc receptor-like protein 2,24662,52,0.83 [0.48-1.45],0.5127189437607158
Chapter II Neoplasms,Melanoma in situ,FCRL3,Fc receptor-like protein 3,24024,50,0.91 [0.56-1.47],0.7038389506885858
Chapter II Neoplasms,Melanoma in situ,FCRL5,Fc receptor-like protein 5,24462,53,0.77 [0.50-1.19],0.2402862991599052
Chapter II Neoplasms,Melanoma in situ,FCRL6,Fc receptor-like protein 6,24460,52,1.34 [0.92-1.94],0.1272388023216562
Chapter II Neoplasms,Melanoma in situ,FCRLB,Fc receptor-like B,23885,50,1.16 [0.78-1.73],0.4643637278219152
Chapter II Neoplasms,Melanoma in situ,FDX1,"Adrenodoxin, mitochondrial",20559,37,1.29 [0.90-1.86],0.1661936651974161
Chapter II Neoplasms,Melanoma in situ,FDX2,"Ferredoxin-2, mitochondrial",20559,37,1.21 [0.74-1.98],0.4440507389938335
Chapter II Neoplasms,Melanoma in situ,FEN1,Flap endonuclease 1,23885,50,0.74 [0.45-1.20],0.2185543565223765
Chapter II Neoplasms,Melanoma in situ,FES,Tyrosine-protein kinase Fes/Fps,23885,50,1.09 [0.65-1.81],0.7480878662301932
Chapter II Neoplasms,Melanoma in situ,FETUB,Fetuin-B,24499,53,1.49 [0.71-3.11],0.2898671728936535
Chapter II Neoplasms,Melanoma in situ,FGA,Fibrinogen alpha chain,20755,41,0.58 [0.21-1.58],0.2872631542016375
Chapter II Neoplasms,Melanoma in situ,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",21191,40,1.34 [0.93-1.92],0.1139355321385061
Chapter II Neoplasms,Melanoma in situ,FGF12,Fibroblast growth factor 12,20617,41,1.23 [0.78-1.93],0.3767384065323255
Chapter II Neoplasms,Melanoma in situ,FGF16,Fibroblast growth factor 16,20617,41,1.61 [1.08-2.41],0.0203317442470392
Chapter II Neoplasms,Melanoma in situ,FGF19,Fibroblast growth factor 19,24564,52,0.98 [0.71-1.34],0.8920327868561543
Chapter II Neoplasms,Melanoma in situ,FGF2,Fibroblast growth factor 2,24460,52,1.38 [0.98-1.95],0.0689642774755174
Chapter II Neoplasms,Melanoma in situ,FGF20,Fibroblast growth factor 20,20617,41,1.25 [0.71-2.17],0.4408015304515998
Chapter II Neoplasms,Melanoma in situ,FGF21,Fibroblast growth factor 21,24657,52,1.15 [0.94-1.40],0.1780675695597017
Chapter II Neoplasms,Melanoma in situ,FGF23,Fibroblast growth factor 23,24651,52,1.12 [0.76-1.65],0.5635123172546441
Chapter II Neoplasms,Melanoma in situ,FGF3,Fibroblast growth factor 3,20617,41,1.37 [0.66-2.85],0.3976449961827348
Chapter II Neoplasms,Melanoma in situ,FGF5,Fibroblast growth factor 5,24024,50,0.64 [0.29-1.42],0.2738667173222634
Chapter II Neoplasms,Melanoma in situ,FGF6,Fibroblast growth factor 6,20617,41,0.89 [0.40-1.95],0.764743474870757
Chapter II Neoplasms,Melanoma in situ,FGF7,Fibroblast growth factor 7,20471,40,1.34 [1.04-1.72],0.0224024493268269
Chapter II Neoplasms,Melanoma in situ,FGF9,Fibroblast growth factor 9,20428,40,1.11 [0.52-2.39],0.780265005995384
Chapter II Neoplasms,Melanoma in situ,FGFBP1,Fibroblast growth factor-binding protein 1,24519,53,0.90 [0.42-1.91],0.7778196162954434
Chapter II Neoplasms,Melanoma in situ,FGFBP2,Fibroblast growth factor-binding protein 2,21216,41,0.94 [0.52-1.72],0.8475817729498217
Chapter II Neoplasms,Melanoma in situ,FGFBP3,Fibroblast growth factor-binding protein 3,21166,40,1.19 [0.53-2.67],0.6740681832633297
Chapter II Neoplasms,Melanoma in situ,FGFR2,Fibroblast growth factor receptor 2,24519,53,1.05 [0.34-3.26],0.9360845435233062
Chapter II Neoplasms,Melanoma in situ,FGFR4,Fibroblast growth factor receptor 4,20746,40,0.94 [0.53-1.67],0.8309388700960701
Chapter II Neoplasms,Melanoma in situ,FGL1,Fibrinogen-like protein 1,21229,41,0.87 [0.54-1.42],0.5826230613685806
Chapter II Neoplasms,Melanoma in situ,FGR,Tyrosine-protein kinase Fgr,23895,51,0.81 [0.49-1.31],0.3844506098415716
Chapter II Neoplasms,Melanoma in situ,FH,"Fumarate hydratase, mitochondrial",20569,40,1.13 [0.85-1.52],0.4008255077725521
Chapter II Neoplasms,Melanoma in situ,FHIP2A,FHF complex subunit HOOK interacting protein 2A,20559,37,0.75 [0.36-1.54],0.4287823398094497
Chapter II Neoplasms,Melanoma in situ,FHIT,Bis(5'-adenosyl)-triphosphatase,23895,51,1.00 [0.72-1.40],0.9993003110480024
Chapter II Neoplasms,Melanoma in situ,FIS1,Mitochondrial fission 1 protein,24425,51,1.26 [0.93-1.70],0.1395294468892753
Chapter II Neoplasms,Melanoma in situ,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,21191,40,1.56 [1.15-2.11],0.0045766411452179
Chapter II Neoplasms,Melanoma in situ,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,24572,52,1.19 [0.96-1.46],0.110431139225542
Chapter II Neoplasms,Melanoma in situ,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,24313,49,1.20 [0.68-2.10],0.5336314298132083
Chapter II Neoplasms,Melanoma in situ,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,24313,49,1.06 [0.81-1.38],0.6694791489999872
Chapter II Neoplasms,Melanoma in situ,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23848,51,1.50 [1.08-2.08],0.0146053604126666
Chapter II Neoplasms,Melanoma in situ,FKBPL,FK506-binding protein-like,21131,40,1.61 [1.00-2.58],0.0513754397578489
Chapter II Neoplasms,Melanoma in situ,FLI1,Friend leukemia integration 1 transcription factor,23885,50,1.19 [0.95-1.48],0.1309864399107853
Chapter II Neoplasms,Melanoma in situ,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,24313,49,0.68 [0.28-1.68],0.4041397300310525
Chapter II Neoplasms,Melanoma in situ,FLT1,Vascular endothelial growth factor receptor 1,24309,50,0.48 [0.14-1.68],0.2485953661233602
Chapter II Neoplasms,Melanoma in situ,FLT3,Receptor-type tyrosine-protein kinase FLT3,23885,50,1.02 [0.46-2.27],0.9580189252860832
Chapter II Neoplasms,Melanoma in situ,FLT3LG,Fms-related tyrosine kinase 3 ligand,24769,52,0.81 [0.39-1.70],0.5792080010291917
Chapter II Neoplasms,Melanoma in situ,FLT4,Vascular endothelial growth factor receptor 3,24519,53,1.35 [0.65-2.77],0.4203657839299525
Chapter II Neoplasms,Melanoma in situ,FMNL1,Formin-like protein 1,23895,51,0.73 [0.45-1.17],0.1875249295162445
Chapter II Neoplasms,Melanoma in situ,FMR1,Synaptic functional regulator FMR1,23885,50,0.92 [0.45-1.87],0.8116235981625534
Chapter II Neoplasms,Melanoma in situ,FN1,Fibronectin,21249,41,0.62 [0.20-1.91],0.408594218469957
Chapter II Neoplasms,Melanoma in situ,FNDC1,Fibronectin type III domain-containing protein 1,21166,40,1.17 [0.61-2.25],0.6314877965775725
Chapter II Neoplasms,Melanoma in situ,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,21108,40,2.09 [1.36-3.22],0.0007998267050101
Chapter II Neoplasms,Melanoma in situ,FOLH1,Glutamate carboxypeptidase 2,20617,41,0.87 [0.63-1.21],0.4051805638155782
Chapter II Neoplasms,Melanoma in situ,FOLR1,Folate receptor alpha,24400,51,0.69 [0.27-1.76],0.4327863877948729
Chapter II Neoplasms,Melanoma in situ,FOLR2,Folate receptor beta,24707,53,0.50 [0.21-1.18],0.111946257002153
Chapter II Neoplasms,Melanoma in situ,FOLR3,Folate receptor gamma,24442,53,0.97 [0.85-1.11],0.7026517618091173
Chapter II Neoplasms,Melanoma in situ,FOS,Proto-oncogene c-Fos,20428,40,1.25 [0.56-2.82],0.5847517109214015
Chapter II Neoplasms,Melanoma in situ,FOSB,Protein fosB,23895,51,0.83 [0.41-1.68],0.6097269342976035
Chapter II Neoplasms,Melanoma in situ,FOXJ3,Forkhead box protein J3,20617,41,1.33 [0.76-2.33],0.3149999734100963
Chapter II Neoplasms,Melanoma in situ,FOXO1,Forkhead box protein O1,24460,52,1.24 [0.94-1.64],0.126693757034666
Chapter II Neoplasms,Melanoma in situ,FOXO3,Forkhead box protein O3,23885,50,1.08 [0.85-1.37],0.5500777849142222
Chapter II Neoplasms,Melanoma in situ,FRMD4B,FERM domain-containing protein 4B,20559,37,1.57 [1.06-2.33],0.0246363806514314
Chapter II Neoplasms,Melanoma in situ,FRMD7,FERM domain-containing protein 7,20638,38,1.37 [0.62-3.02],0.4422765672318913
Chapter II Neoplasms,Melanoma in situ,FRZB,Secreted frizzled-related protein 3,24237,49,0.42 [0.19-0.94],0.035511495953658
Chapter II Neoplasms,Melanoma in situ,FSHB,Follitropin subunit beta,20637,41,1.04 [0.65-1.64],0.8742289172470352
Chapter II Neoplasms,Melanoma in situ,FST,Follistatin,24529,52,1.13 [0.71-1.81],0.606141565251083
Chapter II Neoplasms,Melanoma in situ,FSTL1,Follistatin-related protein 1,20637,41,1.69 [0.47-6.10],0.41976192183419
Chapter II Neoplasms,Melanoma in situ,FSTL3,Follistatin-related protein 3,24409,50,1.09 [0.46-2.58],0.8489834407526127
Chapter II Neoplasms,Melanoma in situ,FTCD,Formimidoyltransferase-cyclodeaminase,21130,40,1.08 [0.77-1.52],0.6504282625869918
Chapter II Neoplasms,Melanoma in situ,FUCA1,Tissue alpha-L-fucosidase,24596,53,1.19 [0.86-1.63],0.2960403097201817
Chapter II Neoplasms,Melanoma in situ,FUOM,Fucose mutarotase,20746,40,1.05 [0.66-1.68],0.8266604020396733
Chapter II Neoplasms,Melanoma in situ,FURIN,Furin,24519,53,1.19 [0.59-2.43],0.6248832703684184
Chapter II Neoplasms,Melanoma in situ,FUS,RNA-binding protein FUS,23847,50,1.02 [0.54-1.90],0.9553150789207896
Chapter II Neoplasms,Melanoma in situ,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",20789,40,0.77 [0.43-1.36],0.3699029361849276
Chapter II Neoplasms,Melanoma in situ,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24707,53,0.80 [0.46-1.39],0.432670096639655
Chapter II Neoplasms,Melanoma in situ,FUT8,"Alpha-(1,6)-fucosyltransferase",24313,49,0.79 [0.50-1.24],0.3068250202593844
Chapter II Neoplasms,Melanoma in situ,FXN,"Frataxin, mitochondrial",24689,52,1.23 [0.89-1.70],0.205713425936748
Chapter II Neoplasms,Melanoma in situ,FXYD5,FXYD domain-containing ion transport regulator 5,24024,50,1.47 [1.06-2.03],0.0203460848258248
Chapter II Neoplasms,Melanoma in situ,FYB1,FYN-binding protein 1,24424,53,1.12 [0.86-1.46],0.412873132399308
Chapter II Neoplasms,Melanoma in situ,FZD10,Frizzled-10,20638,38,1.14 [0.73-1.78],0.5654914432155153
Chapter II Neoplasms,Melanoma in situ,FZD8,Frizzled-8,20569,40,1.09 [0.55-2.14],0.8120542757081051
Chapter II Neoplasms,Melanoma in situ,GABARAP,Gamma-aminobutyric acid receptor-associated protein,21108,40,1.49 [0.92-2.42],0.1064891759086155
Chapter II Neoplasms,Melanoma in situ,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,20824,40,1.03 [0.67-1.59],0.8770325770573838
Chapter II Neoplasms,Melanoma in situ,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,20569,40,1.05 [0.69-1.61],0.8081750264504011
Chapter II Neoplasms,Melanoma in situ,GAD1,Glutamate decarboxylase 1,20471,40,1.08 [0.34-3.46],0.9001255890149271
Chapter II Neoplasms,Melanoma in situ,GAD2,Glutamate decarboxylase 2,20617,41,1.27 [0.78-2.06],0.3388385858131461
Chapter II Neoplasms,Melanoma in situ,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,20824,40,0.61 [0.25-1.48],0.2750894263398449
Chapter II Neoplasms,Melanoma in situ,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,20637,41,1.62 [0.99-2.66],0.0533109955057023
Chapter II Neoplasms,Melanoma in situ,GAGE2A,G antigen 2A,20471,40,0.66 [0.35-1.24],0.1961740330248759
Chapter II Neoplasms,Melanoma in situ,GAL,Galanin peptides,24564,52,0.72 [0.49-1.06],0.0996504982653416
Chapter II Neoplasms,Melanoma in situ,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24350,50,1.30 [0.53-3.16],0.5659422053285507
Chapter II Neoplasms,Melanoma in situ,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,24689,52,0.61 [0.24-1.59],0.3155540471887853
Chapter II Neoplasms,Melanoma in situ,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,24024,50,0.63 [0.34-1.17],0.1420349058653665
Chapter II Neoplasms,Melanoma in situ,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,21225,41,0.59 [0.19-1.82],0.3634573238414771
Chapter II Neoplasms,Melanoma in situ,GALNT7,N-acetylgalactosaminyltransferase 7,24350,50,1.88 [0.57-6.19],0.301239889725466
Chapter II Neoplasms,Melanoma in situ,GAMT,Guanidinoacetate N-methyltransferase,20559,37,1.10 [0.51-2.39],0.8073215704431937
Chapter II Neoplasms,Melanoma in situ,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,20303,40,0.69 [0.31-1.55],0.3716578501804676
Chapter II Neoplasms,Melanoma in situ,GART,Trifunctional purine biosynthetic protein adenosine-3,21191,40,0.77 [0.42-1.42],0.4042707223738437
Chapter II Neoplasms,Melanoma in situ,GAS2,Growth arrest-specific protein 2,20824,40,0.89 [0.48-1.67],0.7265451419125564
Chapter II Neoplasms,Melanoma in situ,GAS6,Growth arrest-specific protein 6,24587,51,0.73 [0.27-1.94],0.5279378829656494
Chapter II Neoplasms,Melanoma in situ,GASK1A,Golgi-associated kinase 1A,20559,37,1.32 [0.65-2.69],0.4403000757852944
Chapter II Neoplasms,Melanoma in situ,GAST,Gastrin,21166,40,1.00 [0.77-1.29],0.9842125516601242
Chapter II Neoplasms,Melanoma in situ,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,20471,40,0.78 [0.25-2.48],0.6794240823434616
Chapter II Neoplasms,Melanoma in situ,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",20637,41,1.52 [1.09-2.12],0.0132513564580716
Chapter II Neoplasms,Melanoma in situ,GBA,Lysosomal acid glucosylceramidase,20638,38,0.94 [0.53-1.67],0.8260191340992997
Chapter II Neoplasms,Melanoma in situ,GBP1,Guanylate-binding protein 1,21127,40,1.28 [0.82-1.98],0.271051006197828
Chapter II Neoplasms,Melanoma in situ,GBP2,Guanylate-binding protein 2,24024,50,0.89 [0.58-1.36],0.5964730146478028
Chapter II Neoplasms,Melanoma in situ,GBP4,Guanylate-binding protein 4,23895,51,0.81 [0.47-1.40],0.4605850345475909
Chapter II Neoplasms,Melanoma in situ,GBP6,Guanylate-binding protein 6,20559,37,0.60 [0.24-1.49],0.2710994304237856
Chapter II Neoplasms,Melanoma in situ,GC,Vitamin D-binding protein,21249,41,0.65 [0.21-2.06],0.466906068510893
Chapter II Neoplasms,Melanoma in situ,GCC1,GRIP and coiled-coil domain-containing protein 1,21166,40,1.41 [1.06-1.87],0.0191495215133126
Chapter II Neoplasms,Melanoma in situ,GCG,Pro-glucagon,23885,50,1.06 [0.87-1.30],0.5657029412606076
Chapter II Neoplasms,Melanoma in situ,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20236,40,0.60 [0.29-1.22],0.1577293148637566
Chapter II Neoplasms,Melanoma in situ,GCLM,Glutamate--cysteine ligase regulatory subunit,20559,37,1.24 [0.70-2.21],0.4650262865008319
Chapter II Neoplasms,Melanoma in situ,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",24350,50,1.23 [0.60-2.53],0.5765144387778234
Chapter II Neoplasms,Melanoma in situ,GDF15,Growth/differentiation factor 15,24765,53,1.14 [0.64-2.02],0.6643067506916894
Chapter II Neoplasms,Melanoma in situ,GDF2,Growth/differentiation factor 2,24482,53,1.25 [0.63-2.48],0.523693891316312
Chapter II Neoplasms,Melanoma in situ,GDNF,Glial cell line-derived neurotrophic factor,23895,51,0.71 [0.36-1.41],0.3315165351191519
Chapter II Neoplasms,Melanoma in situ,GET3,ATPase GET3,21225,41,1.15 [0.70-1.87],0.5789544356399265
Chapter II Neoplasms,Melanoma in situ,GFAP,Glial fibrillary acidic protein,23851,50,0.75 [0.42-1.34],0.3320516950028019
Chapter II Neoplasms,Melanoma in situ,GFER,FAD-linked sulfhydryl oxidase ALR,23885,50,1.26 [0.86-1.84],0.2310770087416406
Chapter II Neoplasms,Melanoma in situ,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,23885,50,1.08 [0.91-1.28],0.3890030858856351
Chapter II Neoplasms,Melanoma in situ,GFRA1,GDNF family receptor alpha-1,24657,52,0.49 [0.19-1.26],0.1394429551929081
Chapter II Neoplasms,Melanoma in situ,GFRA2,GDNF family receptor alpha-2,24350,50,0.54 [0.17-1.73],0.2984431676924438
Chapter II Neoplasms,Melanoma in situ,GFRA3,GDNF family receptor alpha-3,24232,49,0.53 [0.21-1.34],0.1783040442736628
Chapter II Neoplasms,Melanoma in situ,GFRAL,GDNF family receptor alpha-like,20560,40,0.81 [0.49-1.34],0.400753910411487
Chapter II Neoplasms,Melanoma in situ,GGA1,ADP-ribosylation factor-binding protein GGA1,23895,51,0.88 [0.60-1.29],0.5140410507484676
Chapter II Neoplasms,Melanoma in situ,GGACT,Gamma-glutamylaminecyclotransferase,21225,41,1.45 [0.97-2.17],0.067039309886554
Chapter II Neoplasms,Melanoma in situ,GGCT,Gamma-glutamylcyclotransferase,21188,41,1.58 [0.92-2.73],0.0973574121842315
Chapter II Neoplasms,Melanoma in situ,GGH,Gamma-glutamyl hydrolase,24009,50,1.25 [0.61-2.56],0.5432816173837014
Chapter II Neoplasms,Melanoma in situ,GGT1,Glutathione hydrolase 1 proenzyme,24418,53,0.95 [0.57-1.58],0.8375326236790657
Chapter II Neoplasms,Melanoma in situ,GGT5,Glutathione hydrolase 5 proenzyme,24313,49,0.87 [0.28-2.68],0.8055754545476759
Chapter II Neoplasms,Melanoma in situ,GH1,Somatotropin,24454,53,0.98 [0.86-1.12],0.8141704477410006
Chapter II Neoplasms,Melanoma in situ,GH2,Growth hormone variant,23885,50,0.97 [0.83-1.13],0.669410994406967
Chapter II Neoplasms,Melanoma in situ,GHR,Growth hormone receptor,20746,40,1.24 [0.43-3.60],0.6900344696226594
Chapter II Neoplasms,Melanoma in situ,GHRHR,Growth hormone-releasing hormone receptor,23895,51,0.90 [0.55-1.46],0.6569037604320871
Chapter II Neoplasms,Melanoma in situ,GHRL,Appetite-regulating hormone,24482,53,1.20 [0.87-1.65],0.2626072327344206
Chapter II Neoplasms,Melanoma in situ,GID8,Glucose-induced degradation protein 8 homolog,21191,40,1.12 [0.48-2.62],0.7936422460031087
Chapter II Neoplasms,Melanoma in situ,GIGYF2,GRB10-interacting GYF protein 2,21191,40,1.09 [0.74-1.60],0.6681338954339364
Chapter II Neoplasms,Melanoma in situ,GIMAP7,GTPase IMAP family member 7,20746,40,0.95 [0.37-2.44],0.9180329725512116
Chapter II Neoplasms,Melanoma in situ,GIMAP8,GTPase IMAP family member 8,20471,40,1.00 [0.55-1.80],0.9955807159943162
Chapter II Neoplasms,Melanoma in situ,GIP,Gastric inhibitory polypeptide,20637,41,1.16 [0.60-2.23],0.663101184414383
Chapter II Neoplasms,Melanoma in situ,GIPC2,PDZ domain-containing protein GIPC2,21166,40,0.72 [0.24-2.18],0.5633397616178111
Chapter II Neoplasms,Melanoma in situ,GIPC3,PDZ domain-containing protein GIPC3,21131,40,1.46 [1.05-2.03],0.0229495291566225
Chapter II Neoplasms,Melanoma in situ,GIPR,Gastric inhibitory polypeptide receptor,20617,41,1.37 [0.92-2.03],0.1192437132006618
Chapter II Neoplasms,Melanoma in situ,GIT1,ARF GTPase-activating protein GIT1,20617,41,1.23 [0.91-1.68],0.1820052293630384
Chapter II Neoplasms,Melanoma in situ,GJA8,Gap junction alpha-8 protein,20471,40,1.05 [0.65-1.68],0.8525205382984445
Chapter II Neoplasms,Melanoma in situ,GKN1,Gastrokine-1,23431,50,1.03 [0.41-2.58],0.9477732310130498
Chapter II Neoplasms,Melanoma in situ,GLA,Alpha-galactosidase A,20700,40,1.66 [0.79-3.48],0.1808623065786918
Chapter II Neoplasms,Melanoma in situ,GLB1,Beta-galactosidase,24313,49,1.69 [0.98-2.93],0.059971712466939
Chapter II Neoplasms,Melanoma in situ,GLI2,Zinc finger protein GLI2,20617,41,1.31 [0.66-2.60],0.4431623574173178
Chapter II Neoplasms,Melanoma in situ,GLO1,Lactoylglutathione lyase,24041,51,0.78 [0.51-1.20],0.2619050571418968
Chapter II Neoplasms,Melanoma in situ,GLOD4,Glyoxalase domain-containing protein 4,24390,51,1.17 [0.59-2.30],0.6554651120913653
Chapter II Neoplasms,Melanoma in situ,GLP1R,Glucagon-like peptide 1 receptor,20569,40,1.42 [0.77-2.60],0.2608682786140182
Chapter II Neoplasms,Melanoma in situ,GLRX,Glutaredoxin-1,24330,53,0.71 [0.46-1.10],0.1295838651828414
Chapter II Neoplasms,Melanoma in situ,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",20746,40,1.31 [0.95-1.82],0.1048017834670934
Chapter II Neoplasms,Melanoma in situ,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,23895,51,0.77 [0.42-1.43],0.4131264725218323
Chapter II Neoplasms,Melanoma in situ,GLYR1,Putative oxidoreductase GLYR1,21108,40,0.89 [0.52-1.51],0.6528919137312479
Chapter II Neoplasms,Melanoma in situ,GM2A,Ganglioside GM2 activator,20714,41,0.53 [0.21-1.37],0.1900386102320836
Chapter II Neoplasms,Melanoma in situ,GMFG,Glia maturation factor gamma,21225,41,1.68 [1.11-2.54],0.0138843898104167
Chapter II Neoplasms,Melanoma in situ,GMPR,GMP reductase 1,24769,52,1.04 [0.64-1.69],0.8708440299582987
Chapter II Neoplasms,Melanoma in situ,GMPR2,GMP reductase 2,20746,40,1.36 [0.88-2.12],0.1701186371356729
Chapter II Neoplasms,Melanoma in situ,GNAS,Neuroendocrine secretory protein 55,21191,40,0.95 [0.67-1.36],0.7955917167014143
Chapter II Neoplasms,Melanoma in situ,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,23885,50,1.04 [0.71-1.52],0.8597363834178392
Chapter II Neoplasms,Melanoma in situ,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,20638,38,0.58 [0.25-1.31],0.190371628858402
Chapter II Neoplasms,Melanoma in situ,GNLY,Granulysin,24462,53,0.82 [0.51-1.32],0.406098472322641
Chapter II Neoplasms,Melanoma in situ,GNPDA1,Glucosamine-6-phosphate isomerase 1,20637,41,1.33 [0.66-2.70],0.4308511445198693
Chapter II Neoplasms,Melanoma in situ,GNPDA2,Glucosamine-6-phosphate isomerase 2,20746,40,1.63 [0.73-3.63],0.2290034901154653
Chapter II Neoplasms,Melanoma in situ,GOLGA3,Golgin subfamily A member 3,21191,40,1.26 [0.88-1.79],0.2116650988877904
Chapter II Neoplasms,Melanoma in situ,GOLM2,Protein GOLM2,24707,53,0.62 [0.20-1.89],0.4027754715084018
Chapter II Neoplasms,Melanoma in situ,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,24460,52,1.23 [0.96-1.57],0.1008911621566158
Chapter II Neoplasms,Melanoma in situ,GORASP2,Golgi reassembly-stacking protein 2,21131,40,1.57 [0.87-2.83],0.1315620991722823
Chapter II Neoplasms,Melanoma in situ,GOT1,"Aspartate aminotransferase, cytoplasmic",21216,41,0.59 [0.28-1.24],0.160562212185724
Chapter II Neoplasms,Melanoma in situ,GP1BA,Platelet glycoprotein Ib alpha chain,24338,53,1.35 [0.64-2.86],0.4340534387024916
Chapter II Neoplasms,Melanoma in situ,GP1BB,Platelet glycoprotein Ib beta chain,20559,37,1.54 [0.97-2.44],0.0703023066956417
Chapter II Neoplasms,Melanoma in situ,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,23728,51,0.70 [0.50-0.99],0.0455463608072338
Chapter II Neoplasms,Melanoma in situ,GP5,Platelet glycoprotein V,20746,40,1.99 [0.79-5.02],0.1428161415090406
Chapter II Neoplasms,Melanoma in situ,GP6,Platelet glycoprotein VI,24424,53,1.07 [0.81-1.41],0.6317529219773363
Chapter II Neoplasms,Melanoma in situ,GPA33,Cell surface A33 antigen,24350,50,1.07 [0.89-1.29],0.479122537961842
Chapter II Neoplasms,Melanoma in situ,GPC1,Glypican-1,24689,52,0.57 [0.24-1.31],0.1845283458125955
Chapter II Neoplasms,Melanoma in situ,GPC5,Glypican-5,24313,49,0.64 [0.41-1.00],0.0499753225813444
Chapter II Neoplasms,Melanoma in situ,GPD1,Glycerol-3-phosphate dehydrogenase,21108,40,1.04 [0.59-1.82],0.9027449942748538
Chapter II Neoplasms,Melanoma in situ,GPHA2,Glycoprotein hormone alpha-2,21131,40,0.99 [0.53-1.86],0.9787438801416564
Chapter II Neoplasms,Melanoma in situ,GPI,Glucose-6-phosphate isomerase,21229,41,1.68 [0.96-2.94],0.0684185616924219
Chapter II Neoplasms,Melanoma in situ,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,21131,40,0.94 [0.62-1.40],0.7468465389438943
Chapter II Neoplasms,Melanoma in situ,GPKOW,G-patch domain and KOW motifs-containing protein,23895,51,0.66 [0.24-1.81],0.4221070047418913
Chapter II Neoplasms,Melanoma in situ,GPNMB,Transmembrane glycoprotein NMB,23826,52,0.77 [0.32-1.83],0.5545330246479094
Chapter II Neoplasms,Melanoma in situ,GPR101,Probable G-protein coupled receptor 101,20569,40,1.06 [0.68-1.65],0.8134053344272929
Chapter II Neoplasms,Melanoma in situ,GPR158,Probable G-protein coupled receptor 158,21191,40,0.84 [0.33-2.11],0.7089344791767102
Chapter II Neoplasms,Melanoma in situ,GPR15L,Protein GPR15L,21131,40,0.76 [0.47-1.20],0.2388895205350356
Chapter II Neoplasms,Melanoma in situ,GPR37,Prosaposin receptor GPR37,24041,51,1.57 [1.06-2.31],0.0233091868801644
Chapter II Neoplasms,Melanoma in situ,GPRC5C,G-protein coupled receptor family C group 5 member C,21108,40,0.77 [0.42-1.42],0.4006910806690473
Chapter II Neoplasms,Melanoma in situ,GRAP2,GRB2-related adapter protein 2,24482,53,1.17 [0.97-1.42],0.10941894216945
Chapter II Neoplasms,Melanoma in situ,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,21225,41,1.56 [1.00-2.43],0.0497387131818409
Chapter II Neoplasms,Melanoma in situ,GRIK2,"Glutamate receptor ionotropic, kainate 2",21191,40,1.10 [0.54-2.23],0.791862259669518
Chapter II Neoplasms,Melanoma in situ,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",20569,40,1.15 [0.73-1.82],0.5470400579837977
Chapter II Neoplasms,Melanoma in situ,GRK5,G protein-coupled receptor kinase 5,24041,51,1.14 [0.74-1.74],0.555617311072959
Chapter II Neoplasms,Melanoma in situ,GRN,Progranulin,24343,53,0.43 [0.15-1.20],0.10611611430786
Chapter II Neoplasms,Melanoma in situ,GRP,Gastrin-releasing peptide,20637,41,0.89 [0.50-1.58],0.6993240351180507
Chapter II Neoplasms,Melanoma in situ,GRPEL1,"GrpE protein homolog 1, mitochondrial",24350,50,1.09 [0.74-1.63],0.6563937099323425
Chapter II Neoplasms,Melanoma in situ,GRSF1,G-rich sequence factor 1,20354,40,1.31 [0.94-1.82],0.1145004634530034
Chapter II Neoplasms,Melanoma in situ,GSAP,Gamma-secretase-activating protein,23885,50,0.91 [0.66-1.26],0.5830000457246998
Chapter II Neoplasms,Melanoma in situ,GSN,Gelsolin,21143,41,1.12 [0.22-5.69],0.8922162464796763
Chapter II Neoplasms,Melanoma in situ,GSR,"Glutathione reductase, mitochondrial",21108,41,0.90 [0.23-3.55],0.8751787513594047
Chapter II Neoplasms,Melanoma in situ,GSTA1,Glutathione S-transferase A1,24447,53,1.03 [0.77-1.36],0.8602494635207517
Chapter II Neoplasms,Melanoma in situ,GSTA3,Glutathione S-transferase A3,23885,50,0.89 [0.64-1.25],0.5099329767033287
Chapter II Neoplasms,Melanoma in situ,GSTM4,Glutathione S-transferase Mu 4,20559,37,1.03 [0.68-1.58],0.8788108043383713
Chapter II Neoplasms,Melanoma in situ,GSTP1,Glutathione S-transferase P,23742,51,1.13 [0.81-1.58],0.4682120723824265
Chapter II Neoplasms,Melanoma in situ,GSTT2B,Glutathione S-transferase theta-2B,21166,40,1.00 [0.88-1.13],0.9497450604242478
Chapter II Neoplasms,Melanoma in situ,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,20824,40,0.51 [0.24-1.07],0.0734659404158338
Chapter II Neoplasms,Melanoma in situ,GTPBP2,GTP-binding protein 2,20638,38,1.54 [1.06-2.23],0.0233281577493577
Chapter II Neoplasms,Melanoma in situ,GUCA2A,Guanylin,24343,53,0.85 [0.39-1.84],0.673609469036029
Chapter II Neoplasms,Melanoma in situ,GUCY2C,Heat-stable enterotoxin receptor,20824,40,1.14 [0.84-1.55],0.4063290516592425
Chapter II Neoplasms,Melanoma in situ,GUK1,Guanylate kinase,20559,37,0.94 [0.43-2.09],0.8872298798488996
Chapter II Neoplasms,Melanoma in situ,GUSB,Beta-glucuronidase,24554,53,1.34 [0.90-2.00],0.1430711889764709
Chapter II Neoplasms,Melanoma in situ,GYS1,"Glycogen [starch] synthase, muscle",24041,51,1.07 [0.82-1.39],0.6354183822833047
Chapter II Neoplasms,Melanoma in situ,GZMA,Granzyme A,24769,52,1.26 [0.63-2.52],0.5085733406632531
Chapter II Neoplasms,Melanoma in situ,GZMB,Granzyme B,24460,52,0.79 [0.52-1.19],0.2525737077602372
Chapter II Neoplasms,Melanoma in situ,GZMH,Granzyme H,24041,51,1.08 [0.78-1.48],0.649807485288642
Chapter II Neoplasms,Melanoma in situ,H2AP,Huntingtin-interacting protein M,20471,40,0.86 [0.43-1.75],0.6850168640972505
Chapter II Neoplasms,Melanoma in situ,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",20559,37,1.03 [0.65-1.65],0.8958449319993721
Chapter II Neoplasms,Melanoma in situ,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",24626,52,0.79 [0.56-1.12],0.1845336065526493
Chapter II Neoplasms,Melanoma in situ,HAO1,Hydroxyacid oxidase 1,24689,52,0.92 [0.76-1.11],0.3838972468833083
Chapter II Neoplasms,Melanoma in situ,HARS1,"Histidine--tRNA ligase, cytoplasmic",24462,53,1.23 [0.90-1.69],0.1858178676985019
Chapter II Neoplasms,Melanoma in situ,HAVCR1,Hepatitis A virus cellular receptor 1,24658,52,1.15 [0.76-1.74],0.5076925425765296
Chapter II Neoplasms,Melanoma in situ,HAVCR2,Hepatitis A virus cellular receptor 2,24462,53,0.54 [0.28-1.05],0.0708541948716238
Chapter II Neoplasms,Melanoma in situ,HBEGF,Proheparin-binding EGF-like growth factor,24626,52,0.96 [0.69-1.34],0.803539382240156
Chapter II Neoplasms,Melanoma in situ,HBQ1,Hemoglobin subunit theta-1,24689,52,0.69 [0.45-1.06],0.0881421697900514
Chapter II Neoplasms,Melanoma in situ,HBZ,Hemoglobin subunit zeta,21225,41,0.82 [0.61-1.11],0.1981951748152432
Chapter II Neoplasms,Melanoma in situ,HCG22,Protein PBMUCL2,20559,37,0.93 [0.48-1.80],0.8397972795925361
Chapter II Neoplasms,Melanoma in situ,HCLS1,Hematopoietic lineage cell-specific protein,24769,52,1.07 [0.70-1.65],0.7530264250346719
Chapter II Neoplasms,Melanoma in situ,HDAC8,Histone deacetylase 8,20617,41,0.84 [0.48-1.45],0.5235298559276833
Chapter II Neoplasms,Melanoma in situ,HDAC9,Histone deacetylase 9,20569,40,1.14 [0.76-1.70],0.5234766760631786
Chapter II Neoplasms,Melanoma in situ,HDDC2,5'-deoxynucleotidase HDDC2,21131,40,1.05 [0.54-2.07],0.8826150319479564
Chapter II Neoplasms,Melanoma in situ,HDGF,Hepatoma-derived growth factor,24659,52,1.08 [0.84-1.39],0.5465562718899224
Chapter II Neoplasms,Melanoma in situ,HDGFL2,Hepatoma-derived growth factor-related protein 2,21166,40,1.32 [0.88-1.99],0.1793922889428306
Chapter II Neoplasms,Melanoma in situ,HEBP1,Heme-binding protein 1,24041,51,1.09 [0.73-1.62],0.6731013997080699
Chapter II Neoplasms,Melanoma in situ,HEG1,Protein HEG homolog 1,20746,40,1.03 [0.33-3.24],0.9528550490435124
Chapter II Neoplasms,Melanoma in situ,HEPACAM2,HEPACAM family member 2,21166,40,1.20 [0.59-2.46],0.612204406643982
Chapter II Neoplasms,Melanoma in situ,HEPH,Hephaestin,21225,41,0.71 [0.29-1.77],0.4651926366564328
Chapter II Neoplasms,Melanoma in situ,HEXIM1,Protein HEXIM1,24460,52,1.18 [0.88-1.59],0.2737582909377676
Chapter II Neoplasms,Melanoma in situ,HGF,Hepatocyte growth factor,24769,52,0.67 [0.32-1.41],0.2915247229297395
Chapter II Neoplasms,Melanoma in situ,HGFAC,Hepatocyte growth factor activator,21032,41,1.08 [0.37-3.18],0.8852073140723432
Chapter II Neoplasms,Melanoma in situ,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,23885,50,1.22 [0.89-1.66],0.2117595083767631
Chapter II Neoplasms,Melanoma in situ,HHEX,Hematopoietically-expressed homeobox protein HHEX,21166,40,1.59 [1.09-2.31],0.0167151891922161
Chapter II Neoplasms,Melanoma in situ,HIF1A,Hypoxia-inducible factor 1-alpha,20617,41,0.78 [0.44-1.37],0.3917627905108747
Chapter II Neoplasms,Melanoma in situ,HIP1,Huntingtin-interacting protein 1,20559,37,1.07 [0.46-2.48],0.8703721268083248
Chapter II Neoplasms,Melanoma in situ,HIP1R,Huntingtin-interacting protein 1-related protein,21132,40,1.08 [0.58-2.01],0.7987689334198133
Chapter II Neoplasms,Melanoma in situ,HJV,Hemojuvelin,21191,40,0.90 [0.45-1.83],0.7797284392136112
Chapter II Neoplasms,Melanoma in situ,HK2,Hexokinase-2,24041,51,0.81 [0.33-1.98],0.649758070201456
Chapter II Neoplasms,Melanoma in situ,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",21191,40,0.60 [0.24-1.49],0.2716404729852723
Chapter II Neoplasms,Melanoma in situ,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",24377,52,0.71 [0.35-1.43],0.3338841438952822
Chapter II Neoplasms,Melanoma in situ,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24460,52,2.52 [1.22-5.19],0.0122654055498573
Chapter II Neoplasms,Melanoma in situ,HMBS,Porphobilinogen deaminase,24689,52,0.72 [0.42-1.23],0.2302775989962765
Chapter II Neoplasms,Melanoma in situ,HMCN2,Hemicentin-2,20704,40,0.82 [0.48-1.38],0.4483470717682879
Chapter II Neoplasms,Melanoma in situ,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",20637,41,1.75 [1.12-2.73],0.0144854527073778
Chapter II Neoplasms,Melanoma in situ,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",20559,37,1.71 [1.07-2.75],0.0254301807108169
Chapter II Neoplasms,Melanoma in situ,HMMR,Hyaluronan mediated motility receptor,20435,40,1.32 [0.81-2.15],0.2589726506827625
Chapter II Neoplasms,Melanoma in situ,HMOX1,Heme oxygenase 1,24207,53,1.07 [0.64-1.81],0.7891579016289643
Chapter II Neoplasms,Melanoma in situ,HMOX2,Heme oxygenase 2,23895,51,0.83 [0.47-1.46],0.5268922825643838
Chapter II Neoplasms,Melanoma in situ,HNF1A,Hepatocyte nuclear factor 1-alpha,20638,38,1.26 [0.93-1.70],0.1326285833600506
Chapter II Neoplasms,Melanoma in situ,HNMT,Histamine N-methyltransferase,24191,49,1.41 [0.82-2.43],0.2196363964315787
Chapter II Neoplasms,Melanoma in situ,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,23955,51,1.03 [0.75-1.42],0.8360123932262706
Chapter II Neoplasms,Melanoma in situ,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,21191,40,1.30 [0.79-2.15],0.3063499751733463
Chapter II Neoplasms,Melanoma in situ,HPCAL1,Hippocalcin-like protein 1,24769,52,1.17 [0.84-1.64],0.3592922045515403
Chapter II Neoplasms,Melanoma in situ,HPGDS,Hematopoietic prostaglandin D synthase,23885,50,1.02 [0.52-2.01],0.9556582963657037
Chapter II Neoplasms,Melanoma in situ,HPSE,Heparanase,20937,41,1.31 [0.95-1.81],0.0969209265773954
Chapter II Neoplasms,Melanoma in situ,HRAS,GTPase Hras,20795,40,0.86 [0.58-1.26],0.4376845282163583
Chapter II Neoplasms,Melanoma in situ,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,20637,41,1.20 [0.53-2.68],0.6632934296417226
Chapter II Neoplasms,Melanoma in situ,HRG,Histidine-rich glycoprotein,21139,41,0.86 [0.33-2.20],0.7484737127225138
Chapter II Neoplasms,Melanoma in situ,HS1BP3,HCLS1-binding protein 3,20637,41,1.39 [1.00-1.92],0.0468621419436165
Chapter II Neoplasms,Melanoma in situ,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,24350,50,0.91 [0.47-1.76],0.7747481548536833
Chapter II Neoplasms,Melanoma in situ,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,24689,52,1.08 [0.53-2.17],0.8375991687501639
Chapter II Neoplasms,Melanoma in situ,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,20617,41,1.03 [0.41-2.61],0.9536187147505388
Chapter II Neoplasms,Melanoma in situ,HSBP1,Heat shock factor-binding protein 1,20637,41,1.21 [0.89-1.65],0.2128583174936212
Chapter II Neoplasms,Melanoma in situ,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,24460,52,0.84 [0.45-1.56],0.5739554264105924
Chapter II Neoplasms,Melanoma in situ,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,21166,40,1.43 [0.90-2.26],0.1257192782268607
Chapter II Neoplasms,Melanoma in situ,HSD17B3,Testosterone 17-beta-dehydrogenase 3,20559,37,1.38 [0.80-2.38],0.2482414109054806
Chapter II Neoplasms,Melanoma in situ,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,20637,41,1.04 [0.55-1.96],0.904267125553126
Chapter II Neoplasms,Melanoma in situ,HSP90B1,Endoplasmin,23791,49,0.60 [0.35-1.05],0.0749238128446172
Chapter II Neoplasms,Melanoma in situ,HSPA1A,Heat shock 70 kDa protein 1A,24513,51,1.11 [0.80-1.55],0.5317312658719469
Chapter II Neoplasms,Melanoma in situ,HSPA2,Heat shock-related 70 kDa protein 2,21108,40,1.18 [0.52-2.67],0.6865497405622212
Chapter II Neoplasms,Melanoma in situ,HSPB1,Heat shock protein beta-1,24065,53,1.28 [0.88-1.86],0.2035446267246926
Chapter II Neoplasms,Melanoma in situ,HSPB6,Heat shock protein beta-6,24689,52,1.25 [0.66-2.35],0.4919124674016913
Chapter II Neoplasms,Melanoma in situ,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,24253,53,1.46 [0.54-3.96],0.4546315875802234
Chapter II Neoplasms,Melanoma in situ,HTR1A,5-hydroxytryptamine receptor 1A,20569,40,1.05 [0.72-1.52],0.8148967611738633
Chapter II Neoplasms,Melanoma in situ,HTR1B,5-hydroxytryptamine receptor 1B,20569,40,0.67 [0.30-1.53],0.343285196668006
Chapter II Neoplasms,Melanoma in situ,HTRA2,"Serine protease HTRA2, mitochondrial",24519,53,1.28 [0.87-1.87],0.213526634434591
Chapter II Neoplasms,Melanoma in situ,HYAL1,Hyaluronidase-1,24291,53,1.59 [0.57-4.43],0.3741266768044308
Chapter II Neoplasms,Melanoma in situ,HYOU1,Hypoxia up-regulated protein 1,24765,53,2.04 [0.67-6.22],0.2120831516132637
Chapter II Neoplasms,Melanoma in situ,ICA1,Islet cell autoantigen 1,24024,50,1.22 [0.89-1.65],0.2121773371655252
Chapter II Neoplasms,Melanoma in situ,ICAM1,Intercellular adhesion molecule 1,24338,53,0.97 [0.40-2.31],0.9385338541322952
Chapter II Neoplasms,Melanoma in situ,ICAM2,Intercellular adhesion molecule 2,24765,53,1.30 [0.59-2.83],0.5148481886510865
Chapter II Neoplasms,Melanoma in situ,ICAM3,Intercellular adhesion molecule 3,24765,53,0.68 [0.25-1.84],0.4509988110357432
Chapter II Neoplasms,Melanoma in situ,ICAM4,Intercellular adhesion molecule 4,24460,52,0.85 [0.54-1.35],0.495792763397561
Chapter II Neoplasms,Melanoma in situ,ICAM5,Intercellular adhesion molecule 5,24482,53,0.59 [0.35-1.00],0.0494820537323129
Chapter II Neoplasms,Melanoma in situ,ICOSLG,ICOS ligand,24350,50,0.47 [0.12-1.75],0.2582805946454338
Chapter II Neoplasms,Melanoma in situ,ID4,DNA-binding protein inhibitor ID-4,20824,40,1.14 [0.64-2.05],0.6590926860566826
Chapter II Neoplasms,Melanoma in situ,IDI2,Isopentenyl-diphosphate delta-isomerase 2,23895,51,0.80 [0.46-1.41],0.446499744564904
Chapter II Neoplasms,Melanoma in situ,IDO1,"Indoleamine 2,3-dioxygenase 1",20637,41,0.76 [0.46-1.25],0.2788241446342104
Chapter II Neoplasms,Melanoma in situ,IDS,Iduronate 2-sulfatase,24769,52,0.53 [0.04-7.49],0.6406005378302819
Chapter II Neoplasms,Melanoma in situ,IDUA,Alpha-L-iduronidase,24689,52,1.09 [0.64-1.85],0.7549024816683272
Chapter II Neoplasms,Melanoma in situ,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20652,39,1.60 [0.77-3.32],0.2098548000828581
Chapter II Neoplasms,Melanoma in situ,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,20824,40,0.52 [0.26-1.01],0.0537154388374547
Chapter II Neoplasms,Melanoma in situ,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,20824,40,1.13 [0.52-2.48],0.7525120278283725
Chapter II Neoplasms,Melanoma in situ,IFNAR1,Interferon alpha/beta receptor 1,21131,40,0.63 [0.18-2.18],0.4673573088472814
Chapter II Neoplasms,Melanoma in situ,IFNG,Interferon gamma,24024,50,1.24 [1.01-1.53],0.0421215527375749
Chapter II Neoplasms,Melanoma in situ,IFNGR1,Interferon gamma receptor 1,24564,52,0.41 [0.12-1.46],0.1698003608705069
Chapter II Neoplasms,Melanoma in situ,IFNGR2,Interferon gamma receptor 2,24313,49,1.75 [1.12-2.73],0.0134274106409297
Chapter II Neoplasms,Melanoma in situ,IFNL1,Interferon lambda-1,23895,51,0.85 [0.48-1.52],0.5929842902820874
Chapter II Neoplasms,Melanoma in situ,IFNL2,Interferon lambda-2,20569,40,1.21 [0.83-1.78],0.3196003996564879
Chapter II Neoplasms,Melanoma in situ,IFNLR1,Interferon lambda receptor 1,24460,52,0.99 [0.51-1.92],0.9712239744006512
Chapter II Neoplasms,Melanoma in situ,IFNW1,Interferon omega-1,20559,37,0.96 [0.40-2.27],0.9238328125150992
Chapter II Neoplasms,Melanoma in situ,IFT20,Intraflagellar transport protein 20 homolog,20638,38,1.23 [0.65-2.32],0.5318799752557406
Chapter II Neoplasms,Melanoma in situ,IGBP1,Immunoglobulin-binding protein 1,21191,40,1.18 [0.73-1.90],0.5079506716978781
Chapter II Neoplasms,Melanoma in situ,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,20569,40,0.70 [0.31-1.58],0.3899683959680445
Chapter II Neoplasms,Melanoma in situ,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,21216,41,0.72 [0.22-2.31],0.5790264781485674
Chapter II Neoplasms,Melanoma in situ,IGF1R,Insulin-like growth factor 1 receptor,24350,50,0.72 [0.22-2.42],0.5974827215918811
Chapter II Neoplasms,Melanoma in situ,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,20559,37,0.85 [0.41-1.75],0.6512303010449768
Chapter II Neoplasms,Melanoma in situ,IGF2R,Cation-independent mannose-6-phosphate receptor,24462,53,0.94 [0.33-2.64],0.9030269066287284
Chapter II Neoplasms,Melanoma in situ,IGFBP1,Insulin-like growth factor-binding protein 1,24723,53,1.01 [0.83-1.24],0.904921197898102
Chapter II Neoplasms,Melanoma in situ,IGFBP2,Insulin-like growth factor-binding protein 2,24717,51,0.64 [0.44-0.95],0.0254863023684253
Chapter II Neoplasms,Melanoma in situ,IGFBP3,Insulin-like growth factor-binding protein 3,24528,53,2.53 [0.98-6.52],0.0550915466432214
Chapter II Neoplasms,Melanoma in situ,IGFBP4,Insulin-like growth factor-binding protein 4,24142,53,1.33 [0.72-2.45],0.3567760280381116
Chapter II Neoplasms,Melanoma in situ,IGFBP6,Insulin-like growth factor-binding protein 6,24339,53,0.79 [0.31-1.99],0.6205700870750848
Chapter II Neoplasms,Melanoma in situ,IGFBP7,Insulin-like growth factor-binding protein 7,24765,53,1.04 [0.45-2.36],0.9327848269763818
Chapter II Neoplasms,Melanoma in situ,IGFBPL1,Insulin-like growth factor-binding protein-like 1,24482,53,1.74 [0.87-3.48],0.1146213882884617
Chapter II Neoplasms,Melanoma in situ,IGFL4,Insulin growth factor-like family member 4,20617,41,1.33 [1.05-1.68],0.0175152471895365
Chapter II Neoplasms,Melanoma in situ,IGHMBP2,DNA-binding protein SMUBP-2,20559,37,0.88 [0.50-1.57],0.6684870597008628
Chapter II Neoplasms,Melanoma in situ,IGLC2,Immunoglobulin lambda constant 2,21218,41,1.48 [0.71-3.09],0.3008551108433484
Chapter II Neoplasms,Melanoma in situ,IGLON5,IgLON family member 5,20471,40,1.03 [0.76-1.41],0.8370953006145919
Chapter II Neoplasms,Melanoma in situ,IGSF21,Immunoglobulin superfamily member 21,20637,41,0.85 [0.38-1.90],0.6986141103892134
Chapter II Neoplasms,Melanoma in situ,IGSF3,Immunoglobulin superfamily member 3,24350,50,0.96 [0.45-2.05],0.9146368469339488
Chapter II Neoplasms,Melanoma in situ,IGSF8,Immunoglobulin superfamily member 8,24482,53,2.16 [1.05-4.43],0.0363317986515733
Chapter II Neoplasms,Melanoma in situ,IGSF9,Protein turtle homolog A,21225,41,0.97 [0.68-1.39],0.8803878644706961
Chapter II Neoplasms,Melanoma in situ,IKBKG,NF-kappa-B essential modulator,24460,52,1.12 [0.86-1.46],0.3988988095128986
Chapter II Neoplasms,Melanoma in situ,IKZF2,Zinc finger protein Helios,23885,50,0.97 [0.74-1.27],0.8171938190504681
Chapter II Neoplasms,Melanoma in situ,IL10,Interleukin-10,24024,50,1.17 [0.89-1.53],0.2630864929668748
Chapter II Neoplasms,Melanoma in situ,IL10RA,Interleukin-10 receptor subunit alpha,24024,50,1.05 [0.70-1.56],0.8116751816944033
Chapter II Neoplasms,Melanoma in situ,IL10RB,Interleukin-10 receptor subunit beta,24564,52,0.56 [0.22-1.42],0.2223614659605466
Chapter II Neoplasms,Melanoma in situ,IL11,Interleukin-11,24024,50,0.71 [0.43-1.16],0.1664265349014323
Chapter II Neoplasms,Melanoma in situ,IL12A_IL12B,Interleukin-12,24350,50,0.88 [0.63-1.25],0.4851706317369829
Chapter II Neoplasms,Melanoma in situ,IL12B,Interleukin-12 subunit beta,24769,52,0.90 [0.57-1.44],0.6684602913420987
Chapter II Neoplasms,Melanoma in situ,IL12RB1,Interleukin-12 receptor subunit beta-1,24024,50,1.93 [1.06-3.50],0.0308175954436095
Chapter II Neoplasms,Melanoma in situ,IL12RB2,Interleukin-12 receptor subunit beta-2,20617,41,0.64 [0.29-1.40],0.2582886879091052
Chapter II Neoplasms,Melanoma in situ,IL13,Interleukin-13,24024,50,1.00 [0.61-1.64],0.988307704205446
Chapter II Neoplasms,Melanoma in situ,IL13RA1,Interleukin-13 receptor subunit alpha-1,24130,53,1.12 [0.37-3.41],0.842747550881755
Chapter II Neoplasms,Melanoma in situ,IL13RA2,Interleukin-13 receptor subunit alpha-2,20569,40,1.34 [0.47-3.83],0.5839321077133051
Chapter II Neoplasms,Melanoma in situ,IL15,Interleukin-15,24460,52,1.72 [0.88-3.37],0.1140515499280458
Chapter II Neoplasms,Melanoma in situ,IL15RA,Interleukin-15 receptor subunit alpha,24024,50,1.23 [0.59-2.56],0.5900378032884221
Chapter II Neoplasms,Melanoma in situ,IL16,Pro-interleukin-16,24769,52,0.78 [0.43-1.43],0.4245468914800745
Chapter II Neoplasms,Melanoma in situ,IL17A,Interleukin-17A,23981,50,0.69 [0.34-1.39],0.301781369284249
Chapter II Neoplasms,Melanoma in situ,IL17C,Interleukin-17C,24024,50,0.89 [0.60-1.32],0.5624549791160456
Chapter II Neoplasms,Melanoma in situ,IL17D,Interleukin-17D,24024,50,0.98 [0.45-2.13],0.9598433628013692
Chapter II Neoplasms,Melanoma in situ,IL17F,Interleukin-17F,24024,50,0.80 [0.54-1.18],0.2639117779696342
Chapter II Neoplasms,Melanoma in situ,IL17RA,Interleukin-17 receptor A,24462,53,1.18 [0.67-2.07],0.5569550341432377
Chapter II Neoplasms,Melanoma in situ,IL17RB,Interleukin-17 receptor B,24144,52,0.63 [0.40-1.00],0.048306569679879
Chapter II Neoplasms,Melanoma in situ,IL18,Interleukin-18,24353,51,1.30 [0.77-2.18],0.3237157856833371
Chapter II Neoplasms,Melanoma in situ,IL18BP,Interleukin-18-binding protein,24528,53,1.30 [0.58-2.93],0.522913519702328
Chapter II Neoplasms,Melanoma in situ,IL18R1,Interleukin-18 receptor 1,24769,52,0.58 [0.27-1.25],0.1620762955736031
Chapter II Neoplasms,Melanoma in situ,IL18RAP,Interleukin-18 receptor accessory protein,24158,49,0.90 [0.76-1.05],0.1837090802410907
Chapter II Neoplasms,Melanoma in situ,IL19,Interleukin-19,23876,51,0.69 [0.46-1.03],0.0701045703273741
Chapter II Neoplasms,Melanoma in situ,IL1A,Interleukin-1 alpha,24024,50,1.15 [0.77-1.71],0.4934151660193755
Chapter II Neoplasms,Melanoma in situ,IL1B,Interleukin-1 beta,23906,48,1.28 [0.85-1.93],0.2389347539061189
Chapter II Neoplasms,Melanoma in situ,IL1R1,Interleukin-1 receptor type 1,24418,53,0.41 [0.13-1.27],0.1212959819549977
Chapter II Neoplasms,Melanoma in situ,IL1R2,Interleukin-1 receptor type 2,24404,52,2.22 [0.61-8.15],0.2282568987758921
Chapter II Neoplasms,Melanoma in situ,IL1RAP,Interleukin-1 receptor accessory protein,24462,53,0.90 [0.51-1.57],0.7000576275722641
Chapter II Neoplasms,Melanoma in situ,IL1RL1,Interleukin-1 receptor-like 1,24675,53,1.11 [0.67-1.87],0.6810755925376122
Chapter II Neoplasms,Melanoma in situ,IL1RL2,Interleukin-1 receptor-like 2,24024,50,1.48 [0.78-2.83],0.2301134106947257
Chapter II Neoplasms,Melanoma in situ,IL1RN,Interleukin-1 receptor antagonist protein,24388,51,1.01 [0.64-1.58],0.9735515079261942
Chapter II Neoplasms,Melanoma in situ,IL2,Interleukin-2,24024,50,1.51 [0.67-3.41],0.3226977168342474
Chapter II Neoplasms,Melanoma in situ,IL20,Interleukin-20,24024,50,0.57 [0.30-1.10],0.0938891081121797
Chapter II Neoplasms,Melanoma in situ,IL20RA,Interleukin-20 receptor subunit alpha,24024,50,1.09 [0.65-1.83],0.735375388382131
Chapter II Neoplasms,Melanoma in situ,IL20RB,Interleukin-20 receptor subunit beta,20617,41,0.78 [0.38-1.61],0.5066367040854118
Chapter II Neoplasms,Melanoma in situ,IL21R,Interleukin-21 receptor,20617,41,1.01 [0.59-1.74],0.9680557217059484
Chapter II Neoplasms,Melanoma in situ,IL22,Interleukin-22,21108,40,0.86 [0.53-1.41],0.5526961703778456
Chapter II Neoplasms,Melanoma in situ,IL22RA1,Interleukin-22 receptor subunit alpha-1,24024,50,0.86 [0.46-1.61],0.6382815567121309
Chapter II Neoplasms,Melanoma in situ,IL24,Interleukin-24,24024,50,1.23 [0.79-1.92],0.3578210619511562
Chapter II Neoplasms,Melanoma in situ,IL25,Interleukin-25,20395,40,0.99 [0.41-2.40],0.9910684150795666
Chapter II Neoplasms,Melanoma in situ,IL2RA,Interleukin-2 receptor subunit alpha,24304,50,0.51 [0.26-1.02],0.0563427517280751
Chapter II Neoplasms,Melanoma in situ,IL2RB,Interleukin-2 receptor subunit beta,24024,50,0.77 [0.37-1.62],0.4969756132287578
Chapter II Neoplasms,Melanoma in situ,IL2RG,Cytokine receptor common subunit gamma,21108,40,0.96 [0.43-2.16],0.925159405646234
Chapter II Neoplasms,Melanoma in situ,IL3,Interleukin-3,20471,40,0.92 [0.57-1.47],0.716056240455762
Chapter II Neoplasms,Melanoma in situ,IL31,Interleukin-31,20617,41,1.08 [0.67-1.75],0.7430204278337846
Chapter II Neoplasms,Melanoma in situ,IL31RA,Interleukin-31 receptor subunit alpha,20546,39,0.60 [0.28-1.29],0.1915917089019675
Chapter II Neoplasms,Melanoma in situ,IL32,Interleukin-32,24460,52,0.73 [0.40-1.34],0.3065330394869431
Chapter II Neoplasms,Melanoma in situ,IL33,Interleukin-33,24024,50,0.75 [0.40-1.42],0.3807965095160354
Chapter II Neoplasms,Melanoma in situ,IL34,Interleukin-34,23858,51,0.59 [0.31-1.13],0.1104763884358613
Chapter II Neoplasms,Melanoma in situ,IL36A,Interleukin-36 alpha,20617,41,0.98 [0.58-1.67],0.9502661829101736
Chapter II Neoplasms,Melanoma in situ,IL36G,Interleukin-36 gamma,20552,41,0.83 [0.50-1.38],0.4677794477514604
Chapter II Neoplasms,Melanoma in situ,IL3RA,Interleukin-3 receptor subunit alpha,24024,50,1.14 [0.51-2.54],0.7429792606912962
Chapter II Neoplasms,Melanoma in situ,IL4,Interleukin-4,24024,50,0.97 [0.74-1.26],0.7989448867450852
Chapter II Neoplasms,Melanoma in situ,IL4R,Interleukin-4 receptor subunit alpha,24460,52,0.69 [0.33-1.44],0.3286513701978159
Chapter II Neoplasms,Melanoma in situ,IL5,Interleukin-5,24024,50,0.93 [0.77-1.13],0.474765474591177
Chapter II Neoplasms,Melanoma in situ,IL5RA,Interleukin-5 receptor subunit alpha,24460,52,1.01 [0.64-1.59],0.9792387299401154
Chapter II Neoplasms,Melanoma in situ,IL6,Interleukin-6,24350,50,0.87 [0.58-1.29],0.4779252357376568
Chapter II Neoplasms,Melanoma in situ,IL6R,Interleukin-6 receptor subunit alpha,24291,53,1.40 [0.69-2.86],0.3501475258503314
Chapter II Neoplasms,Melanoma in situ,IL6ST,Interleukin-6 receptor subunit beta,24482,53,0.47 [0.11-1.93],0.2940676757852565
Chapter II Neoplasms,Melanoma in situ,IL7,Interleukin-7,24460,52,1.09 [0.75-1.58],0.6643327371759864
Chapter II Neoplasms,Melanoma in situ,IL7R,Interleukin-7 receptor subunit alpha,24462,53,0.70 [0.45-1.10],0.1252875755341775
Chapter II Neoplasms,Melanoma in situ,IL9,Interleukin-9,20824,40,0.83 [0.44-1.57],0.562775515744316
Chapter II Neoplasms,Melanoma in situ,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23860,51,1.18 [0.80-1.74],0.4116170408112598
Chapter II Neoplasms,Melanoma in situ,IMMT,MICOS complex subunit MIC60,21108,40,1.41 [0.83-2.40],0.2081605262130878
Chapter II Neoplasms,Melanoma in situ,IMPA1,Inositol monophosphatase 1,24313,49,1.29 [0.87-1.92],0.2036493862671853
Chapter II Neoplasms,Melanoma in situ,IMPACT,Protein IMPACT,21166,40,1.15 [0.68-1.96],0.59709304031063
Chapter II Neoplasms,Melanoma in situ,IMPG1,Interphotoreceptor matrix proteoglycan 1,20569,40,1.14 [0.44-2.92],0.7865421983665013
Chapter II Neoplasms,Melanoma in situ,ING1,Inhibitor of growth protein 1,23848,51,1.22 [0.77-1.93],0.4043746923283958
Chapter II Neoplasms,Melanoma in situ,INHBB,Inhibin beta B chain,20746,40,0.61 [0.32-1.15],0.1285553812136968
Chapter II Neoplasms,Melanoma in situ,INHBC,Inhibin beta C chain,24462,53,0.93 [0.53-1.65],0.8143195454232979
Chapter II Neoplasms,Melanoma in situ,INPP1,Inositol polyphosphate 1-phosphatase,24350,50,1.26 [0.81-1.95],0.3048389112242423
Chapter II Neoplasms,Melanoma in situ,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20637,41,1.33 [0.81-2.19],0.257985065898509
Chapter II Neoplasms,Melanoma in situ,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",21191,40,1.13 [0.59-2.16],0.7073684045085864
Chapter II Neoplasms,Melanoma in situ,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",24350,50,1.11 [0.86-1.43],0.4231099081345694
Chapter II Neoplasms,Melanoma in situ,INSL3,Insulin-like 3,21166,40,1.05 [0.69-1.61],0.805965548637944
Chapter II Neoplasms,Melanoma in situ,INSL4,Early placenta insulin-like peptide,21108,40,1.29 [0.87-1.93],0.2087645261975369
Chapter II Neoplasms,Melanoma in situ,INSL5,Insulin-like peptide INSL5,21131,40,0.84 [0.60-1.18],0.3202871785511719
Chapter II Neoplasms,Melanoma in situ,INSR,Insulin receptor,20617,41,1.95 [0.33-11.54],0.4610272588945762
Chapter II Neoplasms,Melanoma in situ,IPCEF1,Interactor protein for cytohesin exchange factors 1,24272,49,1.02 [0.77-1.35],0.8751752144813075
Chapter II Neoplasms,Melanoma in situ,IQGAP2,Ras GTPase-activating-like protein IQGAP2,24350,50,0.92 [0.58-1.46],0.7210261028469023
Chapter II Neoplasms,Melanoma in situ,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",24041,51,1.07 [0.82-1.40],0.6185632248350088
Chapter II Neoplasms,Melanoma in situ,IRAK1,Interleukin-1 receptor-associated kinase 1,24024,50,1.31 [0.93-1.85],0.1224144437843986
Chapter II Neoplasms,Melanoma in situ,IRAK4,Interleukin-1 receptor-associated kinase 4,24460,52,1.15 [0.90-1.46],0.2564518019807882
Chapter II Neoplasms,Melanoma in situ,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,23529,50,1.02 [0.52-2.02],0.9431976898638296
Chapter II Neoplasms,Melanoma in situ,ISM1,Isthmin-1,24460,52,1.25 [0.69-2.28],0.45976024297505
Chapter II Neoplasms,Melanoma in situ,ISM2,Isthmin-2,21216,41,1.42 [0.90-2.24],0.1304954136925986
Chapter II Neoplasms,Melanoma in situ,IST1,IST1 homolog,20980,40,1.35 [0.99-1.85],0.0553915607399624
Chapter II Neoplasms,Melanoma in situ,ITGA11,Integrin alpha-11,24460,52,0.99 [0.49-2.03],0.9842517711193794
Chapter II Neoplasms,Melanoma in situ,ITGA2,Integrin alpha-2,20746,40,1.34 [0.53-3.34],0.5363760803593882
Chapter II Neoplasms,Melanoma in situ,ITGA5,Integrin alpha-5,24462,53,0.83 [0.31-2.21],0.7027943703518849
Chapter II Neoplasms,Melanoma in situ,ITGA6,Integrin alpha-6,24460,52,1.17 [0.76-1.80],0.4788806165208116
Chapter II Neoplasms,Melanoma in situ,ITGAL,Integrin alpha-L,20617,41,1.72 [0.83-3.57],0.1425954343933041
Chapter II Neoplasms,Melanoma in situ,ITGAM,Integrin alpha-M,24462,53,0.66 [0.30-1.45],0.3053301492240993
Chapter II Neoplasms,Melanoma in situ,ITGAV,Integrin alpha-V,24689,52,1.68 [0.37-7.54],0.4991059212551066
Chapter II Neoplasms,Melanoma in situ,ITGAX,Integrin alpha-X,20824,40,0.82 [0.44-1.54],0.5428673004778056
Chapter II Neoplasms,Melanoma in situ,ITGB1,Integrin beta-1,24406,53,1.54 [0.53-4.47],0.4313961501287877
Chapter II Neoplasms,Melanoma in situ,ITGB1BP1,Integrin beta-1-binding protein 1,23885,50,0.73 [0.39-1.35],0.3180469453674225
Chapter II Neoplasms,Melanoma in situ,ITGB1BP2,Integrin beta-1-binding protein 2,24041,51,1.15 [0.92-1.45],0.2201383330207726
Chapter II Neoplasms,Melanoma in situ,ITGB2,Integrin beta-2,24314,51,1.06 [0.44-2.51],0.9023965344102802
Chapter II Neoplasms,Melanoma in situ,ITGB5,Integrin beta-5,24519,53,1.46 [0.81-2.63],0.2089514459138358
Chapter II Neoplasms,Melanoma in situ,ITGB6,Integrin beta-6,24024,50,0.95 [0.40-2.22],0.8988477735062543
Chapter II Neoplasms,Melanoma in situ,ITGB7,Integrin beta-7,24689,52,0.72 [0.41-1.26],0.2448169236566653
Chapter II Neoplasms,Melanoma in situ,ITGBL1,Integrin beta-like protein 1,21216,41,1.10 [0.48-2.54],0.8163654350200228
Chapter II Neoplasms,Melanoma in situ,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,21249,41,3.38 [1.48-7.72],0.0037866846312697
Chapter II Neoplasms,Melanoma in situ,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,24528,53,1.12 [0.59-2.13],0.7231801667488313
Chapter II Neoplasms,Melanoma in situ,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,21249,41,1.35 [0.46-3.92],0.586053861930433
Chapter II Neoplasms,Melanoma in situ,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,21108,40,1.45 [0.87-2.42],0.1590126504041201
Chapter II Neoplasms,Melanoma in situ,ITM2A,Integral membrane protein 2A,24460,52,1.07 [0.71-1.61],0.7437915827741144
Chapter II Neoplasms,Melanoma in situ,ITPA,Inosine triphosphate pyrophosphatase,20559,37,1.12 [0.71-1.78],0.6278399761660023
Chapter II Neoplasms,Melanoma in situ,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",20637,41,1.29 [0.94-1.78],0.1182624028059564
Chapter II Neoplasms,Melanoma in situ,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",20569,40,0.99 [0.52-1.86],0.9730730879235696
Chapter II Neoplasms,Melanoma in situ,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",23895,51,1.04 [0.63-1.69],0.8850375659041522
Chapter II Neoplasms,Melanoma in situ,IZUMO1,Izumo sperm-egg fusion protein 1,20471,40,0.65 [0.29-1.46],0.2968576975107151
Chapter II Neoplasms,Melanoma in situ,JAM2,Junctional adhesion molecule B,24707,53,1.21 [0.46-3.19],0.6952580126769108
Chapter II Neoplasms,Melanoma in situ,JAM3,Junctional adhesion molecule C,20746,40,1.49 [0.87-2.56],0.1460464204696672
Chapter II Neoplasms,Melanoma in situ,JCHAIN,Immunoglobulin J chain,24024,50,0.86 [0.57-1.30],0.4807428505481632
Chapter II Neoplasms,Melanoma in situ,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,20471,40,0.91 [0.52-1.60],0.7421231625717031
Chapter II Neoplasms,Melanoma in situ,JPT2,Jupiter microtubule associated homolog 2,21131,40,1.53 [1.08-2.17],0.0173957413521336
Chapter II Neoplasms,Melanoma in situ,JUN,Transcription factor AP-1,24024,50,0.96 [0.59-1.57],0.8675253176222724
Chapter II Neoplasms,Melanoma in situ,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,24350,50,1.07 [0.61-1.88],0.8248890600902874
Chapter II Neoplasms,Melanoma in situ,KAZN,Kazrin,21131,40,1.32 [0.99-1.77],0.0623916993947571
Chapter II Neoplasms,Melanoma in situ,KCNC4,Potassium voltage-gated channel subfamily C member 4,20569,40,1.19 [0.76-1.86],0.457093725488876
Chapter II Neoplasms,Melanoma in situ,KCNH2,Potassium voltage-gated channel subfamily H member 2,20638,38,1.05 [0.71-1.55],0.819436480311895
Chapter II Neoplasms,Melanoma in situ,KCNIP4,Kv channel-interacting protein 4,23895,51,1.41 [1.04-1.89],0.0248367867315324
Chapter II Neoplasms,Melanoma in situ,KCTD5,BTB/POZ domain-containing protein KCTD5,20751,40,0.89 [0.44-1.79],0.7388977952773598
Chapter II Neoplasms,Melanoma in situ,KDM3A,Lysine-specific demethylase 3A,20617,41,0.95 [0.69-1.32],0.7749160042238574
Chapter II Neoplasms,Melanoma in situ,KDR,Vascular endothelial growth factor receptor 2,24519,53,1.63 [0.62-4.27],0.3173544441003779
Chapter II Neoplasms,Melanoma in situ,KEL,Kell blood group glycoprotein,23895,51,1.01 [0.50-2.03],0.9725768589543622
Chapter II Neoplasms,Melanoma in situ,KHDC3L,KH domain-containing protein 3,20471,40,1.24 [0.90-1.70],0.1906046635026845
Chapter II Neoplasms,Melanoma in situ,KHK,Ketohexokinase,20637,41,1.40 [0.88-2.23],0.1569093937061739
Chapter II Neoplasms,Melanoma in situ,KIAA0319,Dyslexia-associated protein KIAA0319,21166,40,0.68 [0.24-1.96],0.4781426814381737
Chapter II Neoplasms,Melanoma in situ,KIAA1549,UPF0606 protein KIAA1549,20824,40,1.05 [0.69-1.62],0.8095113270613317
Chapter II Neoplasms,Melanoma in situ,KIAA1549L,UPF0606 protein KIAA1549L,20824,40,1.16 [0.41-3.26],0.7734227384841055
Chapter II Neoplasms,Melanoma in situ,KIAA2013,Uncharacterized protein KIAA2013,21108,40,0.66 [0.31-1.37],0.2603855493632867
Chapter II Neoplasms,Melanoma in situ,KIF1C,Kinesin-like protein KIF1C,20559,37,1.13 [0.51-2.50],0.7575112638513415
Chapter II Neoplasms,Melanoma in situ,KIF20B,Kinesin-like protein KIF20B,20569,40,1.01 [0.69-1.49],0.957444891587504
Chapter II Neoplasms,Melanoma in situ,KIF22,Kinesin-like protein KIF22,20559,37,0.93 [0.72-1.21],0.6020891279937379
Chapter II Neoplasms,Melanoma in situ,KIFBP,KIF-binding protein,24350,50,1.09 [0.81-1.48],0.5686777070198454
Chapter II Neoplasms,Melanoma in situ,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,21108,40,1.05 [0.73-1.50],0.8085429577123213
Chapter II Neoplasms,Melanoma in situ,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23885,50,1.06 [0.75-1.48],0.7533830319935566
Chapter II Neoplasms,Melanoma in situ,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,21131,40,0.95 [0.80-1.14],0.5895003160123689
Chapter II Neoplasms,Melanoma in situ,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,23885,50,0.94 [0.76-1.16],0.537258288453347
Chapter II Neoplasms,Melanoma in situ,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,20471,40,1.30 [1.04-1.62],0.0197432053971601
Chapter II Neoplasms,Melanoma in situ,KIRREL1,Kin of IRRE-like protein 1,20569,40,1.09 [0.71-1.70],0.6859975124590953
Chapter II Neoplasms,Melanoma in situ,KIRREL2,Kin of IRRE-like protein 2,23895,51,0.80 [0.42-1.52],0.4890986514461637
Chapter II Neoplasms,Melanoma in situ,KIT,Mast/stem cell growth factor receptor Kit,24499,53,0.88 [0.38-2.04],0.7710425471956682
Chapter II Neoplasms,Melanoma in situ,KITLG,Kit ligand,24482,53,0.90 [0.46-1.73],0.7447855793867577
Chapter II Neoplasms,Melanoma in situ,KLB,Beta-klotho,23895,51,1.21 [0.86-1.69],0.271819545505585
Chapter II Neoplasms,Melanoma in situ,KLF4,Krueppel-like factor 4,20569,40,0.79 [0.36-1.74],0.5522106859666847
Chapter II Neoplasms,Melanoma in situ,KLHL41,Kelch-like protein 41,21191,40,0.86 [0.45-1.63],0.6350618351594641
Chapter II Neoplasms,Melanoma in situ,KLK1,Kallikrein-1,24215,51,0.95 [0.77-1.16],0.5929443146561042
Chapter II Neoplasms,Melanoma in situ,KLK10,Kallikrein-10,24446,53,0.87 [0.47-1.61],0.6526523092997795
Chapter II Neoplasms,Melanoma in situ,KLK11,Kallikrein-11,24270,53,0.49 [0.21-1.16],0.1040358678883664
Chapter II Neoplasms,Melanoma in situ,KLK12,Kallikrein-12,23885,50,1.12 [0.92-1.35],0.2535395177629473
Chapter II Neoplasms,Melanoma in situ,KLK13,Kallikrein-13,23897,48,1.13 [0.62-2.07],0.6849696043630471
Chapter II Neoplasms,Melanoma in situ,KLK14,Kallikrein-14,24689,52,0.87 [0.51-1.49],0.6086552603825244
Chapter II Neoplasms,Melanoma in situ,KLK15,Kallikrein-15,21075,40,1.08 [0.60-1.95],0.8043913242322982
Chapter II Neoplasms,Melanoma in situ,KLK3,Prostate-specific antigen,21216,41,0.78 [0.52-1.16],0.2254125029635892
Chapter II Neoplasms,Melanoma in situ,KLK4,Kallikrein-4,24689,52,1.08 [0.72-1.61],0.7006280388311789
Chapter II Neoplasms,Melanoma in situ,KLK6,Kallikrein-6,24484,53,0.76 [0.34-1.74],0.5206428886616581
Chapter II Neoplasms,Melanoma in situ,KLK7,Kallikrein-7,20201,40,0.74 [0.33-1.65],0.460757414709849
Chapter II Neoplasms,Melanoma in situ,KLK8,Kallikrein-8,23620,51,0.78 [0.37-1.61],0.4992993506319071
Chapter II Neoplasms,Melanoma in situ,KLKB1,Plasma kallikrein,20847,41,2.36 [0.80-6.94],0.1180737923615073
Chapter II Neoplasms,Melanoma in situ,KLRB1,Killer cell lectin-like receptor subfamily B member 1,24769,52,1.21 [0.61-2.38],0.5908067542623303
Chapter II Neoplasms,Melanoma in situ,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,20569,40,0.84 [0.47-1.50],0.5586237961244693
Chapter II Neoplasms,Melanoma in situ,KLRD1,Natural killer cells antigen CD94,24769,52,1.47 [0.86-2.51],0.1539406840333794
Chapter II Neoplasms,Melanoma in situ,KLRF1,Killer cell lectin-like receptor subfamily F member 1,20617,41,1.08 [0.54-2.14],0.8342281741231157
Chapter II Neoplasms,Melanoma in situ,KLRK1,NKG2-D type II integral membrane protein,21166,40,1.08 [0.56-2.11],0.8179524396607796
Chapter II Neoplasms,Melanoma in situ,KRT14,"Keratin, type I cytoskeletal 14",23140,47,1.39 [0.68-2.83],0.3646016851796742
Chapter II Neoplasms,Melanoma in situ,KRT17,"Keratin, type I cytoskeletal 17",20559,37,1.25 [0.62-2.52],0.5250967490494141
Chapter II Neoplasms,Melanoma in situ,KRT18,"Keratin, type I cytoskeletal 18",24350,50,0.94 [0.68-1.30],0.7167967815325326
Chapter II Neoplasms,Melanoma in situ,KRT19,"Keratin, type I cytoskeletal 19",24431,52,0.99 [0.67-1.45],0.9401444749499396
Chapter II Neoplasms,Melanoma in situ,KRT5,"Keratin, type II cytoskeletal 5",23895,51,1.20 [0.75-1.92],0.4568331260270168
Chapter II Neoplasms,Melanoma in situ,KRT6C,"Keratin, type II cytoskeletal 6C",20559,37,0.84 [0.36-1.99],0.6995436956823227
Chapter II Neoplasms,Melanoma in situ,KRT8,"Keratin, type II cytoskeletal 8",20569,40,1.09 [0.73-1.62],0.6875684206770708
Chapter II Neoplasms,Melanoma in situ,KYAT1,Kynurenine--oxoglutarate transaminase 1,24432,53,1.25 [0.83-1.89],0.2911404379427416
Chapter II Neoplasms,Melanoma in situ,KYNU,Kynureninase,24769,52,1.38 [0.83-2.31],0.2150557721518479
Chapter II Neoplasms,Melanoma in situ,L1CAM,Neural cell adhesion molecule L1,24519,53,0.69 [0.30-1.61],0.3928864748380964
Chapter II Neoplasms,Melanoma in situ,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,21225,41,1.41 [1.02-1.94],0.0365245731399881
Chapter II Neoplasms,Melanoma in situ,LACRT,Extracellular glycoprotein lacritin,21071,39,1.44 [0.89-2.33],0.1354252312847224
Chapter II Neoplasms,Melanoma in situ,LACTB2,Endoribonuclease LACTB2,24482,53,1.21 [0.85-1.73],0.2887349508762993
Chapter II Neoplasms,Melanoma in situ,LAG3,Lymphocyte activation gene 3 protein,24350,50,1.19 [0.67-2.14],0.5502536873259743
Chapter II Neoplasms,Melanoma in situ,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24444,52,1.72 [0.86-3.41],0.1224795784659133
Chapter II Neoplasms,Melanoma in situ,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,24313,49,1.05 [0.82-1.34],0.7207909989485051
Chapter II Neoplasms,Melanoma in situ,LAMA1,Laminin subunit alpha-1,20559,37,1.02 [0.58-1.79],0.9472558173591452
Chapter II Neoplasms,Melanoma in situ,LAMA4,Laminin subunit alpha-4,24564,52,0.76 [0.36-1.60],0.4714723500665373
Chapter II Neoplasms,Melanoma in situ,LAMB1,Laminin subunit beta-1,20637,41,1.39 [0.52-3.75],0.5089649838633417
Chapter II Neoplasms,Melanoma in situ,LAMP1,Lysosome-associated membrane glycoprotein 1,20643,41,1.46 [0.86-2.50],0.1645417030667775
Chapter II Neoplasms,Melanoma in situ,LAMP2,Lysosome-associated membrane glycoprotein 2,23734,51,1.28 [0.35-4.70],0.709836154771387
Chapter II Neoplasms,Melanoma in situ,LAMP3,Lysosome-associated membrane glycoprotein 3,24721,52,1.08 [0.65-1.78],0.7679624572250418
Chapter II Neoplasms,Melanoma in situ,LAMTOR5,Ragulator complex protein LAMTOR5,21108,40,1.30 [0.71-2.41],0.3973040022054872
Chapter II Neoplasms,Melanoma in situ,LAP3,Cytosol aminopeptidase,24024,50,1.47 [0.95-2.30],0.0862265955008459
Chapter II Neoplasms,Melanoma in situ,LARP1,La-related protein 1,21108,40,1.17 [0.77-1.76],0.4674777947832547
Chapter II Neoplasms,Melanoma in situ,LAT,Linker for activation of T-cells family member 1,24769,52,1.15 [0.83-1.59],0.4084246437808486
Chapter II Neoplasms,Melanoma in situ,LAT2,Linker for activation of T-cells family member 2,24350,50,1.05 [0.86-1.29],0.6058922913684235
Chapter II Neoplasms,Melanoma in situ,LATS1,Serine/threonine-protein kinase LATS1,20617,41,1.53 [1.10-2.13],0.0123953842288226
Chapter II Neoplasms,Melanoma in situ,LAYN,Layilin,24266,49,1.24 [0.56-2.77],0.5954608167038032
Chapter II Neoplasms,Melanoma in situ,LBP,Lipopolysaccharide-binding protein,24528,53,0.76 [0.50-1.14],0.1872807160736092
Chapter II Neoplasms,Melanoma in situ,LBR,Delta(14)-sterol reductase LBR,24707,53,1.06 [0.76-1.47],0.725250722460684
Chapter II Neoplasms,Melanoma in situ,LCAT,Phosphatidylcholine-sterol acyltransferase,21229,41,1.22 [0.31-4.81],0.7726386495932516
Chapter II Neoplasms,Melanoma in situ,LCN15,Lipocalin-15,21191,40,0.81 [0.46-1.43],0.4755810675887904
Chapter II Neoplasms,Melanoma in situ,LCN2,Neutrophil gelatinase-associated lipocalin,23689,49,0.90 [0.44-1.86],0.7796857630800591
Chapter II Neoplasms,Melanoma in situ,LCP1,Plastin-2,21216,41,1.08 [0.59-1.99],0.7964281287475347
Chapter II Neoplasms,Melanoma in situ,LDLR,Low-density lipoprotein receptor,24529,51,1.02 [0.64-1.63],0.9439204127965604
Chapter II Neoplasms,Melanoma in situ,LDLRAP1,Low density lipoprotein receptor adapter protein 1,21191,40,1.30 [0.96-1.78],0.0916418646583296
Chapter II Neoplasms,Melanoma in situ,LECT2,Leukocyte cell-derived chemotaxin-2,21225,41,1.29 [0.86-1.94],0.2239245297043543
Chapter II Neoplasms,Melanoma in situ,LEFTY2,Left-right determination factor 2,24657,52,1.17 [0.74-1.84],0.5098453372538767
Chapter II Neoplasms,Melanoma in situ,LEG1,Protein LEG1 homolog,20005,38,0.95 [0.60-1.53],0.8478896270141721
Chapter II Neoplasms,Melanoma in situ,LELP1,Late cornified envelope-like proline-rich protein 1,20569,40,1.09 [0.75-1.60],0.6396973400032222
Chapter II Neoplasms,Melanoma in situ,LEO1,RNA polymerase-associated protein LEO1,21191,40,1.03 [0.37-2.85],0.9564972754347222
Chapter II Neoplasms,Melanoma in situ,LEP,Leptin,24482,53,1.27 [0.87-1.84],0.2100754205289362
Chapter II Neoplasms,Melanoma in situ,LEPR,Leptin receptor,24482,53,0.74 [0.33-1.67],0.4663123610708969
Chapter II Neoplasms,Melanoma in situ,LETM1,Mitochondrial proton/calcium exchanger protein,21191,40,1.37 [0.82-2.29],0.2348242168367749
Chapter II Neoplasms,Melanoma in situ,LGALS1,Galectin-1,24482,53,0.90 [0.43-1.89],0.7762909404403953
Chapter II Neoplasms,Melanoma in situ,LGALS3,Galectin-3,24525,50,1.25 [0.54-2.87],0.6071204444987651
Chapter II Neoplasms,Melanoma in situ,LGALS3BP,Galectin-3-binding protein,21249,41,0.99 [0.38-2.61],0.9912967933033752
Chapter II Neoplasms,Melanoma in situ,LGALS4,Galectin-4,24444,52,1.40 [0.89-2.19],0.1407802744939013
Chapter II Neoplasms,Melanoma in situ,LGALS7_LGALS7B,Galectin-7,24434,51,0.80 [0.42-1.51],0.4903585412996035
Chapter II Neoplasms,Melanoma in situ,LGALS8,Galectin-8,24707,53,1.45 [1.00-2.11],0.052127725661527
Chapter II Neoplasms,Melanoma in situ,LGALS9,Galectin-9,24441,52,1.03 [0.46-2.30],0.935938224094468
Chapter II Neoplasms,Melanoma in situ,LGMN,Legumain,24564,52,0.90 [0.45-1.78],0.7534011793067095
Chapter II Neoplasms,Melanoma in situ,LHB,Lutropin subunit beta,23885,50,0.91 [0.67-1.24],0.5627669913783946
Chapter II Neoplasms,Melanoma in situ,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,24476,51,0.81 [0.53-1.25],0.3410130324464718
Chapter II Neoplasms,Melanoma in situ,LIF,Leukemia inhibitory factor,23895,51,0.69 [0.40-1.19],0.1795784602411534
Chapter II Neoplasms,Melanoma in situ,LIFR,Leukemia inhibitory factor receptor,24460,52,0.77 [0.28-2.17],0.6271513932843725
Chapter II Neoplasms,Melanoma in situ,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,24462,53,0.85 [0.43-1.68],0.6393300883651343
Chapter II Neoplasms,Melanoma in situ,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,21216,41,0.97 [0.79-1.18],0.7330214758214717
Chapter II Neoplasms,Melanoma in situ,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,20559,37,1.00 [0.54-1.84],0.9922484612616512
Chapter II Neoplasms,Melanoma in situ,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,24454,53,1.09 [0.51-2.36],0.8235741958332232
Chapter II Neoplasms,Melanoma in situ,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,21225,41,0.94 [0.63-1.41],0.7784741038752085
Chapter II Neoplasms,Melanoma in situ,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24765,53,0.73 [0.30-1.77],0.4896243773993272
Chapter II Neoplasms,Melanoma in situ,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,24627,51,0.78 [0.39-1.55],0.4724404557310268
Chapter II Neoplasms,Melanoma in situ,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,24024,50,1.09 [0.60-1.99],0.7778586335605592
Chapter II Neoplasms,Melanoma in situ,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,24765,53,0.96 [0.68-1.34],0.7927239668852398
Chapter II Neoplasms,Melanoma in situ,LIPF,Gastric triacylglycerol lipase,20637,41,0.99 [0.59-1.66],0.9786276740624216
Chapter II Neoplasms,Melanoma in situ,LMNB1,Lamin-B1,21086,40,0.67 [0.40-1.11],0.1208295549756467
Chapter II Neoplasms,Melanoma in situ,LMNB2,Lamin-B2,21166,40,1.28 [0.46-3.60],0.6384757459183947
Chapter II Neoplasms,Melanoma in situ,LMOD1,Leiomodin-1,21191,40,1.10 [0.49-2.48],0.821964289916639
Chapter II Neoplasms,Melanoma in situ,LMOD2,Leiomodin-2,20569,40,0.66 [0.37-1.18],0.164717851278802
Chapter II Neoplasms,Melanoma in situ,LONP1,"Lon protease homolog, mitochondrial",20637,41,1.38 [1.00-1.91],0.0513222664956519
Chapter II Neoplasms,Melanoma in situ,LPA,Apolipoprotein(a),20737,41,0.93 [0.79-1.10],0.4076751591713955
Chapter II Neoplasms,Melanoma in situ,LPCAT2,Lysophosphatidylcholine acyltransferase 2,24350,50,0.62 [0.26-1.45],0.2685337410306149
Chapter II Neoplasms,Melanoma in situ,LPL,Lipoprotein lipase,24482,53,0.84 [0.51-1.39],0.508829971164251
Chapter II Neoplasms,Melanoma in situ,LPO,Lactoperoxidase,23699,49,0.94 [0.61-1.46],0.796033630195831
Chapter II Neoplasms,Melanoma in situ,LPP,Lipoma-preferred partner,20559,37,1.56 [1.01-2.42],0.0440840374423023
Chapter II Neoplasms,Melanoma in situ,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,20559,37,1.20 [0.78-1.85],0.4003899818612566
Chapter II Neoplasms,Melanoma in situ,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,20638,38,1.35 [0.87-2.08],0.1804659304426084
Chapter II Neoplasms,Melanoma in situ,LRG1,Leucine-rich alpha-2-glycoprotein,21249,41,1.00 [0.31-3.18],0.9994803375859184
Chapter II Neoplasms,Melanoma in situ,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,24626,52,2.03 [1.01-4.07],0.0472484866790715
Chapter II Neoplasms,Melanoma in situ,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,20546,41,0.49 [0.14-1.72],0.2670281831900708
Chapter II Neoplasms,Melanoma in situ,LRP1,Prolow-density lipoprotein receptor-related protein 1,24350,50,0.80 [0.31-2.09],0.6481360713661073
Chapter II Neoplasms,Melanoma in situ,LRP11,Low-density lipoprotein receptor-related protein 11,24482,53,0.77 [0.37-1.58],0.4737808093058291
Chapter II Neoplasms,Melanoma in situ,LRP2,Low-density lipoprotein receptor-related protein 2,20638,38,0.73 [0.29-1.85],0.5095683132857978
Chapter II Neoplasms,Melanoma in situ,LRP2BP,LRP2-binding protein,20638,38,0.81 [0.50-1.29],0.3667791874750989
Chapter II Neoplasms,Melanoma in situ,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,24707,53,1.04 [0.68-1.57],0.8674674743921853
Chapter II Neoplasms,Melanoma in situ,LRRC25,Leucine-rich repeat-containing protein 25,24350,50,0.80 [0.41-1.57],0.5142699170734597
Chapter II Neoplasms,Melanoma in situ,LRRC37A2,Leucine-rich repeat-containing protein 37A2,21131,40,1.72 [0.85-3.49],0.1309298595135195
Chapter II Neoplasms,Melanoma in situ,LRRC38,Leucine-rich repeat-containing protein 38,20638,38,0.80 [0.40-1.59],0.5229088782967927
Chapter II Neoplasms,Melanoma in situ,LRRC59,Leucine-rich repeat-containing protein 59,21225,41,1.76 [1.05-2.97],0.0332807779564112
Chapter II Neoplasms,Melanoma in situ,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,21108,40,1.55 [0.90-2.68],0.1150414404105696
Chapter II Neoplasms,Melanoma in situ,LRRN1,Leucine-rich repeat neuronal protein 1,24024,50,0.60 [0.32-1.14],0.1208465067216884
Chapter II Neoplasms,Melanoma in situ,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,20638,38,1.36 [0.75-2.46],0.3127789547691905
Chapter II Neoplasms,Melanoma in situ,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,21191,40,0.86 [0.26-2.79],0.7952081031687727
Chapter II Neoplasms,Melanoma in situ,LSM1,U6 snRNA-associated Sm-like protein LSm1,23885,50,1.05 [0.68-1.62],0.8192238541810057
Chapter II Neoplasms,Melanoma in situ,LSM8,U6 snRNA-associated Sm-like protein LSm8,20824,40,1.06 [0.77-1.46],0.732349560352963
Chapter II Neoplasms,Melanoma in situ,LSP1,Lymphocyte-specific protein 1,24460,52,0.56 [0.29-1.05],0.0696747198546461
Chapter II Neoplasms,Melanoma in situ,LTA,Lymphotoxin-alpha,24460,52,0.62 [0.34-1.13],0.1186043296934527
Chapter II Neoplasms,Melanoma in situ,LTA4H,Leukotriene A-4 hydrolase,24689,52,1.05 [0.70-1.58],0.8015981275062473
Chapter II Neoplasms,Melanoma in situ,LTB,Lymphotoxin-beta,21108,40,1.21 [0.55-2.64],0.6372997511322563
Chapter II Neoplasms,Melanoma in situ,LTBP2,Latent-transforming growth factor beta-binding protein 2,24765,53,0.66 [0.29-1.50],0.324128152380849
Chapter II Neoplasms,Melanoma in situ,LTBP3,Latent-transforming growth factor beta-binding protein 3,23885,50,0.89 [0.54-1.46],0.6427256871790622
Chapter II Neoplasms,Melanoma in situ,LTBR,Tumor necrosis factor receptor superfamily member 3,24305,51,0.64 [0.24-1.72],0.3781074490748457
Chapter II Neoplasms,Melanoma in situ,LTO1,Protein LTO1 homolog,24024,50,1.05 [0.58-1.88],0.8777372381321991
Chapter II Neoplasms,Melanoma in situ,LUZP2,Leucine zipper protein 2,21108,40,0.52 [0.24-1.14],0.10255097459524
Chapter II Neoplasms,Melanoma in situ,LXN,Latexin,24196,49,0.87 [0.59-1.29],0.4880395667180187
Chapter II Neoplasms,Melanoma in situ,LY6D,Lymphocyte antigen 6D,24304,51,0.67 [0.32-1.40],0.2912772509379666
Chapter II Neoplasms,Melanoma in situ,LY75,Lymphocyte antigen 75,24460,52,1.63 [0.84-3.16],0.1476794993513882
Chapter II Neoplasms,Melanoma in situ,LY9,T-lymphocyte surface antigen Ly-9,24234,51,1.46 [0.60-3.51],0.4021741654311355
Chapter II Neoplasms,Melanoma in situ,LY96,Lymphocyte antigen 96,24313,49,0.82 [0.39-1.73],0.6110374179722033
Chapter II Neoplasms,Melanoma in situ,LYAR,Cell growth-regulating nucleolar protein,23885,50,1.01 [0.64-1.58],0.9792217678080488
Chapter II Neoplasms,Melanoma in situ,LYN,Tyrosine-protein kinase Lyn,24350,50,1.14 [0.85-1.54],0.3657120311819547
Chapter II Neoplasms,Melanoma in situ,LYPD1,Ly6/PLAUR domain-containing protein 1,23895,51,0.99 [0.67-1.46],0.947319882053685
Chapter II Neoplasms,Melanoma in situ,LYPD3,Ly6/PLAUR domain-containing protein 3,24334,53,0.47 [0.23-0.95],0.0366802565829063
Chapter II Neoplasms,Melanoma in situ,LYPD8,Ly6/PLAUR domain-containing protein 8,23885,50,0.72 [0.42-1.23],0.2279304288962604
Chapter II Neoplasms,Melanoma in situ,LYPLA2,Acyl-protein thioesterase 2,20569,40,0.91 [0.66-1.25],0.5549346001527853
Chapter II Neoplasms,Melanoma in situ,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,20638,38,1.42 [1.17-1.73],0.000376141380604
Chapter II Neoplasms,Melanoma in situ,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,21249,41,0.49 [0.10-2.30],0.3629446594310306
Chapter II Neoplasms,Melanoma in situ,LYZL2,Lysozyme-like protein 2,20471,40,1.18 [0.55-2.55],0.6702281969495821
Chapter II Neoplasms,Melanoma in situ,LZTFL1,Leucine zipper transcription factor-like protein 1,20746,40,1.50 [1.00-2.25],0.0493525521145279
Chapter II Neoplasms,Melanoma in situ,M6PR,Cation-dependent mannose-6-phosphate receptor,20637,41,1.82 [1.22-2.72],0.0032122078198435
Chapter II Neoplasms,Melanoma in situ,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,24235,49,1.12 [0.71-1.76],0.6398332557549694
Chapter II Neoplasms,Melanoma in situ,MAEA,E3 ubiquitin-protein transferase MAEA,23885,50,0.81 [0.41-1.59],0.5320158853471944
Chapter II Neoplasms,Melanoma in situ,MAG,Myelin-associated glycoprotein,20638,38,0.82 [0.42-1.59],0.5561684847075803
Chapter II Neoplasms,Melanoma in situ,MAGEA3,Melanoma-associated antigen 3,20824,40,0.86 [0.63-1.18],0.338974505947059
Chapter II Neoplasms,Melanoma in situ,MAGED1,Melanoma-associated antigen D1,23885,50,1.37 [0.86-2.18],0.1905866910436237
Chapter II Neoplasms,Melanoma in situ,MAMDC2,MAM domain-containing protein 2,21225,41,1.58 [0.65-3.85],0.3120285171737389
Chapter II Neoplasms,Melanoma in situ,MAMDC4,Apical endosomal glycoprotein,21108,40,1.24 [0.74-2.09],0.42096156500963
Chapter II Neoplasms,Melanoma in situ,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20637,41,0.64 [0.20-2.04],0.4487835690165945
Chapter II Neoplasms,Melanoma in situ,MAN2B2,Epididymis-specific alpha-mannosidase,21225,41,1.51 [0.91-2.51],0.1137132642587773
Chapter II Neoplasms,Melanoma in situ,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",20471,40,1.22 [0.70-2.11],0.4892728805052072
Chapter II Neoplasms,Melanoma in situ,MANF,Mesencephalic astrocyte-derived neurotrophic factor,24564,52,1.17 [0.94-1.46],0.1483263486511853
Chapter II Neoplasms,Melanoma in situ,MANSC1,MANSC domain-containing protein 1,24519,53,0.50 [0.20-1.20],0.1199302885155372
Chapter II Neoplasms,Melanoma in situ,MANSC4,MANSC domain-containing protein 4,20559,37,1.36 [0.88-2.10],0.1657107941347709
Chapter II Neoplasms,Melanoma in situ,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,20569,40,0.85 [0.32-2.21],0.7337740324958364
Chapter II Neoplasms,Melanoma in situ,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,20559,37,1.09 [0.71-1.69],0.6903190646244817
Chapter II Neoplasms,Melanoma in situ,MAP2,Microtubule-associated protein 2,21166,40,1.91 [1.14-3.20],0.0134418457154463
Chapter II Neoplasms,Melanoma in situ,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,21131,40,1.47 [0.94-2.30],0.0893840366773135
Chapter II Neoplasms,Melanoma in situ,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,24460,52,1.11 [0.87-1.42],0.3843514576528601
Chapter II Neoplasms,Melanoma in situ,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,23885,50,1.06 [0.83-1.37],0.6359226470810526
Chapter II Neoplasms,Melanoma in situ,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,24266,49,1.11 [0.89-1.40],0.3477275344764339
Chapter II Neoplasms,Melanoma in situ,MAPK13,Mitogen-activated protein kinase 13,20471,40,1.08 [0.57-2.05],0.8039446240490667
Chapter II Neoplasms,Melanoma in situ,MAPK9,Mitogen-activated protein kinase 9,24460,52,1.69 [0.98-2.91],0.0576437610473815
Chapter II Neoplasms,Melanoma in situ,MAPKAPK2,MAP kinase-activated protein kinase 2,20824,40,1.44 [0.99-2.11],0.0588084092680479
Chapter II Neoplasms,Melanoma in situ,MAPRE3,Microtubule-associated protein RP/EB family member 3,20471,40,0.89 [0.70-1.14],0.3506839651996893
Chapter II Neoplasms,Melanoma in situ,MAPT,Microtubule-associated protein tau,23895,51,0.85 [0.55-1.32],0.4741317228126311
Chapter II Neoplasms,Melanoma in situ,MARCO,Macrophage receptor MARCO,24482,53,1.36 [0.53-3.48],0.5267986429574767
Chapter II Neoplasms,Melanoma in situ,MARS1,"Methionine--tRNA ligase, cytoplasmic",20700,40,1.32 [0.93-1.86],0.1187493427613095
Chapter II Neoplasms,Melanoma in situ,MASP1,Mannan-binding lectin serine protease 1,24266,49,1.11 [0.38-3.25],0.8452274826723833
Chapter II Neoplasms,Melanoma in situ,MATN2,Matrilin-2,24488,52,0.79 [0.34-1.80],0.5689617081172968
Chapter II Neoplasms,Melanoma in situ,MATN3,Matrilin-3,24272,49,0.63 [0.28-1.45],0.2810376524409717
Chapter II Neoplasms,Melanoma in situ,MAVS,Mitochondrial antiviral-signaling protein,23885,50,1.16 [0.89-1.52],0.2657212642851486
Chapter II Neoplasms,Melanoma in situ,MAX,Protein max,23895,51,1.29 [1.02-1.63],0.0341004256810769
Chapter II Neoplasms,Melanoma in situ,MB,Myoglobin,24765,53,0.55 [0.32-0.95],0.0312154905004241
Chapter II Neoplasms,Melanoma in situ,MBL2,Mannose-binding protein C,20950,41,0.84 [0.64-1.10],0.2015279389721269
Chapter II Neoplasms,Melanoma in situ,MCAM,Cell surface glycoprotein MUC18,24528,53,1.27 [0.61-2.62],0.5271244345845647
Chapter II Neoplasms,Melanoma in situ,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",21191,40,1.75 [1.18-2.58],0.0049598999612089
Chapter II Neoplasms,Melanoma in situ,MCEMP1,Mast cell-expressed membrane protein 1,20617,41,0.89 [0.64-1.26],0.5180944701179742
Chapter II Neoplasms,Melanoma in situ,MCFD2,Multiple coagulation factor deficiency protein 2,24374,51,1.82 [1.06-3.10],0.028617214263638
Chapter II Neoplasms,Melanoma in situ,MCTS1,Malignant T-cell-amplified sequence 1,21131,40,1.28 [0.43-3.81],0.6526195928680929
Chapter II Neoplasms,Melanoma in situ,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,24313,49,1.12 [0.78-1.61],0.5546859132819646
Chapter II Neoplasms,Melanoma in situ,MDH1,"Malate dehydrogenase, cytoplasmic",21106,41,1.16 [0.57-2.35],0.6826821710429813
Chapter II Neoplasms,Melanoma in situ,MDK,Midkine,24439,53,1.02 [0.64-1.64],0.9220204796825195
Chapter II Neoplasms,Melanoma in situ,MDM1,Nuclear protein MDM1,20638,38,1.56 [0.62-3.88],0.344187582873149
Chapter II Neoplasms,Melanoma in situ,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",20637,41,1.36 [1.00-1.85],0.0534972844081895
Chapter II Neoplasms,Melanoma in situ,MED18,Mediator of RNA polymerase II transcription subunit 18,23885,50,1.24 [0.90-1.72],0.1901225240981146
Chapter II Neoplasms,Melanoma in situ,MED21,Mediator of RNA polymerase II transcription subunit 21,20559,37,0.55 [0.23-1.32],0.1772505936785792
Chapter II Neoplasms,Melanoma in situ,MEGF10,Multiple epidermal growth factor-like domains protein 10,24444,52,0.81 [0.44-1.48],0.4922432610169424
Chapter II Neoplasms,Melanoma in situ,MEGF11,Multiple epidermal growth factor-like domains protein 11,20559,37,1.85 [1.05-3.27],0.0344398963453722
Chapter II Neoplasms,Melanoma in situ,MEGF9,Multiple epidermal growth factor-like domains protein 9,24675,53,1.83 [0.64-5.26],0.2631077805710358
Chapter II Neoplasms,Melanoma in situ,MELTF,Melanotransferrin,21225,41,2.10 [0.78-5.65],0.1394284132348751
Chapter II Neoplasms,Melanoma in situ,MENT,Protein MENT,20746,40,1.42 [0.36-5.58],0.6127079562309892
Chapter II Neoplasms,Melanoma in situ,MEP1A,Meprin A subunit alpha,21131,40,1.18 [0.78-1.79],0.4372319848234479
Chapter II Neoplasms,Melanoma in situ,MEP1B,Meprin A subunit beta,24482,53,0.92 [0.75-1.13],0.4310787334823164
Chapter II Neoplasms,Melanoma in situ,MEPE,Matrix extracellular phosphoglycoprotein,24444,52,0.98 [0.35-2.71],0.9692070843211986
Chapter II Neoplasms,Melanoma in situ,MERTK,Tyrosine-protein kinase Mer,24769,52,0.68 [0.26-1.80],0.4389122810611772
Chapter II Neoplasms,Melanoma in situ,MESD,LRP chaperone MESD,24462,53,1.14 [0.93-1.39],0.1956151651291549
Chapter II Neoplasms,Melanoma in situ,MET,Hepatocyte growth factor receptor,24522,52,1.76 [0.51-6.06],0.3730036876923708
Chapter II Neoplasms,Melanoma in situ,METAP1,Methionine aminopeptidase 1,23895,51,1.15 [0.53-2.52],0.7181901654448546
Chapter II Neoplasms,Melanoma in situ,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",24460,52,1.17 [0.88-1.56],0.2881621129697509
Chapter II Neoplasms,Melanoma in situ,METAP2,Methionine aminopeptidase 2,24657,52,1.28 [0.84-1.97],0.2524094948674235
Chapter II Neoplasms,Melanoma in situ,MFAP3,Microfibril-associated glycoprotein 3,24041,51,0.95 [0.56-1.59],0.8388517322917839
Chapter II Neoplasms,Melanoma in situ,MFAP3L,Microfibrillar-associated protein 3-like,20638,38,1.03 [0.66-1.62],0.8824280544888148
Chapter II Neoplasms,Melanoma in situ,MFAP4,Microfibril-associated glycoprotein 4,20746,40,1.59 [0.61-4.13],0.3380807061330174
Chapter II Neoplasms,Melanoma in situ,MFAP5,Microfibrillar-associated protein 5,24765,53,1.26 [0.69-2.31],0.4519679552052772
Chapter II Neoplasms,Melanoma in situ,MFGE8,Lactadherin,24462,53,1.39 [0.81-2.38],0.237134851116899
Chapter II Neoplasms,Melanoma in situ,MGLL,Monoglyceride lipase,24529,52,1.17 [0.88-1.55],0.2921275224364317
Chapter II Neoplasms,Melanoma in situ,MGMT,Methylated-DNA--protein-cysteine methyltransferase,24460,52,1.06 [0.87-1.30],0.552111773269388
Chapter II Neoplasms,Melanoma in situ,MIA,Melanoma-derived growth regulatory protein,24519,53,0.59 [0.29-1.17],0.1287929332170974
Chapter II Neoplasms,Melanoma in situ,MICALL2,MICAL-like protein 2,20638,38,1.30 [0.88-1.91],0.1883248537393143
Chapter II Neoplasms,Melanoma in situ,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,24460,52,1.30 [1.00-1.68],0.0471637385199444
Chapter II Neoplasms,Melanoma in situ,MIF,Macrophage migration inhibitory factor,24418,52,1.06 [0.74-1.52],0.7336752862767654
Chapter II Neoplasms,Melanoma in situ,MILR1,Allergin-1,24024,50,0.59 [0.35-1.01],0.0530083417554114
Chapter II Neoplasms,Melanoma in situ,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,21108,40,1.37 [1.03-1.83],0.0309474225599873
Chapter II Neoplasms,Melanoma in situ,MINK1,Misshapen-like kinase 1,21166,40,1.50 [1.07-2.11],0.0177404056341026
Chapter II Neoplasms,Melanoma in situ,MITD1,MIT domain-containing protein 1,24313,49,1.15 [0.88-1.49],0.3065995107319753
Chapter II Neoplasms,Melanoma in situ,MKI67,Proliferation marker protein Ki-67,20617,41,0.84 [0.38-1.89],0.6763671220418522
Chapter II Neoplasms,Melanoma in situ,MLLT1,Protein ENL,20471,40,1.19 [0.83-1.71],0.3397892319548745
Chapter II Neoplasms,Melanoma in situ,MLN,Promotilin,24460,52,1.03 [0.78-1.35],0.8575453277236562
Chapter II Neoplasms,Melanoma in situ,MME,Neprilysin,24350,50,0.92 [0.66-1.27],0.6004965130749516
Chapter II Neoplasms,Melanoma in situ,MMP1,Interstitial collagenase,23602,50,1.12 [0.84-1.48],0.4331073235927246
Chapter II Neoplasms,Melanoma in situ,MMP10,Stromelysin-2,24421,52,0.66 [0.42-1.04],0.073789665684237
Chapter II Neoplasms,Melanoma in situ,MMP12,Macrophage metalloelastase,24513,52,0.73 [0.44-1.20],0.2143614172261343
Chapter II Neoplasms,Melanoma in situ,MMP13,Collagenase 3,23895,51,0.53 [0.25-1.15],0.1104864935975062
Chapter II Neoplasms,Melanoma in situ,MMP15,Matrix metalloproteinase-15,21225,41,1.04 [0.60-1.81],0.8941128156011648
Chapter II Neoplasms,Melanoma in situ,MMP3,Stromelysin-1,24462,53,0.77 [0.45-1.32],0.3424634055434213
Chapter II Neoplasms,Melanoma in situ,MMP7,Matrilysin,24002,51,1.29 [0.76-2.19],0.3405614415488498
Chapter II Neoplasms,Melanoma in situ,MMP8,Neutrophil collagenase,24669,53,0.94 [0.67-1.31],0.7028841781185993
Chapter II Neoplasms,Melanoma in situ,MMP9,Matrix metalloproteinase-9,24429,53,0.92 [0.62-1.37],0.6888091928899883
Chapter II Neoplasms,Melanoma in situ,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",20559,37,1.16 [0.64-2.09],0.627313466136528
Chapter II Neoplasms,Melanoma in situ,MN1,Transcriptional activator MN1,20638,38,0.94 [0.53-1.64],0.8144458616563232
Chapter II Neoplasms,Melanoma in situ,MNAT1,CDK-activating kinase assembly factor MAT1,20824,40,1.00 [0.51-1.94],0.9945577996861704
Chapter II Neoplasms,Melanoma in situ,MNDA,Myeloid cell nuclear differentiation antigen,24447,53,0.84 [0.65-1.10],0.2168002713576817
Chapter II Neoplasms,Melanoma in situ,MOCS2,Molybdopterin synthase catalytic subunit,20746,40,1.22 [0.78-1.89],0.3786683608325395
Chapter II Neoplasms,Melanoma in situ,MOG,Myelin-oligodendrocyte glycoprotein,24689,52,1.04 [0.48-2.26],0.9267912769058768
Chapter II Neoplasms,Melanoma in situ,MORC3,MORC family CW-type zinc finger protein 3,21166,40,1.14 [0.42-3.07],0.79697794750964
Chapter II Neoplasms,Melanoma in situ,MORF4L1,Mortality factor 4-like protein 1,20824,40,0.61 [0.24-1.51],0.2846185448755223
Chapter II Neoplasms,Melanoma in situ,MORF4L2,Mortality factor 4-like protein 2,20471,40,0.78 [0.32-1.89],0.5748529704138609
Chapter II Neoplasms,Melanoma in situ,MORN4,MORN repeat-containing protein 4,20471,40,1.08 [0.76-1.51],0.6780028885292657
Chapter II Neoplasms,Melanoma in situ,MPHOSPH8,M-phase phosphoprotein 8,24041,51,1.17 [0.86-1.61],0.3192039672721674
Chapter II Neoplasms,Melanoma in situ,MPI,Mannose-6-phosphate isomerase,24350,50,1.16 [0.87-1.54],0.3162331463011415
Chapter II Neoplasms,Melanoma in situ,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,24529,52,1.17 [0.84-1.64],0.3490393767381274
Chapter II Neoplasms,Melanoma in situ,MPO,Myeloperoxidase,24462,53,0.74 [0.43-1.28],0.2805569458281181
Chapter II Neoplasms,Melanoma in situ,MPRIP,Myosin phosphatase Rho-interacting protein,21073,40,0.80 [0.40-1.59],0.5267584173978275
Chapter II Neoplasms,Melanoma in situ,MRC1,Macrophage mannose receptor 1,21229,41,2.48 [0.90-6.83],0.0789680853020162
Chapter II Neoplasms,Melanoma in situ,MRI1,Methylthioribose-1-phosphate isomerase,20638,38,0.85 [0.54-1.35],0.4984218582183944
Chapter II Neoplasms,Melanoma in situ,MRPL24,"39S ribosomal protein L24, mitochondrial",20559,37,1.03 [0.48-2.20],0.9355881964721732
Chapter II Neoplasms,Melanoma in situ,MRPL28,"39S ribosomal protein L28, mitochondrial",21191,40,0.94 [0.40-2.21],0.8929166891372808
Chapter II Neoplasms,Melanoma in situ,MRPL46,"39S ribosomal protein L46, mitochondrial",23895,51,0.72 [0.27-1.93],0.5186417144864126
Chapter II Neoplasms,Melanoma in situ,MRPL52,"39S ribosomal protein L52, mitochondrial",20435,40,0.78 [0.23-2.65],0.6851845036491049
Chapter II Neoplasms,Melanoma in situ,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",21191,40,1.09 [0.74-1.60],0.665338131965371
Chapter II Neoplasms,Melanoma in situ,MRPS16,"28S ribosomal protein S16, mitochondrial",20617,41,1.32 [0.61-2.87],0.4792015331471042
Chapter II Neoplasms,Melanoma in situ,MSLN,Mesothelin,24319,50,0.94 [0.57-1.56],0.8105398115211
Chapter II Neoplasms,Melanoma in situ,MSLNL,Mesothelin-like protein,20638,38,1.07 [0.47-2.43],0.8692292319897893
Chapter II Neoplasms,Melanoma in situ,MSMB,Beta-microseminoprotein,24394,51,0.89 [0.62-1.27],0.510892313325459
Chapter II Neoplasms,Melanoma in situ,MSR1,Macrophage scavenger receptor types I and II,24707,53,0.96 [0.56-1.63],0.8806408599667219
Chapter II Neoplasms,Melanoma in situ,MSRA,Mitochondrial peptide methionine sulfoxide reductase,24519,53,1.22 [0.88-1.69],0.2319206294825603
Chapter II Neoplasms,Melanoma in situ,MST1,Hepatocyte growth factor-like protein,20923,41,0.93 [0.61-1.41],0.7348446441213909
Chapter II Neoplasms,Melanoma in situ,MSTN,Growth/differentiation factor 8,24041,51,0.78 [0.48-1.27],0.313776390112745
Chapter II Neoplasms,Melanoma in situ,MTDH,Protein LYRIC,20617,41,1.42 [1.03-1.95],0.0305972107382705
Chapter II Neoplasms,Melanoma in situ,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",21166,40,1.62 [0.67-3.90],0.283902775009033
Chapter II Neoplasms,Melanoma in situ,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,20824,40,1.22 [0.94-1.58],0.1356218311539331
Chapter II Neoplasms,Melanoma in situ,MTIF3,"Translation initiation factor IF-3, mitochondrial",21131,40,1.38 [1.00-1.92],0.0532927570594646
Chapter II Neoplasms,Melanoma in situ,MTPN,Myotrophin,24041,51,0.91 [0.42-1.99],0.8140802049223876
Chapter II Neoplasms,Melanoma in situ,MTR,Methionine synthase,20559,37,1.14 [0.74-1.74],0.5583425931261613
Chapter II Neoplasms,Melanoma in situ,MTSS1,Protein MTSS 1,21131,40,1.29 [0.98-1.69],0.0648445946520699
Chapter II Neoplasms,Melanoma in situ,MTSS2,Protein MTSS 2,21108,40,1.30 [0.97-1.74],0.0846628535826721
Chapter II Neoplasms,Melanoma in situ,MTUS1,Microtubule-associated tumor suppressor 1,20824,40,0.87 [0.50-1.53],0.6293724018619368
Chapter II Neoplasms,Melanoma in situ,MUC13,Mucin-13,23895,51,1.89 [1.18-3.02],0.0082322212877742
Chapter II Neoplasms,Melanoma in situ,MUC16,Mucin-16,24350,50,1.02 [0.89-1.16],0.8059473102209747
Chapter II Neoplasms,Melanoma in situ,MUC2,Mucin-2,21216,41,0.81 [0.58-1.14],0.2222786479570913
Chapter II Neoplasms,Melanoma in situ,MUCL3,Mucin-like protein 3,20471,40,0.92 [0.44-1.89],0.8113942773726716
Chapter II Neoplasms,Melanoma in situ,MVK,Mevalonate kinase,24024,50,1.17 [0.86-1.60],0.3165858202582989
Chapter II Neoplasms,Melanoma in situ,MXRA8,Matrix remodeling-associated protein 8,20746,40,0.95 [0.35-2.57],0.924700916325703
Chapter II Neoplasms,Melanoma in situ,MYBPC1,"Myosin-binding protein C, slow-type",21225,41,0.97 [0.63-1.52],0.9093487528182252
Chapter II Neoplasms,Melanoma in situ,MYBPC2,"Myosin-binding protein C, fast-type",20637,41,0.93 [0.64-1.37],0.7209883867096696
Chapter II Neoplasms,Melanoma in situ,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,21191,40,1.12 [0.74-1.69],0.586006651587408
Chapter II Neoplasms,Melanoma in situ,MYDGF,Myeloid-derived growth factor,21225,41,1.45 [1.08-1.93],0.0122373778115411
Chapter II Neoplasms,Melanoma in situ,MYH4,Myosin-4,20559,37,1.18 [0.67-2.10],0.5655679040890016
Chapter II Neoplasms,Melanoma in situ,MYH7B,Myosin-7B,20471,40,1.18 [0.64-2.16],0.5930719696115381
Chapter II Neoplasms,Melanoma in situ,MYH9,Myosin-9,21216,41,1.35 [1.03-1.75],0.0280457856787032
Chapter II Neoplasms,Melanoma in situ,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",20559,37,0.45 [0.16-1.26],0.1302191522173458
Chapter II Neoplasms,Melanoma in situ,MYL3,Myosin light chain 3,20637,41,0.84 [0.54-1.29],0.4237609192662277
Chapter II Neoplasms,Melanoma in situ,MYL4,Myosin light chain 4,20637,41,0.59 [0.30-1.18],0.1386011220610144
Chapter II Neoplasms,Melanoma in situ,MYL6B,Myosin light chain 6B,20638,38,0.92 [0.64-1.31],0.6303746767566234
Chapter II Neoplasms,Melanoma in situ,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",20638,38,0.86 [0.41-1.80],0.6918275346307327
Chapter II Neoplasms,Melanoma in situ,MYO6,Unconventional myosin-VI,21191,40,1.19 [0.62-2.31],0.5980611567198231
Chapter II Neoplasms,Melanoma in situ,MYO9B,Unconventional myosin-IXb,24024,50,1.04 [0.71-1.52],0.8427768403939144
Chapter II Neoplasms,Melanoma in situ,MYOC,Myocilin,24462,53,0.68 [0.41-1.14],0.1412186252905271
Chapter II Neoplasms,Melanoma in situ,MYOM1,Myomesin-1,20569,40,0.66 [0.29-1.47],0.3058637648257401
Chapter II Neoplasms,Melanoma in situ,MYOM2,Myomesin-2,20559,37,0.75 [0.37-1.53],0.4259296710701141
Chapter II Neoplasms,Melanoma in situ,MYOM3,Myomesin-3,20746,40,0.86 [0.62-1.21],0.3929984219356595
Chapter II Neoplasms,Melanoma in situ,MZB1,Marginal zone B- and B1-cell-specific protein,24523,52,0.74 [0.44-1.24],0.252786922040647
Chapter II Neoplasms,Melanoma in situ,MZT1,Mitotic-spindle organizing protein 1,23885,50,1.24 [0.82-1.89],0.3069353552824638
Chapter II Neoplasms,Melanoma in situ,NAA10,N-alpha-acetyltransferase 10,20559,37,1.41 [0.76-2.62],0.2777860700133387
Chapter II Neoplasms,Melanoma in situ,NAA80,N-alpha-acetyltransferase 80,20638,38,1.37 [1.06-1.76],0.0173102327260426
Chapter II Neoplasms,Melanoma in situ,NAAA,N-acylethanolamine-hydrolyzing acid amidase,24203,49,1.30 [0.87-1.95],0.2046047206662178
Chapter II Neoplasms,Melanoma in situ,NACC1,Nucleus accumbens-associated protein 1,21108,40,1.06 [0.62-1.83],0.8220838769649841
Chapter II Neoplasms,Melanoma in situ,NADK,NAD kinase,24482,53,0.41 [0.24-0.70],0.0009187235055403
Chapter II Neoplasms,Melanoma in situ,NAGA,Alpha-N-acetylgalactosaminidase,20583,41,1.10 [0.72-1.69],0.6523433089331272
Chapter II Neoplasms,Melanoma in situ,NAGK,N-acetyl-D-glucosamine kinase,20599,41,1.31 [0.79-2.15],0.2940390480806657
Chapter II Neoplasms,Melanoma in situ,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,20746,40,2.90 [0.68-12.40],0.1504845876946567
Chapter II Neoplasms,Melanoma in situ,NAMPT,Nicotinamide phosphoribosyltransferase,23885,50,0.70 [0.39-1.24],0.2175610612076786
Chapter II Neoplasms,Melanoma in situ,NAP1L4,Nucleosome assembly protein 1-like 4,21095,40,1.87 [0.87-4.02],0.1075826813030419
Chapter II Neoplasms,Melanoma in situ,NAPRT,Nicotinate phosphoribosyltransferase,21166,40,0.57 [0.20-1.58],0.279237324446223
Chapter II Neoplasms,Melanoma in situ,NARS1,"Asparagine--tRNA ligase, cytoplasmic",21191,40,1.76 [0.92-3.39],0.0874708370700692
Chapter II Neoplasms,Melanoma in situ,NBL1,Neuroblastoma suppressor of tumorigenicity 1,24519,53,1.01 [0.39-2.65],0.9836647732768912
Chapter II Neoplasms,Melanoma in situ,NBN,Nibrin,24024,50,0.66 [0.36-1.20],0.1737112769061034
Chapter II Neoplasms,Melanoma in situ,NCAM1,Neural cell adhesion molecule 1,24528,53,0.78 [0.35-1.76],0.5480008417453053
Chapter II Neoplasms,Melanoma in situ,NCAM2,Neural cell adhesion molecule 2,24462,53,0.45 [0.18-1.12],0.0845240753310466
Chapter II Neoplasms,Melanoma in situ,NCAN,Neurocan core protein,24707,53,0.70 [0.36-1.33],0.2757029243391652
Chapter II Neoplasms,Melanoma in situ,NCF2,Neutrophil cytosol factor 2,24419,52,0.71 [0.51-0.99],0.0440171055785042
Chapter II Neoplasms,Melanoma in situ,NCK2,Cytoplasmic protein NCK2,24564,52,1.17 [0.93-1.47],0.177087393902278
Chapter II Neoplasms,Melanoma in situ,NCLN,Nicalin,24024,50,1.08 [0.72-1.62],0.708107805756462
Chapter II Neoplasms,Melanoma in situ,NCR1,Natural cytotoxicity triggering receptor 1,24427,52,0.85 [0.42-1.70],0.6449093326515962
Chapter II Neoplasms,Melanoma in situ,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,21131,40,1.44 [0.60-3.50],0.416105765624609
Chapter II Neoplasms,Melanoma in situ,NCS1,Neuronal calcium sensor 1,24689,52,1.51 [0.63-3.62],0.3568655786131365
Chapter II Neoplasms,Melanoma in situ,NDRG1,Protein NDRG1,23895,51,0.91 [0.62-1.35],0.6523803034008113
Chapter II Neoplasms,Melanoma in situ,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,21108,40,1.02 [0.64-1.63],0.9247679828099796
Chapter II Neoplasms,Melanoma in situ,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,20572,41,1.74 [0.82-3.70],0.1500708169793944
Chapter II Neoplasms,Melanoma in situ,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,21131,40,1.36 [0.98-1.88],0.0682214942777475
Chapter II Neoplasms,Melanoma in situ,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",23885,50,1.21 [0.96-1.52],0.1014171021010784
Chapter II Neoplasms,Melanoma in situ,NEB,Nebulin,20559,37,0.68 [0.25-1.83],0.4489956788035975
Chapter II Neoplasms,Melanoma in situ,NECAP2,Adaptin ear-binding coat-associated protein 2,20559,37,1.36 [0.90-2.07],0.143060798258481
Chapter II Neoplasms,Melanoma in situ,NECTIN1,Nectin-1,20617,41,0.71 [0.26-1.90],0.4899101683902273
Chapter II Neoplasms,Melanoma in situ,NECTIN2,Nectin-2,24454,53,1.48 [0.62-3.53],0.3802825326896484
Chapter II Neoplasms,Melanoma in situ,NECTIN4,Nectin-4,24519,53,0.45 [0.18-1.08],0.0751140142840965
Chapter II Neoplasms,Melanoma in situ,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,20617,41,0.87 [0.48-1.58],0.6397230104075404
Chapter II Neoplasms,Melanoma in situ,NEDD9,Enhancer of filamentation 1,20617,41,1.38 [0.69-2.76],0.3553810805221531
Chapter II Neoplasms,Melanoma in situ,NEFL,Neurofilament light polypeptide,23818,51,1.12 [0.62-2.02],0.718092877971555
Chapter II Neoplasms,Melanoma in situ,NEK7,Serine/threonine-protein kinase Nek7,20824,40,0.95 [0.61-1.46],0.8079981112159034
Chapter II Neoplasms,Melanoma in situ,NELL1,Protein kinase C-binding protein NELL1,24519,53,0.79 [0.43-1.44],0.4447311121202197
Chapter II Neoplasms,Melanoma in situ,NELL2,Protein kinase C-binding protein NELL2,24564,52,0.83 [0.34-2.02],0.6767981459407976
Chapter II Neoplasms,Melanoma in situ,NENF,Neudesin,21108,40,0.91 [0.68-1.22],0.5367938263776735
Chapter II Neoplasms,Melanoma in situ,NEO1,Neogenin,21191,40,0.74 [0.37-1.48],0.3960121032445072
Chapter II Neoplasms,Melanoma in situ,NEXN,Nexilin,21229,41,1.49 [1.04-2.14],0.0314097759438201
Chapter II Neoplasms,Melanoma in situ,NFASC,Neurofascin,24769,52,1.59 [0.66-3.83],0.2986517174592681
Chapter II Neoplasms,Melanoma in situ,NFAT5,Nuclear factor of activated T-cells 5,20617,41,1.03 [0.73-1.46],0.8490175835056177
Chapter II Neoplasms,Melanoma in situ,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",24460,52,1.17 [0.91-1.50],0.2125717661079554
Chapter II Neoplasms,Melanoma in situ,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",24024,50,1.15 [0.77-1.71],0.4935559481881392
Chapter II Neoplasms,Melanoma in situ,NFE2,Transcription factor NF-E2 45 kDa subunit,20637,41,1.38 [0.93-2.04],0.1049313373100303
Chapter II Neoplasms,Melanoma in situ,NFIC,Nuclear factor 1 C-type,21191,40,1.08 [0.55-2.10],0.8222183800023225
Chapter II Neoplasms,Melanoma in situ,NFKB1,Nuclear factor NF-kappa-B p105 subunit,20559,37,1.38 [0.92-2.08],0.1197009839661395
Chapter II Neoplasms,Melanoma in situ,NFKB2,Nuclear factor NF-kappa-B p100 subunit,20824,40,1.15 [0.76-1.73],0.5222119015583777
Chapter II Neoplasms,Melanoma in situ,NFKBIE,NF-kappa-B inhibitor epsilon,23885,50,0.93 [0.55-1.58],0.7970474427810369
Chapter II Neoplasms,Melanoma in situ,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",21131,40,1.39 [1.04-1.86],0.0249020297498408
Chapter II Neoplasms,Melanoma in situ,NFX1,Transcriptional repressor NF-X1,20559,37,1.40 [0.94-2.10],0.1000017752040988
Chapter II Neoplasms,Melanoma in situ,NFYA,Nuclear transcription factor Y subunit alpha,20559,37,1.04 [0.48-2.23],0.9214490173823134
Chapter II Neoplasms,Melanoma in situ,NGF,Beta-nerve growth factor,24313,49,2.21 [0.54-8.97],0.2671250634085249
Chapter II Neoplasms,Melanoma in situ,NGFR,Tumor necrosis factor receptor superfamily member 16,21225,41,1.82 [1.01-3.29],0.0454271142349598
Chapter II Neoplasms,Melanoma in situ,NGRN,Neugrin,21166,40,2.24 [0.85-5.86],0.1010112335893997
Chapter II Neoplasms,Melanoma in situ,NHLRC3,NHL repeat-containing protein 3,20263,40,1.58 [0.59-4.26],0.362165703798961
Chapter II Neoplasms,Melanoma in situ,NID1,Nidogen-1,24457,53,0.89 [0.47-1.68],0.715879646158993
Chapter II Neoplasms,Melanoma in situ,NID2,Nidogen-2,24462,53,1.07 [0.78-1.48],0.664202619426258
Chapter II Neoplasms,Melanoma in situ,NINJ1,Ninjurin-1,23885,50,0.81 [0.48-1.36],0.4199522361403822
Chapter II Neoplasms,Melanoma in situ,NIT1,Deaminated glutathione amidase,20637,41,1.08 [0.58-2.04],0.8017408092004833
Chapter II Neoplasms,Melanoma in situ,NIT2,Omega-amidase NIT2,21148,41,1.55 [1.05-2.29],0.0275860074905586
Chapter II Neoplasms,Melanoma in situ,NLGN1,Neuroligin-1,20638,38,0.91 [0.55-1.51],0.728784568603408
Chapter II Neoplasms,Melanoma in situ,NLGN2,Neuroligin-2,20569,40,1.06 [0.57-1.95],0.8575881930862407
Chapter II Neoplasms,Melanoma in situ,NME1,Nucleoside diphosphate kinase A,20617,41,1.88 [0.55-6.35],0.31154915737588
Chapter II Neoplasms,Melanoma in situ,NME3,Nucleoside diphosphate kinase 3,24488,52,0.50 [0.16-1.56],0.234462731894758
Chapter II Neoplasms,Melanoma in situ,NMI,N-myc-interactor,21021,40,1.19 [0.80-1.78],0.3963726889867934
Chapter II Neoplasms,Melanoma in situ,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,24313,49,0.71 [0.47-1.06],0.0919059281234354
Chapter II Neoplasms,Melanoma in situ,NMRK2,Nicotinamide riboside kinase 2,20471,40,0.69 [0.27-1.75],0.4385515283975012
Chapter II Neoplasms,Melanoma in situ,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,21191,40,1.39 [1.01-1.91],0.04567323225941
Chapter II Neoplasms,Melanoma in situ,NOMO1,Nodal modulator 1,24462,53,1.27 [0.47-3.45],0.6360591883077272
Chapter II Neoplasms,Melanoma in situ,NOP56,Nucleolar protein 56,20559,37,0.97 [0.73-1.30],0.8466834552384184
Chapter II Neoplasms,Melanoma in situ,NOS1,"Nitric oxide synthase, brain",23895,51,0.99 [0.62-1.58],0.962285973276498
Chapter II Neoplasms,Melanoma in situ,NOS2,"Nitric oxide synthase, inducible",20559,37,1.31 [0.64-2.69],0.4637958502861191
Chapter II Neoplasms,Melanoma in situ,NOS3,"Nitric oxide synthase, endothelial",23895,51,1.05 [0.65-1.69],0.8334505137460986
Chapter II Neoplasms,Melanoma in situ,NOTCH1,Neurogenic locus notch homolog protein 1,24765,53,0.63 [0.13-3.01],0.5595540500846574
Chapter II Neoplasms,Melanoma in situ,NOTCH2,Neurogenic locus notch homolog protein 2,21216,41,1.65 [0.41-6.60],0.4799338797601684
Chapter II Neoplasms,Melanoma in situ,NOTCH3,Neurogenic locus notch homolog protein 3,24765,53,0.85 [0.41-1.75],0.6586913924702189
Chapter II Neoplasms,Melanoma in situ,NPC2,NPC intracellular cholesterol transporter 2,20865,41,1.40 [0.57-3.41],0.4613204618869436
Chapter II Neoplasms,Melanoma in situ,NPDC1,Neural proliferation differentiation and control protein 1,24482,53,0.68 [0.28-1.66],0.4032283299917834
Chapter II Neoplasms,Melanoma in situ,NPHS1,Nephrin,20617,41,1.12 [0.48-2.64],0.7882373587944319
Chapter II Neoplasms,Melanoma in situ,NPHS2,Podocin,20617,41,0.97 [0.72-1.31],0.8266373714824313
Chapter II Neoplasms,Melanoma in situ,NPL,N-acetylneuraminate lyase,21225,41,1.40 [0.73-2.67],0.3107001367521271
Chapter II Neoplasms,Melanoma in situ,NPPB,Natriuretic peptides B,24041,51,1.42 [1.15-1.75],0.0011138740211755
Chapter II Neoplasms,Melanoma in situ,NPPC,C-type natriuretic peptide,24460,52,0.77 [0.43-1.35],0.3580463382322365
Chapter II Neoplasms,Melanoma in situ,NPR1,Atrial natriuretic peptide receptor 1,20559,37,0.60 [0.24-1.53],0.2866553024135815
Chapter II Neoplasms,Melanoma in situ,NPTN,Neuroplastin,23885,50,1.09 [0.83-1.42],0.5400483356160704
Chapter II Neoplasms,Melanoma in situ,NPTX1,Neuronal pentraxin-1,24462,53,0.45 [0.24-0.86],0.0163723863086
Chapter II Neoplasms,Melanoma in situ,NPTX2,Neuronal pentraxin-2,21216,41,0.88 [0.36-2.16],0.7816332664667978
Chapter II Neoplasms,Melanoma in situ,NPTXR,Neuronal pentraxin receptor,24482,53,1.09 [0.54-2.19],0.819337226687875
Chapter II Neoplasms,Melanoma in situ,NPY,Pro-neuropeptide Y,24689,52,1.09 [0.75-1.58],0.6588333467753191
Chapter II Neoplasms,Melanoma in situ,NRCAM,Neuronal cell adhesion molecule,24482,53,0.64 [0.26-1.57],0.3293528502404966
Chapter II Neoplasms,Melanoma in situ,NRGN,Neurogranin,21229,41,1.33 [0.96-1.84],0.0839150207422628
Chapter II Neoplasms,Melanoma in situ,NRN1,Neuritin,21191,40,1.28 [0.67-2.41],0.4543667103358716
Chapter II Neoplasms,Melanoma in situ,NRP1,Neuropilin-1,24581,53,0.80 [0.33-1.89],0.6058378135389912
Chapter II Neoplasms,Melanoma in situ,NRP2,Neuropilin-2,24462,53,1.04 [0.45-2.42],0.9247490132977226
Chapter II Neoplasms,Melanoma in situ,NRTN,Neurturin,24024,50,0.93 [0.55-1.55],0.7683565219262848
Chapter II Neoplasms,Melanoma in situ,NRXN3,Neurexin-3,20638,38,0.46 [0.14-1.47],0.189319293085176
Chapter II Neoplasms,Melanoma in situ,NSFL1C,NSFL1 cofactor p47,24707,53,1.00 [0.69-1.44],0.999745972243704
Chapter II Neoplasms,Melanoma in situ,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",21225,41,1.60 [1.08-2.36],0.0189265462128018
Chapter II Neoplasms,Melanoma in situ,NT5C1A,Cytosolic 5'-nucleotidase 1A,21166,40,1.31 [0.60-2.86],0.4949065733541408
Chapter II Neoplasms,Melanoma in situ,NT5C3A,Cytosolic 5'-nucleotidase 3A,24417,52,1.22 [0.92-1.62],0.1682005124899091
Chapter II Neoplasms,Melanoma in situ,NT5E,5'-nucleotidase,24519,53,0.93 [0.59-1.45],0.7404066856076204
Chapter II Neoplasms,Melanoma in situ,NTF3,Neurotrophin-3,24460,52,1.30 [0.67-2.52],0.4377323936180071
Chapter II Neoplasms,Melanoma in situ,NTF4,Neurotrophin-4,23885,50,0.80 [0.37-1.72],0.5649743794341432
Chapter II Neoplasms,Melanoma in situ,NTRK2,BDNF/NT-3 growth factors receptor,24482,53,0.59 [0.23-1.52],0.2700892936625716
Chapter II Neoplasms,Melanoma in situ,NTRK3,NT-3 growth factor receptor,24707,53,0.49 [0.16-1.52],0.2199746231826025
Chapter II Neoplasms,Melanoma in situ,NTproBNP,N-terminal prohormone of brain natriuretic peptide,24482,53,1.38 [1.10-1.74],0.0064106228361757
Chapter II Neoplasms,Melanoma in situ,NUB1,NEDD8 ultimate buster 1,24460,52,1.12 [0.84-1.48],0.4417105032429134
Chapter II Neoplasms,Melanoma in situ,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,21108,40,1.02 [0.77-1.36],0.8823018727112796
Chapter II Neoplasms,Melanoma in situ,NUCB2,Nucleobindin-2,24654,52,1.77 [0.96-3.29],0.0689694488362452
Chapter II Neoplasms,Melanoma in situ,NUDC,Nuclear migration protein nudC,24769,52,1.28 [0.87-1.88],0.2156968884539215
Chapter II Neoplasms,Melanoma in situ,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,20637,41,1.74 [0.90-3.38],0.1020032546670172
Chapter II Neoplasms,Melanoma in situ,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,20559,37,1.22 [0.75-1.99],0.4237139039084475
Chapter II Neoplasms,Melanoma in situ,NUDT16,U8 snoRNA-decapping enzyme,21099,40,1.23 [0.88-1.71],0.222243492461531
Chapter II Neoplasms,Melanoma in situ,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],24350,50,1.20 [0.80-1.80],0.3696076454281083
Chapter II Neoplasms,Melanoma in situ,NUDT5,ADP-sugar pyrophosphatase,24462,53,1.10 [0.69-1.75],0.695388810783732
Chapter II Neoplasms,Melanoma in situ,NUMB,Protein numb homolog,20617,41,1.47 [1.02-2.12],0.0368324199515532
Chapter II Neoplasms,Melanoma in situ,NUP50,Nuclear pore complex protein Nup50,20559,37,0.41 [0.11-1.51],0.1809164019653162
Chapter II Neoplasms,Melanoma in situ,NXPE4,NXPE family member 4,20559,37,1.40 [0.72-2.71],0.321601489422644
Chapter II Neoplasms,Melanoma in situ,NXPH1,Neurexophilin-1,23895,51,1.35 [0.78-2.34],0.2873450143128946
Chapter II Neoplasms,Melanoma in situ,NXPH3,Neurexophilin-3,20617,41,2.11 [0.79-5.63],0.1346682711786563
Chapter II Neoplasms,Melanoma in situ,OBP2B,Odorant-binding protein 2b,24232,49,0.82 [0.55-1.21],0.31961164299607
Chapter II Neoplasms,Melanoma in situ,OCLN,Occludin,21191,40,0.95 [0.46-1.97],0.8950698368126818
Chapter II Neoplasms,Melanoma in situ,ODAM,Odontogenic ameloblast-associated protein,23858,51,0.86 [0.51-1.45],0.5753630540198049
Chapter II Neoplasms,Melanoma in situ,OFD1,Oral-facial-digital syndrome 1 protein,20824,40,0.92 [0.57-1.49],0.7287377379093547
Chapter II Neoplasms,Melanoma in situ,OGA,Protein O-GlcNAcase,21131,40,1.34 [0.89-2.02],0.1653978233129401
Chapter II Neoplasms,Melanoma in situ,OGFR,Opioid growth factor receptor,24350,50,0.95 [0.44-2.07],0.9036096623622784
Chapter II Neoplasms,Melanoma in situ,OGN,Mimecan,24462,53,0.93 [0.50-1.75],0.8247460026519217
Chapter II Neoplasms,Melanoma in situ,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,20824,40,0.87 [0.52-1.46],0.5921411537940434
Chapter II Neoplasms,Melanoma in situ,OLFM4,Olfactomedin-4,19984,40,0.83 [0.66-1.05],0.1231296972833237
Chapter II Neoplasms,Melanoma in situ,OLR1,Oxidized low-density lipoprotein receptor 1,24234,52,0.76 [0.49-1.18],0.2204415160260111
Chapter II Neoplasms,Melanoma in situ,OMD,Osteomodulin,24564,52,0.60 [0.36-1.00],0.0515696964775379
Chapter II Neoplasms,Melanoma in situ,OMG,Oligodendrocyte-myelin glycoprotein,24350,50,1.15 [0.78-1.70],0.4881754595453911
Chapter II Neoplasms,Melanoma in situ,OMP,Olfactory marker protein,20569,40,1.07 [0.60-1.91],0.8060018062262798
Chapter II Neoplasms,Melanoma in situ,OPHN1,Oligophrenin-1,21166,40,1.34 [1.01-1.77],0.0412460231826712
Chapter II Neoplasms,Melanoma in situ,OPLAH,5-oxoprolinase,20637,41,1.34 [0.90-2.00],0.1477648800107402
Chapter II Neoplasms,Melanoma in situ,OPTC,Opticin,24350,50,0.82 [0.45-1.48],0.5033540291601104
Chapter II Neoplasms,Melanoma in situ,ORM1,Alpha-1-acid glycoprotein 1,21175,41,0.82 [0.18-3.69],0.7979509679821379
Chapter II Neoplasms,Melanoma in situ,OSBPL2,Oxysterol-binding protein-related protein 2,21166,40,0.91 [0.40-2.07],0.8309428177283646
Chapter II Neoplasms,Melanoma in situ,OSCAR,Osteoclast-associated immunoglobulin-like receptor,24488,52,0.78 [0.37-1.64],0.5141010127026473
Chapter II Neoplasms,Melanoma in situ,OSM,Oncostatin-M,24329,52,0.92 [0.65-1.30],0.6237391452534
Chapter II Neoplasms,Melanoma in situ,OSMR,Oncostatin-M-specific receptor subunit beta,24581,53,0.85 [0.26-2.81],0.7869691878043812
Chapter II Neoplasms,Melanoma in situ,OSTN,Osteocrin,20638,38,0.88 [0.38-2.02],0.759621822390642
Chapter II Neoplasms,Melanoma in situ,OTOA,Otoancorin,20569,40,0.78 [0.39-1.55],0.4743473706860085
Chapter II Neoplasms,Melanoma in situ,OTUD6B,Deubiquitinase OTUD6B,21131,40,1.68 [1.04-2.70],0.0326546739242954
Chapter II Neoplasms,Melanoma in situ,OTUD7B,OTU domain-containing protein 7B,21191,40,1.54 [0.98-2.41],0.0584902983162379
Chapter II Neoplasms,Melanoma in situ,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",20637,41,1.61 [1.07-2.40],0.0209479375647818
Chapter II Neoplasms,Melanoma in situ,OXT,Oxytocin-neurophysin 1,24707,53,1.25 [1.05-1.47],0.0099968482602598
Chapter II Neoplasms,Melanoma in situ,P4HB,Protein disulfide-isomerase,24327,53,1.79 [0.99-3.25],0.0544693365796535
Chapter II Neoplasms,Melanoma in situ,PACS2,Phosphofurin acidic cluster sorting protein 2,20559,37,1.60 [1.00-2.56],0.0491673901692623
Chapter II Neoplasms,Melanoma in situ,PADI2,Protein-arginine deiminase type-2,24024,50,1.14 [0.80-1.63],0.4634022459693034
Chapter II Neoplasms,Melanoma in situ,PADI4,Protein-arginine deiminase type-4,23858,51,0.76 [0.51-1.14],0.1899020515717732
Chapter II Neoplasms,Melanoma in situ,PAEP,Glycodelin,24313,49,1.03 [0.86-1.22],0.7745108058800552
Chapter II Neoplasms,Melanoma in situ,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,21191,40,0.86 [0.64-1.16],0.3288920745635879
Chapter II Neoplasms,Melanoma in situ,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",20824,40,1.29 [0.74-2.27],0.3675000104597354
Chapter II Neoplasms,Melanoma in situ,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,24041,51,1.01 [0.65-1.57],0.973408937806024
Chapter II Neoplasms,Melanoma in situ,PAGR1,PAXIP1-associated glutamate-rich protein 1,20637,41,1.66 [1.02-2.70],0.0401713257396042
Chapter II Neoplasms,Melanoma in situ,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,20428,40,0.86 [0.47-1.56],0.6204840052813922
Chapter II Neoplasms,Melanoma in situ,PAK4,Serine/threonine-protein kinase PAK 4,23895,51,1.07 [0.72-1.58],0.7295432406347468
Chapter II Neoplasms,Melanoma in situ,PALLD,Palladin,20617,41,1.12 [0.56-2.25],0.7457816353499886
Chapter II Neoplasms,Melanoma in situ,PALM,Paralemmin-1,21016,40,1.16 [0.41-3.26],0.7801084021070647
Chapter II Neoplasms,Melanoma in situ,PALM2,Paralemmin-2,21166,40,1.01 [0.46-2.24],0.9740784976902545
Chapter II Neoplasms,Melanoma in situ,PALM3,Paralemmin-3,20559,37,0.78 [0.46-1.34],0.3737776782290446
Chapter II Neoplasms,Melanoma in situ,PAM,Peptidyl-glycine alpha-amidating monooxygenase,24637,51,2.18 [0.85-5.58],0.105770286501312
Chapter II Neoplasms,Melanoma in situ,PAMR1,Inactive serine protease PAMR1,24462,53,1.27 [0.53-3.06],0.5887722465441324
Chapter II Neoplasms,Melanoma in situ,PAPPA,Pappalysin-1,24024,50,0.64 [0.38-1.09],0.1032499323946941
Chapter II Neoplasms,Melanoma in situ,PARD3,Partitioning defective 3 homolog,20824,40,1.37 [1.03-1.83],0.0308198312542548
Chapter II Neoplasms,Melanoma in situ,PARK7,Parkinson disease protein 7,24462,53,0.89 [0.56-1.41],0.6157653377908092
Chapter II Neoplasms,Melanoma in situ,PARP1,Poly [ADP-ribose] polymerase 1,24460,52,0.91 [0.56-1.47],0.7010525103614114
Chapter II Neoplasms,Melanoma in situ,PAXX,Protein PAXX,20746,40,1.03 [0.53-2.00],0.9239620560489832
Chapter II Neoplasms,Melanoma in situ,PBK,Lymphokine-activated killer T-cell-originated protein kinase,20471,40,0.83 [0.31-2.26],0.7220233548559432
Chapter II Neoplasms,Melanoma in situ,PBLD,Phenazine biosynthesis-like domain-containing protein,23895,51,1.44 [0.92-2.25],0.1144608630031871
Chapter II Neoplasms,Melanoma in situ,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,21131,40,1.32 [0.55-3.14],0.5312275358290908
Chapter II Neoplasms,Melanoma in situ,PCARE,Photoreceptor cilium actin regulator,20569,40,0.98 [0.69-1.41],0.9194180499194754
Chapter II Neoplasms,Melanoma in situ,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,20696,40,0.88 [0.46-1.68],0.7004736038796682
Chapter II Neoplasms,Melanoma in situ,PCBP2,Poly(rC)-binding protein 2,21191,40,1.42 [0.95-2.14],0.0890515460236116
Chapter II Neoplasms,Melanoma in situ,PCDH1,Protocadherin-1,24685,51,0.87 [0.26-2.93],0.8231947781845157
Chapter II Neoplasms,Melanoma in situ,PCDH12,Protocadherin-12,21191,40,0.86 [0.26-2.83],0.8080215837354516
Chapter II Neoplasms,Melanoma in situ,PCDH17,Protocadherin-17,24482,53,0.75 [0.37-1.54],0.4307515236336211
Chapter II Neoplasms,Melanoma in situ,PCDH7,Protocadherin-7,21131,40,1.58 [0.86-2.90],0.1420547084798024
Chapter II Neoplasms,Melanoma in situ,PCDH9,Protocadherin-9,21131,40,0.97 [0.39-2.38],0.9463758692947506
Chapter II Neoplasms,Melanoma in situ,PCDHB15,Protocadherin beta-15,21108,40,1.29 [0.65-2.59],0.4640630365843732
Chapter II Neoplasms,Melanoma in situ,PCNA,Proliferating cell nuclear antigen,20471,40,1.15 [0.78-1.70],0.4698312382323601
Chapter II Neoplasms,Melanoma in situ,PCSK7,Proprotein convertase subtilisin/kexin type 7,21108,40,0.88 [0.44-1.78],0.7292501834971137
Chapter II Neoplasms,Melanoma in situ,PCSK9,Proprotein convertase subtilisin/kexin type 9,24765,53,1.09 [0.58-2.02],0.7961152166074374
Chapter II Neoplasms,Melanoma in situ,PCYT2,Ethanolamine-phosphate cytidylyltransferase,21131,40,1.59 [1.08-2.35],0.0186206331520717
Chapter II Neoplasms,Melanoma in situ,PDAP1,28 kDa heat- and acid-stable phosphoprotein,21225,41,1.34 [0.99-1.81],0.058800417444982
Chapter II Neoplasms,Melanoma in situ,PDCD1,Programmed cell death protein 1,24654,52,0.75 [0.39-1.43],0.3803457077038378
Chapter II Neoplasms,Melanoma in situ,PDCD1LG2,Programmed cell death 1 ligand 2,24350,50,0.66 [0.29-1.49],0.3196834612318533
Chapter II Neoplasms,Melanoma in situ,PDCD5,Programmed cell death protein 5,24707,53,1.19 [0.79-1.77],0.4042465722979574
Chapter II Neoplasms,Melanoma in situ,PDCD6,Programmed cell death protein 6,24482,53,1.17 [0.79-1.74],0.442826961813683
Chapter II Neoplasms,Melanoma in situ,PDCL2,Phosducin-like protein 2,20471,40,0.91 [0.49-1.66],0.748708099722305
Chapter II Neoplasms,Melanoma in situ,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",20471,40,0.79 [0.40-1.55],0.4895849708710488
Chapter II Neoplasms,Melanoma in situ,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",20559,37,0.87 [0.49-1.54],0.6328369370369311
Chapter II Neoplasms,Melanoma in situ,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",20746,40,1.31 [0.97-1.78],0.0828067758397913
Chapter II Neoplasms,Melanoma in situ,PDGFA,Platelet-derived growth factor subunit A,24765,53,1.11 [0.79-1.55],0.5518282726729589
Chapter II Neoplasms,Melanoma in situ,PDGFB,Platelet-derived growth factor subunit B,24564,52,0.99 [0.75-1.31],0.9455034385225132
Chapter II Neoplasms,Melanoma in situ,PDGFC,Platelet-derived growth factor C,23885,50,0.69 [0.29-1.68],0.4135635261902455
Chapter II Neoplasms,Melanoma in situ,PDGFRA,Platelet-derived growth factor receptor alpha,24482,53,0.64 [0.26-1.57],0.3315651809499969
Chapter II Neoplasms,Melanoma in situ,PDGFRB,Platelet-derived growth factor receptor beta,24765,53,0.83 [0.42-1.63],0.5819291661198871
Chapter II Neoplasms,Melanoma in situ,PDIA2,Protein disulfide-isomerase A2,20471,40,1.03 [0.48-2.18],0.9461933643278188
Chapter II Neoplasms,Melanoma in situ,PDIA3,Protein disulfide-isomerase A3,20746,40,1.20 [0.39-3.69],0.7466932699681393
Chapter II Neoplasms,Melanoma in situ,PDIA4,Protein disulfide-isomerase A4,21216,41,1.86 [1.22-2.82],0.0038600256043823
Chapter II Neoplasms,Melanoma in situ,PDIA5,Protein disulfide-isomerase A5,20471,40,1.30 [0.88-1.91],0.1817954004059614
Chapter II Neoplasms,Melanoma in situ,PDLIM5,PDZ and LIM domain protein 5,21191,40,1.36 [1.04-1.78],0.0267899636121323
Chapter II Neoplasms,Melanoma in situ,PDLIM7,PDZ and LIM domain protein 7,24564,52,1.14 [0.95-1.38],0.1675861389222889
Chapter II Neoplasms,Melanoma in situ,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",23885,50,0.88 [0.52-1.49],0.6282103564282402
Chapter II Neoplasms,Melanoma in situ,PDRG1,p53 and DNA damage-regulated protein 1,20638,38,0.80 [0.41-1.56],0.5090609934646277
Chapter II Neoplasms,Melanoma in situ,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,20471,40,1.27 [0.87-1.87],0.2169407896927268
Chapter II Neoplasms,Melanoma in situ,PDZD2,PDZ domain-containing protein 2,20559,37,1.42 [0.90-2.26],0.1331459192109007
Chapter II Neoplasms,Melanoma in situ,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,20617,41,0.96 [0.49-1.86],0.8952608113478633
Chapter II Neoplasms,Melanoma in situ,PEAR1,Platelet endothelial aggregation receptor 1,24765,53,1.33 [0.45-3.90],0.6025336501630243
Chapter II Neoplasms,Melanoma in situ,PEBP1,Phosphatidylethanolamine-binding protein 1,24462,53,0.94 [0.62-1.42],0.7569617794039059
Chapter II Neoplasms,Melanoma in situ,PECAM1,Platelet endothelial cell adhesion molecule,24462,53,1.47 [0.66-3.26],0.3434987042990212
Chapter II Neoplasms,Melanoma in situ,PECR,Peroxisomal trans-2-enoyl-CoA reductase,20637,41,1.41 [0.60-3.31],0.4323885771820772
Chapter II Neoplasms,Melanoma in situ,PENK,Proenkephalin-A,20746,40,1.18 [0.44-3.18],0.7391833811023558
Chapter II Neoplasms,Melanoma in situ,PEPD,Xaa-Pro dipeptidase,21229,41,1.17 [0.37-3.70],0.7881906378623368
Chapter II Neoplasms,Melanoma in situ,PER3,Period circadian protein homolog 3,20617,41,1.31 [1.03-1.67],0.0280489381648649
Chapter II Neoplasms,Melanoma in situ,PF4,Platelet factor 4,21088,41,1.11 [0.83-1.50],0.4812552416321723
Chapter II Neoplasms,Melanoma in situ,PFDN2,Prefoldin subunit 2,23895,51,1.21 [0.80-1.84],0.3673145280499404
Chapter II Neoplasms,Melanoma in situ,PFDN4,Prefoldin subunit 4,20471,40,0.92 [0.52-1.63],0.7740143746180664
Chapter II Neoplasms,Melanoma in situ,PFDN6,Prefoldin subunit 6,20638,38,1.24 [0.86-1.77],0.2460345520756243
Chapter II Neoplasms,Melanoma in situ,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",24316,50,0.99 [0.72-1.37],0.957310656382472
Chapter II Neoplasms,Melanoma in situ,PGA4,Pepsin A-4,21229,41,0.86 [0.54-1.35],0.5089106708947417
Chapter II Neoplasms,Melanoma in situ,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",21225,41,1.37 [0.81-2.32],0.2356155130545201
Chapter II Neoplasms,Melanoma in situ,PGF,Placenta growth factor,24769,52,0.71 [0.24-2.08],0.5325672357834265
Chapter II Neoplasms,Melanoma in situ,PGLYRP1,Peptidoglycan recognition protein 1,24627,51,1.02 [0.56-1.85],0.9577360180703468
Chapter II Neoplasms,Melanoma in situ,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,20973,41,0.68 [0.26-1.75],0.4222872425847985
Chapter II Neoplasms,Melanoma in situ,PGLYRP4,Peptidoglycan recognition protein 4,20559,37,0.66 [0.34-1.31],0.2381704042770037
Chapter II Neoplasms,Melanoma in situ,PGM2,Phosphoglucomutase-2,20638,38,0.84 [0.45-1.55],0.5693751009803178
Chapter II Neoplasms,Melanoma in situ,PGR,Progesterone receptor,20617,41,0.91 [0.67-1.25],0.5708562171894431
Chapter II Neoplasms,Melanoma in situ,PHACTR2,Phosphatase and actin regulator 2,21191,40,1.29 [0.99-1.68],0.0563426303686137
Chapter II Neoplasms,Melanoma in situ,PHLDB1,Pleckstrin homology-like domain family B member 1,21131,40,1.75 [1.04-2.94],0.0349460046042079
Chapter II Neoplasms,Melanoma in situ,PHLDB2,Pleckstrin homology-like domain family B member 2,20471,40,1.04 [0.76-1.42],0.8057721219953942
Chapter II Neoplasms,Melanoma in situ,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,24313,49,0.91 [0.39-2.15],0.8365432209382976
Chapter II Neoplasms,Melanoma in situ,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,20746,40,1.71 [0.84-3.47],0.1410677948041529
Chapter II Neoplasms,Melanoma in situ,PI16,Peptidase inhibitor 16,21229,41,0.64 [0.19-2.17],0.471135697176762
Chapter II Neoplasms,Melanoma in situ,PI3,Elafin,24124,49,0.78 [0.47-1.31],0.3551944924318374
Chapter II Neoplasms,Melanoma in situ,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",21191,40,1.35 [0.94-1.94],0.1058252159481493
Chapter II Neoplasms,Melanoma in situ,PIGR,Polymeric immunoglobulin receptor,24160,51,1.00 [0.48-2.05],0.9953182374007606
Chapter II Neoplasms,Melanoma in situ,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,24460,52,0.68 [0.45-1.02],0.0653078607137053
Chapter II Neoplasms,Melanoma in situ,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24462,53,0.69 [0.25-1.92],0.4834599082087919
Chapter II Neoplasms,Melanoma in situ,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,20617,41,1.04 [0.63-1.74],0.8696083448820116
Chapter II Neoplasms,Melanoma in situ,PILRA,Paired immunoglobulin-like type 2 receptor alpha,24462,53,0.85 [0.47-1.52],0.5830573861597192
Chapter II Neoplasms,Melanoma in situ,PILRB,Paired immunoglobulin-like type 2 receptor beta,24482,53,0.94 [0.62-1.44],0.7842020162180173
Chapter II Neoplasms,Melanoma in situ,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,20746,40,0.74 [0.49-1.13],0.1685098252684786
Chapter II Neoplasms,Melanoma in situ,PITHD1,PITH domain-containing protein 1,20428,40,1.19 [0.89-1.60],0.2413858649189397
Chapter II Neoplasms,Melanoma in situ,PKD1,Polycystin-1,21225,41,1.20 [0.38-3.77],0.7581310687925754
Chapter II Neoplasms,Melanoma in situ,PKD2,Polycystin-2,20559,37,1.29 [0.81-2.05],0.2869662754421941
Chapter II Neoplasms,Melanoma in situ,PKLR,Pyruvate kinase PKLR,24478,51,0.78 [0.52-1.16],0.2155564962810483
Chapter II Neoplasms,Melanoma in situ,PKN3,Serine/threonine-protein kinase N3,20824,40,1.07 [0.73-1.57],0.7276332393671583
Chapter II Neoplasms,Melanoma in situ,PLA2G10,Group 10 secretory phospholipase A2,24313,49,1.11 [0.72-1.70],0.6439933980566157
Chapter II Neoplasms,Melanoma in situ,PLA2G15,Phospholipase A2 group XV,24519,53,0.38 [0.17-0.89],0.0262935586307962
Chapter II Neoplasms,Melanoma in situ,PLA2G1B,Phospholipase A2,24722,53,0.81 [0.44-1.46],0.4776317289535853
Chapter II Neoplasms,Melanoma in situ,PLA2G2A,"Phospholipase A2, membrane associated",24408,53,1.14 [0.77-1.70],0.5067174072076303
Chapter II Neoplasms,Melanoma in situ,PLA2G4A,Cytosolic phospholipase A2,24564,52,1.26 [0.96-1.67],0.0997920274851778
Chapter II Neoplasms,Melanoma in situ,PLA2G7,Platelet-activating factor acetylhydrolase,24462,53,0.86 [0.38-1.92],0.7067238873596902
Chapter II Neoplasms,Melanoma in situ,PLAT,Tissue-type plasminogen activator,24675,53,0.89 [0.55-1.44],0.6388204563393945
Chapter II Neoplasms,Melanoma in situ,PLAU,Urokinase-type plasminogen activator,24462,53,0.46 [0.19-1.11],0.0829283876482541
Chapter II Neoplasms,Melanoma in situ,PLAUR,Urokinase plasminogen activator surface receptor,24280,51,0.90 [0.34-2.42],0.8409888109128496
Chapter II Neoplasms,Melanoma in situ,PLB1,"Phospholipase B1, membrane-associated",21166,40,1.16 [0.70-1.93],0.5666611265433438
Chapter II Neoplasms,Melanoma in situ,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",20617,41,1.00 [0.53-1.88],0.9965892658245024
Chapter II Neoplasms,Melanoma in situ,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",21166,40,1.54 [1.13-2.10],0.0064141939420173
Chapter II Neoplasms,Melanoma in situ,PLEKHO1,Pleckstrin homology domain-containing family O member 1,21166,40,1.57 [1.04-2.36],0.0300902169319288
Chapter II Neoplasms,Melanoma in situ,PLG,Plasminogen,20694,41,0.76 [0.20-2.84],0.6831787488255576
Chapter II Neoplasms,Melanoma in situ,PLIN1,Perilipin-1,23895,51,0.80 [0.37-1.72],0.5680428148122908
Chapter II Neoplasms,Melanoma in situ,PLIN3,Perilipin-3,24482,53,1.07 [0.61-1.87],0.8103903298125772
Chapter II Neoplasms,Melanoma in situ,PLPBP,Pyridoxal phosphate homeostasis protein,24482,53,1.09 [0.77-1.55],0.6368923076454389
Chapter II Neoplasms,Melanoma in situ,PLSCR3,Phospholipid scramblase 3,21135,40,1.45 [0.88-2.36],0.1419297230152971
Chapter II Neoplasms,Melanoma in situ,PLTP,Phospholipid transfer protein,24670,51,0.68 [0.35-1.33],0.2586990152005526
Chapter II Neoplasms,Melanoma in situ,PLXDC1,Plexin domain-containing protein 1,23885,50,0.68 [0.29-1.57],0.3621779190938839
Chapter II Neoplasms,Melanoma in situ,PLXDC2,Plexin domain-containing protein 2,21166,40,1.64 [0.61-4.38],0.3254176561088886
Chapter II Neoplasms,Melanoma in situ,PLXNA4,Plexin-A4,24460,52,1.18 [0.87-1.60],0.276702925872532
Chapter II Neoplasms,Melanoma in situ,PLXNB2,Plexin-B2,24648,53,1.05 [0.37-2.96],0.9313511900981536
Chapter II Neoplasms,Melanoma in situ,PLXNB3,Plexin-B3,24401,51,1.40 [0.84-2.33],0.1955526897409528
Chapter II Neoplasms,Melanoma in situ,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,24388,53,1.00 [0.88-1.14],0.9972440901249484
Chapter II Neoplasms,Melanoma in situ,PMCH,Pro-MCH,20559,37,1.05 [0.74-1.48],0.7844525694364062
Chapter II Neoplasms,Melanoma in situ,PMM2,Phosphomannomutase 2,20559,37,1.18 [0.71-1.97],0.5230852859501258
Chapter II Neoplasms,Melanoma in situ,PMS1,PMS1 protein homolog 1,20638,38,0.90 [0.47-1.72],0.757624385922999
Chapter II Neoplasms,Melanoma in situ,PMVK,Phosphomevalonate kinase,23857,51,1.19 [0.92-1.54],0.1763747865079623
Chapter II Neoplasms,Melanoma in situ,PNLIP,Pancreatic triacylglycerol lipase,21229,41,0.84 [0.51-1.39],0.4922938247646993
Chapter II Neoplasms,Melanoma in situ,PNLIPRP1,Inactive pancreatic lipase-related protein 1,21166,40,1.13 [0.76-1.66],0.5507441326525677
Chapter II Neoplasms,Melanoma in situ,PNLIPRP2,Pancreatic lipase-related protein 2,24444,52,0.97 [0.90-1.05],0.4246229092293844
Chapter II Neoplasms,Melanoma in situ,PNMA1,Paraneoplastic antigen Ma1,20637,41,1.74 [1.14-2.66],0.0105343065509801
Chapter II Neoplasms,Melanoma in situ,PNMA2,Paraneoplastic antigen Ma2,20569,40,0.52 [0.24-1.11],0.0921628708022023
Chapter II Neoplasms,Melanoma in situ,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",24024,50,0.98 [0.79-1.20],0.8097284969287639
Chapter II Neoplasms,Melanoma in situ,PODXL,Podocalyxin,24350,50,0.49 [0.10-2.51],0.3930167269125535
Chapter II Neoplasms,Melanoma in situ,PODXL2,Podocalyxin-like protein 2,24519,53,1.19 [0.49-2.88],0.6999267555900497
Chapter II Neoplasms,Melanoma in situ,POF1B,Protein POF1B,20617,41,0.81 [0.39-1.68],0.5764789523566829
Chapter II Neoplasms,Melanoma in situ,POLR2A,DNA-directed RNA polymerase II subunit RPB1,20617,41,0.96 [0.35-2.61],0.9393026892200176
Chapter II Neoplasms,Melanoma in situ,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24350,50,0.86 [0.40-1.87],0.7047997390886372
Chapter II Neoplasms,Melanoma in situ,POMC,Pro-opiomelanocortin,20637,41,0.92 [0.60-1.42],0.7064034845109897
Chapter II Neoplasms,Melanoma in situ,PON1,Serum paraoxonase/arylesterase 1,21229,41,1.69 [0.50-5.70],0.4011190012073738
Chapter II Neoplasms,Melanoma in situ,PON2,Serum paraoxonase/arylesterase 2,24041,51,0.76 [0.37-1.57],0.4581777830523509
Chapter II Neoplasms,Melanoma in situ,PON3,Serum paraoxonase/lactonase 3,24564,52,1.00 [0.40-2.50],0.9958511113871288
Chapter II Neoplasms,Melanoma in situ,POSTN,Periostin,21216,41,1.13 [0.51-2.53],0.7604836987309678
Chapter II Neoplasms,Melanoma in situ,PPBP,Platelet basic protein,21080,41,1.37 [0.97-1.93],0.0711848748526866
Chapter II Neoplasms,Melanoma in situ,PPCDC,Phosphopantothenoylcysteine decarboxylase,24707,53,1.13 [0.68-1.87],0.6406905827253289
Chapter II Neoplasms,Melanoma in situ,PPIB,Peptidyl-prolyl cis-trans isomerase B,24452,51,1.22 [0.94-1.59],0.137374128045032
Chapter II Neoplasms,Melanoma in situ,PPIE,Peptidyl-prolyl cis-trans isomerase E,20824,40,1.32 [0.93-1.88],0.1233472036932232
Chapter II Neoplasms,Melanoma in situ,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",21216,41,1.49 [1.04-2.13],0.0279762819008741
Chapter II Neoplasms,Melanoma in situ,PPL,Periplakin,20617,41,1.20 [0.50-2.88],0.6872097258287289
Chapter II Neoplasms,Melanoma in situ,PPM1A,Protein phosphatase 1A,23885,50,1.60 [0.87-2.97],0.1322597028864568
Chapter II Neoplasms,Melanoma in situ,PPM1B,Protein phosphatase 1B,20617,41,0.88 [0.53-1.47],0.6297174940246705
Chapter II Neoplasms,Melanoma in situ,PPM1F,Protein phosphatase 1F,21225,41,1.74 [1.01-2.99],0.044076944942295
Chapter II Neoplasms,Melanoma in situ,PPME1,Protein phosphatase methylesterase 1,24350,50,0.85 [0.57-1.27],0.4290185381053982
Chapter II Neoplasms,Melanoma in situ,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,21108,40,1.45 [1.03-2.04],0.0314274942616415
Chapter II Neoplasms,Melanoma in situ,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,24519,53,1.14 [0.89-1.46],0.3103833673457748
Chapter II Neoplasms,Melanoma in situ,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,20824,40,1.01 [0.67-1.53],0.9562984694001044
Chapter II Neoplasms,Melanoma in situ,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,21191,40,1.31 [0.94-1.83],0.105534810714002
Chapter II Neoplasms,Melanoma in situ,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,21191,40,1.39 [0.70-2.74],0.3445560156217734
Chapter II Neoplasms,Melanoma in situ,PPP1R2,Protein phosphatase inhibitor 2,24482,53,1.21 [0.90-1.63],0.1975449952215127
Chapter II Neoplasms,Melanoma in situ,PPP1R9B,Neurabin-2,24769,52,1.20 [0.93-1.55],0.1614704895639228
Chapter II Neoplasms,Melanoma in situ,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,21131,40,1.17 [0.91-1.49],0.213954205328234
Chapter II Neoplasms,Melanoma in situ,PPP3R1,Calcineurin subunit B type 1,24313,49,1.14 [0.63-2.08],0.6643883811243925
Chapter II Neoplasms,Melanoma in situ,PPT1,Palmitoyl-protein thioesterase 1,20638,38,1.02 [0.69-1.51],0.91306159361033
Chapter II Neoplasms,Melanoma in situ,PPY,Pancreatic prohormone,24393,53,1.05 [0.83-1.34],0.6894341463580995
Chapter II Neoplasms,Melanoma in situ,PQBP1,Polyglutamine-binding protein 1,23885,50,0.86 [0.52-1.40],0.5425220136972124
Chapter II Neoplasms,Melanoma in situ,PRAME,Melanoma antigen preferentially expressed in tumors,20471,40,1.52 [0.58-4.01],0.3975513317922509
Chapter II Neoplasms,Melanoma in situ,PRAP1,Proline-rich acidic protein 1,21216,41,1.19 [0.56-2.54],0.6459501427213539
Chapter II Neoplasms,Melanoma in situ,PRC1,Protein regulator of cytokinesis 1,21108,40,0.92 [0.45-1.87],0.8180058954883612
Chapter II Neoplasms,Melanoma in situ,PRCP,Lysosomal Pro-X carboxypeptidase,24601,53,1.03 [0.47-2.25],0.9454874813451912
Chapter II Neoplasms,Melanoma in situ,PRDX1,Peroxiredoxin-1,23810,49,1.12 [0.85-1.47],0.424810887884307
Chapter II Neoplasms,Melanoma in situ,PRDX2,Peroxiredoxin-2,20887,41,0.54 [0.32-0.92],0.022413113043545
Chapter II Neoplasms,Melanoma in situ,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",24024,50,1.04 [0.73-1.46],0.8390603594393597
Chapter II Neoplasms,Melanoma in situ,PRDX5,"Peroxiredoxin-5, mitochondrial",24769,52,1.13 [0.79-1.62],0.505688159021556
Chapter II Neoplasms,Melanoma in situ,PRDX6,Peroxiredoxin-6,24689,52,1.15 [0.77-1.71],0.4946502365151328
Chapter II Neoplasms,Melanoma in situ,PREB,Prolactin regulatory element-binding protein,24024,50,1.17 [0.53-2.59],0.7007193307276507
Chapter II Neoplasms,Melanoma in situ,PRELP,Prolargin,24444,52,0.58 [0.26-1.30],0.1850180822908796
Chapter II Neoplasms,Melanoma in situ,PRG2,Bone marrow proteoglycan,21216,41,0.72 [0.39-1.32],0.2825846777608856
Chapter II Neoplasms,Melanoma in situ,PRG3,Proteoglycan 3,21216,41,0.81 [0.44-1.50],0.5062323740423843
Chapter II Neoplasms,Melanoma in situ,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,24024,50,1.19 [0.77-1.84],0.433050464027341
Chapter II Neoplasms,Melanoma in situ,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,20638,38,1.40 [0.62-3.18],0.4210287394384032
Chapter II Neoplasms,Melanoma in situ,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,24482,53,1.19 [0.89-1.59],0.2314584233418791
Chapter II Neoplasms,Melanoma in situ,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,21126,40,1.41 [0.99-2.01],0.059324191692977
Chapter II Neoplasms,Melanoma in situ,PRKCQ,Protein kinase C theta type,24024,50,0.97 [0.54-1.77],0.9288782021840828
Chapter II Neoplasms,Melanoma in situ,PRKD2,Serine/threonine-protein kinase D2,20559,37,0.92 [0.45-1.87],0.8159940709671737
Chapter II Neoplasms,Melanoma in situ,PRKG1,cGMP-dependent protein kinase 1,20746,40,1.29 [1.01-1.65],0.0375213112030028
Chapter II Neoplasms,Melanoma in situ,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23885,50,1.16 [0.81-1.67],0.4286757820834029
Chapter II Neoplasms,Melanoma in situ,PRL,Prolactin,24707,53,1.18 [0.87-1.61],0.2857257392479023
Chapter II Neoplasms,Melanoma in situ,PRND,Prion-like protein doppel,21166,40,0.71 [0.38-1.32],0.2746011209633499
Chapter II Neoplasms,Melanoma in situ,PROC,Vitamin K-dependent protein C,24499,53,2.09 [0.81-5.39],0.1266113916123872
Chapter II Neoplasms,Melanoma in situ,PROCR,Endothelial protein C receptor,20559,37,1.13 [0.54-2.37],0.7482656403139907
Chapter II Neoplasms,Melanoma in situ,PROK1,Prokineticin-1,24460,52,1.07 [0.74-1.55],0.7246029857006235
Chapter II Neoplasms,Melanoma in situ,PROS1,Vitamin K-dependent protein S,21249,41,1.05 [0.32-3.49],0.933441930862268
Chapter II Neoplasms,Melanoma in situ,PRR4,Proline-rich protein 4,20608,39,0.87 [0.54-1.37],0.5396121114802941
Chapter II Neoplasms,Melanoma in situ,PRR5,Proline-rich protein 5,20617,41,1.19 [0.68-2.09],0.541737203781512
Chapter II Neoplasms,Melanoma in situ,PRRT3,Proline-rich transmembrane protein 3,20637,41,0.60 [0.26-1.39],0.2352806531028954
Chapter II Neoplasms,Melanoma in situ,PRSS2,Trypsin-2,24528,53,1.14 [0.72-1.81],0.5855740712478515
Chapter II Neoplasms,Melanoma in situ,PRSS22,Brain-specific serine protease 4,20617,41,0.49 [0.17-1.35],0.1658696796454678
Chapter II Neoplasms,Melanoma in situ,PRSS27,Serine protease 27,24392,53,0.77 [0.41-1.43],0.4081601316486634
Chapter II Neoplasms,Melanoma in situ,PRSS53,Serine protease 53,21166,40,1.35 [0.61-2.99],0.4560698650516829
Chapter II Neoplasms,Melanoma in situ,PRSS8,Prostasin,24354,51,1.04 [0.55-1.95],0.90014886577824
Chapter II Neoplasms,Melanoma in situ,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,23895,51,1.19 [0.94-1.50],0.1503346836188266
Chapter II Neoplasms,Melanoma in situ,PRTG,Protogenin,24689,52,0.87 [0.33-2.33],0.7836304342349792
Chapter II Neoplasms,Melanoma in situ,PRTN3,Myeloblastin,23843,49,0.38 [0.20-0.71],0.0022024520361047
Chapter II Neoplasms,Melanoma in situ,PRUNE2,Protein prune homolog 2,20824,40,1.70 [0.78-3.67],0.1789387335598202
Chapter II Neoplasms,Melanoma in situ,PSAP,Prosaposin,21025,41,1.98 [0.92-4.27],0.0804975776192891
Chapter II Neoplasms,Melanoma in situ,PSAPL1,Proactivator polypeptide-like 1,21131,40,0.95 [0.52-1.75],0.867817866412083
Chapter II Neoplasms,Melanoma in situ,PSCA,Prostate stem cell antigen,21131,40,0.90 [0.80-1.00],0.0565099170519514
Chapter II Neoplasms,Melanoma in situ,PSG1,Pregnancy-specific beta-1-glycoprotein 1,24313,49,0.96 [0.77-1.19],0.7216035722054748
Chapter II Neoplasms,Melanoma in situ,PSIP1,PC4 and SFRS1-interacting protein,24460,52,1.09 [0.77-1.55],0.6290468941912759
Chapter II Neoplasms,Melanoma in situ,PSMA1,Proteasome subunit alpha type-1,23885,50,0.68 [0.37-1.25],0.2165339748362716
Chapter II Neoplasms,Melanoma in situ,PSMC3,26S proteasome regulatory subunit 6A,20471,40,0.63 [0.22-1.78],0.3833255814540286
Chapter II Neoplasms,Melanoma in situ,PSMD1,26S proteasome non-ATPase regulatory subunit 1,21191,40,1.08 [0.60-1.96],0.7994295140256867
Chapter II Neoplasms,Melanoma in situ,PSMD5,26S proteasome non-ATPase regulatory subunit 5,20638,38,1.37 [0.92-2.02],0.1182152119877035
Chapter II Neoplasms,Melanoma in situ,PSMD9,26S proteasome non-ATPase regulatory subunit 9,24350,50,0.68 [0.41-1.11],0.119873834883622
Chapter II Neoplasms,Melanoma in situ,PSME1,Proteasome activator complex subunit 1,24286,49,0.81 [0.41-1.59],0.5389211655231094
Chapter II Neoplasms,Melanoma in situ,PSME2,Proteasome activator complex subunit 2,24201,49,0.89 [0.45-1.76],0.731965228440459
Chapter II Neoplasms,Melanoma in situ,PSMG3,Proteasome assembly chaperone 3,24460,52,0.66 [0.40-1.09],0.1078946153870497
Chapter II Neoplasms,Melanoma in situ,PSMG4,Proteasome assembly chaperone 4,20617,41,0.90 [0.52-1.55],0.7037164326048218
Chapter II Neoplasms,Melanoma in situ,PSPN,Persephin,24460,52,0.95 [0.74-1.22],0.6853470445462923
Chapter II Neoplasms,Melanoma in situ,PSRC1,Proline/serine-rich coiled-coil protein 1,23885,50,1.17 [0.78-1.74],0.4439518242777643
Chapter II Neoplasms,Melanoma in situ,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,19975,38,1.42 [1.03-1.95],0.0326716515260429
Chapter II Neoplasms,Melanoma in situ,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",23895,51,0.92 [0.40-2.08],0.8348176975361917
Chapter II Neoplasms,Melanoma in situ,PTGDS,Prostaglandin-H2 D-isomerase,24260,53,0.75 [0.30-1.87],0.5302110120621946
Chapter II Neoplasms,Melanoma in situ,PTGES2,Prostaglandin E synthase 2,20461,39,1.67 [1.01-2.77],0.0457693414893387
Chapter II Neoplasms,Melanoma in situ,PTGR1,Prostaglandin reductase 1,21225,41,1.15 [0.80-1.65],0.4408147595814103
Chapter II Neoplasms,Melanoma in situ,PTH,Parathyroid hormone,20638,38,1.46 [1.01-2.11],0.0467511612640873
Chapter II Neoplasms,Melanoma in situ,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,24460,52,1.18 [0.67-2.07],0.5686023357648224
Chapter II Neoplasms,Melanoma in situ,PTK7,Inactive tyrosine-protein kinase 7,23895,51,0.86 [0.44-1.67],0.6568468194915262
Chapter II Neoplasms,Melanoma in situ,PTN,Pleiotrophin,24041,51,1.05 [0.64-1.73],0.8392622346593066
Chapter II Neoplasms,Melanoma in situ,PTP4A3,Protein tyrosine phosphatase type IVA 3,20617,41,1.31 [0.80-2.13],0.2841568151776287
Chapter II Neoplasms,Melanoma in situ,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,24313,49,1.25 [0.92-1.70],0.1578575956170747
Chapter II Neoplasms,Melanoma in situ,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,24529,52,1.19 [0.89-1.58],0.2334960083889604
Chapter II Neoplasms,Melanoma in situ,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,20574,41,1.03 [0.49-2.16],0.93781571862823
Chapter II Neoplasms,Melanoma in situ,PTPRB,Receptor-type tyrosine-protein phosphatase beta,21225,41,0.66 [0.24-1.84],0.4285260370464561
Chapter II Neoplasms,Melanoma in situ,PTPRC,Receptor-type tyrosine-protein phosphatase C,21216,41,0.78 [0.21-2.97],0.7164632721756485
Chapter II Neoplasms,Melanoma in situ,PTPRF,Receptor-type tyrosine-protein phosphatase F,24765,53,0.99 [0.43-2.30],0.986580512328448
Chapter II Neoplasms,Melanoma in situ,PTPRH,Receptor-type tyrosine-protein phosphatase H,21131,40,1.12 [0.61-2.06],0.7230519846002199
Chapter II Neoplasms,Melanoma in situ,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,21131,40,0.66 [0.14-2.99],0.5858542086792111
Chapter II Neoplasms,Melanoma in situ,PTPRM,Receptor-type tyrosine-protein phosphatase mu,24414,52,2.55 [0.97-6.73],0.0581147908743572
Chapter II Neoplasms,Melanoma in situ,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,24223,49,1.22 [0.53-2.82],0.6336117048108092
Chapter II Neoplasms,Melanoma in situ,PTPRR,Receptor-type tyrosine-protein phosphatase R,21166,40,1.22 [0.54-2.77],0.6345110822136779
Chapter II Neoplasms,Melanoma in situ,PTPRS,Receptor-type tyrosine-protein phosphatase S,24765,53,0.58 [0.22-1.57],0.2875033522908023
Chapter II Neoplasms,Melanoma in situ,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,21225,41,0.79 [0.31-2.01],0.6204032202573053
Chapter II Neoplasms,Melanoma in situ,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,20746,40,1.48 [0.90-2.44],0.1247186859321652
Chapter II Neoplasms,Melanoma in situ,PTS,6-pyruvoyl tetrahydrobiopterin synthase,23787,51,1.08 [0.69-1.68],0.7360229627761188
Chapter II Neoplasms,Melanoma in situ,PTTG1,Securin,20824,40,1.20 [0.62-2.32],0.5886691158216834
Chapter II Neoplasms,Melanoma in situ,PTX3,Pentraxin-related protein PTX3,24460,52,0.76 [0.49-1.19],0.233899294897621
Chapter II Neoplasms,Melanoma in situ,PVALB,Parvalbumin alpha,24595,52,1.09 [0.87-1.35],0.4604114855203263
Chapter II Neoplasms,Melanoma in situ,PVR,Poliovirus receptor,24707,53,0.91 [0.47-1.78],0.7849535657462531
Chapter II Neoplasms,Melanoma in situ,PXDNL,Peroxidasin-like protein,21108,40,1.18 [0.78-1.78],0.4454442457717087
Chapter II Neoplasms,Melanoma in situ,PXN,Paxillin,23895,51,0.93 [0.58-1.49],0.7715770795959467
Chapter II Neoplasms,Melanoma in situ,PYDC1,Pyrin domain-containing protein 1,20637,41,1.38 [0.77-2.48],0.2796376465493335
Chapter II Neoplasms,Melanoma in situ,PYY,Peptide YY,20559,37,0.72 [0.50-1.05],0.0861770541178264
Chapter II Neoplasms,Melanoma in situ,PZP,Pregnancy zone protein,21249,41,1.42 [0.89-2.25],0.1403840194496788
Chapter II Neoplasms,Melanoma in situ,QDPR,Dihydropteridine reductase,24364,53,1.08 [0.62-1.88],0.7748102367495773
Chapter II Neoplasms,Melanoma in situ,QPCT,Glutaminyl-peptide cyclotransferase,24466,53,0.64 [0.25-1.61],0.3429480709592958
Chapter II Neoplasms,Melanoma in situ,QSOX1,Sulfhydryl oxidase 1,20808,41,0.90 [0.40-2.03],0.7953290988651202
Chapter II Neoplasms,Melanoma in situ,RAB10,Ras-related protein Rab-10,21225,41,1.46 [0.87-2.46],0.1485178172033322
Chapter II Neoplasms,Melanoma in situ,RAB11FIP3,Rab11 family-interacting protein 3,21225,41,1.37 [1.03-1.81],0.0305266144979947
Chapter II Neoplasms,Melanoma in situ,RAB27B,Ras-related protein Rab-27B,21225,41,1.43 [0.96-2.12],0.0799119371156294
Chapter II Neoplasms,Melanoma in situ,RAB2B,Ras-related protein Rab-2B,21108,40,1.67 [1.15-2.43],0.0070840553295058
Chapter II Neoplasms,Melanoma in situ,RAB33A,Ras-related protein Rab-33A,20559,37,1.31 [0.85-2.04],0.2250914294011294
Chapter II Neoplasms,Melanoma in situ,RAB37,Ras-related protein Rab-37,24024,50,1.00 [0.75-1.34],0.975642474636675
Chapter II Neoplasms,Melanoma in situ,RAB39B,Ras-related protein Rab-39B,20559,37,1.02 [0.72-1.43],0.926798054605177
Chapter II Neoplasms,Melanoma in situ,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,20569,40,1.17 [0.78-1.77],0.4452704947155438
Chapter II Neoplasms,Melanoma in situ,RAB44,Ras-related protein Rab-44,21108,40,0.54 [0.21-1.36],0.1887012289961144
Chapter II Neoplasms,Melanoma in situ,RAB6A,Ras-related protein Rab-6A,24460,52,1.54 [0.98-2.43],0.0628056807100836
Chapter II Neoplasms,Melanoma in situ,RAB6B,Ras-related protein Rab-6B,23895,51,0.93 [0.55-1.58],0.7896929904169738
Chapter II Neoplasms,Melanoma in situ,RABEP1,Rab GTPase-binding effector protein 1,20746,40,1.20 [0.81-1.76],0.3612502692980976
Chapter II Neoplasms,Melanoma in situ,RABEPK,Rab9 effector protein with kelch motifs,23885,50,1.08 [0.74-1.58],0.6929264130284081
Chapter II Neoplasms,Melanoma in situ,RABGAP1L,Rab GTPase-activating protein 1-like,24024,50,0.97 [0.63-1.47],0.8696049754735571
Chapter II Neoplasms,Melanoma in situ,RAC3,Ras-related C3 botulinum toxin substrate 3,20638,38,1.04 [0.67-1.60],0.8689132622304024
Chapter II Neoplasms,Melanoma in situ,RAD23B,UV excision repair protein RAD23 homolog B,23885,50,0.93 [0.54-1.61],0.8080350554937761
Chapter II Neoplasms,Melanoma in situ,RAD51,DNA repair protein RAD51 homolog 1,20824,40,0.90 [0.49-1.65],0.7252441944227725
Chapter II Neoplasms,Melanoma in situ,RALB,Ras-related protein Ral-B,20617,41,2.07 [1.00-4.25],0.0486275311199148
Chapter II Neoplasms,Melanoma in situ,RALY,RNA-binding protein Raly,21108,40,1.29 [0.83-2.02],0.2547974889069869
Chapter II Neoplasms,Melanoma in situ,RANBP1,Ran-specific GTPase-activating protein,20637,41,1.01 [0.58-1.78],0.9615238487619704
Chapter II Neoplasms,Melanoma in situ,RANBP2,E3 SUMO-protein ligase RanBP2,20569,40,1.63 [0.77-3.43],0.1980658264995266
Chapter II Neoplasms,Melanoma in situ,RANGAP1,Ran GTPase-activating protein 1,23885,50,0.87 [0.51-1.49],0.6133557413804316
Chapter II Neoplasms,Melanoma in situ,RAP1A,Ras-related protein Rap-1A,20617,41,0.89 [0.54-1.45],0.6301903336127718
Chapter II Neoplasms,Melanoma in situ,RAPGEF2,Rap guanine nucleotide exchange factor 2,20824,40,1.47 [0.89-2.42],0.1302107083511214
Chapter II Neoplasms,Melanoma in situ,RARRES1,Retinoic acid receptor responder protein 1,23885,50,0.93 [0.43-2.01],0.8550241894874064
Chapter II Neoplasms,Melanoma in situ,RARRES2,Retinoic acid receptor responder protein 2,24581,53,1.37 [0.87-2.17],0.1774440741267767
Chapter II Neoplasms,Melanoma in situ,RASA1,Ras GTPase-activating protein 1,23895,51,0.73 [0.34-1.59],0.4348057293194255
Chapter II Neoplasms,Melanoma in situ,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,20471,40,1.30 [0.68-2.49],0.4199220326435965
Chapter II Neoplasms,Melanoma in situ,RASSF2,Ras association domain-containing protein 2,23885,50,0.71 [0.42-1.20],0.1956115135193134
Chapter II Neoplasms,Melanoma in situ,RBFOX3,RNA binding protein fox-1 homolog 3,21191,40,0.58 [0.23-1.44],0.240205590820268
Chapter II Neoplasms,Melanoma in situ,RBKS,Ribokinase,23915,49,0.83 [0.49-1.38],0.4647061056548973
Chapter II Neoplasms,Melanoma in situ,RBM17,Splicing factor 45,21191,40,1.62 [1.15-2.29],0.0056058060012175
Chapter II Neoplasms,Melanoma in situ,RBM19,Probable RNA-binding protein 19,20559,37,1.29 [0.76-2.19],0.3392126459703791
Chapter II Neoplasms,Melanoma in situ,RBM25,RNA-binding protein 25,20471,40,1.31 [0.73-2.36],0.3636868759843058
Chapter II Neoplasms,Melanoma in situ,RBP1,Retinol-binding protein 1,20638,38,0.79 [0.46-1.36],0.3925217414367962
Chapter II Neoplasms,Melanoma in situ,RBP2,Retinol-binding protein 2,24350,50,0.90 [0.64-1.26],0.5296845338861245
Chapter II Neoplasms,Melanoma in situ,RBP5,Retinol-binding protein 5,24350,50,1.31 [0.86-1.99],0.2070015925239154
Chapter II Neoplasms,Melanoma in situ,RBP7,Retinoid-binding protein 7,21131,40,0.83 [0.49-1.41],0.4876198511278155
Chapter II Neoplasms,Melanoma in situ,RBPMS,RNA-binding protein with multiple splicing,20617,41,0.97 [0.61-1.54],0.901711458272942
Chapter II Neoplasms,Melanoma in situ,RBPMS2,RNA-binding protein with multiple splicing 2,20637,41,1.30 [0.98-1.72],0.0719845294550106
Chapter II Neoplasms,Melanoma in situ,RCC1,Regulator of chromosome condensation,21108,40,0.93 [0.50-1.72],0.8180849891673335
Chapter II Neoplasms,Melanoma in situ,RCOR1,REST corepressor 1,24041,51,0.88 [0.48-1.63],0.6836622633603004
Chapter II Neoplasms,Melanoma in situ,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,20637,41,0.93 [0.22-3.95],0.9187867834680676
Chapter II Neoplasms,Melanoma in situ,REEP4,Receptor expression-enhancing protein 4,21191,40,1.37 [0.88-2.11],0.1603002900844082
Chapter II Neoplasms,Melanoma in situ,REG1A,Lithostathine-1-alpha,24311,53,1.17 [0.71-1.91],0.5409726648417164
Chapter II Neoplasms,Melanoma in situ,REG1B,Lithostathine-1-beta,24765,53,1.06 [0.69-1.62],0.7930805056809355
Chapter II Neoplasms,Melanoma in situ,REG3A,Regenerating islet-derived protein 3-alpha,24765,53,1.30 [0.89-1.89],0.1732614513193627
Chapter II Neoplasms,Melanoma in situ,REG3G,Regenerating islet-derived protein 3-gamma,21108,40,0.57 [0.25-1.29],0.1760669478183894
Chapter II Neoplasms,Melanoma in situ,REG4,Regenerating islet-derived protein 4,24488,52,0.79 [0.46-1.36],0.3918003257851861
Chapter II Neoplasms,Melanoma in situ,RELB,Transcription factor RelB,20617,41,1.35 [0.86-2.11],0.1904199575428644
Chapter II Neoplasms,Melanoma in situ,RELT,Tumor necrosis factor receptor superfamily member 19L,24462,53,0.93 [0.36-2.40],0.8855231481371715
Chapter II Neoplasms,Melanoma in situ,REN,Renin,24482,53,1.06 [0.74-1.51],0.7580374860088075
Chapter II Neoplasms,Melanoma in situ,REPS1,RalBP1-associated Eps domain-containing protein 1,20617,41,2.14 [1.31-3.52],0.0025741559339608
Chapter II Neoplasms,Melanoma in situ,REST,RE1-silencing transcription factor,20471,40,1.81 [1.08-3.02],0.0239630883219827
Chapter II Neoplasms,Melanoma in situ,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,24350,50,0.60 [0.32-1.14],0.1211004950555783
Chapter II Neoplasms,Melanoma in situ,RETN,Resistin,24391,50,0.73 [0.38-1.40],0.3465841085382772
Chapter II Neoplasms,Melanoma in situ,REXO2,"Oligoribonuclease, mitochondrial",20559,37,1.19 [0.69-2.06],0.5318231217289305
Chapter II Neoplasms,Melanoma in situ,RFC4,Replication factor C subunit 4,21108,40,2.00 [0.71-5.60],0.1873038973693719
Chapter II Neoplasms,Melanoma in situ,RGCC,Regulator of cell cycle RGCC,21191,40,1.51 [1.03-2.22],0.0352770190702389
Chapter II Neoplasms,Melanoma in situ,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,20824,40,1.34 [0.97-1.86],0.0755445771910249
Chapter II Neoplasms,Melanoma in situ,RGMA,Repulsive guidance molecule A,24707,53,0.64 [0.29-1.41],0.2655140884660038
Chapter II Neoplasms,Melanoma in situ,RGMB,RGM domain family member B,24707,53,0.53 [0.20-1.41],0.2046730519206114
Chapter II Neoplasms,Melanoma in situ,RGS10,Regulator of G-protein signaling 10,21191,40,1.68 [1.18-2.41],0.0043325486849131
Chapter II Neoplasms,Melanoma in situ,RGS8,Regulator of G-protein signaling 8,24024,50,1.12 [0.81-1.56],0.4854511966169281
Chapter II Neoplasms,Melanoma in situ,RHOC,Rho-related GTP-binding protein RhoC,24162,49,1.11 [0.89-1.39],0.3381593789014405
Chapter II Neoplasms,Melanoma in situ,RICTOR,Rapamycin-insensitive companion of mTOR,20617,41,1.06 [0.58-1.93],0.8570513361379934
Chapter II Neoplasms,Melanoma in situ,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20746,40,0.76 [0.40-1.43],0.3886772148439322
Chapter II Neoplasms,Melanoma in situ,RILP,Rab-interacting lysosomal protein,24626,52,0.96 [0.64-1.44],0.8395157422678478
Chapter II Neoplasms,Melanoma in situ,RILPL2,RILP-like protein 2,21225,41,1.39 [1.02-1.90],0.0397463259823537
Chapter II Neoplasms,Melanoma in situ,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,20559,37,0.95 [0.58-1.55],0.8384873400041873
Chapter II Neoplasms,Melanoma in situ,RLN1,Prorelaxin H1,21191,40,1.08 [0.77-1.52],0.6705747689833697
Chapter II Neoplasms,Melanoma in situ,RLN2,Prorelaxin H2,20714,40,1.10 [0.90-1.34],0.3413731669994044
Chapter II Neoplasms,Melanoma in situ,RNASE1,Ribonuclease pancreatic,21229,41,1.40 [0.41-4.74],0.5868735938810248
Chapter II Neoplasms,Melanoma in situ,RNASE10,Inactive ribonuclease-like protein 10,20637,41,0.79 [0.41-1.53],0.4837284843075988
Chapter II Neoplasms,Melanoma in situ,RNASE3,Eosinophil cationic protein,24357,53,0.94 [0.74-1.18],0.5735760471495859
Chapter II Neoplasms,Melanoma in situ,RNASE4,Ribonuclease 4,20542,38,1.19 [0.37-3.79],0.7662580457351247
Chapter II Neoplasms,Melanoma in situ,RNASE6,Ribonuclease K6,21075,41,0.35 [0.10-1.24],0.1051531091719783
Chapter II Neoplasms,Melanoma in situ,RNASEH2A,Ribonuclease H2 subunit A,21191,40,0.97 [0.53-1.76],0.9151287854817868
Chapter II Neoplasms,Melanoma in situ,RNASET2,Ribonuclease T2,24645,53,1.01 [0.39-2.66],0.9775314375515738
Chapter II Neoplasms,Melanoma in situ,RNF149,E3 ubiquitin-protein ligase RNF149,20637,41,0.84 [0.30-2.34],0.7385857084637917
Chapter II Neoplasms,Melanoma in situ,RNF168,E3 ubiquitin-protein ligase RNF168,20617,41,0.91 [0.44-1.90],0.8052994977971216
Chapter II Neoplasms,Melanoma in situ,RNF31,E3 ubiquitin-protein ligase RNF31,20617,41,1.42 [0.78-2.59],0.2564843520430442
Chapter II Neoplasms,Melanoma in situ,RNF4,E3 ubiquitin-protein ligase RNF4,20824,40,0.69 [0.40-1.17],0.1707899659803325
Chapter II Neoplasms,Melanoma in situ,RNF41,E3 ubiquitin-protein ligase NRDP1,23885,50,1.29 [0.92-1.81],0.1439008441729818
Chapter II Neoplasms,Melanoma in situ,RNF43,E3 ubiquitin-protein ligase RNF43,20824,40,1.11 [0.69-1.77],0.6729542310389882
Chapter II Neoplasms,Melanoma in situ,RNF5,E3 ubiquitin-protein ligase RNF5,20637,41,1.49 [0.96-2.31],0.0748183503069358
Chapter II Neoplasms,Melanoma in situ,ROBO1,Roundabout homolog 1,24488,52,0.73 [0.25-2.14],0.5687061494076925
Chapter II Neoplasms,Melanoma in situ,ROBO2,Roundabout homolog 2,24707,53,0.46 [0.16-1.35],0.1577398752782481
Chapter II Neoplasms,Melanoma in situ,ROBO4,Roundabout homolog 4,20637,41,3.02 [0.57-16.04],0.1952893314564232
Chapter II Neoplasms,Melanoma in situ,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,24482,53,0.97 [0.44-2.15],0.9491615622949724
Chapter II Neoplasms,Melanoma in situ,RP2,Protein XRP2,24350,50,1.15 [0.65-2.03],0.6356877936017125
Chapter II Neoplasms,Melanoma in situ,RPA2,Replication protein A 32 kDa subunit,20617,41,1.38 [0.60-3.16],0.4422643442154041
Chapter II Neoplasms,Melanoma in situ,RPE,Ribulose-phosphate 3-epimerase,20824,40,1.07 [0.71-1.60],0.7481186616538729
Chapter II Neoplasms,Melanoma in situ,RPGR,X-linked retinitis pigmentosa GTPase regulator,20638,38,1.09 [0.52-2.28],0.8189464346715445
Chapter II Neoplasms,Melanoma in situ,RPL14,60S ribosomal protein L14,20637,41,1.33 [0.73-2.41],0.3568298654471294
Chapter II Neoplasms,Melanoma in situ,RPS10,40S ribosomal protein S10,20559,37,0.74 [0.31-1.76],0.4973784770760366
Chapter II Neoplasms,Melanoma in situ,RRAS,Ras-related protein R-Ras,20638,38,1.27 [1.01-1.58],0.0368652486191771
Chapter II Neoplasms,Melanoma in situ,RRM2,Ribonucleoside-diphosphate reductase subunit M2,23885,50,0.70 [0.38-1.30],0.2620803747286161
Chapter II Neoplasms,Melanoma in situ,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,23885,50,1.31 [0.92-1.87],0.1398025796204133
Chapter II Neoplasms,Melanoma in situ,RRP15,RRP15-like protein,20569,40,0.87 [0.63-1.21],0.4018476736199476
Chapter II Neoplasms,Melanoma in situ,RSPO1,R-spondin-1,24313,49,0.71 [0.34-1.49],0.3688724661327783
Chapter II Neoplasms,Melanoma in situ,RSPO3,R-spondin-3,24689,52,0.68 [0.27-1.73],0.4145625515254557
Chapter II Neoplasms,Melanoma in situ,RTBDN,Retbindin,24350,50,1.69 [0.72-3.99],0.2270616622087936
Chapter II Neoplasms,Melanoma in situ,RTKN2,Rhotekin-2,20559,37,0.68 [0.32-1.47],0.3300231148546914
Chapter II Neoplasms,Melanoma in situ,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",21191,40,1.44 [1.05-1.97],0.0236552569869617
Chapter II Neoplasms,Melanoma in situ,RTN4R,Reticulon-4 receptor,24689,52,1.09 [0.54-2.22],0.8058867011513067
Chapter II Neoplasms,Melanoma in situ,RUVBL1,RuvB-like 1,23885,50,1.06 [0.84-1.34],0.6004807960767806
Chapter II Neoplasms,Melanoma in situ,RWDD1,RWD domain-containing protein 1,24707,53,1.16 [0.80-1.69],0.4382578923180656
Chapter II Neoplasms,Melanoma in situ,RYR1,Ryanodine receptor 1,20559,37,1.28 [0.59-2.78],0.5246963061206268
Chapter II Neoplasms,Melanoma in situ,S100A11,Protein S100-A11,24282,53,0.64 [0.34-1.22],0.1744411889305023
Chapter II Neoplasms,Melanoma in situ,S100A12,Protein S100-A12,24118,47,0.76 [0.54-1.09],0.1327870738204742
Chapter II Neoplasms,Melanoma in situ,S100A13,Protein S100-A13,20617,41,1.06 [0.45-2.47],0.8933174890366745
Chapter II Neoplasms,Melanoma in situ,S100A14,Protein S100-A14,21191,40,1.07 [0.60-1.89],0.8177994109561901
Chapter II Neoplasms,Melanoma in situ,S100A16,Protein S100-A16,23858,51,1.20 [0.84-1.70],0.3196245894817519
Chapter II Neoplasms,Melanoma in situ,S100A3,Protein S100-A3,21108,40,1.33 [0.84-2.13],0.2261890313740945
Chapter II Neoplasms,Melanoma in situ,S100A4,Protein S100-A4,24519,53,0.99 [0.65-1.50],0.963449648801622
Chapter II Neoplasms,Melanoma in situ,S100G,Protein S100-G,21191,40,1.30 [0.70-2.43],0.4079329258686106
Chapter II Neoplasms,Melanoma in situ,S100P,Protein S100-P,24041,51,0.86 [0.52-1.42],0.5557840360642586
Chapter II Neoplasms,Melanoma in situ,SAA4,Serum amyloid A-4 protein,21249,41,0.91 [0.32-2.62],0.8600215569916843
Chapter II Neoplasms,Melanoma in situ,SAFB2,Scaffold attachment factor B2,21191,40,0.66 [0.20-2.14],0.4881614599918289
Chapter II Neoplasms,Melanoma in situ,SAG,S-arrestin,20569,40,1.36 [0.92-2.01],0.129123481472596
Chapter II Neoplasms,Melanoma in situ,SAMD9L,Sterile alpha motif domain-containing protein 9-like,24460,52,1.19 [0.86-1.64],0.2918254967896061
Chapter II Neoplasms,Melanoma in situ,SAP18,Histone deacetylase complex subunit SAP18,20824,40,0.87 [0.55-1.37],0.5343133573073737
Chapter II Neoplasms,Melanoma in situ,SARG,Specifically androgen-regulated gene protein,21158,41,1.29 [0.98-1.70],0.07177730658318
Chapter II Neoplasms,Melanoma in situ,SART1,U4/U6.U5 tri-snRNP-associated protein 1,20559,37,1.00 [0.45-2.22],0.9941868927240272
Chapter II Neoplasms,Melanoma in situ,SAT1,Diamine acetyltransferase 1,20559,37,0.81 [0.40-1.65],0.560585980052468
Chapter II Neoplasms,Melanoma in situ,SAT2,Thialysine N-epsilon-acetyltransferase,20824,40,1.13 [0.77-1.66],0.5275130893576582
Chapter II Neoplasms,Melanoma in situ,SATB1,DNA-binding protein SATB1,21191,40,0.91 [0.34-2.47],0.852191392234653
Chapter II Neoplasms,Melanoma in situ,SBSN,Suprabasin,21178,41,1.03 [0.43-2.44],0.951200087711572
Chapter II Neoplasms,Melanoma in situ,SCAMP3,Secretory carrier-associated membrane protein 3,24350,50,1.11 [0.83-1.48],0.4941659949221741
Chapter II Neoplasms,Melanoma in situ,SCARA5,Scavenger receptor class A member 5,24707,53,0.55 [0.24-1.26],0.1554847369358837
Chapter II Neoplasms,Melanoma in situ,SCARB1,Scavenger receptor class B member 1,23895,51,1.25 [0.91-1.72],0.1729693622851969
Chapter II Neoplasms,Melanoma in situ,SCARB2,Lysosome membrane protein 2,23846,49,1.63 [0.67-3.95],0.2799894205446798
Chapter II Neoplasms,Melanoma in situ,SCARF1,Scavenger receptor class F member 1,24765,53,1.19 [0.68-2.08],0.5542925393272052
Chapter II Neoplasms,Melanoma in situ,SCARF2,Scavenger receptor class F member 2,24707,53,0.79 [0.33-1.92],0.604889512895791
Chapter II Neoplasms,Melanoma in situ,SCG2,Secretogranin-2,24591,52,0.88 [0.39-1.98],0.76523577623831
Chapter II Neoplasms,Melanoma in situ,SCG3,Secretogranin-3,24488,52,0.61 [0.29-1.29],0.1978477320519924
Chapter II Neoplasms,Melanoma in situ,SCGB1A1,Uteroglobin,24497,52,1.00 [0.63-1.58],0.9877281729997204
Chapter II Neoplasms,Melanoma in situ,SCGB2A2,Mammaglobin-A,20559,37,0.97 [0.34-2.74],0.9541672544240896
Chapter II Neoplasms,Melanoma in situ,SCGB3A1,Secretoglobin family 3A member 1,20746,40,0.93 [0.26-3.30],0.9067776918724596
Chapter II Neoplasms,Melanoma in situ,SCGB3A2,Secretoglobin family 3A member 2,24529,52,1.01 [0.74-1.38],0.9377607609404396
Chapter II Neoplasms,Melanoma in situ,SCGN,Secretagogin,24024,50,1.09 [0.61-1.95],0.7692071541508264
Chapter II Neoplasms,Melanoma in situ,SCIN,Adseverin,20569,40,1.18 [0.82-1.68],0.3712460143933764
Chapter II Neoplasms,Melanoma in situ,SCLY,Selenocysteine lyase,24626,52,1.13 [0.69-1.86],0.6175800540071277
Chapter II Neoplasms,Melanoma in situ,SCN2A,Sodium channel protein type 2 subunit alpha,20569,40,0.99 [0.52-1.86],0.9633803172844344
Chapter II Neoplasms,Melanoma in situ,SCN2B,Sodium channel subunit beta-2,20638,38,1.22 [0.43-3.44],0.7113586395884081
Chapter II Neoplasms,Melanoma in situ,SCN3A,Sodium channel protein type 3 subunit alpha,20638,38,0.98 [0.43-2.22],0.9635236375893612
Chapter II Neoplasms,Melanoma in situ,SCN3B,Sodium channel subunit beta-3,20569,40,0.98 [0.49-1.93],0.945913144964372
Chapter II Neoplasms,Melanoma in situ,SCN4B,Sodium channel subunit beta-4,20637,41,0.68 [0.33-1.42],0.3027974346119221
Chapter II Neoplasms,Melanoma in situ,SCP2,Non-specific lipid-transfer protein,23885,50,0.96 [0.69-1.33],0.8041292607807041
Chapter II Neoplasms,Melanoma in situ,SCPEP1,Retinoid-inducible serine carboxypeptidase,20566,41,1.33 [0.75-2.35],0.3295054545820825
Chapter II Neoplasms,Melanoma in situ,SCRG1,Scrapie-responsive protein 1,21225,41,1.26 [0.42-3.83],0.6793631615827207
Chapter II Neoplasms,Melanoma in situ,SCRIB,Protein scribble homolog,20637,41,1.10 [0.82-1.48],0.5076432883333711
Chapter II Neoplasms,Melanoma in situ,SCRN1,Secernin-1,24460,52,1.42 [0.98-2.07],0.0648375753800325
Chapter II Neoplasms,Melanoma in situ,SCT,Secretin,20638,38,1.19 [0.60-2.36],0.6145992538800288
Chapter II Neoplasms,Melanoma in situ,SDC1,Syndecan-1,24482,53,0.91 [0.48-1.74],0.7773000109499577
Chapter II Neoplasms,Melanoma in situ,SDC4,Syndecan-4,24482,53,0.70 [0.42-1.18],0.1846399482771988
Chapter II Neoplasms,Melanoma in situ,SDCCAG8,Serologically defined colon cancer antigen 8,21108,40,1.19 [0.92-1.55],0.1887620313236635
Chapter II Neoplasms,Melanoma in situ,SDHB,Succinate dehydrogenase,21131,40,0.90 [0.57-1.42],0.6435296038810006
Chapter II Neoplasms,Melanoma in situ,SDK2,Protein sidekick-2,20746,40,0.72 [0.31-1.69],0.4489183675473077
Chapter II Neoplasms,Melanoma in situ,SEC31A,Protein transport protein Sec31A,20637,41,1.56 [1.03-2.35],0.0358989222939124
Chapter II Neoplasms,Melanoma in situ,SEL1L,Protein sel-1 homolog 1,20637,41,1.29 [0.62-2.65],0.4943238637877739
Chapter II Neoplasms,Melanoma in situ,SELE,E-selectin,24765,53,1.43 [0.87-2.34],0.1537416406617927
Chapter II Neoplasms,Melanoma in situ,SELENOP,Selenoprotein P,21249,41,1.76 [0.53-5.80],0.3522230366022933
Chapter II Neoplasms,Melanoma in situ,SELL,L-selectin,21249,41,1.48 [0.41-5.37],0.5486511992360479
Chapter II Neoplasms,Melanoma in situ,SELP,P-selectin,24528,53,1.19 [0.79-1.81],0.4101202062894387
Chapter II Neoplasms,Melanoma in situ,SELPLG,P-selectin glycoprotein ligand 1,24460,52,1.53 [0.61-3.86],0.3673950891583395
Chapter II Neoplasms,Melanoma in situ,SEMA3F,Semaphorin-3F,24482,53,1.04 [0.40-2.70],0.9404174697932146
Chapter II Neoplasms,Melanoma in situ,SEMA3G,Semaphorin-3G,20746,40,0.94 [0.46-1.92],0.8728208378983093
Chapter II Neoplasms,Melanoma in situ,SEMA4C,Semaphorin-4C,24350,50,0.86 [0.34-2.17],0.7482782076524537
Chapter II Neoplasms,Melanoma in situ,SEMA4D,Semaphorin-4D,24707,53,1.40 [0.62-3.14],0.4182738211720739
Chapter II Neoplasms,Melanoma in situ,SEMA6C,Semaphorin-6C,20617,41,1.29 [0.50-3.36],0.5959935398475094
Chapter II Neoplasms,Melanoma in situ,SEMA7A,Semaphorin-7A,24675,53,0.92 [0.36-2.37],0.860502855239228
Chapter II Neoplasms,Melanoma in situ,SEPTIN3,Neuronal-specific septin-3,21191,40,0.80 [0.52-1.24],0.3180949620466389
Chapter II Neoplasms,Melanoma in situ,SEPTIN7,Septin-7,20824,40,0.89 [0.46-1.71],0.7161580834197738
Chapter II Neoplasms,Melanoma in situ,SEPTIN8,Septin-8,21118,40,0.79 [0.49-1.26],0.3141689284882575
Chapter II Neoplasms,Melanoma in situ,SEPTIN9,Septin-9,24350,50,0.77 [0.31-1.93],0.5790902647960782
Chapter II Neoplasms,Melanoma in situ,SERPINA1,Alpha-1-antitrypsin,20864,41,0.46 [0.01-21.29],0.6901341037670536
Chapter II Neoplasms,Melanoma in situ,SERPINA11,Serpin A11,24765,53,0.92 [0.51-1.65],0.7784439001436763
Chapter II Neoplasms,Melanoma in situ,SERPINA12,Serpin A12,23811,52,1.17 [0.97-1.41],0.1049273688154384
Chapter II Neoplasms,Melanoma in situ,SERPINA3,Alpha-1-antichymotrypsin,21184,41,1.17 [0.15-8.93],0.8762043185930841
Chapter II Neoplasms,Melanoma in situ,SERPINA4,Kallistatin,20864,41,2.48 [0.76-8.12],0.1332900710816181
Chapter II Neoplasms,Melanoma in situ,SERPINA5,Plasma serine protease inhibitor,20938,41,1.51 [0.76-2.98],0.2366737882802244
Chapter II Neoplasms,Melanoma in situ,SERPINA6,Corticosteroid-binding globulin,21249,41,2.95 [0.65-13.29],0.159671225251147
Chapter II Neoplasms,Melanoma in situ,SERPINA7,Thyroxine-binding globulin,21249,41,3.06 [0.66-14.11],0.1513309074863715
Chapter II Neoplasms,Melanoma in situ,SERPINA9,Serpin A9,24228,50,1.07 [0.75-1.52],0.727387437428329
Chapter II Neoplasms,Melanoma in situ,SERPINB1,Leukocyte elastase inhibitor,24385,52,1.03 [0.79-1.35],0.7996038698997641
Chapter II Neoplasms,Melanoma in situ,SERPINB5,Serpin B5,24041,51,1.04 [0.63-1.74],0.8697216852829286
Chapter II Neoplasms,Melanoma in situ,SERPINB6,Serpin B6,24630,52,1.30 [0.88-1.94],0.1910919195097985
Chapter II Neoplasms,Melanoma in situ,SERPINB8,Serpin B8,24769,52,0.71 [0.43-1.16],0.1718240849187613
Chapter II Neoplasms,Melanoma in situ,SERPINB9,Serpin B9,24313,49,1.20 [0.59-2.45],0.6108328374401999
Chapter II Neoplasms,Melanoma in situ,SERPINC1,Antithrombin-III,21207,41,1.88 [0.25-13.90],0.5368028277465458
Chapter II Neoplasms,Melanoma in situ,SERPIND1,Heparin cofactor 2,21207,41,1.03 [0.35-3.01],0.9512046297758638
Chapter II Neoplasms,Melanoma in situ,SERPINE1,Plasminogen activator inhibitor 1,24765,53,1.12 [0.78-1.61],0.5303689627530606
Chapter II Neoplasms,Melanoma in situ,SERPINE2,Glia-derived nexin,21225,41,1.66 [1.08-2.55],0.0208416841370918
Chapter II Neoplasms,Melanoma in situ,SERPINF1,Pigment epithelium-derived factor,20942,41,1.17 [0.38-3.59],0.7831329966313966
Chapter II Neoplasms,Melanoma in situ,SERPINF2,Alpha-2-antiplasmin,20857,41,3.21 [0.42-24.84],0.2637211734814054
Chapter II Neoplasms,Melanoma in situ,SERPING1,Plasma protease C1 inhibitor,21207,41,0.74 [0.15-3.61],0.7111950690154916
Chapter II Neoplasms,Melanoma in situ,SERPINH1,Serpin H1,20824,40,1.11 [0.88-1.40],0.3889308749572748
Chapter II Neoplasms,Melanoma in situ,SERPINI1,Neuroserpin,20700,40,1.37 [0.55-3.43],0.504112126575446
Chapter II Neoplasms,Melanoma in situ,SERPINI2,Serpin I2,21131,40,1.06 [0.63-1.80],0.8149956221755186
Chapter II Neoplasms,Melanoma in situ,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,23895,51,1.11 [0.76-1.62],0.5823432097484104
Chapter II Neoplasms,Melanoma in situ,SETMAR,Histone-lysine N-methyltransferase SETMAR,24236,49,1.38 [0.62-3.09],0.4285443338752775
Chapter II Neoplasms,Melanoma in situ,SEZ6,Seizure protein 6 homolog,20638,38,0.36 [0.12-1.05],0.0621669063343938
Chapter II Neoplasms,Melanoma in situ,SEZ6L,Seizure 6-like protein,24519,53,0.48 [0.20-1.16],0.1033554289354289
Chapter II Neoplasms,Melanoma in situ,SEZ6L2,Seizure 6-like protein 2,24350,50,0.91 [0.31-2.64],0.8589733406129396
Chapter II Neoplasms,Melanoma in situ,SF3B4,Splicing factor 3B subunit 4,24350,50,1.04 [0.75-1.45],0.8225159249408978
Chapter II Neoplasms,Melanoma in situ,SFRP1,Secreted frizzled-related protein 1,24229,49,0.96 [0.52-1.77],0.9046249984258232
Chapter II Neoplasms,Melanoma in situ,SFRP4,Secreted frizzled-related protein 4,20746,40,1.37 [0.66-2.83],0.3958009332459695
Chapter II Neoplasms,Melanoma in situ,SFTPA1,Pulmonary surfactant-associated protein A1,23885,50,0.92 [0.57-1.46],0.7164409327837739
Chapter II Neoplasms,Melanoma in situ,SFTPA2,Pulmonary surfactant-associated protein A2,23885,50,0.74 [0.42-1.28],0.2798477241411847
Chapter II Neoplasms,Melanoma in situ,SFTPD,Pulmonary surfactant-associated protein D,24482,53,0.79 [0.54-1.14],0.2087898768693963
Chapter II Neoplasms,Melanoma in situ,SGSH,N-sulphoglucosamine sulphohydrolase,20889,41,1.09 [0.65-1.84],0.7481497896868456
Chapter II Neoplasms,Melanoma in situ,SH2B3,SH2B adapter protein 3,23885,50,1.09 [0.84-1.41],0.5121934095164355
Chapter II Neoplasms,Melanoma in situ,SH2D1A,SH2 domain-containing protein 1A,24460,52,0.94 [0.61-1.46],0.7878633435422328
Chapter II Neoplasms,Melanoma in situ,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,20569,40,1.09 [0.68-1.73],0.7294203699960988
Chapter II Neoplasms,Melanoma in situ,SH3BP1,SH3 domain-binding protein 1,21131,40,0.82 [0.42-1.59],0.558117743034362
Chapter II Neoplasms,Melanoma in situ,SH3GL3,Endophilin-A3,20696,40,0.98 [0.69-1.41],0.921500701773368
Chapter II Neoplasms,Melanoma in situ,SH3GLB2,Endophilin-B2,21166,40,0.86 [0.55-1.35],0.5038310866969191
Chapter II Neoplasms,Melanoma in situ,SHBG,Sex hormone-binding globulin,21229,41,1.35 [0.76-2.39],0.3105499256203383
Chapter II Neoplasms,Melanoma in situ,SHC1,SHC-transforming protein 1,20471,40,0.74 [0.54-1.00],0.0519725945758887
Chapter II Neoplasms,Melanoma in situ,SHD,SH2 domain-containing adapter protein D,20524,37,0.77 [0.46-1.28],0.3075090640479579
Chapter II Neoplasms,Melanoma in situ,SHH,Sonic hedgehog protein,20617,41,0.65 [0.30-1.38],0.2582192022953066
Chapter II Neoplasms,Melanoma in situ,SHISA5,Protein shisa-5,21216,41,0.60 [0.15-2.37],0.4662579203965649
Chapter II Neoplasms,Melanoma in situ,SHMT1,"Serine hydroxymethyltransferase, cytosolic",24529,52,1.11 [0.84-1.47],0.4506466113705992
Chapter II Neoplasms,Melanoma in situ,SHPK,Sedoheptulokinase,20824,40,1.42 [0.82-2.47],0.210058442115022
Chapter II Neoplasms,Melanoma in situ,SIAE,Sialate O-acetylesterase,24476,53,1.30 [0.79-2.15],0.3085528625984954
Chapter II Neoplasms,Melanoma in situ,SIGLEC1,Sialoadhesin,24564,52,0.89 [0.49-1.61],0.6941958444705676
Chapter II Neoplasms,Melanoma in situ,SIGLEC10,Sialic acid-binding Ig-like lectin 10,24460,52,1.25 [0.58-2.69],0.5689898075907763
Chapter II Neoplasms,Melanoma in situ,SIGLEC15,Sialic acid-binding Ig-like lectin 15,23895,51,1.16 [0.89-1.51],0.2605728229530547
Chapter II Neoplasms,Melanoma in situ,SIGLEC5,Sialic acid-binding Ig-like lectin 5,24462,53,1.07 [0.85-1.35],0.5519705034162048
Chapter II Neoplasms,Melanoma in situ,SIGLEC6,Sialic acid-binding Ig-like lectin 6,24689,52,0.82 [0.39-1.75],0.6085005187704862
Chapter II Neoplasms,Melanoma in situ,SIGLEC7,Sialic acid-binding Ig-like lectin 7,24482,53,1.30 [0.54-3.11],0.557892445660241
Chapter II Neoplasms,Melanoma in situ,SIGLEC8,Sialic acid-binding Ig-like lectin 8,20637,41,1.37 [0.71-2.64],0.3513536359884245
Chapter II Neoplasms,Melanoma in situ,SIGLEC9,Sialic acid-binding Ig-like lectin 9,24658,52,0.97 [0.42-2.21],0.9346178555445004
Chapter II Neoplasms,Melanoma in situ,SIL1,Nucleotide exchange factor SIL1,20637,41,1.55 [0.85-2.84],0.1551561190460391
Chapter II Neoplasms,Melanoma in situ,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,24511,51,0.85 [0.56-1.29],0.4522967070617635
Chapter II Neoplasms,Melanoma in situ,SIRPB1,Signal-regulatory protein beta-1,24393,51,0.75 [0.43-1.32],0.3207825380429243
Chapter II Neoplasms,Melanoma in situ,SIRT1,NAD-dependent protein deacetylase sirtuin-1,20617,41,1.01 [0.74-1.38],0.931062209247324
Chapter II Neoplasms,Melanoma in situ,SIRT2,NAD-dependent protein deacetylase sirtuin-2,24350,50,1.15 [0.87-1.52],0.3252615919143789
Chapter II Neoplasms,Melanoma in situ,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23895,51,1.08 [0.70-1.65],0.7354684168774481
Chapter II Neoplasms,Melanoma in situ,SIT1,Signaling threshold-regulating transmembrane adapter 1,24024,50,0.88 [0.56-1.40],0.5911598542184597
Chapter II Neoplasms,Melanoma in situ,SKAP1,Src kinase-associated phosphoprotein 1,24266,49,0.98 [0.70-1.37],0.8940896761137742
Chapter II Neoplasms,Melanoma in situ,SKAP2,Src kinase-associated phosphoprotein 2,24564,52,1.16 [0.92-1.46],0.224455586847952
Chapter II Neoplasms,Melanoma in situ,SKIV2L,Helicase SKI2W,20559,37,0.88 [0.39-1.98],0.755869384897867
Chapter II Neoplasms,Melanoma in situ,SLA2,Src-like-adapter 2,21191,40,1.35 [1.01-1.79],0.0424960791180979
Chapter II Neoplasms,Melanoma in situ,SLAMF1,Signaling lymphocytic activation molecule,24024,50,1.13 [0.73-1.75],0.5716402486228063
Chapter II Neoplasms,Melanoma in situ,SLAMF6,SLAM family member 6,23885,50,1.31 [0.68-2.51],0.4172909883745532
Chapter II Neoplasms,Melanoma in situ,SLAMF7,SLAM family member 7,24460,52,0.78 [0.51-1.20],0.2574213887044582
Chapter II Neoplasms,Melanoma in situ,SLAMF8,SLAM family member 8,23885,50,0.86 [0.54-1.38],0.530561647458301
Chapter II Neoplasms,Melanoma in situ,SLC12A2,Solute carrier family 12 member 2,20559,37,1.30 [0.62-2.70],0.4884573921375158
Chapter II Neoplasms,Melanoma in situ,SLC13A1,Solute carrier family 13 member 1,21108,40,0.85 [0.47-1.53],0.5846011491489038
Chapter II Neoplasms,Melanoma in situ,SLC16A1,Monocarboxylate transporter 1,23895,51,1.01 [0.66-1.54],0.9616642579905336
Chapter II Neoplasms,Melanoma in situ,SLC1A4,Neutral amino acid transporter A,20638,38,0.64 [0.31-1.33],0.2319096858155181
Chapter II Neoplasms,Melanoma in situ,SLC27A4,Long-chain fatty acid transport protein 4,23895,51,1.29 [0.95-1.76],0.1009094407034565
Chapter II Neoplasms,Melanoma in situ,SLC28A1,Sodium/nucleoside cotransporter 1,20471,40,1.16 [0.75-1.78],0.5073796414613646
Chapter II Neoplasms,Melanoma in situ,SLC34A3,Sodium-dependent phosphate transport protein 2C,20471,40,1.64 [1.19-2.27],0.0024840818964981
Chapter II Neoplasms,Melanoma in situ,SLC39A14,Zinc transporter ZIP14,23895,51,1.31 [0.66-2.57],0.4410171215507469
Chapter II Neoplasms,Melanoma in situ,SLC39A5,Zinc transporter ZIP5,24460,52,1.06 [0.67-1.67],0.8123312133930237
Chapter II Neoplasms,Melanoma in situ,SLC44A4,Choline transporter-like protein 4,20638,38,1.08 [0.71-1.62],0.7301277407235142
Chapter II Neoplasms,Melanoma in situ,SLC4A1,Band 3 anion transport protein,21216,41,0.80 [0.42-1.54],0.5093389215453089
Chapter II Neoplasms,Melanoma in situ,SLC51B,Organic solute transporter subunit beta,20559,37,1.26 [0.89-1.79],0.1952838798970272
Chapter II Neoplasms,Melanoma in situ,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,20746,40,1.41 [0.99-1.99],0.0536227616098071
Chapter II Neoplasms,Melanoma in situ,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,21131,40,0.85 [0.43-1.66],0.6298908534772014
Chapter II Neoplasms,Melanoma in situ,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",20471,40,1.17 [0.74-1.85],0.5060314201025867
Chapter II Neoplasms,Melanoma in situ,SLIT2,Slit homolog 2 protein,23895,51,1.21 [0.78-1.87],0.401328755638361
Chapter II Neoplasms,Melanoma in situ,SLITRK1,SLIT and NTRK-like protein 1,20617,41,0.92 [0.36-2.36],0.8666040985471992
Chapter II Neoplasms,Melanoma in situ,SLITRK2,SLIT and NTRK-like protein 2,24689,52,0.64 [0.35-1.17],0.14419463077625
Chapter II Neoplasms,Melanoma in situ,SLITRK6,SLIT and NTRK-like protein 6,24041,51,0.74 [0.35-1.57],0.4361489336036054
Chapter II Neoplasms,Melanoma in situ,SLK,STE20-like serine/threonine-protein kinase,20824,40,0.99 [0.67-1.46],0.9651266691889386
Chapter II Neoplasms,Melanoma in situ,SLMAP,Sarcolemmal membrane-associated protein,21131,40,1.36 [0.97-1.91],0.0757678853109207
Chapter II Neoplasms,Melanoma in situ,SLURP1,Secreted Ly-6/uPAR-related protein 1,21067,41,1.03 [0.47-2.23],0.9444298220646928
Chapter II Neoplasms,Melanoma in situ,SMAD1,Mothers against decapentaplegic homolog 1,23885,50,1.26 [0.93-1.69],0.1319048055074876
Chapter II Neoplasms,Melanoma in situ,SMAD2,Mothers against decapentaplegic homolog 2,21108,40,1.71 [1.17-2.51],0.00608521297951
Chapter II Neoplasms,Melanoma in situ,SMAD3,Mothers against decapentaplegic homolog 3,21108,40,1.57 [0.91-2.72],0.1067113789729282
Chapter II Neoplasms,Melanoma in situ,SMAD5,Mothers against decapentaplegic homolog 5,24350,50,1.82 [0.52-6.36],0.3463522167614041
Chapter II Neoplasms,Melanoma in situ,SMARCA2,Probable global transcription activator SNF2L2,23895,51,0.74 [0.51-1.08],0.1183688996056665
Chapter II Neoplasms,Melanoma in situ,SMC3,Structural maintenance of chromosomes protein 3,20471,40,0.42 [0.20-0.88],0.0208091269160968
Chapter II Neoplasms,Melanoma in situ,SMNDC1,Survival of motor neuron-related-splicing factor 30,21131,40,0.98 [0.61-1.57],0.9284775257498828
Chapter II Neoplasms,Melanoma in situ,SMOC1,SPARC-related modular calcium-binding protein 1,24689,52,0.81 [0.39-1.71],0.584490746932785
Chapter II Neoplasms,Melanoma in situ,SMOC2,SPARC-related modular calcium-binding protein 2,24564,52,0.98 [0.50-1.89],0.9426889044212624
Chapter II Neoplasms,Melanoma in situ,SMPD1,Sphingomyelin phosphodiesterase,24588,53,1.05 [0.64-1.72],0.8528892037011763
Chapter II Neoplasms,Melanoma in situ,SMPD3,Sphingomyelin phosphodiesterase 3,20617,41,0.94 [0.57-1.57],0.82253466142444
Chapter II Neoplasms,Melanoma in situ,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,24513,51,1.24 [0.83-1.84],0.29439665531048
Chapter II Neoplasms,Melanoma in situ,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,21108,40,1.15 [0.84-1.59],0.3801657101632939
Chapter II Neoplasms,Melanoma in situ,SMS,Spermine synthase,20569,40,1.22 [0.84-1.79],0.2967621692231432
Chapter II Neoplasms,Melanoma in situ,SMTN,Smoothelin,21119,40,1.31 [0.99-1.73],0.057642759525302
Chapter II Neoplasms,Melanoma in situ,SNAP23,Synaptosomal-associated protein 23,24482,53,1.12 [0.84-1.48],0.443050615387154
Chapter II Neoplasms,Melanoma in situ,SNAP25,Synaptosomal-associated protein 25,20569,40,1.49 [0.79-2.78],0.2163465392257061
Chapter II Neoplasms,Melanoma in situ,SNAP29,Synaptosomal-associated protein 29,24519,53,1.10 [0.84-1.43],0.4949123650673371
Chapter II Neoplasms,Melanoma in situ,SNAPIN,SNARE-associated protein Snapin,21191,40,1.56 [0.96-2.52],0.0720055702426227
Chapter II Neoplasms,Melanoma in situ,SNCA,Alpha-synuclein,20746,40,1.09 [0.84-1.41],0.5346004146340012
Chapter II Neoplasms,Melanoma in situ,SNCG,Gamma-synuclein,24313,49,0.92 [0.63-1.36],0.6798546292650706
Chapter II Neoplasms,Melanoma in situ,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",20637,41,0.65 [0.24-1.72],0.3837904531509881
Chapter II Neoplasms,Melanoma in situ,SNRPB2,U2 small nuclear ribonucleoprotein B'',21166,40,0.87 [0.41-1.84],0.7230265136312974
Chapter II Neoplasms,Melanoma in situ,SNU13,NHP2-like protein 1,20559,37,0.49 [0.23-1.03],0.0581401457748281
Chapter II Neoplasms,Melanoma in situ,SNX15,Sorting nexin-15,20746,40,1.24 [0.72-2.14],0.4396715968913822
Chapter II Neoplasms,Melanoma in situ,SNX18,Sorting nexin-18,21131,40,1.20 [0.66-2.18],0.5530540124148176
Chapter II Neoplasms,Melanoma in situ,SNX2,Sorting nexin-2,21108,40,1.15 [0.82-1.61],0.4116091920521378
Chapter II Neoplasms,Melanoma in situ,SNX5,Sorting nexin-5,20637,41,2.23 [1.02-4.89],0.0451987700515458
Chapter II Neoplasms,Melanoma in situ,SNX9,Sorting nexin-9,24482,53,1.12 [0.79-1.58],0.523952570815731
Chapter II Neoplasms,Melanoma in situ,SOD1,Superoxide dismutase [Cu-Zn],23931,50,1.03 [0.62-1.72],0.9048936329402986
Chapter II Neoplasms,Melanoma in situ,SOD2,"Superoxide dismutase [Mn], mitochondrial",24462,53,0.91 [0.47-1.77],0.7816177546807597
Chapter II Neoplasms,Melanoma in situ,SOD3,Extracellular superoxide dismutase,21229,41,0.44 [0.17-1.13],0.0875431028628148
Chapter II Neoplasms,Melanoma in situ,SORBS1,Sorbin and SH3 domain-containing protein 1,21191,40,1.25 [0.66-2.36],0.4934942058284385
Chapter II Neoplasms,Melanoma in situ,SORCS2,VPS10 domain-containing receptor SorCS2,23885,50,1.01 [0.47-2.17],0.9696005446856634
Chapter II Neoplasms,Melanoma in situ,SORD,Sorbitol dehydrogenase,24580,52,0.91 [0.64-1.28],0.5883766739937886
Chapter II Neoplasms,Melanoma in situ,SORT1,Sortilin,24454,53,1.44 [0.76-2.74],0.2614633467723612
Chapter II Neoplasms,Melanoma in situ,SOST,Sclerostin,24454,53,1.05 [0.56-1.96],0.8831231747912883
Chapter II Neoplasms,Melanoma in situ,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,20638,38,0.79 [0.37-1.70],0.5487331435984841
Chapter II Neoplasms,Melanoma in situ,SOX2,Transcription factor SOX-2,21155,40,1.60 [0.53-4.85],0.4030753527001381
Chapter II Neoplasms,Melanoma in situ,SOX9,Transcription factor SOX-9,20638,38,0.50 [0.16-1.57],0.2340194568865538
Chapter II Neoplasms,Melanoma in situ,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,21191,40,2.00 [1.14-3.50],0.016216870379823
Chapter II Neoplasms,Melanoma in situ,SPAG1,Sperm-associated antigen 1,21191,40,1.03 [0.63-1.71],0.8944798812991501
Chapter II Neoplasms,Melanoma in situ,SPARC,SPARC,24519,53,0.88 [0.64-1.22],0.453073430061701
Chapter II Neoplasms,Melanoma in situ,SPARCL1,SPARC-like protein 1,24447,53,1.21 [0.51-2.84],0.6638099667126989
Chapter II Neoplasms,Melanoma in situ,SPART,Spartin,20746,40,1.29 [0.89-1.88],0.1804012621551534
Chapter II Neoplasms,Melanoma in situ,SPESP1,Sperm equatorial segment protein 1,21225,41,1.64 [0.64-4.24],0.3045149000088388
Chapter II Neoplasms,Melanoma in situ,SPINK1,Serine protease inhibitor Kazal-type 1,24462,53,1.15 [0.63-2.10],0.6584789403750034
Chapter II Neoplasms,Melanoma in situ,SPINK2,Serine protease inhibitor Kazal-type 2,20746,40,0.75 [0.31-1.82],0.5322541798695453
Chapter II Neoplasms,Melanoma in situ,SPINK4,Serine protease inhibitor Kazal-type 4,24460,52,1.16 [0.79-1.71],0.4489109247040498
Chapter II Neoplasms,Melanoma in situ,SPINK5,Serine protease inhibitor Kazal-type 5,24462,53,0.50 [0.23-1.06],0.0711693009999071
Chapter II Neoplasms,Melanoma in situ,SPINK6,Serine protease inhibitor Kazal-type 6,24689,52,0.69 [0.44-1.08],0.1033665730539115
Chapter II Neoplasms,Melanoma in situ,SPINK8,Serine protease inhibitor Kazal-type 8,20559,37,0.90 [0.37-2.19],0.8183060435333854
Chapter II Neoplasms,Melanoma in situ,SPINT1,Kunitz-type protease inhibitor 1,24374,52,0.81 [0.28-2.29],0.6869171112635734
Chapter II Neoplasms,Melanoma in situ,SPINT2,Kunitz-type protease inhibitor 2,24564,52,1.02 [0.56-1.85],0.9565059842282752
Chapter II Neoplasms,Melanoma in situ,SPINT3,Kunitz-type protease inhibitor 3,21131,40,0.83 [0.69-1.01],0.0579564892705884
Chapter II Neoplasms,Melanoma in situ,SPOCK1,Testican-1,24313,49,1.49 [0.55-4.04],0.4317486577545449
Chapter II Neoplasms,Melanoma in situ,SPON1,Spondin-1,24488,52,0.71 [0.32-1.56],0.3932954219721264
Chapter II Neoplasms,Melanoma in situ,SPON2,Spondin-2,24368,53,0.56 [0.26-1.20],0.1341973954320017
Chapter II Neoplasms,Melanoma in situ,SPP1,Osteopontin,24717,51,0.70 [0.40-1.21],0.2007071772102996
Chapter II Neoplasms,Melanoma in situ,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",20617,41,1.43 [0.83-2.45],0.1948026666576098
Chapter II Neoplasms,Melanoma in situ,SPRING1,SREBP regulating gene protein,20471,40,0.89 [0.52-1.54],0.6867995114285296
Chapter II Neoplasms,Melanoma in situ,SPRR1B,Cornifin-B,20824,40,1.01 [0.72-1.42],0.9604979677015808
Chapter II Neoplasms,Melanoma in situ,SPRR3,Small proline-rich protein 3,21166,40,0.88 [0.56-1.38],0.5678141762529909
Chapter II Neoplasms,Melanoma in situ,SPRY2,Protein sprouty homolog 2,24024,50,1.09 [0.84-1.43],0.5200282067622176
Chapter II Neoplasms,Melanoma in situ,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",20569,40,1.10 [0.45-2.69],0.8377891885904761
Chapter II Neoplasms,Melanoma in situ,SPTLC1,Serine palmitoyltransferase 1,21166,40,1.90 [1.26-2.88],0.0023920954789633
Chapter II Neoplasms,Melanoma in situ,SRC,Proto-oncogene tyrosine-protein kinase Src,24479,53,1.14 [0.93-1.39],0.2193608331723294
Chapter II Neoplasms,Melanoma in situ,SRP14,Signal recognition particle 14 kDa protein,24350,50,1.07 [0.72-1.58],0.7373898165227939
Chapter II Neoplasms,Melanoma in situ,SRPK2,SRSF protein kinase 2,24460,52,1.18 [0.90-1.56],0.2366445603869163
Chapter II Neoplasms,Melanoma in situ,SRPX,Sushi repeat-containing protein SRPX,21225,41,1.26 [0.52-3.02],0.6081369966046437
Chapter II Neoplasms,Melanoma in situ,SSB,Lupus La protein,23895,51,1.10 [0.76-1.60],0.6066137070668589
Chapter II Neoplasms,Melanoma in situ,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",20617,41,1.57 [0.90-2.74],0.109369874739604
Chapter II Neoplasms,Melanoma in situ,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,24454,53,0.87 [0.70-1.08],0.2131433635356964
Chapter II Neoplasms,Melanoma in situ,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,24528,53,0.76 [0.43-1.34],0.3443635741567616
Chapter II Neoplasms,Melanoma in situ,SSH3,Protein phosphatase Slingshot homolog 3,20471,40,0.92 [0.32-2.64],0.8815560491224819
Chapter II Neoplasms,Melanoma in situ,SSNA1,Sjoegren syndrome nuclear autoantigen 1,21131,40,1.23 [0.70-2.16],0.4695194622546131
Chapter II Neoplasms,Melanoma in situ,ST13,Hsc70-interacting protein,20746,40,0.97 [0.56-1.67],0.9156816727416532
Chapter II Neoplasms,Melanoma in situ,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",24350,50,1.29 [0.77-2.15],0.3388061913712785
Chapter II Neoplasms,Melanoma in situ,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",24765,53,0.98 [0.42-2.29],0.9646001941574792
Chapter II Neoplasms,Melanoma in situ,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",20617,41,1.11 [0.65-1.89],0.7154122442869986
Chapter II Neoplasms,Melanoma in situ,STAB2,Stabilin-2,21216,41,0.90 [0.31-2.55],0.8355231496097736
Chapter II Neoplasms,Melanoma in situ,STAM,Signal transducing adapter molecule 1,21108,40,1.38 [0.68-2.80],0.3732428925056228
Chapter II Neoplasms,Melanoma in situ,STAMBP,STAM-binding protein,24266,49,1.07 [0.73-1.58],0.7327642176520528
Chapter II Neoplasms,Melanoma in situ,STAT2,Signal transducer and activator of transcription 2,20617,41,1.45 [1.00-2.08],0.0485096413545541
Chapter II Neoplasms,Melanoma in situ,STAT5B,Signal transducer and activator of transcription 5B,24350,50,1.07 [0.89-1.28],0.4919705349505107
Chapter II Neoplasms,Melanoma in situ,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,20471,40,1.13 [0.76-1.67],0.5421706100027147
Chapter II Neoplasms,Melanoma in situ,STC1,Stanniocalcin-1,24707,53,0.58 [0.31-1.09],0.0933251634085882
Chapter II Neoplasms,Melanoma in situ,STC2,Stanniocalcin-2,24424,53,1.65 [0.62-4.39],0.3179324392871179
Chapter II Neoplasms,Melanoma in situ,STEAP4,Metalloreductase STEAP4,20569,40,1.19 [0.85-1.65],0.3030800060957275
Chapter II Neoplasms,Melanoma in situ,STIP1,Stress-induced-phosphoprotein 1,24418,52,0.98 [0.67-1.42],0.8965204724716467
Chapter II Neoplasms,Melanoma in situ,STK11,Serine/threonine-protein kinase STK11,24041,51,1.11 [0.79-1.55],0.5633965210629315
Chapter II Neoplasms,Melanoma in situ,STK24,Serine/threonine-protein kinase 24,23895,51,1.25 [0.84-1.86],0.2653076573193237
Chapter II Neoplasms,Melanoma in situ,STK4,Serine/threonine-protein kinase 4,24482,53,1.19 [0.90-1.57],0.218952782139939
Chapter II Neoplasms,Melanoma in situ,STOML2,"Stomatin-like protein 2, mitochondrial",20471,40,1.24 [0.99-1.57],0.0666616691415223
Chapter II Neoplasms,Melanoma in situ,STX16,Syntaxin-16,23885,50,1.08 [0.71-1.65],0.709567613128083
Chapter II Neoplasms,Melanoma in situ,STX1B,Syntaxin-1B,20638,38,1.32 [0.79-2.23],0.2921419877277122
Chapter II Neoplasms,Melanoma in situ,STX3,Syntaxin-3,21166,40,1.05 [0.50-2.19],0.9011449195913722
Chapter II Neoplasms,Melanoma in situ,STX4,Syntaxin-4,24350,50,1.14 [0.78-1.67],0.4886924126100375
Chapter II Neoplasms,Melanoma in situ,STX5,Syntaxin-5,20617,41,0.35 [0.13-0.96],0.0407273256657879
Chapter II Neoplasms,Melanoma in situ,STX6,Syntaxin-6,23885,50,1.23 [0.91-1.67],0.1772711734586265
Chapter II Neoplasms,Melanoma in situ,STX7,Syntaxin-7,20617,41,1.05 [0.57-1.91],0.8824488111016948
Chapter II Neoplasms,Melanoma in situ,STX8,Syntaxin-8,24460,52,1.36 [0.87-2.14],0.1768557277237218
Chapter II Neoplasms,Melanoma in situ,STXBP1,Syntaxin-binding protein 1,21191,40,1.39 [0.94-2.06],0.1040398355637465
Chapter II Neoplasms,Melanoma in situ,STXBP3,Syntaxin-binding protein 3,23885,50,1.19 [0.70-2.02],0.5205899567128791
Chapter II Neoplasms,Melanoma in situ,SUGP1,SURP and G-patch domain-containing protein 1,21131,40,1.65 [0.91-3.00],0.0997028909247203
Chapter II Neoplasms,Melanoma in situ,SUGT1,Protein SGT1 homolog,23885,50,1.11 [0.81-1.51],0.5228281793417383
Chapter II Neoplasms,Melanoma in situ,SULT1A1,Sulfotransferase 1A1,24707,53,1.08 [0.90-1.31],0.4101269637614684
Chapter II Neoplasms,Melanoma in situ,SULT2A1,Bile salt sulfotransferase,24460,52,0.86 [0.53-1.38],0.5262730766170224
Chapter II Neoplasms,Melanoma in situ,SUMF1,Formylglycine-generating enzyme,20617,41,1.03 [0.69-1.54],0.8826269894599987
Chapter II Neoplasms,Melanoma in situ,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,24707,53,1.25 [0.78-2.00],0.3537439639094996
Chapter II Neoplasms,Melanoma in situ,SUOX,"Sulfite oxidase, mitochondrial",21191,40,0.94 [0.58-1.51],0.7922193337258556
Chapter II Neoplasms,Melanoma in situ,SUSD1,Sushi domain-containing protein 1,24041,51,1.21 [0.72-2.03],0.4724761543983511
Chapter II Neoplasms,Melanoma in situ,SUSD2,Sushi domain-containing protein 2,24462,53,0.45 [0.18-1.11],0.0822414118989612
Chapter II Neoplasms,Melanoma in situ,SUSD4,Sushi domain-containing protein 4,21108,40,1.00 [0.49-2.05],0.9961957310416348
Chapter II Neoplasms,Melanoma in situ,SUSD5,Sushi domain-containing protein 5,20636,39,0.91 [0.36-2.27],0.8323282071877153
Chapter II Neoplasms,Melanoma in situ,SV2A,Synaptic vesicle glycoprotein 2A,20638,38,1.28 [0.84-1.95],0.2505432933899679
Chapter II Neoplasms,Melanoma in situ,SWAP70,Switch-associated protein 70,21131,40,1.17 [0.54-2.53],0.6960878732767615
Chapter II Neoplasms,Melanoma in situ,SYAP1,Synapse-associated protein 1,20746,40,1.68 [1.04-2.71],0.0339413496449744
Chapter II Neoplasms,Melanoma in situ,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,20569,40,0.94 [0.53-1.65],0.822172527168711
Chapter II Neoplasms,Melanoma in situ,SYT1,Synaptotagmin-1,21166,40,0.60 [0.22-1.63],0.3161581969058799
Chapter II Neoplasms,Melanoma in situ,SYTL4,Synaptotagmin-like protein 4,21225,41,1.44 [1.00-2.08],0.0529929707004371
Chapter II Neoplasms,Melanoma in situ,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,20824,40,1.33 [1.00-1.77],0.0516326346684634
Chapter II Neoplasms,Melanoma in situ,TACC3,Transforming acidic coiled-coil-containing protein 3,24350,50,1.09 [0.88-1.35],0.438415416796132
Chapter II Neoplasms,Melanoma in situ,TACSTD2,Tumor-associated calcium signal transducer 2,21708,47,0.87 [0.35-2.15],0.7618701133077648
Chapter II Neoplasms,Melanoma in situ,TADA3,Transcriptional adapter 3,21108,40,2.44 [1.42-4.20],0.0012655128691005
Chapter II Neoplasms,Melanoma in situ,TAFA5,Chemokine-like protein TAFA-5,24350,50,0.78 [0.36-1.69],0.5241316187734855
Chapter II Neoplasms,Melanoma in situ,TAGLN3,Transgelin-3,20471,40,1.02 [0.62-1.67],0.9418790862210424
Chapter II Neoplasms,Melanoma in situ,TALDO1,Transaldolase,21146,41,1.29 [0.69-2.41],0.4170659335373531
Chapter II Neoplasms,Melanoma in situ,TANK,TRAF family member-associated NF-kappa-B activator,24024,50,1.27 [0.90-1.78],0.1683794646728929
Chapter II Neoplasms,Melanoma in situ,TAP1,Antigen peptide transporter 1,20824,40,1.03 [0.62-1.70],0.9105694783985362
Chapter II Neoplasms,Melanoma in situ,TARBP2,RISC-loading complex subunit TARBP2,23895,51,1.30 [0.96-1.77],0.0940674250220367
Chapter II Neoplasms,Melanoma in situ,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",20638,38,0.86 [0.54-1.36],0.5145549226382227
Chapter II Neoplasms,Melanoma in situ,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",21108,40,1.54 [0.76-3.12],0.2291251087213437
Chapter II Neoplasms,Melanoma in situ,TAX1BP1,Tax1-binding protein 1,21166,40,1.44 [0.94-2.21],0.0972521046159183
Chapter II Neoplasms,Melanoma in situ,TBC1D17,TBC1 domain family member 17,23895,51,0.84 [0.47-1.53],0.5783052751020024
Chapter II Neoplasms,Melanoma in situ,TBC1D23,TBC1 domain family member 23,24350,50,1.18 [0.90-1.55],0.2392481550721262
Chapter II Neoplasms,Melanoma in situ,TBC1D5,TBC1 domain family member 5,24460,52,1.06 [0.78-1.43],0.7129762624800511
Chapter II Neoplasms,Melanoma in situ,TBCA,Tubulin-specific chaperone A,20746,40,1.27 [0.90-1.78],0.1786465243351601
Chapter II Neoplasms,Melanoma in situ,TBCB,Tubulin-folding cofactor B,24313,49,1.10 [0.86-1.42],0.4478185202792564
Chapter II Neoplasms,Melanoma in situ,TBCC,Tubulin-specific chaperone C,24313,49,1.13 [0.83-1.53],0.4541077304986163
Chapter II Neoplasms,Melanoma in situ,TBL1X,F-box-like/WD repeat-containing protein TBL1X,23885,50,1.29 [0.96-1.73],0.0965982920934694
Chapter II Neoplasms,Melanoma in situ,TBR1,T-box brain protein 1,20638,38,1.24 [0.73-2.10],0.4276413756648376
Chapter II Neoplasms,Melanoma in situ,TCL1A,T-cell leukemia/lymphoma protein 1A,24268,49,0.83 [0.63-1.09],0.1714530561673043
Chapter II Neoplasms,Melanoma in situ,TCL1B,T-cell leukemia/lymphoma protein 1B,24041,51,1.10 [0.84-1.43],0.4831977219941028
Chapter II Neoplasms,Melanoma in situ,TCN1,Transcobalamin-1,20807,39,0.74 [0.28-1.92],0.5369192205742629
Chapter II Neoplasms,Melanoma in situ,TCN2,Transcobalamin-2,24717,51,1.14 [0.49-2.61],0.7653850713126726
Chapter II Neoplasms,Melanoma in situ,TCOF1,Treacle protein,21225,41,1.30 [0.55-3.03],0.5480088947847418
Chapter II Neoplasms,Melanoma in situ,TCP11,T-complex protein 11 homolog,20824,40,0.93 [0.53-1.62],0.7926244029811291
Chapter II Neoplasms,Melanoma in situ,TCTN3,Tectonic-3,21225,41,1.04 [0.38-2.83],0.9410468251745016
Chapter II Neoplasms,Melanoma in situ,TDGF1,Teratocarcinoma-derived growth factor 1,23895,51,1.13 [0.95-1.33],0.1682839958600612
Chapter II Neoplasms,Melanoma in situ,TDO2,"Tryptophan 2,3-dioxygenase",20638,38,0.78 [0.32-1.88],0.5739205196512238
Chapter II Neoplasms,Melanoma in situ,TDP1,Tyrosyl-DNA phosphodiesterase 1,21108,40,0.54 [0.30-0.99],0.044685850990356
Chapter II Neoplasms,Melanoma in situ,TDRKH,Tudor and KH domain-containing protein,23895,51,1.41 [1.08-1.83],0.0108257395733594
Chapter II Neoplasms,Melanoma in situ,TEF,Thyrotroph embryonic factor,20559,37,0.97 [0.46-2.05],0.9439662083511206
Chapter II Neoplasms,Melanoma in situ,TEK,Angiopoietin-1 receptor,24519,53,0.69 [0.22-2.11],0.511949275555513
Chapter II Neoplasms,Melanoma in situ,TERF1,Telomeric repeat-binding factor 1,20617,41,2.09 [0.99-4.39],0.0528848782192989
Chapter II Neoplasms,Melanoma in situ,TET2,Methylcytosine dioxygenase TET2,20795,40,0.89 [0.62-1.27],0.5037613046187697
Chapter II Neoplasms,Melanoma in situ,TEX101,Testis-expressed protein 101,20638,38,0.89 [0.47-1.70],0.729085202215205
Chapter II Neoplasms,Melanoma in situ,TEX33,Testis-expressed protein 33,20824,40,0.79 [0.33-1.94],0.612515186680685
Chapter II Neoplasms,Melanoma in situ,TF,Serotransferrin,21249,41,0.59 [0.15-2.26],0.441446270492088
Chapter II Neoplasms,Melanoma in situ,TFAP2A,Transcription factor AP-2-alpha,20569,40,1.16 [0.74-1.82],0.5209911096435254
Chapter II Neoplasms,Melanoma in situ,TFF1,Trefoil factor 1,24351,53,0.98 [0.70-1.38],0.9175026123235922
Chapter II Neoplasms,Melanoma in situ,TFF2,Trefoil factor 2,24529,52,1.18 [0.77-1.82],0.4437046939882022
Chapter II Neoplasms,Melanoma in situ,TFF3,Trefoil factor 3,24430,53,1.20 [0.79-1.82],0.3912484077697903
Chapter II Neoplasms,Melanoma in situ,TFPI,Tissue factor pathway inhibitor,24368,53,1.07 [0.50-2.28],0.8674047257020812
Chapter II Neoplasms,Melanoma in situ,TFPI2,Tissue factor pathway inhibitor 2,24436,53,0.97 [0.51-1.87],0.9334742310101524
Chapter II Neoplasms,Melanoma in situ,TFRC,Transferrin receptor protein 1,24547,53,0.71 [0.37-1.36],0.308233435720424
Chapter II Neoplasms,Melanoma in situ,TG,Thyroglobulin,21108,40,1.07 [0.82-1.39],0.6159772788544534
Chapter II Neoplasms,Melanoma in situ,TGFA,Protransforming growth factor alpha,24460,52,1.08 [0.63-1.83],0.7880677396113899
Chapter II Neoplasms,Melanoma in situ,TGFB1,Transforming growth factor beta-1 proprotein,24721,52,0.94 [0.49-1.78],0.8396896730791654
Chapter II Neoplasms,Melanoma in situ,TGFB2,Transforming growth factor beta-2 proprotein,21108,40,1.25 [0.76-2.04],0.3759456611545734
Chapter II Neoplasms,Melanoma in situ,TGFBI,Transforming growth factor-beta-induced protein ig-h3,24291,53,2.36 [1.00-5.60],0.0511903194540156
Chapter II Neoplasms,Melanoma in situ,TGFBR1,TGF-beta receptor type-1,20617,41,1.31 [0.40-4.34],0.6553937467262746
Chapter II Neoplasms,Melanoma in situ,TGFBR2,TGF-beta receptor type-2,24519,53,0.68 [0.29-1.63],0.3907806796342739
Chapter II Neoplasms,Melanoma in situ,TGFBR3,Transforming growth factor beta receptor type 3,24765,53,0.83 [0.39-1.76],0.6243649199117851
Chapter II Neoplasms,Melanoma in situ,TGM2,Protein-glutamine gamma-glutamyltransferase 2,24439,53,0.98 [0.71-1.36],0.9120037364994876
Chapter II Neoplasms,Melanoma in situ,TGOLN2,Trans-Golgi network integral membrane protein 2,21229,41,1.08 [0.33-3.56],0.900319183447429
Chapter II Neoplasms,Melanoma in situ,THAP12,52 kDa repressor of the inhibitor of the protein kinase,20428,40,0.73 [0.46-1.14],0.1639495325794321
Chapter II Neoplasms,Melanoma in situ,THBD,Thrombomodulin,24482,53,0.89 [0.36-2.19],0.7944277501201619
Chapter II Neoplasms,Melanoma in situ,THBS2,Thrombospondin-2,24462,53,1.88 [1.04-3.42],0.0375353560749372
Chapter II Neoplasms,Melanoma in situ,THBS4,Thrombospondin-4,24457,53,0.85 [0.50-1.47],0.5709323017526763
Chapter II Neoplasms,Melanoma in situ,THOP1,Thimet oligopeptidase,24383,53,0.82 [0.37-1.83],0.6256325040377964
Chapter II Neoplasms,Melanoma in situ,THPO,Thrombopoietin,24041,51,0.92 [0.47-1.77],0.7969683204676073
Chapter II Neoplasms,Melanoma in situ,THRAP3,Thyroid hormone receptor-associated protein 3,20559,37,0.94 [0.70-1.27],0.6744635777514061
Chapter II Neoplasms,Melanoma in situ,THSD1,Thrombospondin type-1 domain-containing protein 1,20466,39,0.85 [0.34-2.16],0.7394489690103496
Chapter II Neoplasms,Melanoma in situ,THTPA,Thiamine-triphosphatase,21067,40,1.42 [1.01-1.99],0.0436054138434579
Chapter II Neoplasms,Melanoma in situ,THY1,Thy-1 membrane glycoprotein,24707,53,0.60 [0.24-1.51],0.2783677043070411
Chapter II Neoplasms,Melanoma in situ,TIA1,Nucleolysin TIA-1 isoform p40,23776,50,1.18 [0.96-1.44],0.1086351857413174
Chapter II Neoplasms,Melanoma in situ,TIE1,Tyrosine-protein kinase receptor Tie-1,24765,53,0.69 [0.43-1.11],0.1260634748455954
Chapter II Neoplasms,Melanoma in situ,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23848,51,1.05 [0.63-1.75],0.8396304491211768
Chapter II Neoplasms,Melanoma in situ,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20824,40,0.56 [0.22-1.45],0.2330422618637057
Chapter II Neoplasms,Melanoma in situ,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,24528,53,0.56 [0.32-0.99],0.0459387220817889
Chapter II Neoplasms,Melanoma in situ,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,21225,41,2.60 [1.44-4.69],0.001495236745174
Chapter II Neoplasms,Melanoma in situ,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,21166,40,1.54 [1.10-2.15],0.0120079333391709
Chapter II Neoplasms,Melanoma in situ,TIMP1,Metalloproteinase inhibitor 1,24168,52,1.12 [0.47-2.68],0.795760359861208
Chapter II Neoplasms,Melanoma in situ,TIMP2,Metalloproteinase inhibitor 2,21225,41,1.04 [0.32-3.36],0.9481289319922134
Chapter II Neoplasms,Melanoma in situ,TIMP3,Metalloproteinase inhibitor 3,24564,52,0.98 [0.81-1.18],0.7961024660693734
Chapter II Neoplasms,Melanoma in situ,TIMP4,Metalloproteinase inhibitor 4,24462,53,0.93 [0.49-1.73],0.8099632897627949
Chapter II Neoplasms,Melanoma in situ,TINAGL1,Tubulointerstitial nephritis antigen-like,24408,53,0.40 [0.13-1.23],0.1102114974521332
Chapter II Neoplasms,Melanoma in situ,TJAP1,Tight junction-associated protein 1,24519,53,1.12 [0.84-1.50],0.4408674424609207
Chapter II Neoplasms,Melanoma in situ,TJP3,Tight junction protein ZO-3,20569,40,1.03 [0.52-2.03],0.9419552331272396
Chapter II Neoplasms,Melanoma in situ,TK1,"Thymidine kinase, cytosolic",20824,40,1.35 [0.79-2.31],0.2687849557202843
Chapter II Neoplasms,Melanoma in situ,TLR1,Toll-like receptor 1,20617,41,2.66 [1.19-5.95],0.0172403495545071
Chapter II Neoplasms,Melanoma in situ,TLR2,Toll-like receptor 2,20824,40,0.59 [0.16-2.19],0.4269743755323587
Chapter II Neoplasms,Melanoma in situ,TLR3,Toll-like receptor 3,24769,52,0.72 [0.51-1.04],0.0797449144382979
Chapter II Neoplasms,Melanoma in situ,TLR4,Toll-like receptor 4,20617,41,0.61 [0.21-1.84],0.3832431401132853
Chapter II Neoplasms,Melanoma in situ,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,20638,38,1.28 [0.77-2.13],0.3337040771269084
Chapter II Neoplasms,Melanoma in situ,TMED1,Transmembrane emp24 domain-containing protein 1,20824,40,1.05 [0.62-1.79],0.8584702168506356
Chapter II Neoplasms,Melanoma in situ,TMED10,Transmembrane emp24 domain-containing protein 10,20559,37,1.03 [0.57-1.88],0.917150202498867
Chapter II Neoplasms,Melanoma in situ,TMED4,Transmembrane emp24 domain-containing protein 4,20559,37,0.46 [0.20-1.05],0.0654302027003863
Chapter II Neoplasms,Melanoma in situ,TMED8,Protein TMED8,21131,40,1.48 [1.09-2.01],0.0118738657957366
Chapter II Neoplasms,Melanoma in situ,TMEM106A,Transmembrane protein 106A,21108,40,1.42 [0.99-2.03],0.0559884059680653
Chapter II Neoplasms,Melanoma in situ,TMEM132A,Transmembrane protein 132A,20637,41,1.20 [0.76-1.91],0.4302025323443625
Chapter II Neoplasms,Melanoma in situ,TMEM25,Transmembrane protein 25,21191,40,1.43 [0.87-2.35],0.1628024316396137
Chapter II Neoplasms,Melanoma in situ,TMOD4,Tropomodulin-4,20471,40,0.52 [0.24-1.15],0.1053749964811101
Chapter II Neoplasms,Melanoma in situ,TMPRSS11B,Transmembrane protease serine 11B,20569,40,0.84 [0.53-1.32],0.4438526899129118
Chapter II Neoplasms,Melanoma in situ,TMPRSS11D,Transmembrane protease serine 11D,21118,40,0.41 [0.19-0.88],0.0226022079351895
Chapter II Neoplasms,Melanoma in situ,TMPRSS15,Enteropeptidase,24350,50,1.13 [0.86-1.49],0.3913874924332112
Chapter II Neoplasms,Melanoma in situ,TMPRSS5,Transmembrane protease serine 5,24189,49,1.30 [0.66-2.56],0.4548914804737772
Chapter II Neoplasms,Melanoma in situ,TMSB10,Thymosin beta-10,24462,53,1.14 [0.84-1.55],0.4119262398928459
Chapter II Neoplasms,Melanoma in situ,TNC,Tenascin,24528,53,0.84 [0.50-1.41],0.5068502799789609
Chapter II Neoplasms,Melanoma in situ,TNF,Tumor necrosis factor,24000,51,1.34 [0.80-2.26],0.2611145935978233
Chapter II Neoplasms,Melanoma in situ,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,21131,40,1.42 [0.87-2.32],0.1623855850687131
Chapter II Neoplasms,Melanoma in situ,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,24024,50,1.21 [0.63-2.33],0.5622509564089332
Chapter II Neoplasms,Melanoma in situ,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,20746,40,1.46 [0.94-2.26],0.0891230140652722
Chapter II Neoplasms,Melanoma in situ,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,24313,49,1.00 [0.44-2.27],0.999628872986211
Chapter II Neoplasms,Melanoma in situ,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24313,49,0.97 [0.50-1.89],0.9349660704325554
Chapter II Neoplasms,Melanoma in situ,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,24497,50,0.91 [0.55-1.50],0.7114174848847619
Chapter II Neoplasms,Melanoma in situ,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24769,52,1.32 [0.68-2.57],0.4164021126363182
Chapter II Neoplasms,Melanoma in situ,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,24444,52,0.92 [0.39-2.13],0.8397352330645169
Chapter II Neoplasms,Melanoma in situ,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,24519,53,1.17 [0.58-2.35],0.6545864605541858
Chapter II Neoplasms,Melanoma in situ,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24488,52,0.98 [0.43-2.27],0.9702951052090656
Chapter II Neoplasms,Melanoma in situ,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,24024,50,0.68 [0.36-1.29],0.2364663880782941
Chapter II Neoplasms,Melanoma in situ,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24488,52,1.51 [0.66-3.45],0.3299011449819239
Chapter II Neoplasms,Melanoma in situ,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20746,40,0.94 [0.43-2.07],0.8828989879035957
Chapter II Neoplasms,Melanoma in situ,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,24689,52,0.94 [0.40-2.21],0.885245803695121
Chapter II Neoplasms,Melanoma in situ,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24462,53,0.56 [0.21-1.46],0.2330472039540292
Chapter II Neoplasms,Melanoma in situ,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24462,53,1.07 [0.53-2.16],0.8412755039040765
Chapter II Neoplasms,Melanoma in situ,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,24707,53,0.74 [0.30-1.84],0.5185465847272923
Chapter II Neoplasms,Melanoma in situ,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24721,52,0.59 [0.28-1.23],0.1602084847120392
Chapter II Neoplasms,Melanoma in situ,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,24313,49,1.08 [0.67-1.72],0.7525580519415045
Chapter II Neoplasms,Melanoma in situ,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24707,53,0.80 [0.45-1.42],0.4386673020267936
Chapter II Neoplasms,Melanoma in situ,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24313,49,0.74 [0.36-1.54],0.4215833086405564
Chapter II Neoplasms,Melanoma in situ,TNFSF10,Tumor necrosis factor ligand superfamily member 10,24769,52,0.58 [0.23-1.46],0.245358133244182
Chapter II Neoplasms,Melanoma in situ,TNFSF11,Tumor necrosis factor ligand superfamily member 11,24460,52,0.65 [0.44-0.97],0.0338867234264272
Chapter II Neoplasms,Melanoma in situ,TNFSF12,Tumor necrosis factor ligand superfamily member 12,24769,52,0.65 [0.28-1.51],0.3122980900970413
Chapter II Neoplasms,Melanoma in situ,TNFSF13,Tumor necrosis factor ligand superfamily member 13,24564,52,0.88 [0.34-2.28],0.7915930460873329
Chapter II Neoplasms,Melanoma in situ,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,24715,53,1.10 [0.42-2.84],0.849428131964531
Chapter II Neoplasms,Melanoma in situ,TNFSF14,Tumor necrosis factor ligand superfamily member 14,24313,49,0.74 [0.47-1.15],0.1818844258367338
Chapter II Neoplasms,Melanoma in situ,TNFSF8,Tumor necrosis factor ligand superfamily member 8,21216,41,0.69 [0.29-1.63],0.3994099000021557
Chapter II Neoplasms,Melanoma in situ,TNIP1,TNFAIP3-interacting protein 1,21166,40,1.25 [0.91-1.71],0.1761966048164609
Chapter II Neoplasms,Melanoma in situ,TNN,Tenascin-N,21216,41,1.17 [0.59-2.33],0.6448057568241865
Chapter II Neoplasms,Melanoma in situ,TNNI3,"Troponin I, cardiac muscle",24041,51,0.91 [0.70-1.20],0.5118021436000595
Chapter II Neoplasms,Melanoma in situ,TNPO1,Transportin-1,20824,40,0.52 [0.21-1.26],0.1472892159353492
Chapter II Neoplasms,Melanoma in situ,TNR,Tenascin-R,24313,49,0.68 [0.37-1.24],0.20908131143391
Chapter II Neoplasms,Melanoma in situ,TNXB,Tenascin-X,24462,53,0.90 [0.35-2.35],0.8292007155925033
Chapter II Neoplasms,Melanoma in situ,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,21225,41,1.34 [0.94-1.93],0.1074641468171381
Chapter II Neoplasms,Melanoma in situ,TOP1,DNA topoisomerase 1,21131,40,0.94 [0.72-1.23],0.6631500914270185
Chapter II Neoplasms,Melanoma in situ,TOP1MT,"DNA topoisomerase I, mitochondrial",20471,40,1.01 [0.55-1.87],0.9730323935574384
Chapter II Neoplasms,Melanoma in situ,TOP2B,DNA topoisomerase 2-beta,20617,41,1.21 [0.85-1.74],0.2953413581828779
Chapter II Neoplasms,Melanoma in situ,TOR1AIP1,Torsin-1A-interacting protein 1,20637,41,0.89 [0.50-1.61],0.7107780418819314
Chapter II Neoplasms,Melanoma in situ,TP53,Cellular tumor antigen p53,23885,50,1.27 [0.74-2.16],0.3886452179168653
Chapter II Neoplasms,Melanoma in situ,TP53BP1,TP53-binding protein 1,20617,41,0.76 [0.53-1.09],0.138304695436615
Chapter II Neoplasms,Melanoma in situ,TP53I3,Quinone oxidoreductase PIG3,20292,40,1.03 [0.58-1.83],0.9121707108051208
Chapter II Neoplasms,Melanoma in situ,TP53INP1,Tumor protein p53-inducible nuclear protein 1,24041,51,0.66 [0.24-1.78],0.4089200513466434
Chapter II Neoplasms,Melanoma in situ,TP73,Tumor protein p73,20638,38,1.04 [0.42-2.56],0.9391383007711398
Chapter II Neoplasms,Melanoma in situ,TPBGL,Trophoblast glycoprotein-like,20638,38,0.75 [0.32-1.76],0.502616106925891
Chapter II Neoplasms,Melanoma in situ,TPD52L2,Tumor protein D54,20746,40,1.36 [1.01-1.83],0.0436679478137715
Chapter II Neoplasms,Melanoma in situ,TPK1,Thiamin pyrophosphokinase 1,21225,41,1.45 [0.50-4.25],0.4938461886936538
Chapter II Neoplasms,Melanoma in situ,TPM3,Tropomyosin alpha-3 chain,20559,37,0.49 [0.20-1.18],0.1117830976158702
Chapter II Neoplasms,Melanoma in situ,TPMT,Thiopurine S-methyltransferase,23885,50,0.97 [0.69-1.37],0.8837174456295201
Chapter II Neoplasms,Melanoma in situ,TPP1,Tripeptidyl-peptidase 1,24293,52,1.04 [0.60-1.79],0.8888721636977395
Chapter II Neoplasms,Melanoma in situ,TPPP2,Tubulin polymerization-promoting protein family member 2,20824,40,1.29 [0.96-1.73],0.0910733862649355
Chapter II Neoplasms,Melanoma in situ,TPPP3,Tubulin polymerization-promoting protein family member 3,23895,51,1.06 [0.58-1.95],0.8418814003502031
Chapter II Neoplasms,Melanoma in situ,TPR,Nucleoprotein TPR,20559,37,0.81 [0.39-1.68],0.5702290353718344
Chapter II Neoplasms,Melanoma in situ,TPRKB,EKC/KEOPS complex subunit TPRKB,20471,40,0.82 [0.47-1.44],0.4916398410594039
Chapter II Neoplasms,Melanoma in situ,TPSAB1,Tryptase alpha/beta-1,24729,52,0.86 [0.54-1.36],0.5176725873463337
Chapter II Neoplasms,Melanoma in situ,TPSD1,Tryptase delta,21191,40,1.73 [1.13-2.64],0.0115455825848374
Chapter II Neoplasms,Melanoma in situ,TPSG1,Tryptase gamma,20617,41,1.77 [0.82-3.80],0.1432553400931572
Chapter II Neoplasms,Melanoma in situ,TPT1,Translationally-controlled tumor protein,24024,50,0.87 [0.57-1.33],0.520707720877756
Chapter II Neoplasms,Melanoma in situ,TRAF2,TNF receptor-associated factor 2,24460,52,1.09 [0.78-1.54],0.6093832570906154
Chapter II Neoplasms,Melanoma in situ,TRAF3,"TNF receptor-associated factor 3, Isoform 2",20617,41,0.52 [0.20-1.34],0.1747904672555915
Chapter II Neoplasms,Melanoma in situ,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,20559,37,0.43 [0.17-1.13],0.0860403442272161
Chapter II Neoplasms,Melanoma in situ,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,20824,40,1.43 [1.08-1.89],0.0112591160120934
Chapter II Neoplasms,Melanoma in situ,TREH,Trehalase,21216,41,1.04 [0.70-1.53],0.8626102370196538
Chapter II Neoplasms,Melanoma in situ,TREM2,Triggering receptor expressed on myeloid cells 2,24444,52,1.32 [0.82-2.11],0.2538537787292597
Chapter II Neoplasms,Melanoma in situ,TREML1,Trem-like transcript 1 protein,21229,41,1.71 [1.01-2.88],0.0441054813650787
Chapter II Neoplasms,Melanoma in situ,TREML2,Trem-like transcript 2 protein,24462,53,0.60 [0.28-1.28],0.1871661356619653
Chapter II Neoplasms,Melanoma in situ,TRIAP1,TP53-regulated inhibitor of apoptosis 1,24689,52,1.40 [0.97-2.02],0.0703493111412573
Chapter II Neoplasms,Melanoma in situ,TRIM21,E3 ubiquitin-protein ligase TRIM21,24460,52,1.10 [0.79-1.54],0.5611913068880501
Chapter II Neoplasms,Melanoma in situ,TRIM24,Transcription intermediary factor 1-alpha,20778,40,1.41 [0.99-2.03],0.0602217076499746
Chapter II Neoplasms,Melanoma in situ,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,21131,40,1.30 [0.99-1.71],0.0617597873693587
Chapter II Neoplasms,Melanoma in situ,TRIM26,Tripartite motif-containing protein 26,20471,40,0.77 [0.42-1.42],0.4119271385269216
Chapter II Neoplasms,Melanoma in situ,TRIM40,E3 ubiquitin ligase TRIM40,20638,38,1.11 [0.73-1.69],0.6152196796203027
Chapter II Neoplasms,Melanoma in situ,TRIM5,Tripartite motif-containing protein 5,24460,52,1.22 [0.92-1.62],0.1657094197201718
Chapter II Neoplasms,Melanoma in situ,TRIM58,E3 ubiquitin-protein ligase TRIM58,21108,40,1.10 [0.78-1.57],0.5794123693306119
Chapter II Neoplasms,Melanoma in situ,TRPV3,Transient receptor potential cation channel subfamily V member 3,20559,37,0.61 [0.28-1.32],0.2117101862598058
Chapter II Neoplasms,Melanoma in situ,TSC1,Hamartin,20617,41,0.93 [0.61-1.40],0.7234344333211338
Chapter II Neoplasms,Melanoma in situ,TSC22D1,TSC22 domain family protein 1,21191,40,1.40 [0.97-2.02],0.0705334745180191
Chapter II Neoplasms,Melanoma in situ,TSHB,Thyrotropin subunit beta,24482,53,1.03 [0.75-1.42],0.8576369459210372
Chapter II Neoplasms,Melanoma in situ,TSLP,Thymic stromal lymphopoietin,24041,51,0.94 [0.61-1.44],0.7612472090051959
Chapter II Neoplasms,Melanoma in situ,TSNAX,Translin-associated protein X,20559,37,0.95 [0.43-2.11],0.901853563572035
Chapter II Neoplasms,Melanoma in situ,TSPAN1,Tetraspanin-1,24041,51,1.10 [0.60-2.02],0.7557820203022676
Chapter II Neoplasms,Melanoma in situ,TSPAN15,Tetraspanin-15,20559,37,0.79 [0.38-1.64],0.5285300338995671
Chapter II Neoplasms,Melanoma in situ,TSPAN7,Tetraspanin-7,20569,40,0.84 [0.58-1.22],0.3698956228971508
Chapter II Neoplasms,Melanoma in situ,TSPAN8,Tetraspanin-8,21131,40,0.94 [0.69-1.28],0.6779324805998206
Chapter II Neoplasms,Melanoma in situ,TSPYL1,Testis-specific Y-encoded-like protein 1,20617,41,1.59 [0.86-2.94],0.1427771069673513
Chapter II Neoplasms,Melanoma in situ,TST,Thiosulfate sulfurtransferase,23864,51,1.33 [0.97-1.83],0.0758458681781977
Chapter II Neoplasms,Melanoma in situ,TTF2,Transcription termination factor 2,20638,38,1.33 [0.75-2.37],0.3346259548903406
Chapter II Neoplasms,Melanoma in situ,TTN,Titin,20559,37,0.77 [0.44-1.33],0.3503161951922048
Chapter II Neoplasms,Melanoma in situ,TTR,Transthyretin,21017,41,1.58 [0.48-5.23],0.4545994966150984
Chapter II Neoplasms,Melanoma in situ,TUBB3,Tubulin beta-3 chain,20569,40,1.07 [0.36-3.14],0.9075973892490856
Chapter II Neoplasms,Melanoma in situ,TWF2,Twinfilin-2,21216,41,1.52 [1.09-2.13],0.0145991811563792
Chapter II Neoplasms,Melanoma in situ,TXK,Tyrosine-protein kinase TXK,20824,40,0.83 [0.52-1.33],0.4412670243609676
Chapter II Neoplasms,Melanoma in situ,TXLNA,Alpha-taxilin,24313,49,1.15 [0.87-1.53],0.3302779094456384
Chapter II Neoplasms,Melanoma in situ,TXN,Thioredoxin,20874,41,0.83 [0.40-1.73],0.6269116545172284
Chapter II Neoplasms,Melanoma in situ,TXNDC15,Thioredoxin domain-containing protein 15,24519,53,0.84 [0.34-2.08],0.7144825794949254
Chapter II Neoplasms,Melanoma in situ,TXNDC5,Thioredoxin domain-containing protein 5,24707,53,1.24 [0.88-1.74],0.219997836789329
Chapter II Neoplasms,Melanoma in situ,TXNDC9,Thioredoxin domain-containing protein 9,21166,40,1.94 [1.27-2.95],0.001974130760818
Chapter II Neoplasms,Melanoma in situ,TXNL1,Thioredoxin-like protein 1,20532,39,0.94 [0.68-1.30],0.6891111487514303
Chapter II Neoplasms,Melanoma in situ,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",24462,53,1.14 [0.68-1.89],0.6206278950162102
Chapter II Neoplasms,Melanoma in situ,TYMP,Thymidine phosphorylase,24332,53,1.33 [0.93-1.89],0.115031943008456
Chapter II Neoplasms,Melanoma in situ,TYRO3,Tyrosine-protein kinase receptor TYRO3,24482,53,1.40 [0.59-3.27],0.4441176637839445
Chapter II Neoplasms,Melanoma in situ,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",20617,41,1.47 [0.88-2.47],0.1410136304675131
Chapter II Neoplasms,Melanoma in situ,UBAC1,Ubiquitin-associated domain-containing protein 1,24350,50,0.69 [0.34-1.42],0.3115609177534228
Chapter II Neoplasms,Melanoma in situ,UBE2B,Ubiquitin-conjugating enzyme E2 B,21108,40,1.18 [0.45-3.14],0.7337796660265019
Chapter II Neoplasms,Melanoma in situ,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,21225,41,1.57 [1.00-2.48],0.0511369878690183
Chapter II Neoplasms,Melanoma in situ,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,20617,41,1.17 [0.76-1.81],0.4802556372595478
Chapter II Neoplasms,Melanoma in situ,UBQLN3,Ubiquilin-3,20559,37,0.98 [0.50-1.90],0.9419721080774184
Chapter II Neoplasms,Melanoma in situ,UBXN1,UBX domain-containing protein 1,20746,40,1.20 [0.78-1.83],0.4140456070749442
Chapter II Neoplasms,Melanoma in situ,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,21131,40,1.36 [1.09-1.70],0.0060517686354209
Chapter II Neoplasms,Melanoma in situ,UGDH,UDP-glucose 6-dehydrogenase,20559,37,0.79 [0.52-1.19],0.2604205091953328
Chapter II Neoplasms,Melanoma in situ,UHRF2,E3 ubiquitin-protein ligase UHRF2,20559,37,0.50 [0.16-1.57],0.2361556387969547
Chapter II Neoplasms,Melanoma in situ,ULBP2,UL16-binding protein 2,24313,49,0.95 [0.46-1.98],0.8980009658689023
Chapter II Neoplasms,Melanoma in situ,UMOD,Uromodulin,24679,53,0.72 [0.47-1.10],0.1252978448263881
Chapter II Neoplasms,Melanoma in situ,UNC5D,Netrin receptor UNC5D,20617,41,0.89 [0.29-2.72],0.8338555099112221
Chapter II Neoplasms,Melanoma in situ,UNC79,Protein unc-79 homolog,20471,40,1.22 [0.76-1.97],0.4131049202511325
Chapter II Neoplasms,Melanoma in situ,UNG,Uracil-DNA glycosylase,21108,40,1.13 [0.50-2.57],0.76636863724449
Chapter II Neoplasms,Melanoma in situ,UPB1,Beta-ureidopropionase,21225,41,1.02 [0.74-1.40],0.9231170018248996
Chapter II Neoplasms,Melanoma in situ,UPK3A,Uroplakin-3a,20569,40,0.56 [0.33-0.95],0.0332181417311318
Chapter II Neoplasms,Melanoma in situ,UPK3BL1,Uroplakin-3b-like protein 1,20788,40,0.59 [0.26-1.33],0.203292542130509
Chapter II Neoplasms,Melanoma in situ,UROD,Uroporphyrinogen decarboxylase,20746,40,1.45 [0.95-2.22],0.0848680702833709
Chapter II Neoplasms,Melanoma in situ,UROS,Uroporphyrinogen-III synthase,20638,38,1.12 [0.74-1.70],0.591137875323777
Chapter II Neoplasms,Melanoma in situ,USO1,General vesicular transport factor p115,24350,50,1.15 [0.87-1.52],0.3212696833196291
Chapter II Neoplasms,Melanoma in situ,USP25,Ubiquitin carboxyl-terminal hydrolase 25,21108,40,1.40 [0.93-2.09],0.1035867745957919
Chapter II Neoplasms,Melanoma in situ,USP28,Ubiquitin carboxyl-terminal hydrolase 28,21166,40,1.25 [0.64-2.45],0.5118884874250419
Chapter II Neoplasms,Melanoma in situ,USP47,Ubiquitin carboxyl-terminal hydrolase 47,20559,37,1.34 [1.02-1.76],0.0383618713704416
Chapter II Neoplasms,Melanoma in situ,USP8,Ubiquitin carboxyl-terminal hydrolase 8,24041,51,1.14 [0.89-1.47],0.3040146288574408
Chapter II Neoplasms,Melanoma in situ,UXS1,UDP-glucuronic acid decarboxylase 1,23885,50,0.99 [0.61-1.59],0.9508834042161184
Chapter II Neoplasms,Melanoma in situ,VAMP5,Vesicle-associated membrane protein 5,24041,51,0.46 [0.24-0.88],0.0184977854220788
Chapter II Neoplasms,Melanoma in situ,VAMP8,Vesicle-associated membrane protein 8,20617,41,1.36 [0.98-1.88],0.0674138128585573
Chapter II Neoplasms,Melanoma in situ,VASH1,Tubulinyl-Tyr carboxypeptidase 1,24460,52,1.37 [1.03-1.83],0.0292400832145951
Chapter II Neoplasms,Melanoma in situ,VASN,Vasorin,24060,53,0.83 [0.34-2.03],0.6844882233074503
Chapter II Neoplasms,Melanoma in situ,VASP,Vasodilator-stimulated phosphoprotein,21229,41,1.58 [1.07-2.32],0.0207852707419436
Chapter II Neoplasms,Melanoma in situ,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,24350,50,0.63 [0.18-2.24],0.4725174747962664
Chapter II Neoplasms,Melanoma in situ,VAV3,Guanine nucleotide exchange factor VAV3,20569,40,1.37 [1.02-1.85],0.0366143492003925
Chapter II Neoplasms,Melanoma in situ,VCAM1,Vascular cell adhesion protein 1,24499,53,0.90 [0.36-2.30],0.8333763248192594
Chapter II Neoplasms,Melanoma in situ,VCAN,Versican core protein,24707,53,1.00 [0.44-2.27],0.9907933006793262
Chapter II Neoplasms,Melanoma in situ,VCPKMT,Protein-lysine methyltransferase METTL21D,20471,40,1.02 [0.74-1.43],0.8847910864876146
Chapter II Neoplasms,Melanoma in situ,VEGFA,Vascular endothelial growth factor A,24690,52,1.03 [0.67-1.57],0.8937027879838402
Chapter II Neoplasms,Melanoma in situ,VEGFB,Vascular endothelial growth factor B,20617,41,1.61 [0.59-4.40],0.3532159903107376
Chapter II Neoplasms,Melanoma in situ,VEGFC,Vascular endothelial growth factor C,24519,53,0.92 [0.60-1.41],0.686009441840583
Chapter II Neoplasms,Melanoma in situ,VEGFD,Vascular endothelial growth factor D,24729,52,1.07 [0.53-2.18],0.8512581162030103
Chapter II Neoplasms,Melanoma in situ,VGF,Neurosecretory protein VGF,21191,40,1.01 [0.36-2.82],0.9809526615116448
Chapter II Neoplasms,Melanoma in situ,VIM,Vimentin,24041,51,0.91 [0.76-1.10],0.3442502303461322
Chapter II Neoplasms,Melanoma in situ,VIPR1,Vasoactive intestinal polypeptide receptor 1,20637,41,1.29 [0.48-3.46],0.6133771392078344
Chapter II Neoplasms,Melanoma in situ,VIT,Vitrin,21225,41,0.62 [0.28-1.37],0.2385803525938547
Chapter II Neoplasms,Melanoma in situ,VMO1,Vitelline membrane outer layer protein 1 homolog,24350,50,1.40 [0.93-2.11],0.1042920978317702
Chapter II Neoplasms,Melanoma in situ,VNN1,Pantetheinase,21229,41,0.87 [0.59-1.29],0.4983211435559297
Chapter II Neoplasms,Melanoma in situ,VNN2,Vascular non-inflammatory molecule 2,24350,50,0.90 [0.53-1.53],0.6864591039346495
Chapter II Neoplasms,Melanoma in situ,VPS28,Vacuolar protein sorting-associated protein 28 homolog,20824,40,1.66 [1.16-2.36],0.0055730930107089
Chapter II Neoplasms,Melanoma in situ,VPS37A,Vacuolar protein sorting-associated protein 37A,24350,50,1.21 [0.90-1.64],0.2108170123723941
Chapter II Neoplasms,Melanoma in situ,VPS4B,Vacuolar protein sorting-associated protein 4B,21108,40,1.43 [1.07-1.92],0.0151260098701016
Chapter II Neoplasms,Melanoma in situ,VPS53,Vacuolar protein sorting-associated protein 53 homolog,24350,50,1.10 [0.79-1.52],0.5779049973389145
Chapter II Neoplasms,Melanoma in situ,VSIG10,V-set and immunoglobulin domain-containing protein 10,21108,40,0.71 [0.27-1.86],0.4851859025118755
Chapter II Neoplasms,Melanoma in situ,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,20559,37,0.66 [0.23-1.85],0.4280726653013827
Chapter II Neoplasms,Melanoma in situ,VSIG2,V-set and immunoglobulin domain-containing protein 2,21108,40,1.29 [0.78-2.14],0.3248688308166998
Chapter II Neoplasms,Melanoma in situ,VSIG4,V-set and immunoglobulin domain-containing protein 4,24424,53,1.11 [0.58-2.12],0.7561066368979245
Chapter II Neoplasms,Melanoma in situ,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,24447,53,1.31 [0.91-1.88],0.1458804063253612
Chapter II Neoplasms,Melanoma in situ,VSNL1,Visinin-like protein 1,21166,40,0.76 [0.33-1.76],0.5239593079997584
Chapter II Neoplasms,Melanoma in situ,VSTM1,V-set and transmembrane domain-containing protein 1,23895,51,1.19 [0.72-1.94],0.4978223072301027
Chapter II Neoplasms,Melanoma in situ,VSTM2B,V-set and transmembrane domain-containing protein 2B,20824,40,0.98 [0.48-2.00],0.947226611146754
Chapter II Neoplasms,Melanoma in situ,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,24041,51,0.92 [0.58-1.45],0.7173405020167416
Chapter II Neoplasms,Melanoma in situ,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,24707,53,1.04 [0.74-1.45],0.8288249534471934
Chapter II Neoplasms,Melanoma in situ,VTCN1,V-set domain-containing T-cell activation inhibitor 1,23885,50,0.68 [0.30-1.55],0.3577174447872588
Chapter II Neoplasms,Melanoma in situ,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,20746,40,1.37 [0.85-2.20],0.1960575672125685
Chapter II Neoplasms,Melanoma in situ,VWA1,von Willebrand factor A domain-containing protein 1,24657,52,1.17 [0.67-2.06],0.5818509475310325
Chapter II Neoplasms,Melanoma in situ,VWA5A,von Willebrand factor A domain-containing protein 5A,20471,40,1.13 [0.83-1.55],0.442232194252224
Chapter II Neoplasms,Melanoma in situ,VWC2,Brorin,24225,49,0.75 [0.38-1.48],0.4086955644014592
Chapter II Neoplasms,Melanoma in situ,VWC2L,von Willebrand factor C domain-containing protein 2-like,21191,40,0.41 [0.14-1.14],0.0863090756221669
Chapter II Neoplasms,Melanoma in situ,VWF,von Willebrand factor,24765,53,0.86 [0.62-1.19],0.3546319688178311
Chapter II Neoplasms,Melanoma in situ,WARS,"Tryptophan--tRNA ligase, cytoplasmic",24462,53,1.12 [0.59-2.13],0.7325465804796856
Chapter II Neoplasms,Melanoma in situ,WAS,Wiskott-Aldrich syndrome protein,24024,50,1.01 [0.69-1.46],0.9739904098756352
Chapter II Neoplasms,Melanoma in situ,WASF1,Wiskott-Aldrich syndrome protein family member 1,24041,51,1.19 [0.92-1.54],0.1978831715863325
Chapter II Neoplasms,Melanoma in situ,WASF3,Wiskott-Aldrich syndrome protein family member 3,23895,51,1.30 [0.97-1.74],0.0836766604458492
Chapter II Neoplasms,Melanoma in situ,WASHC3,WASH complex subunit 3,21166,40,1.29 [0.91-1.83],0.1519215669485322
Chapter II Neoplasms,Melanoma in situ,WASL,Neural Wiskott-Aldrich syndrome protein,20617,41,0.96 [0.58-1.58],0.8710338290309605
Chapter II Neoplasms,Melanoma in situ,WDR46,WD repeat-containing protein 46,21108,40,0.60 [0.24-1.50],0.2740631869916317
Chapter II Neoplasms,Melanoma in situ,WFDC1,WAP four-disulfide core domain protein 1,20693,40,1.30 [0.84-2.00],0.2325942635164756
Chapter II Neoplasms,Melanoma in situ,WFDC12,WAP four-disulfide core domain protein 12,24646,51,0.89 [0.60-1.32],0.5560390347778404
Chapter II Neoplasms,Melanoma in situ,WFDC2,WAP four-disulfide core domain protein 2,23183,47,1.08 [0.48-2.40],0.8535654636051841
Chapter II Neoplasms,Melanoma in situ,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",24236,49,0.85 [0.45-1.61],0.6249536689736113
Chapter II Neoplasms,Melanoma in situ,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",24488,52,1.12 [0.54-2.34],0.7557217710137893
Chapter II Neoplasms,Melanoma in situ,WIF1,Wnt inhibitory factor 1,24689,52,0.73 [0.35-1.53],0.4040418319282054
Chapter II Neoplasms,Melanoma in situ,WNT9A,Protein Wnt-9a,24024,50,1.15 [0.48-2.76],0.7521504510328026
Chapter II Neoplasms,Melanoma in situ,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,24313,49,1.03 [0.64-1.63],0.9143828560471564
Chapter II Neoplasms,Melanoma in situ,XCL1,Lymphotactin,24689,52,1.11 [0.74-1.66],0.6190702694441435
Chapter II Neoplasms,Melanoma in situ,XG,Glycoprotein Xg,24637,52,0.70 [0.33-1.50],0.3579508815110402
Chapter II Neoplasms,Melanoma in situ,XIAP,E3 ubiquitin-protein ligase XIAP,20617,41,1.47 [0.91-2.36],0.1161502353396122
Chapter II Neoplasms,Melanoma in situ,XPNPEP2,Xaa-Pro aminopeptidase 2,24519,53,1.06 [0.83-1.37],0.6313828021983302
Chapter II Neoplasms,Melanoma in situ,XRCC4,DNA repair protein XRCC4,23895,51,1.19 [0.63-2.26],0.5907279166334165
Chapter II Neoplasms,Melanoma in situ,YAP1,Transcriptional coactivator YAP1,21166,40,0.99 [0.31-3.18],0.98341584284552
Chapter II Neoplasms,Melanoma in situ,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",21131,40,1.36 [1.09-1.70],0.0071065941602982
Chapter II Neoplasms,Melanoma in situ,YES1,Tyrosine-protein kinase Yes,24350,50,1.11 [0.89-1.38],0.3535964338570933
Chapter II Neoplasms,Melanoma in situ,YJU2,Splicing factor YJU2,21108,40,2.06 [1.00-4.25],0.0502373207973988
Chapter II Neoplasms,Melanoma in situ,YOD1,Ubiquitin thioesterase OTU1,20559,37,0.98 [0.59-1.61],0.9232415202838822
Chapter II Neoplasms,Melanoma in situ,YTHDF3,YTH domain-containing family protein 3,24024,50,1.18 [0.88-1.58],0.2788393336847818
Chapter II Neoplasms,Melanoma in situ,YWHAQ,14-3-3 protein theta,20746,40,1.42 [0.95-2.11],0.0859548470800938
Chapter II Neoplasms,Melanoma in situ,YY1,Transcriptional repressor protein YY1,20617,41,0.83 [0.28-2.49],0.7435652510588912
Chapter II Neoplasms,Melanoma in situ,ZBP1,Z-DNA-binding protein 1,20617,41,0.88 [0.41-1.89],0.7357650355282692
Chapter II Neoplasms,Melanoma in situ,ZBTB16,Zinc finger and BTB domain-containing protein 16,23885,50,1.36 [0.98-1.88],0.0673454391746824
Chapter II Neoplasms,Melanoma in situ,ZBTB17,Zinc finger and BTB domain-containing protein 17,24041,51,1.05 [0.58-1.90],0.8741054870040341
Chapter II Neoplasms,Melanoma in situ,ZCCHC8,Zinc finger CCHC domain-containing protein 8,20559,37,0.71 [0.37-1.35],0.295176193641236
Chapter II Neoplasms,Melanoma in situ,ZFYVE19,Abscission/NoCut checkpoint regulator,21131,40,1.29 [0.93-1.79],0.1341945825635623
Chapter II Neoplasms,Melanoma in situ,ZHX2,Zinc fingers and homeoboxes protein 2,21166,40,0.64 [0.20-2.03],0.4447958632646364
Chapter II Neoplasms,Melanoma in situ,ZNF174,Zinc finger protein 174,20617,41,1.05 [0.49-2.24],0.8959131533273001
Chapter II Neoplasms,Melanoma in situ,ZNF75D,Zinc finger protein 75D,20824,40,1.08 [0.68-1.72],0.7554516563970103
Chapter II Neoplasms,Melanoma in situ,ZNF830,Zinc finger protein 830,21108,40,1.01 [0.70-1.45],0.9731644760790494
Chapter II Neoplasms,Melanoma in situ,ZNRD2,Protein ZNRD2,21131,40,1.29 [0.85-1.96],0.2301651466950445
Chapter II Neoplasms,Melanoma in situ,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,21108,40,1.21 [0.73-2.02],0.4559647022331874
Chapter II Neoplasms,Melanoma in situ,ZP3,Zona pellucida sperm-binding protein 3,20637,41,1.04 [0.93-1.17],0.4831418565638981
Chapter II Neoplasms,Melanoma in situ,ZP4,Zona pellucida sperm-binding protein 4,20471,40,1.00 [0.39-2.55],0.9975103822944942
Chapter II Neoplasms,Melanoma in situ,ZPR1,Zinc finger protein ZPR1,20569,40,0.91 [0.64-1.29],0.5938631748226119
